WorldWideScience

Sample records for voriconazole eye drops

  1. Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis

    Directory of Open Access Journals (Sweden)

    Daoud Al-Badriyeh

    2010-05-01

    Full Text Available Daoud Al-Badriyeh, Chin Fen Neoh, Kay Stewart, David CM KongCentre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Victoria, AustraliaAbstract: Fungal keratitis is one of the major causes of ophthalmic mycosis and is difficult to treat. The range of common antifungal agents available for fungal keratitis remains inadequate and is generally associated with poor clinical outcomes. Voriconazole is a new generation triazole antifungal agent. Only marketed in systemic formulation and, with broad-spectrum activity and high intraocular penetration, voriconazole has demonstrated effectiveness against fungal keratitis. Systemic voriconazole, however, is not without side effects and is costly. Voriconazole eye drops have been prepared extemporaneously and used for the treatment of ophthalmic fungal keratitis. The current article sought to review the literature for evidence related to the effectiveness and safety of topical voriconazole and its corneal penetration into the aqueous humor of the eye. The voriconazole eye drops used are typically of 1% concentration, well tolerated by the eye, and are stable. Despite existing evidence to suggest that the eye drops are effective in the treatment of fungal keratitis, more studies are needed, especially in relation to using the eye drops as first-line and stand-alone treatment, preparation of higher concentrations, and optimal dosing frequency.Keywords: voriconazole, fungal keratitis, eye drops, corneal penetration

  2. Design and Evaluation of Voriconazole Eye Drops for the Treatment of Fungal Keratitis

    Directory of Open Access Journals (Sweden)

    Sakshi Malhotra

    2014-01-01

    Full Text Available Voriconazole is a novel antifungal agent with excellent broad spectrum activity commercially available for oral and intravenous administration. The purpose of this study was to prepare ophthalmic formulation of hydroxypropyl beta cyclodextrin (HP-β-CD based voriconazole containing benzalkonium chloride BAK and EDTA with or without viscosity modifiers and study its permeation characteristics through freshly excised goat cornea. The results were observed that viscosity and force of bioadhesion of the voriconazole HP-β-CD solutions containing xanthan gum (XG are more as compared to polyvinyl alcohol. The results revealed that voriconazole drop containing PVA provided least viscosity and higher corneal permeation of drug, while drop formulated with XG had maximum viscosity and least permeation. The HP-β-CD based voriconazole (1.5% ophthalmic formulation containing xanthan gum (1.5, preserved with BAK and EDTA, could provide shelf life of 2 years. The microbiological studies showed that voriconazole ophthalmic solution containing xanthan gum shows better antifungal activity as compared to voriconazole and xanthan gum alone. Thus, it can be concluded that HP-β-CD based voriconazole (1.5%, pH 7.0 ophthalmic solution containing BAK and EDTA with viscosity modifier XG provided maximum precorneal residence time as compared to other viscosity modifiers and polyvinyl alcohol provided less precorneal residence time than other viscosity modifiers.

  3. Dilating Eye Drops

    Science.gov (United States)

    ... Corneal Abrasions Dilating Eye Drops Lazy eye (defined) Pink eye (defined) Retinopathy of Prematurity Strabismus Stye (defined) Vision ... Corneal Abrasions Dilating Eye Drops Lazy eye (defined) Pink eye (defined) Retinopathy of Prematurity Strabismus Stye (defined) Vision ...

  4. Eye Drop Tips

    Science.gov (United States)

    ... Involved News About Us Donate In This Section Eye Drop Tips en Español email Send this article ... the reach of children. Steps For Putting In Eye Drops: Start by tilting your head backward while ...

  5. Effect of formulation factors on in vitro transcorneal permeation of voriconazole from aqueous drops

    Directory of Open Access Journals (Sweden)

    Biswaranjan Mohanty

    2013-01-01

    Full Text Available The purpose of this research was to evaluate the effect the formulation factors on in vitro permeation of voriconazole through freshly isolated goat and sheep corneas. An increase in the pH of the drops from 4.0 to 8.0 resulted in significant (P < 0.05 increase drug permeation. Raising concentration of the drops from 0.05% to 0.2% (w/v significantly, (P < 0.05 increased drug permeation, but decreased the percent permeation. Corneal transport of voriconazole is both pH and concentration dependent. Eye drops containing disodium edetate (ethylenediaminetetraacetic acid alone or combination with benzalkonium chloride showed significantly (P < 0.05 higher permeation as compared with control formulation. Addition of beta-cyclodextrin to the formulation enhanced corneal permeation of voriconazole. Compared with control formulation, voriconazole 0.2% (w/v drop containing viscosity modifier produced significant (P < 0.05 decrease in permeation. Most of the formulations showed higher zone of inhibition against Candida albicans.

  6. Treatment with intrastromal and intracameral voriconazole in 2 eyes with Lasiodiplodia theobromae keratitis: case reports.

    Science.gov (United States)

    Lekhanont, Kaevalin; Nonpassopon, Manachai; Nimvorapun, Nutthida; Santanirand, Pitak

    2015-02-01

    To report the clinical presentation and the role of intrastromal and intracameral voriconazole injection in the management of rare cases of fungal keratitis caused by Lasiodiplodia theobromae.Two eyes of 2 patients with Lasiodiplodia keratitis unresponsive to topical and oral antifungal medications were included in this study. Diagnosis of Lasiodiplodia keratitis was confirmed by microbiological analysis, including culture-based (case 1 and 2) and DNA sequencing techniques (case 2 only).The first patient presented with multiple satellite lesions and one of these infiltrates spread deeply into the cornea, forming a stromal abscess. Another patient had a large full-thickness corneal infiltrates with several fungal balls in the anterior chamber, requiring a limbus-to-limbus therapeutic penetrating keratoplasty. Despite aggressive topical therapy, the stromal abscess continued to worsen in the first case and recurrent keratitis was observed postoperatively in the second case. Voriconazole 50 μg/0.1 mL was administered intracamerally and intrastromally around the fungal abscess as adjuncts to topical antimycotics in the first case. The second patient who needed therapeutic keratoplasty was treated with an intracameral injection of 50 μg/0.1 mL voriconazole at the end of surgery. Postoperatively, 100 μg/0.1 mL voriconazole was also injected intracamerally after the recurrence of infection was noted in the graft. Reinjections were given 48 hours apart in both cases. After the injections, all corneal and anterior chamber lesions were reduced in size and density and completely resolved within 4 weeks.Intrastromal and intracameral voriconazole injections may offer safe and effective treatment options for L theobromae keratitis.

  7. Creation of nano eye-drops and effective drug delivery to the interior of the eye

    Science.gov (United States)

    Ikuta, Yoshikazu; Aoyagi, Shigenobu; Tanaka, Yuji; Sato, Kota; Inada, Satoshi; Koseki, Yoshitaka; Onodera, Tsunenobu; Oikawa, Hidetoshi; Kasai, Hitoshi

    2017-03-01

    Nano eye-drops are a new type of ophthalmic treatment with increased potency and reduced side effects. Compounds in conventional eye-drops barely penetrate into the eye because the cornea, located at the surface of eye, has a strong barrier function for preventing invasion of hydrophilic or large-sized materials from the outside. In this work, we describe the utility of nano eye-drops utilising brinzolamide, a commercially available glaucoma treatment drug, as a target compound. Fabrication of the nanoparticles of brinzolamide prodrug increases the eye penetration rate and results in high drug efficacy, compared with that of commercially available brinzolamide eye-drops formulated as micro-sized structures. In addition, the resulting nano eye-drops were not toxic to the corneal epithelium after repeated administration for 1 week. The nano eye-drops may have applications as a next-generation ophthalmic treatment.

  8. PRESERVATIVES FROM THE EYE DROPS AND THE OCULAR SURFACE.

    Science.gov (United States)

    Coroi, Mihaela Cristina; Bungau, Simona; Tit, Mirela

    2015-01-01

    The use of preservatives in eye drops (eyewashes) has known glory at the beginning, but the side effects that they have on the ocular surface have led to a decrease of their popularity. Lachrymal film dysfunction, ocular hyperemia, dotted keratitis or toxic keratopathy were reported and analyzed in terms of pathophysiological mechanism of the role played by preservatives in ophthalmic drops (eyewashes). This article reviews the most common preservatives and the existing alternatives for the maintenance of the eye sterile drops. Keywords: preservatives, eye drops, ocular surface

  9. [The antiallergic eye drops "polynadyme": development, experimental and clinical studies].

    Science.gov (United States)

    Maĭchuk, Iu F; Pozdniakov, V I; Pozdniakova, V V; Iakushina, L N

    2006-01-01

    The antiallergic eye drops "Polynadyme", proposed by the Helmgolz Moscow Research Institute of Eye Diseases, have been prepared by the "Sintez" PJSC (Kurgan). The drops exert a combination of antihistaminic and vasoconstrictive effects and, for better tolerability, contain a low-toxic preserving complex. The drops are polymer-based, which ensures a long action and an artificial tear effect. Preclinical rabbit trials have shown the safety of the "Polynadyme" eye drops, their specific activity in preventing an allergic reaction, and their antiallergic effect on a model of allergic conjunctivitis. Comparative clinical trials covering 150 patients have yielded excellent and good results in 93% of cases. In acute allergic reactions, hyperemia, itch, and burning diminished just 5 minutes after administration. The "Polynadyme" eye drops are effective in treating pollinous conjunctivitis, spring (vernal) keratoconjunctivitis, allergic reactions when wearing contact lenses, the dry eye syndrome, drug-induced and toxicoallergic conjunctivitis, and other ocular allergic reactions.

  10. Comparison of novel lipid-based eye drops with aqueous eye drops for dry eye: a multicenter, randomized controlled trial

    Directory of Open Access Journals (Sweden)

    Simmons PA

    2015-04-01

    Full Text Available Peter A Simmons, Cindy Carlisle-Wilcox, Joseph G Vehige Ophthalmology Research and Development, Allergan, Inc., Irvine, CA, USA Background: Dry eye may be caused or exacerbated by deficient lipid secretion. Recently, lipid-containing artificial tears have been developed to alleviate this deficiency. Our study compared the efficacy, safety, and acceptability of lipid-containing eye drops with that of aqueous eye drops.Methods: A non-inferiority, randomized, parallel-group, investigator-masked multicenter trial was conducted. Subjects with signs and symptoms of dry eye were randomized to use one of two lipid-containing artificial tears, or one of two aqueous artificial tears. Subjects instilled assigned drops in each eye at least twice daily for 30 days. The primary efficacy analysis tested non-inferiority of a preservative-free lipid tear formulation (LT UD to a preservative-free aqueous tear formulation (AqT UD for change in Ocular Surface Disease Index (OSDI score from baseline at day 30. Secondary measures included OSDI at day 7, tear break-up time (TBUT, corneal and conjunctival staining, Schirmer’s test, acceptability and usage questionnaires, and safety assessments.Results: A total of 315 subjects were randomized and included in the analyses. Subjects reported instilling a median of three doses of study eye drops per day in all groups. At days 7 and 30, all groups showed statistically significant improvements from baseline in OSDI (P<0.001 and TBUT (P≤0.005. LT UD was non-inferior to AqT UD for mean change from baseline in OSDI score at day 30. No consistent or clinically relevant differences for the other efficacy variables were observed. Acceptability was generally similar across the groups and there was a low incidence of adverse events.Conclusion: In this heterogeneous population of dry eye subjects, there were no clinically significant differences in safety, effectiveness, and acceptability between lipid-containing artificial tears

  11. CLINICAL EVALUATION OF INTRASTROMAL VORICONAZOLE IN RECALCITRANT FUNGAL KERATITIS A PROSPECTIVE STUDY AT SAROJINI DEVI EYE HOSPITAL, HYDERABAD

    Directory of Open Access Journals (Sweden)

    Srinivas Prasad

    2015-07-01

    Full Text Available BACKGROUND: Recalcitrant Fungal keratitis is a common ocular infection leading to visual impairment. OBJECTIVES: To evaluate the efficacy of intrastromal Voriconazole in Recalcitrant Fungal keratitis. MATERIALS AND METHODS: This was an interventional study in department of Cornea, Sarojini Devi Eye Hospital, Osmania Medical College, Hyderabad over a period from Feb.2013 Feb.2014. 30 Patients of Fungal Keratitis not responding to routine topical and syst emic antifungal therapy in 7 to 14 days, which were diagnosed as Recalcitrant fungal keratitis were given 5μgms/0.1ml of voriconazole intrastroml injections around the fungal infiltrates in a grid pattern. Details of patients age and sex, type of causative fungal and traumatic agents, size of corneal ulcer, presence of Hypopyon or not, and time taken for hypopyon absorption, and clinical improvement and resolution of the ulcer and visual acuity were noted. RESULTS: This study group of 30 patients diagnosed as Recalcitrant fungal keratitis showed Causative Fungi as Fusarium in 19(63.0%, Aspergillus in 11(37.0%. Causative Traumatic Agents were vegetative matter i n 19 (63.3%, other agents in 8 (26.7% and not known in 3(10.0. 17(56.7% were Males with 13(43. 3% Females. Age wise distribution was 3(10.0% in>10 - 20yrs, 11(36.7% in 20 – 40 yrs, 15(50.0% in 40 - 60 yrs, and 1(3.3% in >60 yrs . The size of the ulcer showed 1/2 of the cornea in 9(30.0%. 19 (63.3% were with hy popyon and 11(36.7% without hypopyon . After Intrastromal Voriconazole, the absorption of Hypopyon in 12 (63.2% was in 2to 4 wks. and in 2(10.5% in > 4 wks. C linical improvement of the Fungal Corneal Ulcer was seen in no case (0.0% in 4 wks. Time (wks. of healing of the Fungal Corneal Ulcer was in 4 - 6wks in 21 (70.0% and in >6wks in 5(16.7%. Visual Acuity was <3/60 in 2(7.7%, 3/60 - <6/60 in 10(33.3%, 6/60 - <6/18 in 9(30.0% and 6/18 – 6/9 in 5(16.7 %. CONCLUSION: Common causes of fungal keratitis in Recalcitrant Fungal

  12. [A correct understanding of preservatives in eye drops].

    Science.gov (United States)

    Liu, Zuguo; Huang, Caihong

    2015-09-01

    Eye drops are the most commonly used preparations in ophthalmology. Preservatives are usually added in order to protect eye drops against pathogenic organisms and increase the solubility of the drugs in multi-dose containers. Ophthalmologists have paid a lot of attention to the preservatives in eye drops because they remain one of the main reasons for ocular surface damage, and even may lead to serious visual impairment in patients with inappropriate use of eye drops. However, it should be noted that the dangers of preservatives become overstated nowadays. It is necessary to completely evaluate the effects of preservatives in ophthalmic preparations, so that ophthalmologists can guide patients to correctly select eye drops containing preservatives and avoid dangerous side effects, according to their eye disease situation, state of tear function and ocular surface changes, cultural background and financial income, cost and benefit and convenience of the use of drugs, and other factors. The direction of the future development in this field is to establish the clinical guideline for use of eye drops containing preservatives, carry out continuing education courses on preservatives and develop ideal preservatives.

  13. Ready-made allogeneic ABO-specific serum eye drops

    DEFF Research Database (Denmark)

    Harritshøj, Lene Holm; Nielsen, Connie; Ullum, Henrik

    2014-01-01

    , registered and stored at -30°C in the blood bank. Upon request, frozen ABO-identical serum drops in lots of 14 bottles could be provided immediately. Safety and efficacy were evaluated in 34 patients with severe ocular surface disease refractory to conventional medical therapy. Patients were treated six...... serum treatment. CONCLUSION: Ready-made ABO-identical allogeneic serum eye drops were straightforwardly produced, quality-assured and registered as a safe standard blood product for the treatment of certain cases of severe dry eye disease. Therapeutic efficacy was comparable to previous reports......PURPOSE: To overcome problems and delays of the preparation of autologous serum eye drops, a production line of ABO-specific allogeneic serum eye drops from male blood donors was set up in a blood bank. Feasibility, clinical routine, safety and efficacy were evaluated in a cohort of patients...

  14. How to Use Eye Drops Properly

    Science.gov (United States)

    ... doses Use the exact number of drops recommended Store medications out of reach of children Copyright 2013, American Society of Health-System Pharmacists. All rights reserved. This material may not be reproduced, displayed, modified, or distributed ...

  15. Clinical treatment of dry eye using 0.03% tacrolimus eye drops.

    Science.gov (United States)

    Moscovici, Bernardo K; Holzchuh, Ricardo; Chiacchio, Brenda B; Santo, Ruth M; Shimazaki, Jun; Hida, Richard Y

    2012-08-01

    To report the clinical outcome of the treatment of dry eyes using 0.03% tacrolimus eye drops (olive oil + tacrolimus 0.03%) (Ophthalmos, Sao Paulo, Brazil). Sixteen eyes of 8 patients with Sjögren syndrome dry eyes (age, 51.13 ± 9.45 years) were enrolled in this study (prospective noncontrolled interventional case series). Patients were instructed to use topical 0.03% tacrolimus eye drops twice a day (every 12 hours) in the lower conjunctival sac. Schirmer I test, break-up time, corneal fluorescein, and rose bengal staining score were performed in all patients 1 day before, and 14, 28, and 90 days after treatment with 0.03% tacrolimus eye drops. The average fluorescein staining and rose bengal staining scores improved statistically significantly after 14 days of treatment and improved even more after 28 and 90 days. The average Schirmer I test did not improve statistically significantly after 28 days of treatment, although we did observe a significant improvement after 90 days of treatment with 0.03% tacrolimus eye drops. The average break-up time did not improve statistically after 14 days of treatment, although we observed a significant improvement after 28 and 90 days of treatment with 0.03% tacrolimus eye drops. Topical 0.03% tacrolimus eye drops successfully improved tear stability and ocular surface status in patients with dry eyes.

  16. Clinical utility of caspofungin eye drops in fungal keratitis.

    Science.gov (United States)

    Neoh, Chin Fen; Daniell, Mark; Chen, Sharon C-A; Stewart, Kay; Kong, David C M

    2014-08-01

    Treatment of fungal keratitis remains challenging. To date, only the polyenes and azoles are commonly used topically in the management of fungal keratitis. Natamycin, a polyene, is the only antifungal eye drop that is commercially available; the remainder are prepared in-house and are used in an 'off-label' manner. Failure of medical treatment for fungal keratitis is common, hence there is a need for more effective topical antifungal therapy. To increase the antifungal eye drop armamentarium, it is important to investigate the utility of other classes of antifungal agents for topical use. Caspofungin, an echinocandin antifungal agent, could potentially be used to address the existing shortcomings. However, little is known about the usefulness of topically administered caspofungin. This review will briefly explore the incidence, epidemiology and antifungal treatment of fungal keratitis. It will focus primarily on evidence related to the efficacy, safety and practicality of using caspofungin eye drops in fungal keratitis.

  17. Therapy of corneal erosions and 'dry eye' with Solcoseryl and Vitasic eye drops.

    Science.gov (United States)

    Krannig, H M; Rohde-Germann, H; Straub, W

    1989-01-01

    A comparative study of Solcoseryl eye drops versus Vitasic eye drops has been carried out under controlled conditions (randomized and double-blind) on a total of 94 patients. 52 had corneal erosion, 30 had dry eye syndrome, 8 cases could not be evaluated. In addition, 2 eyes with photophthalmia were treated with Vitasic and 2 showing keratitis with Solcoseryl. There were no adverse reactions other than 2 instances of stinging with Solcoseryl and 1 case of severe irritation after Vitasic. The patients were examined on days 0, 1, 3 and 7. Results showed a consistent superiority of Solcoseryl eye drops in respect to speed of healing of corneal erosions and moistening of the cornea in the 'dry eye' syndrome which reached statistical significance in some parameters.

  18. Voriconazole for the treatment of refractory Aspergillus fumigatus keratitis

    Directory of Open Access Journals (Sweden)

    Mehta Hijab

    2008-01-01

    Full Text Available We report a case of Aspergillus fumigatus keratitis in a 53-year-old, well-controlled diabetic female who did not respond to standard antifungal treatment. She was started on topical natamycin eye drops, but the infiltrate continued to progress. Topical amphotericin B and systemic ketoconazole was added, however, there was no response and the infiltrate increased further. She was then switched to topical and systemic voriconazole. Steady resolution of the infiltrate was noted within 2 weeks of therapy.

  19. Analysis of ocular toxicity of fluconazole and voriconazole eyedrops using HET-CAM

    Directory of Open Access Journals (Sweden)

    A. Fernández-Ferreiro

    2014-07-01

    Full Text Available Abstract: Purpose: The objective of the study is to provide toxicological information through the HET-CAM test of Fluconazole and Voriconazole eye drops prepared commonly in Pharmacy Servi - ces for the treatment of fungal keratitis. Method: Experimental Study. The ocular toxicity of topical voriconazole 10 mg/ml and fluconazole 2 mg/ml were evalua ted by the hen‘s egg test (HET on the chorioallantoic membrane (CAM. The effects on blood vessels were based on its behavior during 300 seconds and processes that may occur at each time, then we calculated the irritation index (is, irritation score. Results and conclusions: Both eye drops, voriconazol and fluconazole have been proven to be safe, since the IS that we obtained was zero for both samples and did not present significant signs of irritation. Therefore, these eyedrops are conside red suitable for ocular use from a toxicological point of view.

  20. Eye Irritation Test of Bovis Calculus Pharmacopuncture Solutions for Eye Drop

    Directory of Open Access Journals (Sweden)

    Hyeong-sik Seo

    2008-06-01

    Full Text Available Objective : This study was done to investigate the safety of Bovis Calculus pharmacopuncture solution manufactured with freezing dryness method to use eye drop. Methods : The eye irritation test of this material was performed according to the Regulation of Korea Food & Drug Administration (2005. 10. 21, KFDA 2005-60. After Bovis Calculus pharmacopuncture solution was medicated in the left eye of the rabbits, the auther observed eye irritation of the cornea, iris, conjunctiva at 1, 2, 3, 4 & 7day. Results : 1. After Bovis Calculus pharmacopuncture solution was medicated in the left eye of the rabbits, there wasn’t physical problem at 9 rabbits. 2. After Bovis Calculus pharmacopuncture solutionwas medicated in the left eye of the rabbits, there wasn’t eye irritation of the cornea, iris, conjunctiva at 1, 2, 3, 4 & 7day. Conclusions : I suggested that Bovis Calculus pharmacopuncture solution didn’t induced eye irritation in rabbits.

  1. [Morphological alterations induced by preservatives in eye drops].

    Science.gov (United States)

    Huber-van der Velden, K K; Thieme, H; Eichhorn, M

    2012-11-01

    A large number of experimental and clinical investigations carried out recently have confirmed that the chronic application of eye drops induces significant cytological and histological impairment in ocular tissues. It is also generally accepted that preservatives are the components responsible for the observed changes. The most commonly used preservative in ophthalmology is benzalkonium chloride (BAC), which has a relatively high toxicity. Possible consequences of preservatives on the eye are chronic inflammation and subsequent fibrosis of the subconjunctiva and cell loss and structural changes in the conjunctival epithelium as well as in the epithelial and endothelial layers of the cornea. Frequently, dry eye symptoms occur or deteriorate during therapy. During the last few years new preservatives have been developed which seem to have fewer side effects; however, relatively little data are available with regard to these new substances. To minimize impairments of the eye, preservative-free formulations should be considered for therapy.

  2. [Study of biopharmaceutic characteristics of cromoglycate eye drops].

    Science.gov (United States)

    Klimas, Rimantas; Inkeniene, Asta Marija; Briedis, Vitalis; Gerbutaviciene, Rima Jūrate

    2003-01-01

    One of the factors influencing the release of active substance from the drug formulation is presence of polymeric substance resulting in increase of viscosity of eye drops. Diffusion of sodium cromoglycate from polyvinyl alcohol 1.4%, 3% solutions and hypromellose 1% aqueous solution was investigated using in vitro method and diffusion coefficients were evaluated. Release of sodium cromoglycate from polyvinyl alcohol 1.4%, 3% solutions and hypromellose 1% aqueous solution was slower than the release from aqueous solution of sodium cromoglycate. The sodium cromoglycate diffusion from ophthalmic vehicle process kinetics was influenced by viscosity of these solutions and nature of the used polymers. The diffusion process of sodium cromoglycate from 1.4% PVA solution was more intensive if compared to diffusion from 1% hypromellose solution. The influence of excipients on sodium cromoglycate diffusion from eye drop formulation was evaluated when polymeric solutions have been used as vehicles.

  3. Fluorimetric quantification of brimonidine tartrate in eye drops

    Directory of Open Access Journals (Sweden)

    G Sunitha

    2013-01-01

    Full Text Available A simple and sensitive spectrofluorimetric method has been developed for the estimation of brimonidine tartrate in pure and eye drops. Linearity was obeyed in the range of 0.2-3.0 ΅g/ml in dimethyl formamide as solvent at an emission wavelength (λem of 530 nm after excitation wavelength (λex of 389 nm with good correlation coefficient of 0.998. The limit of detection and limit of quantification for this method were 22.0 and 72.0 ng/ml, respectively. The developed method was statistically validated as per International Conference on Harmonisation guidelines. The percentage relative standard deviation values were found to be less than 2 for accuracy and precision studies. The results obtained were in good agreement with the labelled amounts of the marketed formulations. The proposed method was effectively applied to routine quality control analysis of brimonidine tartrate in their eye drops.

  4. [Retroperitoneal fibrosis with eye-drops containing timolol].

    Science.gov (United States)

    Delorme, E; Vial, T; Rabilloud, M; de Carlan, H; Evreux, J C

    1990-01-01

    Retroperitoneal fibrosis occurred in a 62-year-old man who had been treated during 4 years eye-drops containing timolol. The disease was diagnosed after a sudden episode of nephritic colic. The recovery was progressive and uneventful. No corticosteroid therapy was used. Six months later the patient remained free of symptoms. Although an idiopathic origin could not be excluded, the causal relationship with timolol treatment is likely due to the chronology of events and the lack of other causes.

  5. Efficacy of atropine and anisodamine eye drops for adolescent pseudomyopia

    Directory of Open Access Journals (Sweden)

    Hui-Jie Wang

    2017-03-01

    Full Text Available AIM:To investigate the effect and local influence of atropine and anisodamine eye drops on adolescent pseudomyopia. METHODS:Totally 110 cases of juvenile pseudomyopia were randomly divided into two groups, the control group was given 10g/L atropine sulfate eye gel, and the observation group was treated with 5g/L raceanisodamine eye drops. The efficacy of two methods, the changes of axial length and intraocular pressure before and after treatment, and the incidence of adverse reactions were compared. RESULTS: There was no significant difference in cure rate between the two groups(χ2=0.533, P=0.465, but the effective rate of observation group was significantly better than the control group(χ2=3.907, P=0.048. Compared with the same group before treatment, the length of the axial length of the two groups increased in different degrees,and the increase value of the observation group was significantly higher than that of the control group, the difference was statistically significant(PP>0.05. The intraocular pressure of the two groups was significantly lower than that of the same group before treatment, and the difference between the two groups after treatments was not statistically significant(P >0.05. The incidence of adverse reactions in the observation group was significantly lower than that in the control group(χ2=18.939, PCONCLUSION: Anisodamine eye drops in the treatment of juvenile pseudomyopia has obvious curative effect, its efficacy and safety are better than atropine eye gel.

  6. Fungal Keratitis Caused by Drechslera spp. Treated with Voriconazole: A Case Report

    Directory of Open Access Journals (Sweden)

    Margarita I. Echavez

    2013-01-01

    Full Text Available Objective. To present a case of Drechslera spp. keratitis treated with topical Voriconazole. Method. A case report. Results. A 52-year-old diabetic male presented with a one-week history of foreign body sensation of the left eye, self-medicated with Neomycin, Polymyxin B, and Dexamethasone eye drops, and was diagnosed to have bacterial conjunctivitis, which was treated with Levofloxacin drops. The patient developed a corneal opacity after 2 days and was initially seen with a visual acuity of counting fingers on the left eye, with a 3 mm central corneal ulcer with feathery borders. No hypopyon was noted. The right eye had a visual acuity of 20/20 and had unremarkable findings. Corneal scraping of the ulcer showed no organisms on Gram and Giemsa stain. Cultures were positive for Drechslera spp. and patient was started on Natamycin drops every 15 minutes, Atropine drops 3× a day, and Levofloxacin was continued every 4 hours. The ulcer increased to 4 mm, the infiltrates became deeper involving the midstroma, and there was appearance of a 2 mm hypopyon. Natamycin was shifted to Voriconazole eye drops every 15 minutes. There was note of a decrease in the size of the ulcer and clearing of the infiltrates with the new treatment regimen. Final visual acuity after 29 days of treatment was 20/40 with note of a slight corneal haze in the area of the previous ulcer. Conclusion. Voriconazole may be safe and effective in the treatment of Drechslera keratitis. There was no perforation and there was immediate decrease in the size of the ulcer. This is the first known case of Drechslera keratitis treated with Voriconazole eye drops in the Philippines.

  7. Stability of ceftazidime in 1% and 5% buffered eye drops determined with HPLC method.

    Science.gov (United States)

    Kodym, Anna; Hapka-Zmich, Dominika; Gołab, Marta; Gwizdala, Magdalena

    2011-01-01

    The aim of the studies was to determine with HPLC method the stability of ceftazidime in buffered 1% and 5% eye drops of proposed formulary composition, which were stored for 30 days at the temperature of 4 degrees C and 20 degrees C and protected from light. The 1% and 5% eye drops were prepared under aseptic conditions by dissolving Biotum (ceftazidimum), dry injection formulation, in citrate buffer of pH 6.10-6.24. The viscosity of the eye drops was increased with polyvinyl alcohol, phenylmercuric borate combined with 2-phenylethanol was used to preserve the eye drops. The eye drops were stored for 30 days in sterile glass bottles at the temperature of 4 degrees C and 20 degrees C and protected from light. The concentration of ceftazidime and pyridine was analyzed simultaneously with HPLC method every three days; pH, osmotic pressure and viscosity were examined as well as the organoleptic analysis of the eye drops (clarity, color, odor). Storage temperature had the biggest impact on ceftazidime stability in the eye drops. The stability of the drops depended also on ceftazidime concentration in the eye drops, the presence of preservatives and polyvinyl alcohol. The time of 10% ceftazidime degradation in buffered 1% and 5% eye drops, stored at the temperature of 4 degrees C, was from 27 to 18 days in 1% eye drops and from 21 to 12 days in 5% eye drops, depending on their composition. In the eye drops which were stored at the temperature of 20 degrees C 10% ceftazidime degradation occurred on the 3rd day of storage in all 1% and 5% formulary versions.

  8. [Eye-drops from olden times to the XIXth century].

    Science.gov (United States)

    Esteva de Sagrera, Juan

    2015-01-01

    The Spanish word "colirio" comes from the Latin collyrium, which in turn came from the Greek kollirion. Initially, the Romans use this word in a general way, but due to their use mainly in ophthalmology, the use of the term became restricted to those topical medications destined for the care and prevention of ocular diseases, from solutions and suspensions to poultices, salves and ointments. During the Middle Ages "colirio" included not only substances used to dilate ladies' pupils for aesthetic reasons but also medications for ocular hygiene and treatment. The Industrial Revolution of the XIXth century barely modified ophthalmic pharmaceutical technology. It is only since the World War II that the preparation of eye-drops has undergone a rapid development and improvement, adopting the concept of sterility as a necessary condition for all ophthalmic solutions and taking very precise rules for their elaboration and conditioning from different pharmacopeia.

  9. [Preservatives in eye drops: toward awareness of their toxicity].

    Science.gov (United States)

    Vaede, D; Baudouin, C; Warnet, J-M; Brignole-Baudouin, F

    2010-09-01

    Preservatives are present in numerous multidose eyedrops and provide the sterility of the solution against bacteria and fungi. However, numerous studies have shown their toxicity for the ocular surface, particularly in long-term treatments. The most widely used preservative in eyedrops is benzalkonium chloride. This quaternary ammonium acts as a detergent, antiseptic, disinfectant, fungicide, bactericide, and spermicide. Its use on the ocular surface therefore has significant consequences. Indeed, the preservatives are pro-apoptotic, pro-inflammatory and they cause the dissolution of the lachrymal film. The prolonged administration of one or several eye drops containing preservatives induces changes in the superficial structures (conjunctiva, cornea) as well as in deeper structures (trabecula, lens). The least severe symptoms are irritation and discomfort, including sensation of a foreign body, itching, or burning sensations. However, more severe side effects have been described, such as chronic inflammation of variable intensity or the progressive development of fibrosis with higher risk of failure after glaucoma filtering surgery. Ideally, preservative-free eyedrops should be recommended, or at least a reduction of the number of instilled preserved eyedrops should be considered. All these strategies could increase patient comfort, quality of life, and compliance, with better outcome at the time of filtering surgery.

  10. Topical 100% Serum Eye Drops for Treating Corneal Epithelial Defect after Ocular Surgery

    Directory of Open Access Journals (Sweden)

    Kaevalin Lekhanont

    2013-01-01

    Full Text Available The purpose of this study was to investigate the efficacy and safety of topical 100% serum eye drops for corneal epithelial defect after ocular surgery. A total of 181 patients who received topical 100% serum therapy for the treatment of corneal epithelial defect following several different types of ocular surgery were recruited into this study. Each patient already failed conventional medical therapy before being prescribed 100% serum eye drops. Slit-lamp biomicroscopic examination with fluorescein staining was performed at baseline and all follow-up visits. The main outcome measures were the rate of complete healing of the corneal epithelial defect and incidence of adverse events. One hundred and seventy-eight eyes (98.34% received autologous serum eye drops, and 3 (1.66% received allogeneic serum eye drops. The overall success rate of treating persistent postoperative epithelial defect using 100% serum eye drops was 93.92% (95% CI 0.88–0.98. The median time to complete corneal epithelialization was 4 days (95% CI 4-5. Adverse reactions were observed in 3 patients (1.66%, including sticky sensation with minimal eye discomfort and asymptomatic trace corneal subepithelial infiltration. No serious complications were reported. In conclusion, 100% serum eye drops are effective, safe, and tolerable for treating postoperative corneal epithelial defect following ocular surgeries.

  11. A Case-Control Study on the Oxidative Balance of 50% Autologous Serum Eye Drops

    Directory of Open Access Journals (Sweden)

    Patrícia Ioschpe Gus

    2016-01-01

    Full Text Available Importance. Autologous serum (AS eye drops are recommended for severe dry eye in patients with ocular surface disease. No description of the antioxidant balance of AS eye drops has been reported in the literature. Objective. This study sought to evaluate the total reactive antioxidant potential (TRAP and concentration of reactive oxygen species (ROS in samples of 50% AS eye drops and their correlations with the demographic characteristics and lifestyle habits of patients with ocular surface disease and healthy controls. Design. This was a case-control study with a 3-month follow-up period. Participants. 16 patients with severe dry eye disease of different etiologies and 17 healthy controls matched by age, gender, and race were included. Results. TRAP and ROS were detected at all evaluated times. There were no differences in the mean ROS (p=0.429 or TRAP (p=0.475 levels between cases and controls. No statistically significant differences in the concentrations of ROS or TRAPs were found at 0, 15, or 30 days (p for ROS = 0.087 and p for TRAP = 0.93. Neither the demographic characteristics nor the lifestyle habits were correlated with the oxidative balance of the 50% AS eye drops. Conclusions and Relevance. Both fresh and frozen 50% AS eye drops present antioxidant capacities and ROS in an apparently stable balance. Moreover, patients with ocular surface disease and normal controls produce equivalent AS eye drops in terms of oxidative properties.

  12. Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose

    Directory of Open Access Journals (Sweden)

    Cohen S

    2013-12-01

    Full Text Available Stephen Cohen,1 Anna Martin,2 Kenneth Sall31Cohen Optometry, Scottsdale, AZ, USA; 2Alcon Laboratories Inc, Fort Worth, TX, USA; 3Sall Research Medical Center Inc, Artesia, CA, USABackground: The purpose of this study was to compare changes in corneal staining in patients with dry eye after 6 weeks of treatment with Systane® Gel Drops or Refresh Liquigel® lubricant eye drops.Methods: Patients aged ≥18 years with a sodium fluorescein corneal staining sum score of ≥3 in either eye and best-corrected visual acuity of 0.6 logarithm of the minimum angle of resolution or better in each eye who were using a lubricant eye gel or ointment for dry eye were included in this randomized, parallel-group, multicenter, double-blind trial. Patients were randomized to four times daily Systane® Gel Drops (polyethylene glycol 400 0.4% and propylene glycol 0.3% or Refresh LiquiGel® Drops (carboxymethylcellulose sodium 1% for 6 weeks. The primary efficacy outcome was mean change from baseline to week 6 in sodium fluorescein corneal staining. Supportive efficacy outcomes included conjunctival staining, tear film break-up time, Patient Global Assessment of Improvement, Impact of Dry Eye on Everyday Life (IDEEL Treatment Satisfaction/Treatment Bother Questionnaire, Single Symptom Comfort Scale, and Ocular Symptoms Questionnaire. The safety analysis comprised recording of adverse events.Results: In total, 147 patients (Systane group, n=73; Refresh group, n=74; mean ± standard deviation age, 57±16 years were enrolled and included in the safety and efficacy analyses. Corneal staining was significantly reduced from baseline to week 6 for Systane and Refresh (−3.4±2.5 and −2.5±2.6 units, respectively; P<0.0001, t-test, with a significantly greater improvement with Systane versus Refresh (P=0.0294. Results for conjunctival staining, tear film break-up time, and patient-reported outcome questionnaires were not statistically different between groups. No safety

  13. [Studies on hyaluronic acid as dendifier in Shuanghuanglian eye-drops].

    Science.gov (United States)

    Ma, Man-ling; Liu, Lu; Sun, Shu-ying

    2005-08-01

    To study the possibility of hyaluronic acid as densifier of Shuanguangliao eye-drops. The factors related with hyaluronic acid s viscosity, such as pH-value and storing temperature, are tested in this experiment. At the same time, we checked the stimulation, stability of the densifier. There was not effect on viscosity of pH-value and storing temperature. No stimulation on the eye was found after densified with hyaluronic acid. The viscosity properties of hyaluronic acid are stablile. The hyaliuronic acid added to Shuanghuanglian eye-drops are stabiliable and it can be applied in eye-drops. The increased viscosity is benefit to extend the residence time of drug in eye.

  14. Clinical assessment of diclofenac sodium eye drops in toric intraocular lens implantation

    Directory of Open Access Journals (Sweden)

    Yan Luo

    2013-05-01

    Full Text Available AIM:To evaluate the application of diclofenac sodium eye drops in toric intraocular lens implantation. METHODS: From January 2011 to February 2012, 38 eyes of 37 patients, who underwent toric intraocular lens implantation in this hospital, were randomly divided into diclofenac sodium eye drops group(trial groupand control group. Patient's degree of cooperation during surgery and inflammation postoperation after 1 day, 3,7, days, 1 month and 3 months were evaluated. RESULTS: Patient's degree of cooperation during surgery in the trial group(1.53±0.62was significantly better than in the control group(2.40±0.88, P<0.05. Inflammation reaction was gentle in the trial group 1 day postoperatively. CONCLUSION: Diclofenac sodium eye drops used during toric intraocular lens implantation can obviously alleviate eye irritation, and increase the cooperation of patients.

  15. Anti-inflammatory and Antihistaminic Study of a Unani Eye Drop Formulation

    Directory of Open Access Journals (Sweden)

    Latif Abdul

    2010-03-01

    Full Text Available The Unani eye drop is an ophthalmic formulation prepared for its beneficial effects in the inflammatory and allergic conditions of the eyes. In the present study, the Unani eye drop formulation was prepared and investigated for its anti-inflammatory and antihistaminic activity, using in vivo and in vitro experimental models respectively. The Unani eye drop formulation exhibited significant anti-inflammatory activity in turpentine liniment-induced ocular inflammation in rabbits. The preparation also showed antihistaminic activity in isolated guinea-pig ileum. The anti-inflammatory and antihistaminic activity of eye drop may be due to presence of active ingredients in the formulation. Although there are many drugs in Unani repository which are mentioned in classical books or used in Unani clinical practice effectively in treatment of eye diseases by various Unani physicians. Inspite of the availability of vast literature, there is a dearth of commercial Unani ocular preparations. So, keeping this in mind, the eye drop formulation was prepared and its anti-inflammatory and antihistaminic activity was carried out in animal models. Thus, in view of the importance of alternative anti-inflammatory and anti- allergic drugs, it becomes imperative to bring these indigenous drugs to the front foot and evaluate their activities.

  16. Effects of benzydamine eye drops on the rabbit's eye reaction to surgical, physical, and chemical stimuli

    Energy Technology Data Exchange (ETDEWEB)

    Tomazzoli, L.; Bonora, A.; Luparini, M.R.; Durando, L.; Ciarniello, M.G.; Cioli, V.; Bonomi, L.

    The effects of benzydamine eye drops on the ocular reaction to different irritating stimuli in rabbits are reported. Benzydamine at the concentration of 0.1% reduces inflammatory tissue changes induced by AgNO3 burning of the cornea and inhibits the blood-aqueous barrier breakdown due to peripheral iridectomy or laser irradiation of the iris. Benzydamine reduces the aqueous PGE2 concentration to a similar extent as a 0.5% commercially available eye drop formulation of piroxicam. This result is in contrast with previous in vitro results demonstrating that benzydamine is devoid of any effects on PG synthesis. The possibility that PGE2 reduction is an indirect effect due to other biochemical activities of benzydamine is discussed. In the normal eye benzydamine manifests a local anaesthetic effect which is not accompanied by irritative changes in the anterior segment of the eye, changes in the intraocular pressure or pupillary size. It is suggested that in the clinical use of benzydamine eye drops the local anaesthetic activity may contribute to reducing both the neurogenic component of ocular inflammation and acute pain following injuries to the eye.

  17. Application of hydrochloric cyclopentolate eye drops in the mydriasis test and optometry for children with hyperopia

    Directory of Open Access Journals (Sweden)

    Hong-Ping Yin

    2016-02-01

    Full Text Available AIM:To observe and study the comprehensive application effect of hydrochloric cyclopentolate eye drops in the mydriasis test and optometry for children with hyperopia.METHODS:Eighty-four children with hyperopia who were intervened with mydriasis test and optometry in our hospital from February 2014 to March 2015 were selected as the research object,and they were intervened with mydriasis test and optometry by tropicamide or hydrochloric cyclopentolate eye drops. The diopter, pupil diameter and residual regulation before administration and at different time after administration of the two methods were compared,and the detected results of the two groups with different severity degree were compared too.RESULTS:The diopter, pupil diameter and residual regulation before administration of the two eye drops had no significant differences(all P>0.05,while the residual regulation after using hydrochloric cyclopentolate eye drops at 20, 40, 60min and 24h were all smaller than those after using tropicamide(all PP>0.05. The pupil diameter of the two groups at 48h after administration both had no significant differences to those before administration(all P>0.05.CONCLUSION:The comprehensive application effect of hydrochloric cyclopentolate eye drops in the mydriasis test and optometry of children with hyperopia is better,and its paralysis effect for ciliaris is obvious.

  18. [Keratomycosis due to Fusarium oxysporum treated with the combination povidone iodine eye drops and oral fluconazole].

    Science.gov (United States)

    Diongue, K; Sow, A S; Nguer, M; Seck, M C; Ndiaye, M; Badiane, A S; Ndiaye, J M; Ndoye, N W; Diallo, M A; Diop, A; Ndiaye, Y D; Dieye, B; Déme, A; Ndiaye, I M; Ndir, O; Ndiaye, D

    2015-12-01

    In developing countries where systemic antifungal are often unavailable, treatment of filamentous fungi infection as Fusarium is sometimes very difficult to treat. We report the case of a keratomycosis due to Fusarium oxysporum treated by povidone iodine eye drops and oral fluconazole. The diagnosis of abscess in the cornea was retained after ophthalmological examination for a 28-year-old man with no previous ophthalmological disease, addressed to the Ophthalmological clinic at the University Hospital Le Dantec in Dakar for a left painful red eye with decreased visual acuity lasting for 15 days. The patient did not receive any foreign body into the eye. Samples by corneal scraping were made for microbiological analysis and the patient was hospitalized and treated with a reinforced eye drops based treatment (ceftriaxone+gentamicin). The mycological diagnosis revealed the presence of a mold: F. oxysporum, which motivated the replacement of the initial treatment by eye drops containing iodized povidone solution at 1% because of the amphotericin B unavailability. Due to the threat of visual loss, oral fluconazole was added to the local treatment with eye drops povidone iodine. The outcome was favorable with a healing abscess and visual acuity amounted to 1/200th. Furthermore, we noted sequels such as pannus and pillowcase. The vulgarization of efficient topical antifungal in developing countries would be necessary to optimize fungal infection treatment. Copyright © 2015 Elsevier Masson SAS. All rights reserved.

  19. Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjögren's syndrome patients

    Science.gov (United States)

    Aragona, P; Di Stefano, G; Ferreri, F; Spinella, R; Stilo, A

    2002-01-01

    Aim: To study the effect of the treatment of dry eye in Sjögren's syndrome patients with hypotonic or isotonic hyaluronate eye drops. Methods: 40 Sjögren's syndrome patients were divided in two groups and treated as follows: group 1 with hypotonic (150 mOsm/l) 0.4% hyaluronate eye drops; group 2 with isotonic 0.4% hyaluronate eye drops. The eye drops were instilled six times a day for 90 days. Grading of subjective symptoms, break up time (BUT), corneal fluorescein staining, conjunctival rose bengal staining, Schirmer's I test, and conjunctival impression cytology were carried out at 0 and 15, 30, 90 days from the beginning of the study. Patients were examined in a blind fashion. For the statistical analysis the Student's t test, Mann-Whitney U test, and χ2 test were performed. Results: Symptoms were statistically significantly improved at day 15 in both groups but group 1 patients had a global score statistically significantly better group 2 (p=0.02). At day 15 group 1 patients had an improvement from baseline values of BUT (p=0.003), fluorescein, and rose bengal score (p=0.000001 and p=0.0004 respectively). Group 2 patients had, at day 15, an improvement of BUT and fluorescein score compared to baseline values (p=0.05 and p=0.0001 respectively). A comparison between the two groups showed better results for group 1 patients at day 15 for rose bengal stain (p=0.01) and for BUT (p=0.05) and fluorescein score (p=0.0003) at day 90. The conjunctival impression cytology showed that group 1 had a statistically significant better total score than group 2 starting from day 15 and lasting throughout the study (p<0.02). Also group 2 patients showed an improvement from baseline values starting from day 30 (p=0.000005). Conclusion: Hyaluronate eye drops are useful for treating severe dry eye in Sjögren's syndrome patients. The use of a formulation with pronounced hypotonicity showed better effects on corneoconjunctival epithelium than the isotonic solution. PMID:12140209

  20. Stability of cefuroxime in 1% and 5% buffered eye drops determined with HPLC method.

    Science.gov (United States)

    Kodym, Anna; Wiśniewski, Andrzej; Knioła, Dawid; Olejniczak, Monika

    2011-01-01

    The aim of the studies was to develop formulary technologies of 1% and 5% eye drops containing cefuroxime with stability of at least 10-12 days. The stability was defined as the time required to reach the cutoff value of 10% degradation of cefuroxime in the drops, as determined using an HPLC assay. The drops should have such properties as optical clarity, pH in the range of 3.5 to 8.5 and osmotic pressure not lower than 280 mOsm/L. Additionally, drops of enhanced viscosity within the range 7-9 mPaxs were developed. Drops (1% and 5%) were prepared under aseptic conditions by dissolving Biofuroksym (Cefuroxime natricum) IBA Bioton--the form of the drug for dry injections--in citrate buffer of pH 6.05-6.28. Polyvinyl alcohol was used to increase the viscosity of the drops. Phenylmercuric borate at the final concentration of 0.001% was used together with beta-phenylethyl alcohol at the final concentration of 0.4% to preserve the drops. The drops were stored for 30 days in tightly closed glass bottles at the temperature of 4 degrees C and 20 degrees C, protected from light. As the course of the infection may differ in intensity, location and the area of the infection in the eye, the composition of the drops was developed at two concentrations (1% and 5%), and five formulary versions for each concentration were prepared. The concentration of cefuroxime in the drops was determined every three days using HPLC. Such properties as pH, osmotic pressure and viscosity were also examined. Additionally, organoleptic analysis (clarity, color, odor) was performed. Physical and chemical properties of all formulations of 1% and 5% drops containing cefuroxime prepared in citrate buffer of pH 6.05-6.28 met the standards set in the objective of the work. The stability of cefuroxime in buffered drops stored at the temperature of 4 degrees C, determined with HPLC as the time of 10% degradation of cefuroxime, was 15 days for 1% and 5% drops. In the drops, which were buffered and of

  1. Proficiency of eye drop instillation in postoperative cataract patients in Ghana

    Directory of Open Access Journals (Sweden)

    Liu Y

    2013-10-01

    Full Text Available Yang Liu,1 Amanda Murdoch,2 Ken Bassett,3 Shafik Dharamsi4 1Faculty of Land and Food Systems, University of British Columbia, Vancouver, BC, Canada; 2Queen’s School of Medicine, Queen’s University, Kingston, ON, Canada; 3Departments of Family Practice and Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC, Canada; 4Department of Family Practice, University of British Columbia, Vancouver, BC, Canada Objective: The purpose of the study was to evaluate the efficacy of postoperative instruction on proficiency of eye drop instillation following cataract surgery, and to determine whether such proficiency correlates with the prevalence and/or duration of irritation and pain experienced in operated eyes. Design: This was a prospective, nonrandomized control trial with an educational intervention conducted via a single eye clinic in Accra, Ghana. Participants: The 218 subjects who completed the study were postoperative cataract surgery patients whose surgery had been funded by the nongovernmental organization Unite for Sight. Methods: Patients were evaluated on their ability to administer eye drops correctly on their first attempt on postoperative day one. If unsuccessful, patients were given an educational session that consisted of verbal instructions and an educational video. Both groups (successful and unsuccessful on the first postoperative day were tested again for proficiency on postoperative day 30. The baseline group was evaluated only on postoperative day 30 and consisted of 36 patients. Results: Of the 133 patients who received the educational session on eye drop instillation, 112 (84% exhibited proficiency on postoperative day 30 as compared with 29 of 49 patients (59% who did not receive the intervention. Additionally, there were fewer reports of pain and irritation following cataract extraction in the patients who received the educational session. Conclusion: This study supports the efficacy of patient

  2. The Experimental Study of Safety and Efficacy in Using Bovis Calculus Pharmacopuncture Solution as Eye Drop

    Directory of Open Access Journals (Sweden)

    Hyeongsik Seo

    2009-09-01

    Full Text Available Objectives : This experimental study was performed to investigate the safety and efficacy of Bovis Calculus pharmacopuncture solution manufactured with freezing dryness method to use eye drop. To identify the use of it as eye drop, the eye irritation test of rabbits and the antibacterial test of Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, Aspergillus niger, Fusarium oxysporum, and Candida albicans were performed. Methods : 1. The eye irritation test of this material was performed according to the Regulation of Korea Food & Drug Administration(2005. 10. 21, KFDA 2005-60. After Bovis Calculus pharmacopuncture solution was administered in the left eye of the rabbits, eye irritation of the cornea, iris and conjunctiva was observed at 1, 2, 3, 4 & 7day. 2. After administering Bovis Calculus pharmacopuncture solution on bacterial species(Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, Aspergillus niger, Fusarium oxysporum, Candida albicans which cause Keratitis, MIC(Minimum Inhibition Concentration and the size of inhibition zone were measured. Anti-bacterial potency was also measured using the size of inhibition zone. Results : 1. After Bovis Calculus pharmacopuncture solution was administered in the left eye of the rabbits, it was found that none of nine rabbits have abnormal signs and weight changes. 2. After Bovis Calculus pharmacopuncture solution was medicated in the left eye of the rabbits, no eye irritation of the cornea, iris and conjunctiva was observed at 1, 2, 3, 4 & 7day. 3. There was no response to MIC on bacterial species (Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, Aspergillus niger, Fusarium oxysporum, Candida albicans after Bovis Calculus pharmacopuncture solution was medicated. Conclusions : The present study suggests that Bovis Calculus pharmacopuncture solution is a nontoxic and non-irritant medicine, which does not cause eye irritation in

  3. Decrease in Corneal Damage due to Benzalkonium Chloride by the Addition of Mannitol into Timolol Maleate Eye Drops.

    Science.gov (United States)

    Nagai, Noriaki; Yoshioka, Chiaki; Tanino, Tadatoshi; Ito, Yoshimasa; Okamoto, Norio; Shimomura, Yoshikazu

    2015-01-01

    We investigated the protective effects of mannitol on corneal damage caused by benzalkonium chloride (BAC), which is used as a preservative in commercially available timolol maleate eye drops, using rat debrided corneal epithelium and a human cornea epithelial cell line (HCE-T). Corneal wounds were monitored using a fundus camera TRC-50X equipped with a digital camera; eye drops were instilled into rat eyes five times a day after corneal epithelial abrasion. The viability of HCE-T cells was calculated by TetraColor One; and Escherichia coli (ATCC 8739) were used to measure antimicrobial activity. The reducing effects on transcorneal penetration and intraocular pressure (IOP) of the eye drops were determined using rabbits. The corneal wound healing rate and rate constant (kH), as well as cell viability, were higher following treatment with 0.005% BAC solution containing 0.5% mannitol than in the case BAC solution alone; the antimicrobial activity was approximately the same for BAC solutions with and without mannitol. In addition, the kH for rat eyes instilled with commercially available timolol maleate eye drops containing 0.5% mannitol was significantly higher than that for eyes instilled with timolol maleate eye drops without mannitol, and the addition of mannitol did not affect the corneal penetration or IOP reducing effect of the timolol maleate eye drops. A preservative system comprising BAC and mannitol may provide effective therapy for glaucoma patients requiring long-term treatment with anti-glaucoma agents.

  4. Evaluation of the in vitro ocular toxicity of the fortified antibiotic eye drops prepared at the Hospital Pharmacy Departments

    Directory of Open Access Journals (Sweden)

    Anxo Fernández-Ferreiro

    2016-12-01

    Full Text Available The use of parenteral antibiotic eye drop formulations with non-marketed compositions or concentrations, commonly called fortified antibiotic eye drops, is a common practice in Ophthalmology in the hospital setting. The aim of this study was to evaluate the in vitro ocular toxicity of the main fortified antibiotic eye drops prepared in the Hospital Pharmacy Departments. We have conducted an in vitro experimental study in order to test the toxicity of gentamicin, amikacin, cefazolin, ceftazidime, vancomycin, colistimethate sodium and imipenem-cilastatin eye drops; their cytotoxicity and acute tissue irritation have been evaluated. Cell-based assays were performed on human stromal keratocytes, using a cell-based impedance biosensor system [xCELLigence Real-Time System Cell Analyzer (RTCA], and the Hen’s Egg Test for the ocular irritation tests. All the eye drops, except for vancomycin and imipenem, have shown a cytotoxic effect dependent on concentration and time; higher concentrations and longer exposure times will cause a steeper decline in the population of stromal keratocytes. Vancomycin showed a major initial cytotoxic effect, which was reverted over time; and imipenem appeared as a non-toxic compound for stromal cells. The eye drops with the highest irritating effect on the ocular surface were gentamicin and vancomycin. Those antibiotic eye drops prepared at the Hospital Pharmacy Departments included in this study were considered as compounds potentially cytotoxic for the ocular surface; this toxicity was dependent on the concentration used

  5. Evaluation of the in vitro ocular toxicity of the fortified antibiotic eye drops prepared at the Hospital Pharmacy Departments.

    Science.gov (United States)

    Fernández-Ferreiro, Anxo; González-Barcia, Miguel; Gil-Martínez, María; Santiago Varela, María; Pardo, María; Blanco-Méndez, José; Piñeiro-Ces, Antonio; Lamas Díaz, María Jesús; Otero-Espinar, Francisco J

    2016-09-01

    The use of parenteral antibiotic eye drop formulations with non-marketed compositions or concentrations, commonly called fortified antibiotic eye drops, is a common practice in Ophthalmology in the hospital setting. The aim of this study was to evaluate the in vitro ocular toxicity of the main fortified antibiotic eye drops prepared in the Hospital Pharmacy Departments. We have conducted an in vitro experimental study in order to test the toxicity of gentamicin, amikacin, cefazolin, ceftazidime, vancomycin, colistimethate sodium and imipenem-cilastatin eye drops; their cytotoxicity and acute tissue irritation have been evaluated. Cell-based assays were performed on human stromal keratocytes, using a cell-based impedance biosensor system [xCELLigence Real-Time System Cell Analyzer (RTCA)], and the Hen's Egg Test for the ocular irritation tests. All the eye drops, except for vancomycin and imipenem, have shown a cytotoxic effect dependent on concentration and time; higher concentrations and longer exposure times will cause a steeper decline in the population of stromal keratocytes. Vancomycin showed a major initial cytotoxic effect, which was reverted over time; and imipenem appeared as a non-toxic compound for stromal cells. The eye drops with the highest irritating effect on the ocular surface were gentamicin and vancomycin. Those antibiotic eye drops prepared at the Hospital Pharmacy Departments included in this study were considered as compounds potentially cytotoxic for the ocular surface; this toxicity was dependent on the concentration used.

  6. Effect of Cyclosporin a Eye Drop on Keratoconjunctivitis Sicca and Its Mechanism

    Institute of Scientific and Technical Information of China (English)

    SUN Jinghua; LIU Changming; ZHANG Yuzhao; WANG Hui

    2005-01-01

    In this study, the effect of cyclosporin A (CsA) eye drop on keratoconjunctivitis Sicca (KCS) and its mechanism were studied. The KCS models were established by injecting Pertussis vaccine, complete freunds adjuvant (CFA) and antigen of conjunctiva from isotype mice. Then the KCS models were treated with cyclosporin A eye drop. Changes in breaking-up time (BUT), lacrimal secretion in 30 min and diversion in 24 h were measured. The percentage of beaker cells, the lymphocytic infiltration in conjunctiva were observed. The expression levels of Aquaporin-3(AQP3) in conjunctiva epithelial cells, beaker cells and accessory lacrimal gland were immunohistochemically detected. The results showed that there were significant differences in BUT, the percentage of beaker cells, lacrimal secretion in 30 min, the lymphocytic infiltration and the expression of AQP3 between the experimental group and an control group. It was concludedthat CsA eye drop exerts marked therapeutic effect on KCS by inhibiting T lymph cells, increasing the goblet cells and AQP3 expression in conjunctiva.

  7. Clinical research of loratadine and diclofenac sodium eye drops for allergic conjunctivitis

    Directory of Open Access Journals (Sweden)

    Jian Shen

    2016-01-01

    Full Text Available AIM: To investigate clinical efficacy of loratadine and diclofenac sodium eye drops for allergic conjunctivitis and to improve the outcomes of patients with allergic conjunctivitis.METHODS: The selected 154 patients(158 eyeswith allergic conjunctivitis were randomly divided into control group and observation group, 77 patients(79 eyes in each group. Patients in control group were treated with loratadine. Patients in observation group were treated with diclofenac sodium eye drops besides loratadine. Scores on symptoms and physical signs of two groups were compared and clinical efficacy of two group was evaluated and compared. RESULTS: Before treatments, the scores on symptoms and physical signs of two groups were not significantly different(P>0.05. After treatments,the scores of observation group on eye itching, tearing, photophobia, burning sensation and foreign body sensation were respectively 1.03±0.10, 0.83±0.10, 0.62±0.06, 0.80±0.05 and 1.10±0.09score. The scores on conjunctival congestion and edema, secretions, nipple-like follicular on palpebral conjunctiva, limbus change, corneal epithelial changes as well as eyelid and periocular edema of observation group were respectively 0.95±0.08,0.63±0.05,1.32±0.13,0.67±0.06,0.72±0.06, 0.55±0.04score.All the aspects mentioned above were lower in observation group than in control group and the differences were statistically significant(PPCONCLUSION: Systemic treatment of loratadine combined with local treatment of diclofenac sodium eye drops for allergic conjunctivitis can relieve the clinical signs and symptoms better, make the treatment more effective with easy drug administration, which is an effective treatment.

  8. Clinical observation of Danzhi Xiaoyao Capsule with hypromellose 2910,dextran 70 and glycerol eye drops for dry eye in menopausal patients

    Directory of Open Access Journals (Sweden)

    Wen-Li Cai

    2016-06-01

    Full Text Available AIM: To evaluate the clinical effects, corneal surface shape and corneal thickness variation after treated by Danzhi Xiaoyao Capsule combined with hypromellose 2910,dextran 70 and glycerol eye drops for dry eye in menopausal patients. METHODS: Eighty menopausal patients(160 eyesdiagnosed as dry eye were randomly divided into groups A and B(40 patients each. Group A was treated with hypromellose 2910,dextran 70 and glycerol eye drops only and group B was treated with Danzhi Xiaoyao Capsule and eye drops. Before and 1mo after treatment, the clinical effects were evaluated by symptom scores, fluorescein staining(FL, tear film breakup time(BUTand Schirmer Ⅰ test. While the corneal surface regularity index(SRI, surface asymmetry index(SAIand central corneal thickness(CCTwere observed. RESULTS: At 1mo after treatment, the symptoms scores and FL scores of the 2 groups decreased significantly(PPPP>0.05. CONCLUSION: Combination therapy of Danzhi Xiaoyao Capsule and hypromellose 2910,dextran 70 and glycerol eye drops for menopausal patients with dry eye is more effective than single eye drops, and can improve the symptoms and signs.

  9. Evaluation of the efficacy and safety of a new device for eye drops instillation in patients with glaucoma.

    Science.gov (United States)

    Junqueira, Daniela M; Lopes, Flavio S; de Souza, Fabiola C; Dorairaj, Syril; Prata, Tiago S

    2015-01-01

    This study evaluated the efficacy and safety of a new device (Eyedrop(®)) designed for eye drop instillation in patients with and without glaucoma. This prospective study included consecutive patients with glaucoma and healthy participants. After a complete eye examination and determination of baseline intraocular pressure (IOP), topical hypotensive medication was introduced in both eyes, and the Eyedrop(®) delivery device (a plastic device in which the bottle with eye drops is inserted) was made available to all participants (with video and written instructions) for use in one eye, randomly chosen. In the second phase, all patients were evaluated by an experienced examiner for IOP determination, investigation of possible associated side effects, and ease of instilling eye drops (by a visual analog scale [VAS]; 0-10). Thirty two participants (mean age 42.3±16.2 years) were evaluated. Of these, 44% had glaucoma. There was no significant difference in mean IOP variation when comparing the eye using (-3.9±2.9 mmHg) or not using the device (-3.3±2.6 mmHg; P=0.36). The subjective rating of the facility of drops instillation was significantly higher with the Eyedrop(®) applicator (VAS =7.6±1.6) than without it (VAS =6.2±1.8; P5) among participants without prior experience with eye drop instillation (78.6% [11/14]) versus those already experienced (66.7% [12/18]). No difference in the frequency of side effects or in the distribution pattern of fluorescein between eyes was observed (P≥0.63). Eyedrop(®) received a better subjective response regarding the ease of instillation of hypotensive eye drops compared to traditional instillation, especially in patients with no previous experience with eye drops. Using the device did not result in any loss of hypotensive effect or increase in the frequency of side effects.

  10. Recurrent central serous chorioretinopathy with dexamethasone eye drop used nasally for rhinitis

    Directory of Open Access Journals (Sweden)

    Gunjan Prakash

    2013-01-01

    Full Text Available Central serous chorioretinopathy (CSC is characterized by serous retinal detachment at the posterior pole. Several factors have been implicated in the pathogenesis, and endogenous or exogenous corticosteroids are thought to play a major role. Here we present a case of a 35-year-old male with complaints of a dark circle in front of his right eye. Fundus examination, optical coherence tomography and fundus fluorescein angiography were performed. The patient was diagnosed with CSC. CSC resolved completely within seven weeks. Four weeks later the CSC recurred and spontaneously resolved over eight weeks. Overall, the patient had three additional recurrences of CSC in the same eye over the next year. A detailed history taking revealed the patient was using 0.1% dexamethasone eye drops nasally for recurrent rhinitis for few days prior to each episode of CSC. This indicates the strong correlation between steroids given by any route and the pathogenesis of CSC.

  11. Influence of local application of glaucoma medications-travoprost eye drops on patients' tear film function.

    Science.gov (United States)

    Zhang, Chengpu

    2015-03-01

    This study discussed about the influence of local application of glaucoma medications -- travoprost eye drops to patients' tear film function. We selected 24 patients, 45 eyes with primary open-angle glaucoma or intraocular hypertension. All of the patients topically used the travoprost eye drops for one time every night. After and before the pharmacy, we proceeded 1, 2, 3 mo lines symptom score and Schirmer's test (St), corneal fluorescein staining (FL), breakup time of tear film (BUT). Average value of symptom score and FL of all the patients before pharmacy were 1.32 ± 1. 55, 0.42 ± 0.68, and 1, 2, 3mo after pharmacy were respectively 2.68 ± 1.59, 0.96 ± 0.81; 4.97 ± 1.62, 1.46 ± 0.62; 6.21 ± 1.33, 1.88 ± 0.44. Symptom score and FL of 1, 2, 3 mo patients after pharmacy were all prominent higher than it before pharmacy (P=0.00), and it gradually increased. The average value of patients symptom BUT and St before pharmacy were (7.71 ± 0.87s), (8.32 ± 2.63mm /5min) and 1, 2, 3 mo after pharmacy were respectively (6.93 ± 1.17s), (7.69 ± 3. 33mm /5min); (5.48 ± 1.29s), (6.79 ± 2.94mm /5min); (4.33 ± 1.83s), (5.98 ± 3.11mm/5min). BUT and St value after pharmacy were prominent all lower than the level before pharmacy (P=0.00). And it gradually reduced. Short-term use of travoprost eye drops would aggravate the corneal irritation of patients, and decrease the tear film stability and tear secretion.

  12. Development of a cyclodextrin-based aqueous cyclosporin A eye drop formulations.

    Science.gov (United States)

    Jóhannsdóttir, Sunna; Jansook, Phatsawee; Stefánsson, Einar; Loftsson, Thorsteinn

    2015-09-30

    Cyclosporin A (CyA) is a lipophilic, cyclic polypeptide drug with anti-inflammatory properties. It is used in topical treatment of dry eyes and is now commercially available in oil based surfactant containing eye drops. Surfactants can irritate the eye surface causing burning, itching and irritation of the conjunctiva, and oil-based drops can result in blurred vision. Thus, the aim of this study was to develop surfactant free aqueous 0.05% (w/v) CyA eye drops where the drug is present in an aqueous vehicle containing CyA/cyclodextrin (CyA/CD) nanoparticles. The effects of the natural α-, β- and γ-cyclodextrins (αCD, βCD and γCD), as well as of the water soluble hydroxypropyl derivatives of γCD and αCD (HPγCD, HPαCD) and randomly methylated βCD (RMβCD), were determined in pure water. αCD had the best solubilizing effect increasing the solubility of CyA above 0.05% upon addition of only 5% (w/v) αCD. γCD did not have as good solubilizing effect but was tested further due to its superior ability to form nanoparticles and its favorable toxicological profile. Seven eye drop formulations were prepared and tested. All contained 0.05% (w/v) CyA in addition to polyvinyl alcohol, benzalkonium chloride, disodium edetate and various amounts of CD (αCD, γCD and mixtures thereof). When the formulation contained only αCD most of the drug was dissolved but some small aggregates were formed with hydrodynamic diameter of about 6 and 155 nm. When the formulation contained only γCD negligible CyA/CD complexation occurred with most of the drug present as solid CyA particles. When the formulation contained a mixture of αCD and γCD, where αCD concentration was at least 3% (w/v), the entire drug content was dissolved in the media under formation of relatively large (100-2000 nm) CyA/CD nanoparticles. αCD solubilized the drug while γCD enhanced nanoparticle formation. The effect of polyvinyl alcohol, benzalkonium chloride and disodium edetate on the nanoparticle

  13. A clinical study on "Computer vision syndrome" and its management with Triphala eye drops and Saptamrita Lauha.

    Science.gov (United States)

    Gangamma, M P; Poonam; Rajagopala, Manjusha

    2010-04-01

    American Optometric Association (AOA) defines computer vision syndrome (CVS) as "Complex of eye and vision problems related to near work, which are experienced during or related to computer use". Most studies indicate that Video Display Terminal (VDT) operators report more eye related problems than non-VDT office workers. The causes for the inefficiencies and the visual symptoms are a combination of individual visual problems and poor office ergonomics. In this clinical study on "CVS", 151 patients were registered, out of whom 141 completed the treatment. In Group A, 45 patients had been prescribed Triphala eye drops; in Group B, 53 patients had been prescribed the Triphala eye drops and SaptamritaLauha tablets internally, and in Group C, 43 patients had been prescribed the placebo eye drops and placebo tablets. In total, marked improvement was observed in 48.89, 54.71 and 06.98% patients in groups A, B and C, respectively.

  14. Regulation of retinal proteome by topical antiglaucomatous eye drops in an inherited glaucoma rat model.

    Directory of Open Access Journals (Sweden)

    Maurice Schallenberg

    Full Text Available Examination of the response of the retinal proteome to elevated intraocular pressure (IOP and to the pharmacological normalization of IOP is crucial, in order to develop drugs with neuroptorective potential. We used a hereditary rat model of ocular hypertension to lower IOP with travaprost and dorzolamide applied topically on the eye surface, and examine changes of the retinal proteome. Our data demonstrate that elevated IOP causes alterations in the retinal protein profile, in particular in high-mobility-group-protein B1 (HMGB1, calmodulin, heat-shock-protein (HSP 70 and carbonic anhydrase II expression. The changes of the retinal proteome by dorzolamide or travoprost are different and independent of the IOP lowering effect. This fact suggests that the eye drops exert a direct IOP-independent effect on retinal metabolism. Further investigations are required to elucidate the potential neuroprotective mechanisms signaled through changes of HMGB1, calmodulin, HSP70 and carbonic anhydrase II expression in glaucoma. The data may facilitate development of eye drops that exert neuroprotection through direct pharmacological effect.

  15. Meta analysis about the efficacy and safety of anti-ocular hypertension eye drops without benzalkonium chloride

    Institute of Scientific and Technical Information of China (English)

    Yan-Qing Wang; Xin Wang; Ping Liu

    2013-01-01

    Objective:To explore the safety and efficacy of eye drops without benzalkonium chloride(BAK) in treating glaucoma and ocular hypertension.Methods:The clinical case-control literatures about eye drops withoutBAK treating glaucoma and ocular hypertension were retrieved in PubMed,EMBASE,Cochrane andChineseBiological andMedical database.Meta5.0 software was used to analyze the literatures.Results:Five clinicalcontrol studies were included.The results indicated both eye drops could lower the intraocular pressure, and the intraocular pressure-lowering difference between two eye drops was0.07 mmHg(95%CI:0.04,0.19)(P>0.05).Two adverse reactions occurred more were conjunctival injection(10.78%) and allergic conjunctivitis (4.78%).The odd ratio of two eye drops occurring conjunctival injection and allergic conjunctivitis was0.67(95%CI,0.25,1.10) and0.82(95%CI,0.09,1.54), respectively(P<0.05) in fixed effect model.Conclusions:There is no difference between the eye drops with or withoutBAK in lowering intraocular pressure, but the latter is of higher safety.In consideration of the relatively small sample size of this research, more high-quality clinical research contrasts are needed as evidence.

  16. The Effect of Autologous Platelet Lysate Eye Drops: An In Vivo Confocal Microscopy Study

    Directory of Open Access Journals (Sweden)

    Antonio M. Fea

    2016-01-01

    Full Text Available Purpose. To determine the effectiveness of autologous platelet lysate (APL eye drops in patients with primary Sjögren syndrome (SS dry eye, refractory to standard therapy, in comparison with patients treated with artificial tears. We focused on the effect of APL on cornea morphology with the in vivo confocal microscopy (IVCM. Methods. Patients were assigned to two groups: group A used autologous platelet lysate QID, and group B used preservative-free artificial tears QID, for 90 days. Ophthalmological assessments included ocular surface disease index (OSDI, best corrected visual acuity (BCVA, Schirmer test, fluorescein score, and breakup time (BUT. A subgroup of patients in group A underwent IVCM: corneal basal epithelium, subbasal nerves, Langerhans cells, anterior stroma activated keratocytes, and reflectivity were evaluated. Results. 60 eyes of 30 patients were enrolled; in group A (n=20 patients mean OSDI, fluorescein score, and BUT showed significant improvement compared with group B (n=10 patients. The IVCM showed a significant increase in basal epithelium cells density and subbasal nerve plexus density and number and a decrease in Langerhans cells density (p<0.05. Conclusion. APL was found effective in the treatment of SS dry eye. IVCM seems to be a useful tool to visualize cornea morphologic modifications.

  17. The Effect of Autologous Platelet Lysate Eye Drops: An In Vivo Confocal Microscopy Study

    Science.gov (United States)

    Fea, Antonio M.; Testa, Valeria; Machetta, Federica; Parisi, Simone; D'Antico, Sergio; Spinetta, Roberta; Fusaro, Enrico; Grignolo, Federico M.

    2016-01-01

    Purpose. To determine the effectiveness of autologous platelet lysate (APL) eye drops in patients with primary Sjögren syndrome (SS) dry eye, refractory to standard therapy, in comparison with patients treated with artificial tears. We focused on the effect of APL on cornea morphology with the in vivo confocal microscopy (IVCM). Methods. Patients were assigned to two groups: group A used autologous platelet lysate QID, and group B used preservative-free artificial tears QID, for 90 days. Ophthalmological assessments included ocular surface disease index (OSDI), best corrected visual acuity (BCVA), Schirmer test, fluorescein score, and breakup time (BUT). A subgroup of patients in group A underwent IVCM: corneal basal epithelium, subbasal nerves, Langerhans cells, anterior stroma activated keratocytes, and reflectivity were evaluated. Results. 60 eyes of 30 patients were enrolled; in group A (n = 20 patients) mean OSDI, fluorescein score, and BUT showed significant improvement compared with group B (n = 10 patients). The IVCM showed a significant increase in basal epithelium cells density and subbasal nerve plexus density and number and a decrease in Langerhans cells density (p < 0.05). Conclusion. APL was found effective in the treatment of SS dry eye. IVCM seems to be a useful tool to visualize cornea morphologic modifications. PMID:27200376

  18. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.

    Science.gov (United States)

    Gause, Samuel; Hsu, Kuan-Hui; Shafor, Chancellor; Dixon, Phillip; Powell, Kristin Conrad; Chauhan, Anuj

    2016-07-01

    Ophthalmic drug for the anterior chamber diseases are delivered into tears by either eye drops or by extended release devices placed in the eyes. The instilled drug exits the eye through various routes including tear drainage into the nose through the canaliculi and transport across various ocular membranes. Understanding the mechanisms relevant to each route can be useful in predicting the dependency of ocular bioavailability on various formulation parameters, such as drug concentration, salinity, viscosity, etc. Mathematical modeling has been developed for each of the routes and validated by comparison with experiments. The individual models can be combined into a system model to predict the fraction of the instilled drug that reaches the target. This review summarizes the individual models for the transport of drugs across the cornea and conjunctiva and the canaliculi tear drainage. It also summarizes the combined tear dynamics model that can predict the ocular bioavailability of drugs instilled as eye drops. The predictions from the individual models and the combined model are in good agreement with experimental data. Both experiments and models predict that the corneal bioavailability for drugs delivered through eye drops is less than 5% due to the small area of the cornea in comparison to the conjunctiva, and the rapid clearance of the instilled solution by tear drainage. A contact lens is a natural choice for delivering drugs to the cornea due to the placement of the contact in the immediate vicinity of the cornea. The drug released by the contact towards the cornea surface is trapped in the post lens tear film for extended duration of at least 30min allowing transport of a large portion into the cornea. The model predictions backed by in vivo animal and clinical data show that the bioavailability increases to about 50% with contact lenses. This realization has encouraged considerable research towards delivering ocular drugs by contact lenses. Commercial

  19. [N-acetyl-aspartylglutamic acid eye drops in allergic-type conjuctivitis. Double-blind comparative clinical study].

    Science.gov (United States)

    Bonnet, M; Ducournau, D; Lumbroso, P; Serpin, G

    1985-01-01

    Fifty patients with allergic conjunctivitis were included in a double-blind randomized clinical trial designed to compare the efficiency and tolerance of two antiallergic eye-drops: one containing NAAGA (22 patients), the other one containing disodium Cromoglycate (28 patients). Both treatments were used at a dosage of 1 drop 4 times per day. Ocular symptoms, conjunctivo-corneal signs and the subjective ocular condition assessed by the patients themselves with visual analogue scales, were all significantly improved by both eye-drops during the first month of treatment. Statistical analysis showed that patient ocular condition improved more rapidly with NAAGA eye-drops. In 25 patients (12 in the NAAGA group and 13 in the Cromoglycate group), the study was continued for an additional month according to a cross-over protocol. During the 2nd month of treatment, additional improvement of ocular symptoms and signs were observed with both eye-drops but more markedly in those patients who received NAAGA after Cromoglycate. Ocular tolerance was good for both eye-drops.

  20. Clinical observation of Esculin and Digitalisglycosides eye drops and acupoint massage on patients with video display terminal asthenopia

    Directory of Open Access Journals (Sweden)

    Qing-He Sun

    2015-05-01

    Full Text Available AIM: To evaluate the efficacy of Esculin and Digitalisglycosides eye drops and acupoint massage alone or combination of both on video display terminal(VDTasthenopia.METHODS: Totally, 224 patients with VDT asthenopia were randomly divided into eye drops group(n=56received the intervention by Esculin and Digitalisglycosides eye drops, acupoint massage group(n=56received the intervention by acupoint massage around the eyes, and combination group(n=56received the intervention by combination of both and control group received the intervention by ocular hygiene instruction. The effect was evaluated after 4wk. The symptoms curative effect index, tear film break-up time(BUT, Schirmer I test(SItand corneal fluorescein staining score were as the indexes of evaluation.RESULTS: The symptoms curative effect index of combination group(78.96±5.29% was higher than that of eye drops group(69.55±6.23% and acupoint massage group(71.15±6.41%, which of after both groups was higher than that of control group(33.01±4.26%(PPPCONCLUSION: Esculin and Digitalisglycosides eye drops and acupoint massage could improve symptoms and ocular physiology in patient with VDT asthenopia, and the effects of the combinative use of both are synergistic.

  1. Levocabastine eye drops are effective and well tolerated for the treatment of allergic conjunctivitis in children

    Directory of Open Access Journals (Sweden)

    Brunello Wüthrich

    1995-01-01

    Full Text Available This open-label, prospective, multicentre, 4-week trial was undertaken to assess the efficacy and tolerability of twice daily levocabastine eye drops (0.5 mg/ml, with sodium cromoglycate nasal spray for the relief of concurrent nasal symptoms if required, in a total of 233 children with seasonal allergic conjunctivitis. No correlation between efficacy, tolerability and age was found. Investigator assessments revealed that the total severity of ocular symptoms decreased by 84 ± 34% in patients < 12 years and 85 ± 30% in those ≥ 12 years, with corresponding reductions in the total severity of ocular findings of 84% in both patient groups over the 4-week treatment period. Global assessments of therapeutic efficacy revealed the effect of therapy on ocular symptoms to be excellent or good in 81% of patients < 12 years and 82% of those ≥ 12 years after 2 weeks of treatment, with corresponding values at the end of the trial of 88% and 82% in the two groups, respectively. Treatment tolerability was considered to be excellent or good by 94% of patients overall. Application site reactions were the most common adverse event associated with ocular levocabastine, occurring in 13% of patients < 12 years and 9% of those ≥ 12 years. Twice daily levocabastine eye drops therefore appear to be effective and well tolerated for the treatment of seasonal allergic conjunctivitis in children.

  2. A preliminary study of the neuroprotective role of citicoline eye drops in glaucomatous optic neuropathy.

    Science.gov (United States)

    Roberti, Gloria; Tanga, Lucia; Parisi, Vincenzo; Sampalmieri, Massimo; Centofanti, Marco; Manni, Gianluca

    2014-05-01

    To study the neuroprotective effect of topical citicoline. Experimental phase to evaluate the ability of citicoline eye drops to reach the vitreous and the retina: The right eyes of 5 mice CD1 were treated with two drops per day for three days of citicoline 1% and 2% (OMK1, Omikron Italia s.r.l.), and then the vitreous was analyzed with the liquid chromatography and spectrometry mass (LC-MS/MS). Clinical phase to determine if topical citicoline is able to delay glaucoma progression, considering perimetric parameters and electro functional tests. Patients were randomized in two groups, OMK1 and OAG. The first group was treated with OMK1 three times per day, plus hypotensive therapy for two months and one month of wash out. The second group was treated only with hypotensive treatment for three months. LC-MS/MS detected the molecule very well, and only OMK1 showed systemic absorption. Thirty-four patients were enrolled, 16 in the OMK1 and 18 in the OAG group. Perimetric parameters showed a positive trend in individual eyes of patients in OMK1 group, but these values were not statistically significant in the whole group. Retinal ganglion cells function improved as shown by reduced P50 latency (P = 0.04) and increased P50-N95 amplitude (P < 0.0001) of pattern electroretinogram, up to 30 days after the washout (P = 0.01; P = 0.002). Visual evoked potential and retino-cortical time improvement regressed after 30 days of washout. In OAG group, there was any change during the follow-up. No adverse reactions were reported in both groups. Topical citicoline seems to have a neuroprotective action.

  3. Protective effects of naringenin eye drops on N-methyl-N-nitrosourea-induced photoreceptor cell death in rats

    Directory of Open Access Journals (Sweden)

    Jun-Li Lin

    2014-06-01

    Full Text Available AIM: To investigate the effects of naringenin eye drops on N-methyl-N-nitrosourea (MNU-induced photoreceptor cell death in rats.METHODS: Photoreceptor cell death was induced by single intraperitoneal injection of MNU (60 mg/kg in rats. Both eyes of all animals were instilled with one drop of vehicle, 0.5% or 1.0% naringenin eye drops three times per day from 7d before to 17d after MNU injection. Effects of naringenin on MNU-induced photoreceptor cell death were evaluated by electrophysiological and histological analysis.RESULTS:Flash electroretinography (FERG and oscillatory potentials (OPs recordings showed that the vehicle control group had remarkable reduction of amplitudes and prolongation of latency times. FERG and OPs responses were significantly reversed in MNU-induced rats treated with 0.5% or 1.0% naringenin eye drops compared with the vehicle control. The retinal morphological results showed that naringenin dose-dependently preserved the outer nuclear layer, outer retina and total retina.CONCLUSION:These results indicate that topical treatment with naringenin eye drops prevented retinal neurons from MNU-induced structural and functional damages.

  4. Voriconazole and the liver

    Institute of Scientific and Technical Information of China (English)

    2015-01-01

    Voriconazole is an azole useful for the prophylaxis andthe treatment of aspergillosis and other fungal infectionsin immunosuppressed subjects, as those found in aplasiaafter aggressive polychemotherapy treatments, afterhematopoietic stem cell, liver or lung transplantation.Its administration in therapeutic doses lead to extremelyvaried serum levels from patient to patient and even tothe same patient. The explanations are varied nonlinearpharmacokinetics, certain patient-related factors,including genetic polymorphisms in the cytochrome P4502C19 gene, the kidney and liver function, simultaneousadministration with other drugs metabolised by the samecytochrome. It is recommended to maintain the serumconcentrations of voriconazole between 1.5 and 4 μg/mL.At lower values its efficacy decreases and at highervalues the risk of neurological toxicity increases. Evenat these concentrations it is not excluded the possibleappearance of a variety of toxic effects, including onthe liver, manifested by cholestasis, hepatocytolisis, ortheir combination. It is recommended to monitor theclinical and laboratory evolution of all patients treatedwith voriconazole, and of the serum levels of the drugof those who belong to risk groups, even if there is stillno consensus on this issue, given the lack of correlationbetween the serum level and the occurrence of adverseeffects in many patients.

  5. Treatment of Sjögren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study.

    Science.gov (United States)

    Moscovici, Bernardo Kaplan; Holzchuh, Ricardo; Sakassegawa-Naves, Fernando Eiji; Hoshino-Ruiz, Diego Ricardo; Albers, Marcos Bottene Villa; Santo, Ruth Miyuki; Hida, Richard Yudi

    2015-10-01

    To describe the clinical efficacy of the treatment of Sjögren's syndrome dry eye using 0.03% tacrolimus eye drop. Prospective double-blind randomized study. Institutional outpatient clinic. Forty-eight eyes of twenty-four patients with dry eye related to Sjögren syndrome were enrolled in this study. The patients were randomized in 2 groups: tacrolimus (n=14) and vehicle (n=10) group. The tacrolimus group received a vial containing tacrolimus 0.03% (almond oil as vehicle) and the other group received the almond oil vehicle. All patients were instructed to use the eye drops every 12h in the lower conjunctival sac. Schirmer I test, break-up-time (BUT), corneal fluorescein and Rose Bengal staining scores were evaluated in all patients one day before the treatment (baseline), 7, 14, 28 and 90 days after treatment with the eye drops. The average fluorescein and Rose Bengal scores improved statistically after 7 days of treatment and even more after 90 days. The average Schirmer I and BUT values were unchanged after 7, 14 and 21 days but did show an improvement relative to baseline after 28 days of treatment. Schirmer I, BUT, fluorescein and Rose Bengal did not show any statistical significance in the vehicle group. Topical 0.03% tacrolimus eye drop improved tear stability and ocular surface status in cases of inflammatory or SS-related dry eye. ClinicalTrials.gov Identifier: NCT01850979. Copyright © 2015 British Contact Lens Association. Published by Elsevier Ltd. All rights reserved.

  6. Nerve growth factor eye drops improve visual acuity and electrofunctional activity in age-related macular degeneration: a case report

    Directory of Open Access Journals (Sweden)

    Alessandro Lambiase

    2009-12-01

    Full Text Available Age-related macular degeneration (ARMD is a severe disease affecting visual function in the elderly. Currently available surgical and medical options do not guarantee a significant impact on the outcome of the disease. We describe the effects of nerve growth factor eye drop treatment in a 94 years old female with ARMD, whose visual acuity was progressively worsening in spite of previous surgical and medical treatments. NGF eye drops improved visual acuity and electrofunctional parameters as early as 3 months after initiation of treatment. These results are in line with previous reports on a neuroprotective effect of NGF on retinal cells and on NGF eye drops bioavailability in the retina and optic nerve. No side effects were observed after five years of follow-up, suggesting that topical NGF treatment may be a safe and effective therapy for ARMD.

  7. A randomized clinical evaluation of the safety of Systane® Lubricant Eye Drops for the relief of dry eye symptoms following LASIK refractive surgery

    Directory of Open Access Journals (Sweden)

    Daniel Durrie

    2008-12-01

    Full Text Available Daniel Durrie, Jason StahlDurrie Vision, Overland Park, Kansas, USAPurpose: To evaluate the safety of Systane® Lubricant Eye Drops in relieving the symptoms of dry eye following laser-assisted in situ keratomileusis (LASIK surgery.Methods: This was a randomized, double-masked, single-center, placebo-controlled, contralateral eye study of 30 patients undergoing LASIK surgery. The mean age of patients was 42.4 ± 10.7 years, and the mean spherical equivalent was −3.29 (range, +1.75 to −7.38. Patients’ right and left eyes were randomized to receive either Systane® or placebo – a preserved, thimerosal-free saline solution – beginning from the day of surgery and ending 30 days following surgery. Outcome measures included tear film break up time (TFBUT, visual acuity, degree of corneal and conjunctival staining, and treatment-related adverse events.Results: Preoperatively, placebo-treated eyes had statistically significantly higher sum corneal staining score than Systane®-treated eyes (p = 0.0464; however, the difference was clinically insignificant (p = 0.27. Two weeks post operatively, the average TFBUT in the Systane®-treated eyes was 1.23 seconds longer than that of the placebo-treated eyes (p = 0.028. All other evaluated variables were comparable between the two treatments. No adverse events were reported in the study.Conclusion: Systane® Lubricant Eye Drops are safe for use following LASIK surgery to relieve the discomfort symptoms of dry eye associated with the procedure.Keywords: Systane®, safety, dry eye, LASIK

  8. Physical and chemical properties and stability of sodium cefazolin in buffered eye drops determined with HPLC method.

    Science.gov (United States)

    Kodym, Anna; Bilski, Piotr; Domańska, Agata; Hełminiak, Łukasz; Jabłońska, Maria; Jachymska, Anna

    2012-01-01

    The aim of the studies was to analyze the stability of 1% and 5% eye drops containing sodium cefazolin, prepared in citrate buffer of pH 6.11-6.27, which were stored at the temperature of 4 degrees C and 20 degrees C with light protection. The drops were prepared under aseptic conditions by dissolving sodium cefazolin (Biofazolin, IBA Bioton), dry injection form of the drug, in citrate buffer. The viscosity of the drops was increased using polyvinyl alcohol. The drops were preserved with phenylmercuric borate of 0.001% concentration mixed with beta-phenylethyl alcohol of 0.4% concentration in the drops. The concentration of cefazolin was determined at every three days using HPLC method. Besides, the measurements of pH, osmotic pressure and viscosity were performed as well as the organoleptic analysis of the drops (clarity, color, odor). The concentration of cefazolin in 1% drops after the 30-day-storage at the temperature of 4 degrees C, depending on their composition, decreased in the range of 2.17-6.02%. In 5% drops the decrease in cefazolin concentration was similar, i.e., after 30-day-storage at the temperature of 4 degrees C it was 1.62-6.76%. In 1% and 5% drops stored at the temperature of 20 degrees C the stability of the drops determined as the 10% degradation time of cefazolin was in the range of 9-15 days.

  9. Treatment of Recurrent Corneal Epithelial Defect by Autologous Serum Eye Drop

    Directory of Open Access Journals (Sweden)

    Hossein Mohammad Rabei

    2015-02-01

    Full Text Available Background: The aim of the present study was to evaluate the efficacy of autologous serum eye drop in treatment of recurrent corneal epithelial defect.Materials and Methods: Fourteen patients with recurrent corneal epithelial defect were studied. Autologous serum was prepared from the patients and diluted in 20% normal saline. The patients were instructed to use the autologous serum every six hours. Patients were followed for a mean period of 18 months.Results: Four males (28.6% and 10 females (71.4% entered the study. Four patients stopped the treatment after three months with complete satisfaction from treatment. Patients reported a reduction in frequency and severity of attacks 4.6±2 weeks after the start of treatment. The mean number of attacks before the procedure was 7.6±0.9 per year which was reduced to 2.2±0.9 per year after treatment (p<0.001. The main side effects in patients were eye pruritus and redness which were well tolerated by patients.Conclusion: Autologous serum application seems to be a safe and effective method to treat recurrent corneal epithelial defect.

  10. Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops

    Directory of Open Access Journals (Sweden)

    Inoue K

    2015-04-01

    Full Text Available Kenji Inoue,1 Minako Shiokawa,1 Kyoko Ishida,2 Goji Tomita2 1Inouye Eye Hospital, Tokyo, Japan; 2Department of Ophthalmology, Toho University Ohashi Medical Center, Tokyo, Japan Purpose: To evaluate the safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% fixed-combination (DTFC eye drops to brinzolamide 1.0%/timolol maleate 0.5% fixed-combination (BTFC eye drops in patients with primary open-angle glaucoma or ocular hypertension. Methods: A total of 35 eyes of 35 patients with primary open-angle glaucoma or ocular hypertension using DTFC eye drops were included. Participants discontinued DTFC drops and immediately began using BTFC drops. All other eye drops currently being used were continued. Intraocular pressure (IOP 1 and 3 months after switching medications was compared with baseline IOP. One month after switching medications, participant preference and adherence were evaluated. Adverse reactions were monitored at each study visit. Results: The IOP was 17.9±2.6 mmHg at baseline and 18.3±4.1 mmHg and 17.8±3.4 mmHg 1 month and 3 months after switching medications, respectively (P=0.633. The frequency of missing a dose was not different before (6.1% and after (6.1% switching to BTFC. Significantly fewer participants reported stinging after switching to BTFC (15.2% than while using DTFC (51.5%, P<0.01. Blurred vision was reported with the same frequency before (39.4% and after (42.4% switching to BTFC. A total of 33.3% and 27.3% of patients preferred DTFC and BTFC, respectively. Several patients withdrew from the study because of discomfort (n=2, 5.7%, discharge (n=1, 2.9%, dizziness (n=1, 2.9%, or increased IOP (n=2, 5.7%. Conclusion: Switching from DTFC to BTFC was well tolerated and did not result in IOP changes or a decreased patient adherence. When glaucoma patients complain of stinging with DTFC administration, switching to BTFC is an acceptable treatment option. Keywords: brinzolamide/timolol fixed

  11. Risk identification for quality on stage of pharmaceutical development of combined eye drops for glaucoma treatment

    Directory of Open Access Journals (Sweden)

    Олександр Миколайович Якубчук

    2015-12-01

    Full Text Available Aim: To identify the possible risks associated with critical quality attribute of combined eye drops for the treatment of glaucoma using of common risk evaluation methodologies for plannig a drug quality on the stage of pharmaceutical development. Methods: The paper used method of causal analysis. The maximal number of factors has been define to identify potential factors that provide most significant impact on the drug quality and Ishikawa diagram - graphical representation of causes and effects has been built.Results: Analysis allowed to organize the possible factors affecting the drug quality in the generalized categories: quality control methods, medicines and excipients, primary packaging, proper manufacturing conditions and the stage of the process. The most important factors that are carriers of the risk factors and may lead to negative effects have been identified for the generalized categories.Conclusions: Determined at the stage of pharmaceutical development potential critical quality attribute of AFI, excipients and primary packaging, critical parameters of the process, provide a better understanding, reduction and adoption of risk in subsequent stages of the life cycle of the drug

  12. Development and validation of Ketorolac Tromethamine in eye drop formulation by RP-HPLC method

    Directory of Open Access Journals (Sweden)

    G. Sunil

    2017-02-01

    Full Text Available A simple, precise and accurate method was developed and validated for analysis of Ketorolac Tromethamine in eye drop formulation. An isocratic HPLC analysis was performed on Kromosil C18 column (150 cm × 4.6 mm × 5 μm. The compound was separated with the mixture of methanol and ammonium dihydrogen phosphate buffer in the ratio of 55:45 V/V, pH 3.0 was adjusted with O-phosphoric acid as the mobile phase at flow of 1.5 mL min−1. UV detection was performed at 314 nm using photo diode array detection. The retention time was found to be 6.01 min. The system suitability parameters such as theoretical plate count, tailing and percentage RSD between six standard injections were within the limit. The method was validated according to ICH guidelines. Calibrations were linear over the concentration range of 50–150 μg mL−1 as indicated by correlation coefficient (r of 0.999. The robustness of the method was evaluated by deliberately altering the chromatographic conditions. The developed method can be applicable for routine quantitative analysis.

  13. Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma.

    Science.gov (United States)

    Parisi, Vincenzo; Centofanti, Marco; Ziccardi, Lucia; Tanga, Lucia; Michelessi, Manuele; Roberti, Gloria; Manni, Gianluca

    2015-08-01

    To evaluate the retinal function and the neural conduction along the visual pathways after treatment with citicoline eye drops in patients with open angle glaucoma (OAG). Fifty-six OAG patients (mean age 52.4 ± 4.72 years, IOP  0.01) PERG and VEP values in GC and GP eyes were observed. After treatment with topical citicoline, a significant (p  0.01) to baseline ones. GP eyes showed not significant changes of PERG and VEP values during the entire follow-up. Topical treatment with citicoline in OAG eyes induces an enhancement of the retinal bioelectrical responses (increase of PERG amplitude) with a consequent improvement of the bioelectrical activity of the visual cortex (shortening and increase of VEP implicit time and amplitude, respectively).

  14. The eye drop chart: a pilot study for improving administration of and compliance with topical treatments in glaucoma patients

    Directory of Open Access Journals (Sweden)

    McVeigh KA

    2015-05-01

    Full Text Available Katherine Anne McVeigh,1 Georgios Vakros21Department of Ophthalmology, Royal United Hospital, Combe Park, Bath, UK; 2Department of Ophthalmology, Queen’s Hospital, Romford, Essex, UKAim: In order to improve patient education, compliance, and administration of eye drops prescribed for patients suffering with glaucoma within a UK ophthalmology department, an eye drop chart (EDC was designed, developed, and piloted with patients attending the glaucoma clinic over 1 month.Methods: A cross-sectional prospective pilot study of 25 patients using an administration aid and a self-reported questionnaire. Chi-square tests were used to compare responses pre- and postintervention.Results: Results demonstrated an impressive improvement in nine of eleven categories assessed regarding drop administration and compliance. Patients stating that they always wash their hands increased significantly from 64% (13 participants to 92% (23 participants (P=0.029, and those who always shake the bottle improved from 40% (10 to 84% (21 (P=0.001. Punctal occlusion techniques improved from 44% (11 to 72% (18 (P=0.015. Finally, patients who always discarded the bottle after 28 days of use rose from 68% to 92%, though the difference was not significant (P=0.09. Only the number of drops being administered to the eye and the length of time left between the application of drops remained relatively unchanged. Sixty-four percent reported finding EDC helpful or useful, 52% had positive responses when asked if they would continue using EDC, and 88% would recommend it to a friend.Conclusion: Although there are limitations to the data as they are subjective, descriptive, and limited to sample size of 25, the results of this pilot study have shown promise. The EDC appears to be a cost-effective way at improving patients’ use of topical ocular medications.Keywords: glaucoma, administration, compliance, aid, drop chart

  15. Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops

    Science.gov (United States)

    Inoue, Kenji; Shiokawa, Minako; Ishida, Kyoko; Tomita, Goji

    2015-01-01

    Purpose To evaluate the safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% fixed-combination (DTFC) eye drops to brinzolamide 1.0%/timolol maleate 0.5% fixed-combination (BTFC) eye drops in patients with primary open-angle glaucoma or ocular hypertension. Methods A total of 35 eyes of 35 patients with primary open-angle glaucoma or ocular hypertension using DTFC eye drops were included. Participants discontinued DTFC drops and immediately began using BTFC drops. All other eye drops currently being used were continued. Intraocular pressure (IOP) 1 and 3 months after switching medications was compared with baseline IOP. One month after switching medications, participant preference and adherence were evaluated. Adverse reactions were monitored at each study visit. Results The IOP was 17.9±2.6 mmHg at baseline and 18.3±4.1 mmHg and 17.8±3.4 mmHg 1 month and 3 months after switching medications, respectively (P=0.633). The frequency of missing a dose was not different before (6.1%) and after (6.1%) switching to BTFC. Significantly fewer participants reported stinging after switching to BTFC (15.2%) than while using DTFC (51.5%, P,0.01). Blurred vision was reported with the same frequency before (39.4%) and after (42.4%) switching to BTFC. A total of 33.3% and 27.3% of patients preferred DTFC and BTFC, respectively. Several patients withdrew from the study because of discomfort (n=2, 5.7%), discharge (n=1, 2.9%), dizziness (n=1, 2.9%), or increased IOP (n=2, 5.7%). Conclusion Switching from DTFC to BTFC was well tolerated and did not result in IOP changes or a decreased patient adherence. When glaucoma patients complain of stinging with DTFC administration, switching to BTFC is an acceptable treatment option. PMID:25914520

  16. Voriconazole-induced musical hallucinations.

    Science.gov (United States)

    Agrawal, A K; Sherman, L K

    2004-10-01

    1 Voriconazole (Vfend) is a second-generation azole antifungal that is increasing in popularity especially for the treatment of invasive aspergillosis as well as empirically for the febrile neutropenic patient. In addition, voriconazole tends to have a mild side effect profile with reversible visual disturbances being the most widely described effect. We describe a patient who had musical hallucinations secondary to voriconazole. The patient was a 78-year-old man admitted for induction of chemotherapy for acute myelogenous leukemia (AML) who began to have auditory hallucinations, specifically of Christmas music, the 2nd day of voriconazole therapy. His psychiatric evaluation was otherwise unremarkable. After discontinuing voriconazole the hallucinations decreased in intensity by the 2nd day and ceased altogether by the 3rd day. An extensive literature search, including Pfizer drug trial safety data, yielded no other reports of auditory hallucinations with voriconazole. Several other interesting cases of musical hallucinations secondary to a variety of causes have been reported in the literature, and are reviewed. Notably, musical hallucinations tend to occur secondary to temporal lobe insults and often are of a religious or patriotic theme.

  17. Treatment of Allergic Rhinitis with Ectoine Containing Nasal Spray and Eye Drops in Comparison with Azelastine Containing Nasal Spray and Eye Drops or with Cromoglycic Acid Containing Nasal Spray

    Directory of Open Access Journals (Sweden)

    Nina Werkhäuser

    2014-01-01

    Full Text Available Objectives. Allergic rhinitis is a common disease with increasing prevalence and high impact on economic burden and comorbidities. As treatment with pharmacological drugs is not always satisfactory due to side effects and incomplete efficacy, alternative treatment strategies are needed. Ectoine is an osmolyte with membrane stabilizing and inflammation reducing capacities. Nasal spray and eye drops containing ectoine are promising new treatment regimens for allergic rhinitis sufferers. Design and Methods. The current two noninterventional trials evaluated the efficacy and safety of ectoine containing nasal spray and eye drops for treating allergic rhinitis in comparison with either azelastine or cromoglycic acid containing products. Nasal and ocular symptom developments as well as judgment of tolerability and efficacy were assessed both by investigators and patients over a time period of one to two weeks. Results. Both trials confirmed that ectoine containing products reduced nasal and ocular symptoms in allergic rhinitis patients. Results clearly demonstrated good safety profiles of the ectoine products comparable to those of azelastine and even better to those of cromoglycate products. Conclusion. Ectoine containing nasal spray and eye drops are interesting new treatment strategies for sufferers of allergic rhinitis, combining both good efficacy and absence of side effects.

  18. Treatment of allergic rhinitis with ectoine containing nasal spray and eye drops in comparison with azelastine containing nasal spray and eye drops or with cromoglycic Acid containing nasal spray.

    Science.gov (United States)

    Werkhäuser, Nina; Bilstein, Andreas; Sonnemann, Uwe

    2014-01-01

    Objectives. Allergic rhinitis is a common disease with increasing prevalence and high impact on economic burden and comorbidities. As treatment with pharmacological drugs is not always satisfactory due to side effects and incomplete efficacy, alternative treatment strategies are needed. Ectoine is an osmolyte with membrane stabilizing and inflammation reducing capacities. Nasal spray and eye drops containing ectoine are promising new treatment regimens for allergic rhinitis sufferers. Design and Methods. The current two noninterventional trials evaluated the efficacy and safety of ectoine containing nasal spray and eye drops for treating allergic rhinitis in comparison with either azelastine or cromoglycic acid containing products. Nasal and ocular symptom developments as well as judgment of tolerability and efficacy were assessed both by investigators and patients over a time period of one to two weeks. Results. Both trials confirmed that ectoine containing products reduced nasal and ocular symptoms in allergic rhinitis patients. Results clearly demonstrated good safety profiles of the ectoine products comparable to those of azelastine and even better to those of cromoglycate products. Conclusion. Ectoine containing nasal spray and eye drops are interesting new treatment strategies for sufferers of allergic rhinitis, combining both good efficacy and absence of side effects.

  19. Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement

    OpenAIRE

    Fukushima, Atsuki; Ohashi, Yuichi; Ebihara, Nobuyuki; Uchio, Eiichi; Okamoto, Shigeki; Kumagai, Naoki; Shoji, Jun; Takamura,Etsuko; Nakagawa, Yayoi; Namba, Kenichi; Fujishima, Hiroshi; Miyazaki, Dai

    2014-01-01

    Background The objective of this study was to investigate the efficacy of topical 0.1% tacrolimus in treating refractory allergic conjunctivitis with proliferative lesions and/or corneal involvement. Methods This prospective observational study included 1436 patients with refractory allergic conjunctivitis whose condition had responded poorly to conventional antiallergic drugs and/or topical steroids and/or topical cyclosporine. All patients received tacrolimus eye drops twice daily during th...

  20. Trehalose-Based Eye Drops Preserve Viability and Functionality of Cultured Human Corneal Epithelial Cells during Desiccation

    Directory of Open Access Journals (Sweden)

    Aneta Hill-Bator

    2014-01-01

    Full Text Available This paper presents the evaluation of cytoprotective ability of trehalose-based eye drops in comparison with commercially available preparations during the experimental desiccation of cultured human corneal epithelial cells. Cultured human corneal epithelial cells (hCEC underwent incubation with 7 different, commercially available medicaments used commonly in dry eye syndrome treatment, followed by desiccation trial performed on air under the flow hood for 5, 15, 30, and 45 minutes. Cell viability was quantified by live/dead fluorescent assay, while the presence of apoptotic cells was estimated by immunofluorescent staining for active caspase 3 protein. The preservation of membrane functions was evaluated using neutral red staining, while the preservation of proper morphology and phenotype was determined by fluorescent staining for actin filaments, nuclei, and p63 protein. The trehalose-based eye drops showed the highest efficiency in prevention of cell death from desiccation; moreover, this preparation preserved the normal cellular morphology, functions of cell membrane, and proliferative activity more effectively than other tested medicaments.

  1. A pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertension

    Directory of Open Access Journals (Sweden)

    Navreet Kaur Natt

    2014-01-01

    Full Text Available Aims: The aim was to compare efficacy and cost-effectiveness of bimatoprost 0.03% and brimonidine 0.2% in primary open-angle glaucoma (POAG/ocular hypertension (OHT. Settings and Design: Open, randomized, cross-over, comparative study. Materials and Methods: Forty patients of POAG or OHT with intraocular pressure (IOP <30 mm Hg were included in the study after a written informed consent. The patients were divided randomly into two groups of 20 patients each. Patients of group A were administered bimatoprost 0.03% eye drops once daily, and those of group B brimonidine 0.2% eye drops twice daily for a period of 4 weeks. After a washout period of 4 weeks, the patients were crossed over that is, group A was administered brimonidine 0.2% and group B bimatoprost 0.03%. Fall in IOP at 4 weeks was recorded. The daily cost of each drug was calculated by maximum retail price and the average number of drops per bottle. The cost-effectiveness was then calculated as the cost of drug/mm Hg fall in IOP. Statistics: Independent samples t-test was used to compare the efficacy of both drugs. Results: IOP lowering with bimatoprost (8.9 ± 1.598 mm Hg was significantly (P < 0.0001 higher than brimonidine (6.55 ± 1.26 mm Hg. The number of drops/ml were 33.43 ± 0.52 and 25.49 ± 0.26, respectively, for bimatoprost and brimonidine. Treatment with bimatoprost was costlier than brimonidine with daily costs/eye Rs. 4.02 ± 0.06 and 3.14 ± 0.03, yearly costs/eye Rs. 1467.46 ± 20.74 and 1147.75 ± 11.15, respectively. Bimatoprost was more cost-effective than brimonidine with the cost-effectiveness ratio (CER respectively Rs. 13.10 ± 2.61/mm Hg and Rs. 13.96 ± 2.86/mm Hg. Incremental CER Rs. 10.43/mm Hg implies lower costs/mm Hg extra IOP lowering by bimatoprost than Rs. 13.96 for brimonidine. Conclusion: In spite of being costlier, bimatoprost is more efficacious and cost-effective than brimonidine.

  2. Development of the conceptual framework for the Eye-Drop Satisfaction Questionnaire (EDSQ© in glaucoma using a qualitative study

    Directory of Open Access Journals (Sweden)

    Trudeau Elyse

    2007-08-01

    Full Text Available Abstract Background Compliance is a major issue in glaucoma care. It is usually poor in glaucomatous patients, and may ultimately result in an acceleration of the disease progression and a risk of blindness. Reasons for this poor compliance are complex and multifactorial, amongst which patient satisfaction can be counted. The objective of this study was to develop a questionnaire to assess patient satisfaction and compliance with eye-drop treatment. Methods A qualitative study was carried out to develop the questionnaire. An interview guide was developed based on a literature review. Structured interviews of fifteen French and English patients with primary open-angle glaucoma or intraocular hypertension were conducted by trained interviewers of the native language of the interviewees. General concepts and subconcepts were identified from the transcripts. The questionnaire was developed using the patient verbatim, and submitted to six patients (French and English for cognitive debriefing. Following patients' comments, items were modified and restructured, and a pilot questionnaire was designed. Results Analysis of data from the interviews with patients and clinicians resulted in the elicitation of concepts related to patient satisfaction and compliance with glaucomatous treatment. These were further refined and used to generate a test questionnaire, which consisted of 46 items grouped into 6 domains: patient characteristics, treatment characteristics, patient-clinician relationship, patient experience with the disease and the treatment, interaction between the patient and the treatment, and patient knowledge of the disease and the treatment. Conclusion The Eye-Drop Satisfaction Questionnaire (EDSQ conceptual framework and items were developed simultaneously in French and in English. This questionnaire could be used to evaluate patient satisfaction and compliance with eye-drop treatment and would facilitate the identification of patients at risk

  3. Response of chromoblastomycosis to voriconazole*

    Science.gov (United States)

    de Lima, Alexandre Moretti; Sacht, Gabriely Lessa; de Paula, Lauren Zogbi Pereira; Aseka, Gabriela Kimie; Goetz, Hermann Soares; Gheller, Maicon Felippe; Torraca, Pedro de Freitas Silva

    2016-01-01

    Chromoblastomycosis is a chronic fungal infection of the epidermis, dermis and subcutaneous tissue, in which the most common etiologic agent in Brazil is Fonsecaea pedrosoi. In more advanced cases we found many difficulties in their treatment, and therefore, we report a case of extensive and severe chromoblastomycosis, with therapeutical failure of first choice treatments, but good response to voriconazole. PMID:27828652

  4. The Toxicity of Nonsteroidal Anti-inflammatory Eye Drops against Human Corneal Epithelial Cells in Vitro.

    Science.gov (United States)

    Lee, Jong Soo; Kim, Young Hi; Park, Young Min

    2015-12-01

    This study investigated the toxicity of commercial non-steroid anti-inflammatory drug (NSAID) eye solutions against corneal epithelial cells in vitro. The biologic effects of 1/100-, 1/50-, and 1/10-diluted bromfenac sodium, pranoprofen, diclofenac sodium, and the fluorometholone on corneal epithelial cells were evaluated after 1-, 4-, 12-, and 24-hr of exposure compared to corneal epithelial cell treated with balanced salt solution as control. Cellular metabolic activity, cellular damage, and morphology were assessed. Corneal epithelial cell migration was quantified by the scratch-wound assay. Compared to bromfenac and pranoprofen, the cellular metabolic activity of diclofenac and fluorometholone significantly decreased after 12-hr exposure, which was maintained for 24-hr compared to control. Especially, at 1/10-diluted eye solution for 24-hr exposure, the LDH titers of fluorometholone and diclofenac sodium markedly increased more than those of bromfenac and pranoprofen. In diclofenac sodium, the Na(+) concentration was lower and amount of preservatives was higher than other NSAIDs eye solutions tested. However, the K(+) and Cl(-) concentration, pH, and osmolarity were similar for all NSAIDs eye solutions. Bromfenac and pranoprofen significantly promoted cell migration, and restored wound gap after 48-hr exposure, compared with that of diclofenac or fluorometholone. At 1/50-diluted eye solution for 48-hr exposure, the corneal epithelial cellular morphology of diclofenac and fluorometholone induced more damage than that of bromfenac or pranoprofen. Overall, the corneal epithelial cells in bromfenac and pranoprofen NSAID eye solutions are less damaged compared to those in diclofenac, included fluorometholone as steroid eye solution.

  5. Systane® lubricant eye drops in the management of ocular dryness

    Directory of Open Access Journals (Sweden)

    Benelli U

    2011-06-01

    Full Text Available Umberto BenelliDepartment of Neurosciences, Section of Ophthalmology, University of Pisa, Pisa, ItalyAbstract: The understanding of dry eye disease has advanced recently through increasing recognition that the etiology of the condition involves both tear evaporation and insufficient tear production, and that tear film instability and inflammation play roles in the various stages of the disease. Of significance, it has been recognized that lipid layer thickness correlates with tear film stability. The management of dry eye involves various strategies and therapeutic approaches that address one or more etiopathological components of the disease. The purpose of this review is to outline the characteristics and clinical utility of the Systane® ocular lubricants that contain hydroxypropyl-guar and one or both of the demulcents, ie, polyethylene glycol 400 and propylene glycol. Clinically, these products are safe and are indicated for the temporary relief of burning and irritation due to dryness of the eye. In particular, this review describes the formulations, mechanisms of action, and clinical utility of the newest additions to this topical ocular lubricant family, Systane Ultra® and Systane Balance®. Both of these ocular products are formulated with an intelligent delivery system and both provide symptomatic relief to patients with dry eye. However, Systane Balance is a novel formulation that contains both polymer and lipid components designed to protect the ocular surface and replenish tear film lipids simultaneously, a factor that is of particular relevance to patients who have dry eye associated with meibomian gland dysfunction.Keywords: Systane Ultra, Systane Balance, dry eye, hydroxypropyl-guar, meibomian gland dysfunction, dimyristoylphosphatidylglycerol 

  6. A study to assess the feasibility of undertaking a randomized controlled trial of adherence with eye drops in glaucoma patients

    Directory of Open Access Journals (Sweden)

    Richardson C

    2013-10-01

    Full Text Available Cliff Richardson,1 Lisa Brunton,1 Nicola Olleveant,1 David B Henson,1 Mark Pilling,1 Jane Mottershead,2 Cecilia H Fenerty,2 Anne Fiona Spencer,2 Heather Waterman1 1School of Nursing, Midwifery and Social Work, University of Manchester, 2Royal Manchester Eye Hospital, Central Manchester Foundation Trust, Manchester, United Kingdom Background: Adherence with therapy could influence the progression of glaucoma and ultimately affect the onset of visual impairment in some individuals. This feasibility study evaluated the measures to be used for a future randomized controlled trial assessing the effects of group-based education on adherence with eye drops. Methods: People diagnosed with glaucoma within the previous 12 months attending a regional ophthalmology clinic in the North West of England were recruited. A two-session education program delivered one week apart had been devised as part of a previous project. A combined adult learning and health needs approach to education was taken. Outcomes measured were knowledge of glaucoma, self-report of adherence, illness perception, beliefs about medicines, patient enablement, and general health (Short Form-12. Adherence was also measured objectively using a Medical Events Monitoring System device. Results: Twenty-six participants consented to undertake the educational program and 19 produced analyzable data. Knowledge of glaucoma, illness perception, beliefs about medicine, and patient enablement all showed statistically significant improvements after education. Mean adherence with eye drops was maintained above 85% before and for 3 months after attendance at the educational program. Self-report exaggerated adherence by at least 10% when compared with the objective Medical Events Monitoring System data, and in fact the kappa agreement was zero. Conclusion: All questionnaires other than the Short Form-12 were considered to be valuable measures and use of a Medical Events Monitoring System device was

  7. Topical voriconazole therapy of Purpureocillium lilacinum keratitis that occurred in disposable soft contact lens wearers.

    Science.gov (United States)

    Todokoro, Daisuke; Yamada, Norihiro; Fukuchi, Mariko; Kishi, Shoji

    2014-10-01

    The objective of this study was to describe 2 cases of keratitis caused by Purpureocillium lilacinum (formerly Paecilomyces lilacinus) that occurred in disposable contact lens users, which were successfully treated with topical voriconazole. Case 1 was a healthy 44-year-old woman, who wore weekly disposable contact lenses and had developed a superficial corneal infection in her right eye. For diagnosis, corneal scraping and molecular identification of the cultured pathogen were performed. A corneal smear revealed the presence of fungi. The pathogen was identified as P. lilacinum by traditional morphological identification of fungal culture, and this identification was confirmed by DNA sequencing of the ribosomal internal transcribed spacer (ITS) sequence. Therapy with topical fluconazole, topical pimaricin (natamycin), and oral itraconazole were ineffective. Topical voriconazole showed a significant effect, and the keratitis was successfully treated. Case 2 was a 43-year-old woman with bilateral recurrent peripheral corneal ulcers by meibomian gland dysfunction, who used therapeutic bandage contact lenses on her left eye. However, a corneal abscess with hypopyon occurred in the eye after 3 months. The microbial smear examination showed the presence of fungi and the fungal culture, and the DNA sequence of ITS region revealed that the causative agent was P. lilacinum. The susceptibility testing against antifungal agents showed that voriconazole was effective. The lesion improved gradually by topical voriconazole. As a conclusion, P. lilacinum keratitis can occur in disposable soft contact lens wearer. Early and accurate detection of the pathogenic organism is essential. Topical voriconazole was effective against P. lilacinum keratitis.

  8. Cefazolin-Gentamicin versus Vancomycin-Ceftazidime Eye Drops for Bacterial Corneal Ulcers; a Randomized Clinical Trial

    Directory of Open Access Journals (Sweden)

    Ali-Reza Dehghani

    2009-01-01

    Full Text Available

    PURPOSE: To compare the efficacy of topical cefazolin-gentamicin versus vancomycin-ceftazidime for treatment of bacterial corneal ulcers. METHODS: This randomized double-masked clinical trial was performed on consecutive patients with bacterial corneal ulcers referred to Feiz Hospital, Isfahan, Iran from 2004 to 2005. Patients were randomly assigned to cefazolin-gentamicin or vancomycin-ceftazidime eye drops in a masked fashion. Outcome measures included time for resolution of stromal infiltration, re-epithelization of the epithelial defect, and clearance of anterior chamber inflammation as well as culture results and complications. RESULTS: The study included 89 eyes of 89 patients with bacterial corneal ulcers consisting of 57 (64% male and 32 (36% female subjects. Specimens were culture-negative in 46% of cases. Forty-one eyes received cefazolin-gentamicin and 48 eyes were treated with vancomycin-ceftazidime. Time for resolution of stromal infiltration was 17.7±4.3 days versus 13.8±3.6 days (P=0.04, time to complete re-epithelization was 13.2±3.1 days versus 9.6±2.7 days (P=0.01 and time for clearing of the anterior chamber was 11.6±2.9 days versus 8.1±2.3 days (P

  9. Effects of Long-Term Antiglaucoma Eye Drops on Conjunctival Structures: An In Vivo Confocal Microscopy Study.

    Science.gov (United States)

    Zhu, Wenqing; Kong, Xiangmei; Xu, Jianjiang; Sun, Xinghuai

    2015-01-01

    Purpose. The study was aimed at comparing the long-term effects of different antiglaucoma eye drops on conjunctival structures using laser scanning confocal microscopy. Methods. Eighty patients diagnosed with primary open-angle glaucoma and twenty healthy volunteers were included in this study. The participants were divided into 5 groups according to the different medications. The lachrymal film break-up time, Schirmer's I test, and Ocular Surface Disease Index Questionnaire were performed in all subjects. The confocal microscopy was used to observe the basal epithelial cell density (ECD), goblet cell density (GCD), dendritic cell density (DCD), and subepithelial collagen fiber diameter (SFD). Results. Statistically significant differences were found among the control group and the antiglaucoma therapy groups in the values of three clinical data (P effects of antiglaucoma medications. Less pronounced changes were found in the patients treated with prostaglandin analogue than in the other kinds of antiglaucoma therapies.

  10. Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops

    Directory of Open Access Journals (Sweden)

    Rosin LM

    2013-10-01

    Full Text Available Lauren M Rosin,1 Nicholas P Bell1,2 1Ruiz Department of Ophthalmology and Visual Science, The University of Texas Medical School at Houston, 2Robert Cizik Eye Clinic, Houston, TX, USA Abstract: Timolol (generic name is a frequently used medication for the control of glaucoma. Benzalkonium chloride (BAK is a commonly used preservative in ophthalmic solutions with a broad range of antimicrobial activity; however, this nonspecificity can result in toxicity. Adverse effects attributed to BAK, including conjunctival inflammation and fibrosis, tear film instability, corneal cytotoxicity, anterior chamber inflammation, trabecular meshwork cell apoptosis, cataract development, macular edema, and even systemic effects, have been well documented. These effects can lead to ocular discomfort, poor intraocular pressure control, glaucoma surgery failure, and decreased patient compliance. BAK use in topical medications has decreased recently as newer and less toxic preservatives have become available. Yet these preservatives still exert some toxic effects, especially in patients with chronic eye disease who use multiple drops over extended periods of time. Thus, attempts to reduce overall preservative loads for patients are important, whether it be decreasing the amount of preservative, decreasing the total number of drops patients use, or eliminating preservatives entirely. A preservative-free formulation of timolol, TIMOPTIC® in OCUDOSE®, is available in unit-dose vials. Preservative-free unit-dose vials minimize toxic adverse effects and are a good option for patients with ocular surface disease, on long-term multidrop therapy, or who simply do not tolerate the effects of preservatives due to discomfort. Keywords: glaucoma, ocular toxicity, benzalkonium chloride, preservative-free timolol

  11. Bioavailability of voriconazole in hospitalised patients.

    Science.gov (United States)

    Veringa, Anette; Geling, Sanne; Span, Lambert F R; Vermeulen, Karin M; Zijlstra, Jan G; van der Werf, Tjip S; Kosterink, Jos G W; Alffenaar, Jan-Willem C

    2017-02-01

    An important element in antimicrobial stewardship programmes is early switch from intravenous (i.v.) to oral antimicrobial treatment, especially for highly bioavailable drugs. The antifungal agent voriconazole is available both in i.v. and oral formulations and bioavailability is estimated to be >90% in healthy volunteers, making this drug a suitable candidate for such a transition. Recently, two studies have shown that the bioavailability of voriconazole is substantially lower in patients. However, for both studies various factors that could influence the voriconazole serum concentration, such as inflammation, concomitant intake of food with oral voriconazole, and gastrointestinal complications, were not included in the evaluation. Therefore, in this study a retrospective chart review was performed in adult patients treated with both oral and i.v. voriconazole at the same dose and within a limited (≤5 days) time interval in order to evaluate the effect of switching the route of administration on voriconazole serum concentrations. A total of 13 patients were included. The mean voriconazole trough concentration was 2.28 mg/L [95% confidence interval (CI) 1.29-3.26 mg/L] for i.v. voriconazole administration and 2.04 mg/L (95% CI 0.78-3.30 mg/L) for oral administration. No significant difference was found in the mean oral and i.v. trough concentrations of voriconazole (P = 0.390). The mean bioavailability was 83.0% (95% CI 59.0-107.0%). These findings suggest that factors other than bioavailability may cause the observed difference in voriconazole trough concentrations between oral and i.v. administration in the earlier studies and stress the need for an antimicrobial stewardship team to guide voriconazole dosing.

  12. Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops

    Science.gov (United States)

    Rosin, Lauren M; Bell, Nicholas P

    2013-01-01

    Timolol (generic name) is a frequently used medication for the control of glaucoma. Benzalkonium chloride (BAK) is a commonly used preservative in ophthalmic solutions with a broad range of antimicrobial activity; however, this nonspecificity can result in toxicity. Adverse effects attributed to BAK, including conjunctival inflammation and fibrosis, tear film instability, corneal cytotoxicity, anterior chamber inflammation, trabecular meshwork cell apoptosis, cataract development, macular edema, and even systemic effects, have been well documented. These effects can lead to ocular discomfort, poor intraocular pressure control, glaucoma surgery failure, and decreased patient compliance. BAK use in topical medications has decreased recently as newer and less toxic preservatives have become available. Yet these preservatives still exert some toxic effects, especially in patients with chronic eye disease who use multiple drops over extended periods of time. Thus, attempts to reduce overall preservative loads for patients are important, whether it be decreasing the amount of preservative, decreasing the total number of drops patients use, or eliminating preservatives entirely. A preservative-free formulation of timolol, TIMOPTIC® in OCUDOSE®, is available in unit-dose vials. Preservative-free unit-dose vials minimize toxic adverse effects and are a good option for patients with ocular surface disease, on long-term multidrop therapy, or who simply do not tolerate the effects of preservatives due to discomfort. PMID:24204115

  13. Comparison of the effects of various lubricant eye drops on the in vitro rabbit corneal healing and toxicity.

    Science.gov (United States)

    Dutescu, R Michael; Panfil, Claudia; Schrage, Norbert

    2017-03-02

    Ingredients of lubricant eye drops are potentially harmful to the ocular surface. The products Optive, Optive Fusion, Neopt were tested regarding corneal irritability versus Vismed Multi and 0.01% benzalkonium chloride as negative and positive control, respectively. Formulas (30-40μl per hour) were applied hourly in-vitro for six days on rabbit corneas (n=5, per product) cultured in artificial anterior chambers (EVEIT system). Initially, four corneal abrasions (2.4-4.6mm(2)) were induced. All defects were monitored during drop application by fluorescein stains and photographs. To ensure corneal vitality, glucose and lactate concentrations in artificial anterior chamber fluids were determined photometrically. All products showed a complete corneal healing on day 2. Thereafter, all five Optive-treated corneas developed progressive fluorescein-positive epithelial lesions until day six (24.96μm, ±21.45μm, p0.5) while Vismed Multi did not adversely affect the corneal integrity. Glucose/lactate concentrations remained unchanged while lubricants were applied. Histology revealed epithelial loss and severe alterations of the superficial stroma for Optive. Optive Fusion displayed a comparable pathology. Neopt did not significantly affect the corneal healing and integrity. This study suggested a cumulative corneal toxicity of Optive and, to a lesser extent, Optive Fusion most likely caused by its oxidative preservative, SOC. Clinical data are needed to clarify the application frequency at which corneal toxicity might occur. Neopt and Vismed Multi did not affect the corneal integrity.

  14. INTRACAMERAL AND INTRACORNEAL VORICONAZOLE IN DEEP KERATOMYCOSIS WITH ENDOTHELIAL PLAQUE

    Directory of Open Access Journals (Sweden)

    Srinivas Prasad

    2015-12-01

    Full Text Available Fungal keratitis, one of the major causes of ophthalmic mycosis is second only to cataract as the most common cause of blindness worldwide. OBJECTIVE The aim was to study the intracorneal and intracameral Voriconazole in deep keratomycosis with endothelial plaque. MATERIALS AND METHODS This was a study in the Cornea Clinic of Sarojini Devi Eye Hospital and Regional Institute of Ophthalmology, a Tertiary Care Teaching Hospital of Osmania Medical College (Govt., Hyderabad, over a period from September 2012 to August 2014. The study group included 30 patients who were diagnosed clinically and microbiologically (+ve smear and culture as fungal corneal ulcers with deep stromal infiltrates and endothelial plaque not responding to routine antifungal drugs and given voriconazole intracorneally and intracamerally. Data of patient’s age and sex and history of corneal trauma with type of the agents were noted. The time of healing of the ulcer with the scar formation after intracorneal and intracameral voriconazole was noted and the visual acuity was recorded after the healing of the corneal ulcer. RESULTS Thirty eyes of 30 patients with deep keratomycosis with endothelial plaque were evaluated; 19(63.3% were Males and 11(36.7% were Females. Age distribution was 4(13.3% in >10-20 Yrs, 5(16.7% in 21-30 Yrs, 4(13.3% in 31-40 Yrs, 6(20.0% in 41-50 Yrs, 5(16.7% in 51-60 Yrs and 6(20.0% in 61-70 Yrs. The type of trauma was the organic (Vegetative matter in 19(63.4%, inorganic matter in 8(26.7% and no H/o trauma with the agent not known in 3(10.0%. The causative fungi were Fusarium in 15(50.0%, Aspergillus in 12(40.0% and Candida in 3(10.0. The time of healing of the Fungal Corneal Ulcer after Intracorneal and Intracameral Voriconazole was 4(13.3% in 4-6 wks.; 12 (40.0% in 6-8 wks., 5(16.7% in 8–10 wks., and 4(13.3% in 10–12 wks.; 25(83.3% which were healed by corneal scarring were given 1 (One intracorneal and intracameral injection of Voriconazole. The 5

  15. Nanomicellar Topical Aqueous Drop Formulation of Rapamycin for Back-of-the-Eye Delivery.

    Science.gov (United States)

    Cholkar, Kishore; Gunda, Sriram; Earla, Ravinder; Pal, Dhananjay; Mitra, Ashim K

    2015-06-01

    The objective of this study was to develop a clear, aqueous rapamycin-loaded mixed nanomicellar formulations (MNFs) for the back-of-the-eye delivery. MNF of rapamycin (0.2%) was prepared with vitamin E tocopherol polyethylene glycol succinate (TPGS) (Vit E TPGS) and octoxynol-40 (Oc-40) as polymeric matrix. MNF was characterized by various parameters such as size, charge, shape, and viscosity. Proton nuclear magnetic resonance ((1)H NMR) was used to identify unentrapped rapamycin in MNF. Cytotoxicity was evaluated in human retinal pigment epithelial (D407) and rabbit primary corneal epithelial cells (rPCECs). In vivo posterior ocular rapamycin distribution studies were conducted in male New Zealand white rabbits. The optimized MNF has excellent rapamycin entrapment and loading efficiency. The average size of MNF was 10.98 ± 0.089 and 10.84 ± 0.11 nm for blank and rapamycin-loaded MNF, respectively. TEM analysis revealed that nanomicelles are spherical in shape. Absence of free rapamycin in the MNF was confirmed by (1)H NMR studies. Neither placebo nor rapamycin-loaded MNF produced cytotoxicity on D407 and rPCECs indicating formulations are tolerable. In vivo studies demonstrated a very high rapamycin concentration in retina-choroid (362.35 ± 56.17 ng/g tissue). No drug was identified in the vitreous humor indicating the sequestration of rapamycin in lipoidal retinal tissues. In summary, a clear, aqueous MNF comprising of Vit E TPGS and Oc-40 loaded with rapamycin was successfully developed. Back-of-the-eye tissue distribution studies demonstrated a very high rapamycin levels in retina-choroid (place of drug action) with a negligible drug partitioning into vitreous humor.

  16. Evaluation of pharmacological activities and assessment of intraocular penetration of an ayurvedic polyherbal eye drop (Itone™ in experimental models

    Directory of Open Access Journals (Sweden)

    Velpandian Thirumurthy

    2013-01-01

    Full Text Available Abstract Background The polyherbal eye drop (Itone™ is a mixture of aqueous distillates of nineteen traditionally used ingredients that sum up to impart potency to the formulation and make it a useful adjunct in various ocular pathologies. However, as there have been no controlled experimental studies accounting to the above claim, therefore, the present study was designed to evaluate the polyherbal formulation (PHF for antiangiogenic, anti-inflammatory, anticataract, antioxidant and cytotoxicity in addition to the evaluation of intraocular penetration of PHF in rabbit eyes using LC-MS/MS. Materials and methods Antiangiogenic activity of the PHF was evaluated using in ovo chick chorio-allantoic membrane (CAM assay and in vivo cautery induced corneal neovascularization assay in rats. Anticataract potential was evaluated using steroid induced cataract in developing chick embryos, sodium selenite induced cataract in rat pups and galactose induced cataract in rats. The antioxidant activity was evaluated using di-phenyl picryl hydrazyl (DPPH radical scavenging assay. Anti-inflammatory activity was evaluated in vitro using inhibition of LTB4 formation in human WBCs and in vivo using carrageenan induced paw edema assay in rats. The cytotoxicity was evaluated against HeLa cancer cell lines using (3-(4,5-Dimethylthiazol-2-yl-2,5-diphenyltetrazolium bromide (MTT assay. Furthermore evaluation of the intraocular penetration of the PHF was carried out in rabbit eyes via aqueous humor paracentesis and further analysis using LC-MS/MS. Results PHF significantly inhibited VEGF induced proliferation of new blood vessels in CAM assay and inhibited the cautery induced corneal neovascularization in rats. Additionally, PHF showed noticeable delay in the progression of cataract in the selenite and galactose induced cataract models whereby the PHF treated lenses were graded for stages II and III respectively. However, the PHF did not show any anticataract activity in

  17. A new method to predict the epidemiology of fungal keratitis by monitoring the sales distribution of antifungal eye drops in Brazil.

    Directory of Open Access Journals (Sweden)

    Marlon Moraes Ibrahim

    Full Text Available PURPOSE: Fungi are a major cause of keratitis, although few medications are licensed for their treatment. The aim of this study is to observe the variation in commercialisation of antifungal eye drops, and to predict the seasonal distribution of fungal keratitis in Brazil. METHODS: Data from a retrospective study of antifungal eye drops sales from the only pharmaceutical ophthalmologic laboratory, authorized to dispense them in Brazil (Opthalmos were gathered. These data were correlated with geographic and seasonal distribution of fungal keratitis in Brazil between July 2002 and June 2008. RESULTS: A total of 26,087 antifungal eye drop units were sold, with a mean of 2.3 per patient. There was significant variation in antifungal sales during the year (p<0.01. A linear regression model displayed a significant association between reduced relative humidity and antifungal drug sales (R2 = 0.17,p<0.01. CONCLUSIONS: Antifungal eye drops sales suggest that there is a seasonal distribution of fungal keratitis. A possible interpretation is that the third quarter of the year (a period when the climate is drier, when agricultural activity is more intense in Brazil, suggests a correlation with a higher incidence of fungal keratitis. A similar model could be applied to other diseases, that are managed with unique, or few, and monitorable medications to predict epidemiological aspects.

  18. SIMULTANEOUS ESTIMATION OF MOXIFLOXACIN HCl AND BROMFENAC SODIUM IN EYE DROPS BY SPECTROPHOTOMETRIC METHODS

    Directory of Open Access Journals (Sweden)

    P. J. Vyas*, J. B. Dave and C. N. Patel

    2012-07-01

    Full Text Available Moxifloxacin Hydrochloride is a fluorinated quinolone antibacterial and Bromfenac Sodium is a non-steroidal anti-inflammatory. The combination formulation is used for the treatment of the reduction of post operative inflammatory conditions of the eye. Three new, simple, accurate and precise UV spectrophotometric methods have been developed and validated for the simultaneous determination of Moxifloxacin Hydrochloride (MOX and Bromfenac Sodium (BROM in their combined dosage forms. Method - I is based on simultaneous equation method using two wavelengths, 294 nm (λmax of MOX and 265 nm (λmax of BROM. Method - II Q‐absorption Ratio method using two wavelengths, 294 nm (λmax of MOX and 276.66 nm (Isoabsorptive point. Method - III involves the use of First order derivative technique. Here 301.71 nm, the zero crossing point of Bromfenac Sodium, was selected for the determination of Moxifloxacin Hydrochloride and 293.22 nm, the zero crossing point of Moxifloxacin Hydrochloride, was selected for the determination of Bromfenac Sodium. Methanolic HCL (0.1 M was the solvent used in all three methods. Moxifloxacin showed linearity in the range of 1-14 μg/ml and Bromfenac showed linearity in the range of 1-14 μg/ml in all the methods. All methods were validated statistically and recovery studies were carried out. All methods were found to be accurate, precise and reproducible. These methods were applied to the assay of the drugs in marketed formulation, which were found in the range of 98.0% to 102.0% of the labelled value for both Moxifloxacin and Bromfenac. Hence, the methods herein described can be successfully applied in quality control of combined pharmaceutical dosage forms.

  19. Comparison of the replication and transmissibility of an infectious laryngotracheitis virus vaccine delivered via eye-drop or drinking-water.

    Science.gov (United States)

    Coppo, Mauricio J C; Devlin, Joanne M; Noormohammadi, Amir H

    2012-01-01

    Live attenuated vaccines have been extensively used to control infectious laryngotracheitis (ILT). Most vaccines are registered/recommended for use via eye-drop although vaccination via drinking-water is commonly used in the field. Drinking-water vaccination has been associated with non-uniform protection. Bird-to-bird passage of chick-embryo-origin (CEO) ILT vaccines has been shown to result in reversion to virulence. The purpose of the present study was to examine the replication and transmission of a commercial CEO infectious laryngotracheitis virus (ILTV) vaccine strain following drinking-water or eye-drop inoculation. Two groups of 10 specific-pathogen-free chickens were each vaccinated with Serva ILTV vaccine strain either via eye-drop or drinking-water. Groups of four or five unvaccinated birds were placed in contact with vaccinated birds at regular intervals. Tracheal swabs were collected every 4 days from vaccinated and in-contact birds to assess viral replication and transmission using quantitative polymerase chain reaction. Compared with eye-drop-vaccinated birds, drinking-water-vaccinated birds showed delayed viral replication but had detectable viral DNA for a longer period of time. Transmission to chickens exposed by contact on day 0 of the experiments was similar in both groups. Birds exposed to ILTV by contact with eye-drop vaccinated birds on days 4, 8, 12 and 16 of the experiment had detectable ILTV for up to 8 days post exposure. ILTV was not detected in chickens that were exposed by contact with drinking-water vaccinated birds on day 12 of the experiment or later. Results from this study provide valuable practical information for the use of ILT vaccine.

  20. VORICONAZOLE TOXICITY IN MULTIPLE PENGUIN SPECIES.

    Science.gov (United States)

    Hyatt, Michael W; Georoff, Timothy A; Nollens, Hendrik H; Wells, Rebecca L; Clauss, Tonya M; Ialeggio, Donna M; Harms, Craig A; Wack, Allison N

    2015-12-01

    Aspergillosis is a common respiratory fungal disease in penguins managed under human care. Triazole antifungal drugs, including itraconazole, are most commonly used for treatment; however, itraconazole treatment failures from drug resistance are becoming more common, requiring newer treatment options. Voriconazole, a newer triazole, is being used more often. Until recently, no voriconazole pharmacokinetic studies had been performed in penguins, leading to empiric dosing based on other avian studies. This has led to increased anecdotal reporting of apparent voriconazole toxicity in penguins. This report describes 18 probable and 6 suspected cases of voriconazole toxicity in six penguin species from nine institutions: 12 African penguins (Spheniscus demersus), 5 Humboldt penguins (Spheniscus humboldti), 3 Magellanic penguins (Spheniscus magellanicus), 2 gentoo penguins (Pygoscelis papua papua), 1 macaroni penguin (Eudyptes chrysolophus), and 1 emperor penguin (Aptenodytes forsteri). Observed clinical signs of toxicity included anorexia, lethargy, weakness, ataxia, paresis, apparent vision changes, seizure-like activity, and generalized seizures. Similar signs of toxicity have also been reported in humans, in whom voriconazole therapeutic plasma concentration for Aspergillus spp. infections is 2-6 μg/ml. Plasma voriconazole concentrations were measured in 18 samples from penguins showing clinical signs suggestive of voriconazole toxicity. The concentrations ranged from 8.12 to 64.17 μg/ml, with penguins having plasma concentrations above 30 μg/ml exhibiting moderate to severe neurologic signs, including ataxia, paresis, and seizures. These concentrations were well above those known to result in central nervous system toxicity, including encephalopathy, in humans. This case series highlights the importance of species-specific dosing of voriconazole in penguins and plasma therapeutic drug monitoring. Further investigation, including pharmacokinetic studies, is

  1. Voriconazole as a first-line treatment against potentially pathogenic Acanthamoeba strains from Peru.

    Science.gov (United States)

    Cabello-Vílchez, Alfonso Martín; Martín-Navarro, Carmen M; López-Arencibia, Atteneri; Reyes-Batlle, María; Sifaoui, Ines; Valladares, Basilio; Piñero, José E; Lorenzo-Morales, Jacob

    2014-02-01

    Pathogenic strains of Acanthamoeba genus are the causative agents of fatal granulomatous amoebic encephalitis and a serious sight-threatening infection of the eye known as Acanthamoeba keratitis. In a previous study, Acanthamoeba strains were isolated from nasal swabs collected from healthy individuals in Peru. In the present study, the pathogenic potential of the isolated strains was established based on temperature and osmotolerance assays as well as the secretion rate of extracellular proteases. Based on these experiments, four strains that showed the highest pathogenic potential were selected for sensitivity assays against two molecules (voriconazole and chlorhexidine) which are currently used for the treatment of Acanthamoeba infections. After performing sensitivity and activity assays, it was found that both drugs were active against the tested strains. However, voriconazole showed higher activity against the studied strains compared to chlorhexidine. Therefore, voriconazole should be established as a first-line treatment against Acanthamoeba infections at least in the studied region of Peru.

  2. Voriconazole

    Science.gov (United States)

    ... pump inhibitors such as esomeprazole (Nexium, in Vimovo), lansoprazole (Prevacid), omeprazole (Prilosec, in Prevpac), pantoprazole (Protonix), and ... have ever been treated with chemotherapy medications for cancer, and if you have or have ever had ...

  3. Green synthesized gold nanoparticles decorated graphene oxide for sensitive determination of chloramphenicol in milk, powdered milk, honey and eye drops.

    Science.gov (United States)

    Karthik, R; Govindasamy, Mani; Chen, Shen-Ming; Mani, Veerappan; Lou, Bih-Show; Devasenathipathy, Rajkumar; Hou, Yu-Shen; Elangovan, A

    2016-08-01

    A simple and rapid green synthesis using Bischofia javanica Blume leaves as reducing agent was developed for the preparation of gold nanoparticles (AuNPs). AuNPs decorated graphene oxide (AuNPs/GO) was prepared and employed for the sensitive amperometric determination of chloramphenicol. The green biosynthesis requires less than 40s to reduce gold salts to AuNPs. The formations of AuNPs and AuNPs/GO were evaluated by scanning electron and atomic force microscopies, UV-Visible and energy dispersive X-ray spectroscopies, X-ray diffraction studies, and electrochemical methods. AuNPs/GO composite film modified electrode was fabricated and shown excellent electrocatalytic ability towards chloramphenicol. Under optimal conditions, the amperometric sensing platform has delivered wide linear range of 1.5-2.95μM, low detection limit of 0.25μM and high sensitivity of 3.81μAμM(-1)cm(-2). The developed sensor exhibited good repeatability and reproducibility, anti-interference ability and long-term storage stability. Practical feasibility of the sensor has been demonstrated in food samples (milk, powdered milk and honey) and pharmaceutical sample (eye drops). The green synthesized AuNPs/GO composite has great potential for analysis of food samples in food safety measures.

  4. Effects of Long-Term Antiglaucoma Eye Drops on Conjunctival Structures: An In Vivo Confocal Microscopy Study

    Directory of Open Access Journals (Sweden)

    Wenqing Zhu

    2015-01-01

    Full Text Available Purpose. The study was aimed at comparing the long-term effects of different antiglaucoma eye drops on conjunctival structures using laser scanning confocal microscopy. Methods. Eighty patients diagnosed with primary open-angle glaucoma and twenty healthy volunteers were included in this study. The participants were divided into 5 groups according to the different medications. The lachrymal film break-up time, Schirmer’s I test, and Ocular Surface Disease Index Questionnaire were performed in all subjects. The confocal microscopy was used to observe the basal epithelial cell density (ECD, goblet cell density (GCD, dendritic cell density (DCD, and subepithelial collagen fiber diameter (SFD. Results. Statistically significant differences were found among the control group and the antiglaucoma therapy groups in the values of three clinical data (P<0.05. The GCD, DCD, and SFD showed significant differences in all glaucoma groups when compared to the control (P<0.001. Moreover, the prostaglandin group differed from the other antiglaucoma therapy groups in the GCD and SFD (P<0.05. Conclusions. Our study confirmed the significant differences in the conjunctival structures based on the effects of antiglaucoma medications. Less pronounced changes were found in the patients treated with prostaglandin analogue than in the other kinds of antiglaucoma therapies.

  5. A review of the tolerability and safety of levocabastine eye drops and nasal spray. Implications for patient management

    Directory of Open Access Journals (Sweden)

    Peter H. Howarth

    1995-01-01

    Full Text Available Levocabastine is a highly potent and selective H1-receptor antagonist specifically developed for topical administration by ocular and nasal routes. The clinical effects of levocabastine occur rapidly and are predominantly due to local antihistaminic effects at the site of application. Clinically, levocabastine is well tolerated with an adverse effect profile comparable with that of sodium cromoglycate and placebo. As might be expected from the route of drug administration, local irritation is the most frequent adverse event seen with levocabastine eye drops and nasal spray with an incidence comparable with that in placebo-treated controls. Intranasal application of levocabastine has been shown to have no adverse effect on ciliary activity both in vitro and in vivo, while ocular administration has not been shown to have any significant or consistent adverse effect in both animal and human studies. At therapeutic doses, levocabastine appears to be devoid of significant systemic activity producing no apparent effects on cardiovascular, psychomotor and cognitive function. Since levocabastine undergoes little hepatic metabolism, and only low plasma levels of the drug are attained following topical administration, drug interactions are unlikely.

  6. Ready-made allogeneic ABO-specific serum eye drops: production from regular male blood donors, clinical routine, safety and efficacy.

    Science.gov (United States)

    Harritshøj, Lene Holm; Nielsen, Connie; Ullum, Henrik; Hansen, Morten Bagge; Julian, Hanne Olsen

    2014-12-01

    To overcome problems and delays of the preparation of autologous serum eye drops, a production line of ABO-specific allogeneic serum eye drops from male blood donors was set up in a blood bank. Feasibility, clinical routine, safety and efficacy were evaluated in a cohort of patients with severe ocular surface disorders. Serum was derived from 450 ml whole-blood donations from regular male blood donors, produced and tested according to good manufacturing practice and legislation regulating blood products in Denmark. Serum was diluted to 20% (v/v) with NaCl 0.9%, filtered, bottled, registered and stored at -30°C in the blood bank. Upon request, frozen ABO-identical serum drops in lots of 14 bottles could be provided immediately. Safety and efficacy were evaluated in 34 patients with severe ocular surface disease refractory to conventional medical therapy. Patients were treated six times daily for minimum 2-4 weeks. Objective findings and subjective symptoms were compared between day 0 and after 4 weeks of treatment using the Wilcoxon signed-rank test. Clinically, no side-effects were observed. In total, 59% of the patients with ocular surface changes improved objectively (slit-lamp examination). Partial or full healing of corneal changes, as well as subjective relief of symptoms, was observed in 16 of 20 patients with keratoconjunctivitis sicca (p ABO-identical allogeneic serum eye drops were straightforwardly produced, quality-assured and registered as a safe standard blood product for the treatment of certain cases of severe dry eye disease. Therapeutic efficacy was comparable to previous reports on autologous serum drops. © 2014 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

  7. Benefits of switching from latanoprost to preservative-free tafluprost eye drops: a meta-analysis of two Phase IIIb clinical trials

    Directory of Open Access Journals (Sweden)

    Uusitalo H

    2016-03-01

    Full Text Available Hannu Uusitalo,1 Evgeniy Egorov,2 Kai Kaarniranta,3 Yuri Astakhov,4 Auli Ropo5 On behalf of the Switch Study Tafluprost Study Groups 1Department of Ophthalmology, SILK, University of Tampere, Tampere University Hospital, Tampere, Finland; 2Department of Ophthalmology, The Russian National Research Medical University, Moscow, Russia; 3Department of Ophthalmology, University of Eastern Finland, Kuopio University Hospital, Kuopio, Finland, 4Department of Ophthalmology, First Pavlov State Medical University of St Petersburg, Saint Petersburg, Russia, 5Global Medical Affairs, Santen Oy, Tampere, Finland Introduction: Glaucoma patients frequently exhibit ocular surface side effects during treatment with prostaglandin eye drops. The present work investigated whether glaucoma patients suffering from signs and symptoms of ocular surface disease while using preserved latanoprost eye drops benefited from switching to preservative-free tafluprost eye drops. Patients and methods: The analysis was based on 339 glaucoma patients enrolled in two Phase IIIb trials. The patients were required to have two symptoms, or one sign and one symptom of ocular surface disease at baseline, and at least 6 months preceding treatment with latanoprost eye drops preserved with benzalkonium chloride. All eligible patients were switched from latanoprost to preservative-free tafluprost for a total of 12 weeks. Ocular symptoms and ocular signs were evaluated at baseline and at 2 weeks, 6 weeks, and 12 weeks after commencing treatment with tafluprost. Intraocular pressure (IOP, drop discomfort, and treatment preference were evaluated to investigate the clinical efficacy and patient-related outcomes. Results: After 12 weeks of treatment with preservative-free tafluprost, the incidences of irritation/burning/stinging, foreign body sensation, tearing, itching, and dry eye sensation had diminished to one-third of those reported for preserved latanoprost at baseline. The incidences

  8. 吡诺克辛钠滴眼液渗透压测定%Osmotic Pressure Measurement of Pirenoxinun Sodium Eye Drops

    Institute of Scientific and Technical Information of China (English)

    李智慧; 田海燕; 刘洪海; 李海霞; 刘维彬

    2015-01-01

    Objective:To investigate the feasibility and accuracy of osmometer in the osmolarity measurement of pirenoxinun sodi-um eye drops. Methods:An osmometer was used to measure the osmolarity of pirenoxinun sodium eye drops, and the stability of the osmolality was studied. Results:The osmolarity of pirenoxinun sodium eye drops with different formula conformed to the requirement of ophthalmic preparations. The osmolality showed no significant change at the ambient temperature, indicating the stability of the prepa-ration. Conclusion:The method is simple, rapid and practical, which can be used as the osmolarity measurement method for pirenoxi-nun sodium eye drops.%目的::探讨渗透压计测定吡诺克辛钠滴眼液渗透压摩尔浓度方法的可行性和准确性。方法:使用渗透压计测定吡诺克辛钠滴眼液的渗透压摩尔浓度,并对其渗透压摩尔浓度进行稳定性考察。结果:不同配方吡诺克辛钠滴眼液的渗透压摩尔浓度符合眼用制剂的要求。经过室温留样渗透压摩尔浓度没有明显变化,表明该制剂质量稳定。结论:该方法简便、快速、实用,可作为吡诺克辛钠滴眼液渗透压检测的方法。

  9. 盐酸环喷托酯滴眼液联合复方托吡卡胺滴眼液在学龄期儿童散瞳验光中的应用临床研究%combined application of Cyclopentolate hydrochloride drop eye fluid and Compound Tropicamide Eye Drops in school -age children in mydriatic optometry

    Institute of Scientific and Technical Information of China (English)

    洪茶花

    2014-01-01

    目的:观察盐酸环喷托酯滴眼液联合复方托吡卡胺滴眼液在学龄期儿童散瞳验光中的应用效果。方法60名学龄期儿童,120眼。每例先后用盐酸环喷托酯滴眼液联合复方托吡卡胺滴眼液及1%阿托品扩瞳验光取得验光数值,做自身对照。结果球镜结果相差≤0.25D的总计有115眼,占95.83%;球镜结果相差>0.25D总计有5眼,占4.17%。结论盐酸环喷托酯滴眼液联合复方托吡卡胺滴眼液用于学龄期儿童单纯近视或远视的散瞳效果好,可以替代阿托品,值得临床推广应用。%Objective To observe the ef ect of cyclopentolate hydrochloride eye drops combined with Compound Tropicamide Eye Drops in school-age children in the application ef ect of mydriasis optometry.Methods 60 school-age children,120 eyes.Each case has cyclopentolate hydrochloride eye drops combined with Compound Tropicamide Eye Drops and 1%atropine myd-riatic optometry .optometry values obtained,do their own control.Results the mirror bal result diference is less than 0.25D in 115 eyes,accounting for 95.83%;the mirror bal result difer-ence is >0.25D a total of 5 eyes,accounting for 4.17%.Conclusion cyclopentolate hydrochloride eye drops combined with Compound Tropicamide Eye Drops for school-age children simple myopia or hyperopia mydriatic ef ect is good,can replace atropine,worthy of clinical application.

  10. 复方碘化钾滴眼液无菌检查方法的验证%Validation of sterility test of compound potassium iodide eye drops

    Institute of Scientific and Technical Information of China (English)

    余晓霞; 邱凯锋; 廖庆权

    2014-01-01

    目的:建立复方碘化钾滴眼液无菌检查方法。方法按《中国药典》2010年版二部无菌检查法中薄膜过滤法对复方碘化钾滴眼液的无菌检查方法进行验证。结果该制剂的无菌检查选用薄膜过滤法,以金黄色葡萄球菌为阳性对照菌,冲洗总量100 ml。结论经方法学验证,该法可行,结果可靠。%ObjectiveTo establish the method of sterility test of compound potassium iodide eye drops. MethodsAccording to sterility test in the appendix ofChinese Pharmacopoeia 2010 (section 2), the membrane filteration used in the sterility test of compound potassium iodide eye drops was validated.ResultsThe membrane filteration was used in the sterility test of compound potassium iodide eye drops, and staphylococcus aureus was used as positive control germs and the total amount of irrigation fluid was 100 ml.Conclusion Through the technological validation, the method is applicable and the result is reliable.

  11. Clinical Analysis of Raceanisodamine Eye Drops Effect on Dry Eye%消旋山莨菪碱滴眼液在干眼治疗中的临床应用分析

    Institute of Scientific and Technical Information of China (English)

    梁小庆; 刘焰; 刘堃; 曹晖; 王卫峻; 傅扬; 孙晓东; 许迅

    2011-01-01

    目的:评价0.05%消旋山莨菪碱滴眼液对干眼治疗的临床疗效.方法:选取2009年5月~2010年1月共65例(130眼)干眼患者.使用0.05%消旋山莨菪碱滴眼液每天两次,连续8周.采用SPSS13.0 统计软件对其使用前后不适症状(异物感、烧灼感、畏光、视久模糊、眼痛)及两项体征(角膜荧光素染色(FL)、泪膜破裂时间(BUT))的变化进行处理.统计第0、2、5、8周每只眼每次检查的综合计分.结果:第2、5、8周时FL及BUT与治疗前比,差值均有统计学意义(P< 0.05).干眼患者的综合分平均值在第0、2、5及8周逐渐递减,分别是:11.9、8.6、5.9、4.2.与用药前比较,差异均有统计学意义(P<0.05).结论:0.05%消旋山莨菪碱滴眼液对干眼的不适症状及相关体征具有良好的改善作用.%Objective:To evaluate the clinical efficacy of 0.05% Raceanisodamine Eye Drops on dry eye symptoms and clinical signs.Methods:From May 2009 to January 2010,65 patients(130 eyes)suffering from dry eye were selected.The 0.05%Raceanisodamine Eye Drops was given twice a day for 8 weeks as only treatment.The relative symptoms of dry eye,including foreign body sensation,burning sensation,photophobia,unstable vision,eye pain,and clinical signs of dry eye,including tear film break-up time(BUT) and fluorescein staining of the cornea(FL),were recorded.The differences between before and after using drops were analyzed in statistical processing The main statistical indicator was the composite score,which was the sum of the score of every symptom and sign multiplied by its weight supposed as one.The data records of the dry eye patients' symptoms and signs were sorted out and counted in statistical processing at 0 week,2 weeks,5 weeks,8 weeks.The SPSS 13.0 software was used to analyze the database.The paired-samplest test,frequencies descriptive statistics were used for analysis.Results:There was statistical difference in average score of fluorescein staining of the

  12. Local anaesthetic eye drops for prevention of pain in preterm infants undergoing screening for retinopathy of prematurity.

    LENUS (Irish Health Repository)

    Dempsey, Eugene

    2012-01-31

    BACKGROUND: Screening examinations for retinopathy of prematurity (ROP) are performed routinely in the neonatal intensive care unit and are a recognised cause of pain in the newborn. OBJECTIVES: To determine the effect of instillation of topical anaesthetic eye drops compared with placebo or no treatment on pain in infants undergoing ROP screening. SEARCH STRATEGY: We used the standard search strategy of the Cochrane Neonatal Review Group. This included a search of the Cochrane Neonatal Group register and the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 10, 2010). We identified relevant studies by searching the following: (1) computerised bibliographic databases: MEDLINE (1966 to October 2010), EMBASE (1988 to October 2010) and Web of Science (1975 to March 2010; (2) the Oxford Database of Perinatal Trials. We searched electronically abstracts from PAS from 2000 to 2010 and handsearched abstracts from ESPR from 2000 to 2009. SELECTION CRITERIA: All randomised, or quasi-randomised controlled trials, or randomised cross-over trials. DATA COLLECTION AND ANALYSIS: We used the standard methods of the Cochrane Neonatal Review Group. MAIN RESULTS: We identified two studies for inclusion. Both studies were randomised cross-over trials performed in single centres. Both studies used the Premature Infant Pain Profile (PIPP) score as a measure of pain response. Different methods of evaluating PIPP scores are presented including the absolute PIPP score, a PIPP score > 10 or > 12 and an increase in PIPP >\\/= 4 from the baseline value. There is a nonsignificant reduction in pain scores at one minute and a nonsignificant increase at five minutes post insertion of the speculum. PIPP score > 12 at one minute resulted in a statistically significant reduction in the number of patients who experienced pain (typical risk ratio (RR) 0.56, 95% CI 0.36 to 0.89; typical risk difference (RD) -0.23, 95% CI -0.39 to -0.86; number needed to treat to

  13. Painful periostitis in the setting of chronic voriconazole therapy

    OpenAIRE

    Skaug, Margaret; Spak, Cedric; Oza, Umesh

    2014-01-01

    A 72-year-old woman on chronic voriconazole therapy for recurrent histoplasmosis developed a painful forearm mass. Laboratory and imaging findings were consistent with a diffuse periostitis. Her symptoms resolved after discontinuation of voriconazole. To our knowledge, this is the first case of voriconazole-induced periostitis to be reported in a patient with chronic histoplasmosis.

  14. Voriconazole-related periostitis presenting on magnetic resonance imaging.

    Science.gov (United States)

    Davis, Derik L

    2015-01-01

    Painful periostitis is a complication of long-term antifungal therapy with voriconazole. A high clinical suspicion coupled with imaging and laboratory assessment is useful to establish the diagnosis. Prompt discontinuance of voriconazole typically results in the resolution of symptoms and signs. This report describes the presentation of voriconazole-related periostitis on magnetic resonance imaging.

  15. Voriconazole-related periostitis presenting on magnetic resonance imaging

    OpenAIRE

    Davis, Derik L

    2015-01-01

    Painful periostitis is a complication of long-term antifungal therapy with voriconazole. A high clinical suspicion coupled with imaging and laboratory assessment is useful to establish the diagnosis. Prompt discontinuance of voriconazole typically results in the resolution of symptoms and signs. This report describes the presentation of voriconazole-related periostitis on magnetic resonance imaging.

  16. Painful periostitis in the setting of chronic voriconazole therapy.

    Science.gov (United States)

    Skaug, Margaret; Spak, Cedric; Oza, Umesh

    2014-10-01

    A 72-year-old woman on chronic voriconazole therapy for recurrent histoplasmosis developed a painful forearm mass. Laboratory and imaging findings were consistent with a diffuse periostitis. Her symptoms resolved after discontinuation of voriconazole. To our knowledge, this is the first case of voriconazole-induced periostitis to be reported in a patient with chronic histoplasmosis.

  17. Multiple endpoint analysis of BAC-preserved and unpreserved antiallergic eye drops on a 3D-reconstituted corneal epithelial model

    OpenAIRE

    Pauly, A.; Brasnu, E.; Riancho, L.; Brignole-Baudouin, F.; Baudouin, C

    2011-01-01

    Purpose To compare the effects of benzalkonium chloride (BAC)-preserved and unpreserved antiallergic eye drops on the human 3D-reconstituted corneal epithelial model (3D-HCE). Methods 3D-HCE were treated for 24 h followed or not by a 24 h post-incubation recovery period (24 h+24 h) with phosphate-buffered saline (PBS), 0.01% BAC, unpreserved formulations of ketotifen, N Acetyl-Aspartyl Glutamic Acid (NAAGA), cromoglycate, or BAC-preserved commercial formulations of ketotifen, olopatadine, epi...

  18. Bioavailability of voriconazole in hospitalised patients

    NARCIS (Netherlands)

    Veringa, Anette; Geling, Sanne; Span, Lambert F R; Vermeulen, Karin M; Zijlstra, Jan G; van der Werf, Tjip S; Kosterink, Jos G W; Alffenaar, Jan-Willem C

    2016-01-01

    An important element in antimicrobial stewardship programmes is early switch from intravenous (i.v.) to oral antimicrobial treatment, especially for highly bioavailable drugs. The antifungal agent voriconazole is available both in i.v. and oral formulations and bioavailability is estimated to be >90

  19. Treatment of invasive fungal infections: stability of voriconazole infusion solutions in PVC bags

    Directory of Open Access Journals (Sweden)

    Andréa I.H. Adams

    2008-10-01

    Full Text Available Voriconazole is a novel broad-spectrum antifungal drug, employed in the treatment of invasive fungal infections, and represents an alternative to amphotericin B treatment. The manufacturer recommends that any unused reconstituted product should be stored at 2ºC to 8ºC, for no more than 24 h, but no recommendations about i.v. infusion solutions are given. Previous works have reported on the stability of voriconazole in polyolefin bags and just one in 5% dextrose polyvinyl chloride (PVC bags, at a 4 mg.mL-1 concentration. In this work, the stability of voriconazole as an i.v. infusion solution in 0.9% sodium chloride and in 5% dextrose, in PVC bags, at 0.5 mg.mL-1, stored at 4 ºC and at room temperature, protected from light, was evaluated. These infusion solutions were analyzed for a 21-day period. Chemical stability was evaluated by HPLC assay. Visual inspection was performed and pH of the solutions was measured. No color change or precipitation in the solutions was observed. The drug content remained above 90% for 11 days in 0.9% sodium chloride and for 9 days in 5% dextrose solutions. The i.v. infusion solutions stored at room temperature were not stable. At room temperature, the voriconazole content dropped down to 88.3 and 86.6%, in 0.9% sodium chloride or 5% dextrose solutions, respectively, two days after admixture. Assays performed at the end of the study suggest the sorption of voriconazole by the PVC bags. The results of this study allow cost-effective batch production in the hospital pharmacy.

  20. Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits.

    Science.gov (United States)

    Parrilha, Leticia Rodrigues; Nai, Gisele Alborghetti; Giuffrida, Rogério; Barbero, Rafael Cabral; Padovani, Leticia Dias Fabris; Pereira, Ricardo Henrique Zaquir; Silva, Danielle Alves; Silva, Mariele Catherine Alves; Diniz, Miriely Stein; Andrade, Silvia Franco

    2015-01-01

    To evaluate the effectiveness of topical 1% cyclosporine eye drops diluted in either of the two vehicles-olive and linseed oil-and that of the oils themselves in treating experimentally-induced keratoconjunctivitis sicca (KCS) in rabbits. KCS was induced in 25 New Zealand rabbits using 1% atropine sulfate eye drops for 7 days before treatment and throughout the treatment period (12 weeks). The rabbits were divided into five groups: one control (C) group without KCS induction and four treatment groups in which KCS was induced and treated topically with olive oil (O), linseed oil (L), cyclosporine in olive oil (CO), and cyclosporine in linseed oil (CL). The animals were evaluated using Schirmer tear test 1 (STT), the fluorescein test (FT), tear-film break-up time (TBUT), the rose bengal test (RBT), and histopathological analysis. Values of STT and TBUT significantly decreased 1 week post-induction (poil or linseed oil was effective in the treatment of KCS, although it had better efficacy when diluted in linseed oil. Linseed oil presented better effectiveness, whether associated or not, than olive oil. These results may contribute to the creation of novel topical ophthalmic formulations for KCS treatment in future.

  1. The Effect of Autologous Serum Eye Drop Application on Epithelization in the Treatment of Various Ocular Surface Disorders and its Safety

    Directory of Open Access Journals (Sweden)

    Fatma Selin Kaya

    2012-10-01

    Full Text Available Pur po se: To evaluate the effect of autologous serum application on epithelization in the treatment of ocular surface disorders in hard cases and its safety. Ma te ri al and Met hod: Patients with serious ocular surface disorders, unresponsive to conventional treatment were recruited. Clinical features of retrospective cohort of patients who were prescribed serum drops are presented. From July 2007 to January 2010, 31 eyes of 21 patients, who were given autologous serum eye drops, were included into the study. Clinical examination included epithelial changes, rose bengal/lissamine green staining, fluorescein staining, and tear film break-up time. A history of systemic disease was recorded together with systemic medications used. A complete ocular history was also obtained. Re sults: Autologous serum was used in 7 patients with delayed epithelization after penetrating keratoplasty, in 4 patients with epithelial disturbances secondary to keratitis, in 2 patients with alkali burns, in 3 patients with Stevens-Johnson syndrome, in 1 patient with ligneous conjunctivitis, in 1 patient with epidermolysis bullosa, in 1 patient with corneal burn with hot water, and in 2 patients with Sjogren syndrome. The female:male ratio was 13:8. The mean age was 36.23±24.80 standard deviation (range: 7 months-87 years. No significant sight-threatening complication has been observed with the use of serum drops. Dis cus si on: Autologous serum application is safe and efficient additional therapy in the treatment of serious ocular surface problems in difficult cases. (Turk J Ophthalmol 2012; 42: 336-41

  2. A validated stability-indicating high performance liquid chromatographic method for moxifloxacin hydrochloride and ketorolac tromethamine eye drops and its application in pH dependent degradation kinetics

    Directory of Open Access Journals (Sweden)

    Jayant B Dave

    2013-01-01

    Full Text Available Background and Aim: A fixed dose combination of moxifloxacin hydrochloride and ketorolac tromethamine is used in ratio of 1:1 as eye drops for the treatment of the reduction of post operative inflammatory conditions of the eye. A simple, precise, and accurate High Performance Liquid Chromatographic (HPLC method was developed and validated for determination of moxifloxacin hydrochloride and ketorolac tromethamine in eye drops. Materials and Methods: Isocratic HPLC separation was achieved on a ACE C 18 column (C 18 (5 μm, 150 mm×4.6 mm, i.d. using the mobile phase 10 mM potassium di-hydrogen phosphate buffer pH 4.6-Acetonitrile (75:25 v/v at a flow rate of 1.0 mL/min. The detection was performed at 307 nm. Drugs were subjected to acid, alkali and neutral hydrolysis, oxidation and photo degradation. Moreover, the proposed HPLC method was utilized to investigate the pH dependent degradation kinetics of moxifloxacin hydrochloride and ketorolac tromethamine in buffer solutions at different pH values like 2.0, 6.8 and 9.0. Results and Conclusion: The retention time (t R of moxifloxacin hydrochloride and ketorolac tromethamine were 3.81±0.01 and 8.82±0.02 min, respectively. The method was linear in the concentration range of 2-20 μ/mL each for moxifloxacin hydrochloride and ketorolac tromethamine with a correlation coefficient of 0.9996 and 0.9999, respectively. The method was validated for linearity, precision, accuracy, robustness, specificity, limit of detection and limit of quantitation. The drugs could be effectively separated from different degradation products and hence the method can be used for stability analysis. Different kinetics parameters like apparent first-order rate constant, half-life and t 90 (time for 90% potency left were calculated.

  3. [Role of voriconazole in critically ill patients with invasive mycoses].

    Science.gov (United States)

    Alvarez Lerma, Francisco

    2007-09-30

    This observational study of the use of voriconazole conducted in Spain has identified reasons, characteristics, and forms of use of voriconazole in critically ill patients admitted to the ICU. Voriconale was used for directed treatment (63%), by the intravenous route (75%), as rescue treatment (41%) in severely ill patients (APACHE 21) with high need of resources and therapeutic interventions. Satisfactory clinical response was obtained in 50% of cases, related adverse events were scarce (16%), and withdrawal of voriconazole was not necessary. Clinical indications included empirical, etiologic, and rescue treatment of infections caused by Aspergillus, Candida albicans and most species different than C. albicans. Voriconazole can be used for preemptive therapy in patients at risk of invasive candidasis. When selecting voriconazole, liver function, renal function (i.v. formulation) and history of azoles use should be considered, although none of these circumstances is an absolute contraindication for the prescription of voriconazole in critically ill patients.

  4. Voriconazole-induced psychosis in a case of acute myeloid leukemia with febrile neutropenia

    Directory of Open Access Journals (Sweden)

    Hemendra Singh

    2015-01-01

    Full Text Available Voriconazole-induced psychosis is a rare side effect. It is important that clinicians are made aware of voriconazole-induced potential psychosis. We report a case of voriconazole-induced psychosis that responded to haloperidol.

  5. Efficacy of 2-Month Treatment With Cord Blood Serum Eye Drops in Ocular Surface Disease: An In Vivo Confocal Microscopy Study.

    Science.gov (United States)

    Giannaccare, Giuseppe; Buzzi, Marina; Fresina, Michela; Velati, Claudio; Versura, Piera

    2017-08-01

    To investigate the morphological changes of corneal epithelium and subbasal nerves by in vivo confocal microscopy in patients with ocular surface disease (OSD) treated with cord blood serum (CBS) eye drops. Twenty patients with OSD (mean age 61.1 ± 12.6 years) were included in this prospective 1-arm study and treated with CBS eye drops for 2 months. Corneal sensitivity, Schirmer test score, breakup time, subjective symptoms [Ocular Surface Disease Index (OSDI) and Visual Analogue Scale (VAS)], and corneal staining were evaluated before (T0) and after (T1) treatment. In vivo confocal microscopy analyzed giant epithelial cells, subbasal nerve number and tortuosity, neuromas, beading, and dendritic cells (DCs) in the central cornea. OSDI, Visual Analogue Scale, and Oxford grading values significantly decreased at T1 versus T0 (respectively, 44.1 ± 18.9 vs. 74.2 ± 13.9; 3.7 ± 1.5 vs. 8.9 ± 0.9; and 2.4 ± 1.1 vs. 3.3 ± 1.3; P < 0.0001), whereas corneal sensitivity, Schirmer test score, and breakup time significantly increased (respectively, 49.5 ± 2.6 vs. 47.9 ± 2.9; 3.2 ± 2.0 vs. 2.4 ± 2.2; 4.6 ± 3.1 vs. 3.8 ± 2.1; P < 0.0001). Corneal nerve morphology improved at T1 versus T0 with a higher total nerve number (3.4 ± 1.6 vs. 2.5 ± 1.6 per frame) and lower tortuosity (3.0 ± 0.7 vs. 3.5 ± 0.6) (P < 0.01). The number of patients presenting with giant epithelial cells, beading, and neuromas decreased at T1. DC density did not change after treatment. The detection of neuromas and higher DC density at T0 were associated with greater OSDI reduction at T1 (P < 0.001). CBS eye drops significantly improved corneal nerve morphology and subjective symptoms in patients with severe OSD. The presence of neuromas and higher dendritic cell density at baseline were associated with greater reduction of discomfort symptoms after treatment.

  6. Fluorosis and periostitis deformans as complications of prolonged voriconazole treatment.

    Science.gov (United States)

    Rad, Babak; Saleem, Mohamed; Grant, Susan; Florkowski, Christopher; Coates, Penelope; Gordon, David; Rankin, Wayne

    2015-09-01

    We describe a case of development of painful periostitis deformans in a 39-year-old woman who was receiving long-term voriconazole treatment for Aspergillus infection as a complication of orthotopic liver transplant. Measurement of fluoride levels strongly supports fluorosis to be the mechanism of the voriconazole-induced periostitis deformans and supports the concept that such measurements might be of use in predicting this complication of long-term voriconazole treatment.

  7. Voriconazole Increases while Itraconazole Decreases Plasma Meloxicam Concentrations▿

    OpenAIRE

    Hynninen, V. V.; Olkkola, K T; Bertilsson, L; Kurkinen, K. J.; Korhonen, T; Neuvonen, P. J.; Laine, K

    2008-01-01

    This study investigated the effect of voriconazole, an inhibitor of cytochrome P450 2C9 (CYP2C9) and CYP3A4, and itraconazole, an inhibitor of CYP3A4, on the pharmacokinetics and pharmacodynamics of meloxicam. Twelve healthy volunteers in a crossover study ingested 15 mg of meloxicam without pretreatment (control), after voriconazole pretreatment, and after itraconazole pretreatment. The plasma concentrations of meloxicam, voriconazole, itraconazole, and thromboxane B2 (TxB2) generation were ...

  8. Voriconazole salvage treatment of invasive candidiasis.

    Science.gov (United States)

    Ostrosky-Zeichner, L; Oude Lashof, A M L; Kullberg, B J; Rex, J H

    2003-11-01

    Data on the salvage treatment of invasive candidiasis with voriconazole in 52 patients intolerant of other antifungal agents or with infection refractory to other antifungal agents were analyzed. Patients had received a mean of two previous antifungal agents (range, 1-4 agents), and 83% had received an azole. Manifestations of invasive candidiasis included candidemia (37%), disseminated disease (25%), and infection of other sites (38%). The median duration of voriconazole therapy was 60 days (range, 1-314 days). The overall rate of response was 56% (95%CI, 41-70), with the following response rates observed for individual Candida species: Candida albicans, 44% (20-70); Candida glabrata, 38% (14-68); Candida krusei, 70% (35-93); Candida tropicalis, 67% (30-93); and other Candida spp., 100% (40-100). The response rate in patients who had failed previous azole therapy was 58% (42-73). Common adverse events (~20%) included nausea and emesis, abnormal liver enzymes, and visual disturbances. Serious adverse events occurred in four patients, and nine patients died. Voriconazole has promise as a salvage agent for the treatment of invasive candidiasis, even in the settings of previous azole therapy and infection due to Candida krusei.

  9. Patients undergoing long-term treatment with antihypertensive eye drops responded positively with respect to their ocular surface disorder to oral supplementation with antioxidants and essential fatty acids

    Directory of Open Access Journals (Sweden)

    Galbis-Estrada C

    2013-06-01

    as dryness, burning, photophobia, eye heaviness, and blurred vision, as well as positive changes in eyelashes, hair, nails and skin, were significantly improved in DEDG +S and POAGG +S patients relative to unsupplemented patients.Conclusion: Inflammation biomarkers were differentially expressed in glaucomatous tears, but the differences changed upon antioxidant/essential polyunsaturated fatty acid supplementation. Chronic instillation of antihypertensive eye drops must be considered for integrating protocols to glaucoma standards of care.Keywords: glaucoma, dry eye disorders, tears, cytokines, antioxidants, essential fatty acids

  10. HPLC法测定泊沙康唑滴眼液的含量%Content Determination of Posaconazole Eye Drops by HPLC

    Institute of Scientific and Technical Information of China (English)

    吴伟; 何梅凤; 郭泽莉; 钟建文

    2013-01-01

    目的:建立测定泊沙康唑滴眼液含量的方法.方法:采用高效液相色谱法.色谱柱为Diamonsil C18,流动相为乙腈-水(60∶40),流速为1.0 ml/min,检测波长为262nm,柱温为25℃.结果:泊沙康唑检测质量浓度线性范围为8.181~81.81 μg/ml(r=0.999 9),平均回收率为99.4%,RSD=0.77% (n=9).结论:本方法简便、快速,结果准确,可用于泊沙康唑滴眼液的质量控制.%OBJECTIVE:To establish a method for the content determination of Posaconazole eye drops.METHODS:HPLC method was adopted.The determination was performed on Diamonsil C18 column with mobile phase consisted of acetonitrile-water (60 ∶ 40) at the flow rate of 1.0 ml/min.The detection wavelength was set at 262 nm and column temperature was 25 ℃.RESULTS:The calibration curve of posaconazole was linear within the concentration range of 8.181-81.81 μg/ml (r=0.999 9) with an average recovery of 99.4% (RSD=0.77%,n=9).CONCLUSIONS:The method is simple,rapid and accurate,and it can be used for the quality control of Posaeonazole eye drops.

  11. 双氯芬酸钠滴眼液中苯扎氯铵的测定%Determination of benzalkonium chloride in diclofenac sodium eye drops

    Institute of Scientific and Technical Information of China (English)

    李玮玲

    2013-01-01

    Objective To develop a method to determine benzalkonium chloride in diclofenac sodium eye drops. Methods Separation was performed on a CNW column (150 mmX4.6 mm, 5 urn). The mobile phase consisted of acetonitrile: 5 mmol · L-1 ammonium acetate-1% triethylamine (adjusting pH to 5.0 ± 0.5 by acetic acid) = 65 : 35 (v/v). The UV detection was 214 nm. Results Benzalkonium chloride had a good linearity at 12.50 - 125.00 μg · mL-1, the average recovery of benzalkonium chloride was 99.0% and the RSD was 1.3%. Conclusion The method is simple, rapid and sensitive, and it could be applied to determine benzalkonium chloride in diclofenac sodium eye drops.%目的 采用HPLC双氯芬酸钠滴眼液中苯扎氯铵的含量.方法 乙腈-5mmol·L-1醋酸铵溶液(含1%三乙胺,用冰醋酸调节pH值至5.0±0.5)(65:35)为流动相,CNW色谱柱(150 mm×4.6 mm,5 μm),检测波长为214 nm.结果 苯扎氯铵的测定在12.50~125.00 μg·mL-1与峰面积线性关系良好,苯扎氯铵的平均回收率为99.0%,RSD为1.3%.结论 方法简单、灵敏度高,可用于双氯芬酸钠滴眼液中苯扎氯铵的测定.

  12. Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits

    Directory of Open Access Journals (Sweden)

    Leticia Rodrigues Parrilha

    2015-10-01

    Full Text Available ABSTRACTPurpose:To evaluate the effectiveness of topical 1% cyclosporine eye drops diluted in either of the two vehicles-olive and linseed oil-and that of the oils themselves in treating experimentally-induced keratoconjunctivitis sicca (KCS in rabbits.Methods:KCS was induced in 25 New Zealand rabbits using 1% atropine sulfate eye drops for 7 days before treatment and throughout the treatment period (12 weeks. The rabbits were divided into five groups: one control (C group without KCS induction and four treatment groups in which KCS was induced and treated topically with olive oil (O, linseed oil (L, cyclosporine in olive oil (CO, and cyclosporine in linseed oil (CL. The animals were evaluated using Schirmer tear test 1 (STT, the fluorescein test (FT, tear-film break-up time (TBUT, the rose bengal test (RBT, and histopathological analysis.Results:Values of STT and TBUT significantly decreased 1 week post-induction (p<0.05 and were similar to initial values after the 4th week of treatment, in all groups. After KCS induction, there was significantly less corneal damage in group L than in group CL, as assessed FT and RBT. Histopathology demonstrated that Groups L and CL presented less edema and corneal congestion. There was no significant difference in the goblet cell density (cells/mm2 between the groups (p=0.147.Conclusion:Cyclosporine diluted in olive oil or linseed oil was effective in the treatment of KCS, although it had better efficacy when diluted in linseed oil. Linseed oil presented better effectiveness, whether associated or not, than olive oil. These results may contribute to the creation of novel topical ophthalmic formulations for KCS treatment in future.

  13. Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.

    Science.gov (United States)

    Prajna, N Venkatesh; Krishnan, Tiruvengada; Rajaraman, Revathi; Patel, Sushila; Shah, Ranjeet; Srinivasan, Muthiah; Devi, Lumbini; Das, Manoranjan; Ray, Kathryn J; O'Brien, Kieran S; Oldenburg, Catherine E; McLeod, Stephen D; Zegans, Michael E; Acharya, Nisha R; Lietman, Thomas M; Rose-Nussbaumer, Jennifer

    2017-06-01

    Fusarium keratitis is common and often results in poor outcomes. No new treatments since natamycin have become available. To explore the role of adjuvant oral voriconazole on clinical outcomes in Fusarium keratitis. In this prespecified subgroup analysis of a multicenter, double-masked, placebo-controlled randomized clinical trial, 240 patients from the Aravind Eye Care System in India, the Lumbini Eye Hospital and Bharatpur Eye Hospital in Nepal, and the University of California, San Francisco, who had culture-positive fungal ulcer and baseline visual acuity of 20/400 or worse were randomized to receive oral voriconazole vs placebo. Enrollment started May 24, 2010, and the last patient study visit was November 23, 2015. All patients received topical voriconazole, 1%, and after the results of the Mycotic Ulcer Treatment Trial (MUTT) II became available, topical natamycin, 5%, was added for all patients. Data analysis was performed from September 2 to October 28, 2016. The primary outcome of the trial was the rate of corneal perforation or the need for therapeutic penetrating keratoplasty. Secondary outcomes included rate of reepithelialization, best spectacle-corrected visual acuity, and infiltrate or scar size at 3 months. Of the 240 study participants, 72 (30.4%) were culture positive for Fusarium species (41 [56.9%] male and 31 [43.1%] female; median [interquartile range] age, 50 [45-57] years). Of these, 33 (45.8%) were randomized to oral voriconazole and 39 (54.2%) to placebo. Fusarium ulcers randomized to oral voriconazole had a 0.43-fold decreased hazard of perforation or therapeutic penetrating keratoplasty compared with placebo after controlling for baseline infiltrate depth (95% CI, 0.22-fold to 0.84-fold; P = .01). Multiple linear regression revealed a 1.89-mm decreased infiltrate and/or scar size at 3 weeks (95% CI, -2.69 to -1.09 mm; P Fusarium keratitis may benefit from the addition of oral voriconazole to topical natamycin, and physicians

  14. Successful Treatment of Lasiodiplodia theobromae Keratitis – Assessing the Role of Voriconazole

    Directory of Open Access Journals (Sweden)

    Stephen Tak-lun Li

    2016-10-01

    Full Text Available Purpose: The aim of this paper is to report the successful management of the first case of Lasiodiplodia theobromae keratitis in Hong Kong. Methods: We conducted a case report. Results: A 43-year-old Chinese male with a history of diabetes developed left eye keratitis after a trauma during tree felling. Fungal keratitis was diagnosed using a confocal microscope on day 1, and L. theobromae was confirmed from the culture. He was given oral voriconazole, topical natamycin, and topical and intracameral amphotericin B. The patient’s condition improved after the initial treatment. However, there was a slow progression to descemetocele formation and impending perforation due to corneal melting. Penetrating keratoplasty was performed at 8 weeks after presentation. Final visual recovery was good with no recurrence of infection. The cornea remained clear. Conclusions: We report the first case of L. theobromae keratitis in Hong Kong, and it is the only case so far that involved the use of oral voriconazole in the combination therapy. Early recognition with the aid of confocal microscopy allowed the early start of treatment. The use of newer antifungal voriconazole topically and orally combined with topical amphotericin B appeared to be useful in the eradication of the fungus and prevention of recurrence. Intracameral antifungals might have improved the clinical management.

  15. Successful Treatment of Lasiodiplodia theobromae Keratitis – Assessing the Role of Voriconazole

    Science.gov (United States)

    Li, Stephen Tak-lun; Yiu, Evan Po-fat; Wong, Angela Hiu-yan; Yeung, John Chun-Ting; Yu, Lester Wang-hon

    2016-01-01

    Purpose The aim of this paper is to report the successful management of the first case of Lasiodiplodia theobromae keratitis in Hong Kong. Methods We conducted a case report. Results A 43-year-old Chinese male with a history of diabetes developed left eye keratitis after a trauma during tree felling. Fungal keratitis was diagnosed using a confocal microscope on day 1, and L. theobromae was confirmed from the culture. He was given oral voriconazole, topical natamycin, and topical and intracameral amphotericin B. The patient's condition improved after the initial treatment. However, there was a slow progression to descemetocele formation and impending perforation due to corneal melting. Penetrating keratoplasty was performed at 8 weeks after presentation. Final visual recovery was good with no recurrence of infection. The cornea remained clear. Conclusions We report the first case of L. theobromae keratitis in Hong Kong, and it is the only case so far that involved the use of oral voriconazole in the combination therapy. Early recognition with the aid of confocal microscopy allowed the early start of treatment. The use of newer antifungal voriconazole topically and orally combined with topical amphotericin B appeared to be useful in the eradication of the fungus and prevention of recurrence. Intracameral antifungals might have improved the clinical management. PMID:27843433

  16. Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma.

    Science.gov (United States)

    Lorenz, Katrin; Wasielica-Poslednik, Joanna; Bell, Katharina; Renieri, Giulia; Keicher, Alexander; Ruckes, Christian; Pfeiffer, Norbert; Thieme, Hagen

    2017-01-01

    To demonstrate that preoperative treatment for 28 days with topical dorzolamide/timolol is non-inferior (Δ = 4 mm Hg) to oral acetazolamide and topical dexamethasone (standard therapy) in terms of intraocular pressure (IOP) reduction 3 and 6 months after trabeculectomy in glaucoma patients. Sixty-two eyes undergoing trabeculectomy with mitomycin C were included in this monocentric prospective randomized controlled study. IOP change between baseline and 3 months post-op was defined as the primary efficacy variable. Secondary efficacy variables included the number of 5-fluorouracil (5-FU) injections, needlings, suture lyses, preoperative IOP change, hypertension rate and change of conjunctival redness 3 and 6 months post-op. Safety was assessed based on the documentation of adverse events. Preoperative treatment with topical dorzolamide/timolol was non-inferior to oral acetazolamide and topical dexamethasone in terms of IOP reduction 3 months after trabeculectomy (adjusted means -8.12 mmHg versus -8.30 mmHg; Difference: 0.18; 95% CI -1.91 to 2.26, p = 0.8662). Similar results were found 6 months after trabeculectomy (-9.13 mmHg versus -9.06 mmHg; p = 0.9401). Comparable results were also shown for both groups concerning the classification of the filtering bleb, corneal staining, and numbers of treatments with 5-FU, needlings and suture lyses. More patients reported AEs in the acetazolamide/dexamethasone group than in the dorzolamide/timolol group. Preoperative, preservative-free, fixed-dose dorzolamide/timolol seems to be equally effective as preoperative acetazolamide and dexamethasone and has a favourable safety profile.

  17. Voriconazole metabolism is influenced by severe inflammation : a prospective study

    NARCIS (Netherlands)

    Veringa, Anette; Ter Avest, Mendy; Span, Lambert F R; van den Heuvel, Edwin R; Touw, Daan J; Zijlstra, Jan G; Kosterink, Jos G W; van der Werf, Tjip S; Alffenaar, Jan-Willem C

    2016-01-01

    BACKGROUND: During an infection or inflammation, several drug-metabolizing enzymes in the liver are down-regulated, including cytochrome P450 iso-enzymes. Since voriconazole is extensively metabolized by cytochrome P450 iso-enzymes, the metabolism of voriconazole can be influenced during inflammatio

  18. Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.

    LENUS (Irish Health Repository)

    Glackin, L

    2009-01-01

    Allergic bronchopulmonary aspergillosis (ABPA) can cause a significant clinical deterioration in patients with cystic fibrosis. There is very little research in the current literature with regard to alternatives for treatment, apart from long courses of steroids. We conducted a retrospective review of all our patients with ABPA treated with the antifungal voriconazole and found there was a significant drop in IgE levels post treatment as well as a decrease in steroid dosing. The improvement in FEV was not statistically significant; however there was a very wide variation in pre-treatment levels.

  19. 杞菊滴眼液治疗实验性干眼症泪液减少和角膜上皮病变%Qiju eye drops on treatment of low lacrimal secretion and corneal epithelial lesion of experimental dry eye

    Institute of Scientific and Technical Information of China (English)

    刘宏伟; 彭淑玲; 周毅; 张士贤; 张海娟

    2011-01-01

    目的 观察杞菊滴眼液对干眼症家兔泪液分泌,及干眼症大鼠角膜修复的影响.方法 泪腺注射阿托品制作干眼症家兔模型.将20只实验家兔分为溶剂对照组、卡波姆滴眼液组、杞菊滴眼液低、中、高剂量组,分别予双眼点杞菊滴眼液的溶剂、0.2%卡波姆滴眼液、杞菊滴眼液(每日2次、4次、8次),测定造模前、第1次泪腺注射阿托品后及治疗第3天、第7天时schirmer试验的值.摘除大鼠双侧泪腺,双眼点1%苯扎溴铵溶液制作角膜上皮损伤干眼症大鼠模型,将40只大鼠分为溶剂对照组、羧甲基纤维素钠滴眼液组、杞菊滴眼液低、中、高剂量组.羧甲基纤维素钠滴眼液组予双眼点0.5%羧甲基纤维素钠滴眼液,其余各组用药情况同家兔,记录治疗第7、14和21天角膜荧光素染色的评分值.结果 家兔治疗第3天,卡波姆滴眼液组与溶剂对照组相比.schirmer试验值增加,差异有统计学意义(P<0.05),治疗第7天,杞菊滴眼液中、高剂量组与溶剂对照组相比,schirmer试验值增加,差异有统计学意义(P<0.05).大鼠治疗14天,杞菊滴眼液低、中、高剂量组的角膜荧光素染色评分低于溶剂对照组(P<0.05),治疗21天,杞菊滴眼液低、中、高剂量组和羧甲基纤维素钠滴眼液组的角膜荧光素染色评分均低于溶剂对照组(P<0.05).结论 杞菊滴眼液可缓解实验性干眼症泪液减少,减轻角膜上皮损伤.%OBJECTIVE To examine the effect of Qiju eye drops on the increasing lacrimal secretion and the repairing of corneal epithelial lesion of dry eye rabbit. METHODS The rabbit dry eye model was prepared by injecting atropine in lacrimal gland. The 20 rabbits were grouped into solution group, caromer eye drop group and Qiju eye drop groups of three different dosages. Solutions, 0.2% carbomer eye drops and three dosages of Qiju eye drops (2,4 and 8 times per day)were diffused into both eyes. The schirmer values were

  20. Effect of In Vitro Transcorneal Approach of Aceclofenac Eye Drops through Excised Goat, Sheep, and Buffalo Corneas

    Directory of Open Access Journals (Sweden)

    Vivek Dave

    2015-01-01

    Full Text Available The current study involves the evaluation of factors that influence the transcorneal permeation of aqueous drops of aceclofenac ophthalmic formulation through freshly excised goat, sheep, and buffalo corneas. Aceclofenac formulation with different concentrations 0.1–0.5% (w/v and with different pH and different preservatives, was taken into account. The amount of drug permeated from different formulations was estimated using an Franz diffusion cell. A linear increase in drug permeation was observed with increase in pH (5.5 to 7.4. The apparent permeability coefficient was found to be maximum 15.01±0.45 on goat cornea and maximum transport of aceclofenac was observed at physiological pH of tears (i.e., 7. The results advocate that aceclofenac 0.5% (w/v ophthalmic solution (pH 7.0 containing BAK (0.01% provides maximum in vitro ocular permeability through goat, sheep, and buffalo corneas.

  1. Voriconazole-induced periostitis in a patient with overlap syndromes.

    Science.gov (United States)

    Hirota, Keisho; Yasoda, Akihiro; Fujii, Toshihito; Inagaki, Nobuya

    2014-03-05

    A 52-year-old woman with overlap syndrome and interstitial pneumonia underwent immunosuppressive therapy and she was suspected to suffer from pulmonary aspergillosis. Oral voriconazole was initiated, and a rapid elevation of alkaline phosphatase (ALP) occurred after 4 weeks. After 2 months, the patient presented diffuse pain in bilateral skeletal regions, and bone scintigraphy revealed bilateral multiple areas of increased radiotracer uptake. We suspected the skeletal involvement as voriconazole-induced periostitis. Actually, the plasma fluoride level was increased. Voriconazole was replaced with itraconazole, and after 3 weeks, the patient stopped complaining of bone pain concomitant with the decrease in ALP. Voriconazole-induced periostitis is a rare condition but had previously been reported in solid organ or patients with bone marrow transplant who received a long-term voriconazole therapy. Our present case is distinctive of previous ones, because it occurred in a patient with connective tissue disease which had its rapid progression.

  2. Filamentous fungal endophthalmitis: results of combination therapy with intravitreal amphotericin B and voriconazole

    Directory of Open Access Journals (Sweden)

    Mithal K

    2015-04-01

    Full Text Available Kopal Mithal,1 Avinash Pathengay,1 Abhishek Bawdekar,1 Animesh Jindal,1 Divya Vira,2 Nidhi Relhan,3 Himadri Choudhury,1 Namrata Gupta,1 Varun Gupta,1 Nagendra K Koday,4 Harry W Flynn Jr3 1Retina and Uveitis Services, 2Cornea Services, LV Prasad Eye Institute, GMR Varalakshmi Campus, Visakhapatnam, India; 3Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA; 4Ocular Microbiology Service, LV Prasad Eye Institute, GMR Varalakshmi Campus, Visakhapatnam, India Purpose: To report outcomes of exogenous fungal endophthalmitis treated with combination of intravitreal antifungal agents. Design: Retrospective, non-randomized, interventional, consecutive case series. Methods: Twelve eyes of twelve consecutive cases of filamentous fungal endophthalmitis were treated with a combination of intravitreal amphotericin-B and intravitreal voriconazole (AmB-Vo Regime along with pars plana vitrectomy at a single center. Clinical characteristics, microbiology results, treatment strategy, visual, and anatomical outcomes were analyzed. Results: Ten cases out of the twelve were postoperative endophthalmitis of which nine were part of a post cataract surgery cluster. The remaining included endophthalmitis following keratitis post pterygium excision (1 and following open globe injury (2. The most common fungus was Aspergillus terreus, which was isolated in 8/12, followed by A. flavus in 2/12 and Fusarium solani in 1/12. The presenting visual acuity ranged from light perception (LP to counting fingers. The visual acuity at final follow-up was 20/400 or better in 7/12 eyes (58.33% and 20/60 in 2/12 eyes (range 20/60 to LP. All eyes with corneal involvement had final visual acuity 20/400 or worse. Globe salvage was achieved in all cases. Conclusion: Combining intravitreal amphotericin-B and voriconazole could be a novel treatment strategy in the management of endophthalmitis caused by filamentous fungus. Eyes

  3. Effects of various concentrations of diethylcarbamazine citrate applied as eye drops in ocular onchocerciasis, and the possibilities of improved therapy from continuous non-pulsed delivery.

    Science.gov (United States)

    Jones, B R; Anderson, J; Fuglsang, H

    1978-01-01

    Diethylcarbamazine was given as eye drops in varying concentrations in a half-log dilution series from 1.0 to 0.0001% to patients with ocular onchocerciasis. Migration of microfilariae into the cornea, followed by their straightening and disintegration, was observed with delivery rates as low as 0.1 microgram/hour. Dose-related adverse inflammatory reactions, including the development of globular limbal infiltrates with itching and redness, were seen with delivery rates as low as 0.6 microgram/hour, but substantial inflammatory reactions, including severe vasculitis, were seen only with delivery rates of or above 1.0 microgram/hour. This suggests that it should be possible to achieve beneficial clearing of the microfilarial load, without adverse reactions, by continuous non-pulsed delivery of the drug. Technology exists for such delivery, either directly into the eye or systemically by a transdermal system that could give 3 to 7 days' treatment from each application. The observations reported suggest that after preliminary clearing of the microfilarial load by carefully controlled delivery of DEC it may be possible to maintain therapy by less strictly controlled delivery in DEC-medicated salt, or to use treatment with suramin, without incurring substantial adverse reactions, such as a deterioration in vision in cases in which the optic nerve is already compromised. Continuous non-pulsed DEC delivery systems could have a place in the management of onchocercal sclerosing keratitis. The unique opportunities for using the ocular model to define the requirements for beneficial non-damaging therapy with DEC should be explored in further field trials. Images PMID:678494

  4. Effects of various concentrations of diethylcarbamazine citrate applied as eye drops in ocular onchocerciasis, and the possibilities of improved therapy from continuous non-pulsed delivery.

    Science.gov (United States)

    Jones, B R; Anderson, J; Fuglsang, H

    1978-07-01

    Diethylcarbamazine was given as eye drops in varying concentrations in a half-log dilution series from 1.0 to 0.0001% to patients with ocular onchocerciasis. Migration of microfilariae into the cornea, followed by their straightening and disintegration, was observed with delivery rates as low as 0.1 microgram/hour. Dose-related adverse inflammatory reactions, including the development of globular limbal infiltrates with itching and redness, were seen with delivery rates as low as 0.6 microgram/hour, but substantial inflammatory reactions, including severe vasculitis, were seen only with delivery rates of or above 1.0 microgram/hour. This suggests that it should be possible to achieve beneficial clearing of the microfilarial load, without adverse reactions, by continuous non-pulsed delivery of the drug. Technology exists for such delivery, either directly into the eye or systemically by a transdermal system that could give 3 to 7 days' treatment from each application. The observations reported suggest that after preliminary clearing of the microfilarial load by carefully controlled delivery of DEC it may be possible to maintain therapy by less strictly controlled delivery in DEC-medicated salt, or to use treatment with suramin, without incurring substantial adverse reactions, such as a deterioration in vision in cases in which the optic nerve is already compromised. Continuous non-pulsed DEC delivery systems could have a place in the management of onchocercal sclerosing keratitis. The unique opportunities for using the ocular model to define the requirements for beneficial non-damaging therapy with DEC should be explored in further field trials.

  5. N-Acetylcarnosine sustained drug delivery eye drops to control the signs of ageless vision: Glare sensitivity, cataract amelioration and quality of vision currently available treatment for the challenging 50,000-patient population

    Directory of Open Access Journals (Sweden)

    Mark A Babizhayev

    2008-10-01

    Full Text Available Mark A Babizhayev1, Leslie Burke2, Philip Micans3, Stuart P Richer4,51Innovative Vision Products, Inc., County of New Castle, Delaware, USA; 2Wise Choice Products LLC, London, England, United Kingdom; 3IAS Group, Sark, United Kingdom; 4Eye Clinic DVA Medical Center, North Chicago, Illinois, USA; 5Department of Family and Preventive Medicine, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, USABackground: Innovative Vision Products, Inc. (IVP’s scientists developed the lubricant eye drops (Can-C™ designed as 1% N-acetylcarnosine (NAC prodrug of L-carnosine containing a mucoadhesive cellulose-based compound combined with corneal absorption promoters in a sustained drug delivery system. Only the natural L-isomeric form of NAC raw material was specifically synthesized at the cGMP facility and employed for the manufacturing of Can-C™ eye drops.Objective and study design: In the present clinical study the authors assessed vision before and after 9 month term of topical ocular administration of NAC lubricant eye drops or placebo in 75 symptomatic patients with age-related uncomplicated cataracts in one or both eyes, with acuity in one eye of 20/40 or worse (best-corrected distance, and no previous cataract surgery in either eye and no other ocular abnormality and 72 noncataract subjects ranged in age from 54 to 78 years.Setting: Subjects in these subsample groups have reported complaints of glare and wanted to administer eye drops to get quick eye relief and quality of vision for their daily activities including driving and computer works. Following 9 months of treatment with NAC lubricant eye drops, most patients’ glare scores were improved or returned to normal in disability glare tests with Halometer DG. Improvement in disability glare was accompanied with independent improvement in acuity. Furthermore, patients with the poorest pretreatment vision were as likely to regain certain better visual function after 9

  6. Development and Validation of a Precise Method for Determination of Benzalkonium Chloride (BKC Preservative, in Pharmaceutical Formulation of Latanoprost Eye Drops

    Directory of Open Access Journals (Sweden)

    J. Mehta

    2010-01-01

    Full Text Available A simple and precise reversed phase high performance liquid chromatographic method has been developed and validated for the quantification of benzalkonium chloride (BKC preservative in pharmaceutical formulation of latanoprost eye drops. The analyte was chromatographed on a Waters Spherisorb CN, (4.6×250 mm column packed with particles of 5 μm. The mobile phase, optimized through an experimental design, was a 40:60 (v/v mixture of potassium dihydrogen orthophosphate buffer (pH 5.5 and acetonitrile, pumped at a flow rate of 1.0 mL/min at maintaining column temperature at 30 °C. Maximum UV detection was achieved at 210 nm. The method was validated in terms of linearity, repeatability, intermediate precision and method accuracy. The method was shown to be robust, resisting to small deliberate changes in pH, flow rate and composition (organic ratio of the mobile phase. The method was successfully applied for the determination of BKC in a pharmaceutical formulation of latanoprost ophthalmic solution without any interference from common excipients and drug substance. All the validation parameters were within the acceptance range, concordant to ICH guidelines.

  7. Effect of voriconazole and ultraviolet-A combination therapy compared to voriconazole single treatment on Fusarium solani fungal keratitis.

    Science.gov (United States)

    Choi, Kyoung Sub; Yoon, Sang Chul; Rim, Tyler Hyung Taek; Han, Soo Jung; Kim, Eun-Do; Seo, Kyoung Yul

    2014-06-01

    To demonstrate that ultraviolet-A (UV-A) and voriconazole combination therapy is more effective than voriconazole single treatment for fungal keratitis. The in vitro UV-A (375 nm) fungicidal effect was evaluated on Fusarium solani solutions. Each fungal solution was irradiated with different UV-A irradiation doses. Also, a fungal solution containing voriconazole was also irradiated with UV-A. The in vivo therapeutic effect of UV-A and voriconazole treatment was studied in a rabbit keratitis model. Fungi were injected intrastromally into the cornea of 16 rabbits. Each treatment was initiated 3 days after fungal injection and continued up to 8 days for the following groups: Group 1, control; Group 2, treated with UV-A once a day; Group 3, treated with voriconazole 3 times a day; Group 4, treated with voriconazole 3 times a day and UV-A once a day. On the last day, the sclera-cornea buttons were extracted and microbiological and histological evaluations were performed. The colony-forming units (CFUs) of fungal solutions in culture significantly decreased with UV-A irradiation. The CFUs of fungal solutions containing voriconazole also decreased with UV-A irradiation. In vivo, clinical scores of Group 3 (P=0.03) and Group 4 (P=0.02) 5 days after treatment were significantly lower compared to that of Group 1. The clinical score of Group 4 (P=0.03) 5 days after treatment was significantly lower compared to that of Group 3. The histopathological scores 5 days after treatment were significantly lower in Group 4 compared to those of Group 1 (P<0.01) and Group 3 (P=0.02). Based on our CFU analysis, only Group 4 showed significantly lower CFUs compared to Group 1 (P=0.04). UV-A and voriconazole combination treatment could be a safe and effective alternative to voriconazole single treatment for fungal keratitis.

  8. Microsporidial Stromal Keratitis: Successful Treatment with Topical Voriconazole and Oral Itraconazole

    Science.gov (United States)

    Kim, James; Shenoy, Sudhir; Chévez-Barrios, Patricia; Kapur, Manuj

    2016-01-01

    We report a case of microsporidial stromal keratitis successfully treated with topical voriconazole and oral itraconazole. A 30-year-old Hispanic male construction worker who wears contacts lenses presented with left eye erythematous, epiphora, and mild pain increasing over few days after failing previous antibiotics treatment. His best corrected visual acuity in the left eye was count fingers at three feet, and the slit lamp examination showed 3+ conjunctival injection, a circular central corneal ulcer 3.2 mm in diameter, stromal thinning, and an anterior chamber with white cells, flair, and 0.1 mm hypopyon. A cornea punch biopsy identified microsporidial organisms with some features suggestive of Vittaforma corneae. After treatment with topical voriconazole and oral itraconazole for eight weeks, the patient had complete resolution with no recurrence for over 12 months of follow-up. To our knowledge, this is the first reported case of successful treatment of microsporidial stromal keratitis with antifungals. PMID:28123915

  9. Voriconazole-induced periostitis in two post-transplant patients

    OpenAIRE

    Bucknor, Matthew D.; Gross, Andrew J; LINK, THOMAS M.

    2013-01-01

    While drug-related periostitis has been known of for many years, the specific association of diffuse periostitis with voriconazole (most frequently in transplant patients) has only been recently explicitly addressed in the literature. Recognition of the radiologic and clinical manifestations of voriconazole-related periostitis is important for helping to narrow an otherwise broad differential diagnosis. We present two cases that illustrate different radiologic presentations of this painful ca...

  10. Preparation and ocular retention of aciclovir chitosan eye-drops%阿昔洛韦壳聚糖滴眼液的制备及眼部滞留性考察

    Institute of Scientific and Technical Information of China (English)

    田鹏程; 王军

    2013-01-01

    Objective To study acyclovir (ACV) eye-drops by using chitosan (CS) as the adhesive to prolong the ocular retention.Methods The formula and preparation process of the eye-drops were made,and the quality including appearance,viscosity,pH,concentration and stability was studied.Rabbits as the testing animals,the eye irritation and retention were also observed.Results Compared with that of common ACV eye-drops,the viscosity of ACV-CS eye-drops increased significantly (1.8 × 10-2 Pa · s),and the ocular retention was prolonged (above 60 min)without any irritation (irritation score of 0.25).Conclusion ACV-CS eye-drops are promising with the properties of easy preparation,safe application and prolonged ocular retention.%目的 研制阿昔洛韦(ACV)-壳聚糖(CS)滴眼液,以延长阿昔洛韦的眼部滞留性.方法 以CS为增黏剂制备ACV-CS滴眼液,并对其性状、黏度、pH值、含量、稳定性等进行检测;以家兔为实验动物,分别考察ACV-CS滴眼液的眼部滞留性和眼部刺激性.结果 ACV-CS滴眼液的性状、黏度、pH值、含量、稳定性等均符合要求;与普通ACV滴眼液相比,ACV-CS滴眼液的黏性(1.8×10-2 Pa·s)显著增加,对兔眼部无明显刺激性,刺激反应评分为0.25,并显著延长眼部滞留时间(60 min以上).结论 本品制备简单,使用安全,具有较好的眼部滞留作用,值得进一步研究.

  11. PROSPECTIVE STUDY OF EFFECTIVENESS OF INTRASTROMAL VORICONAZOLE INJECTION IN THE MANAGEMENT OF DEEP NON HEALING FUNGAL CORNEAL ULCER AS AN ADJUNCTIVE THERAPY

    Directory of Open Access Journals (Sweden)

    Yalaka Jayapal

    2015-08-01

    Full Text Available INTRODUCTION : Fungal infections of the cornea usually are difficult to treat. Contemporary antifungal drugs in the treatment of mycotic keratitis are less effective than contemporary antibacterial drugs in the treatment of bacterial keratitis. Moreover, the penetratio n of many antifungal drugs into the cornea is suboptimal, which makes it difficult to treat cases of deep mycotic keratitis. In this present case study we report a series of thirty patients in which intrastromal voriconazole was used in conjunction with to pical treatment to treat successfully deep seated recalcitrant fungal keratitis . AIM AND OBJECTIVE: To evaluate the role of intrastromal injection of voriconazole in the management of deep recalcitrant fungal keratitis as an adjunctive therapy . METHODS AND MA TERIALS: In this interventional case series, thirty eyes of thirty patients with deep stromal recalcitrant fungal keratitis that were unresponsive to topical antifungal therapy underwent intrastromal injection of voriconazole 50μgms/0.1ml. Duration of s tudy was 6 weeks per patient. RESULTS : Before the intracorneal injections, all thirty eyes had gradually worsening lesions on topical medications. After the intervention, a faster reduction in the size of corneal infiltration was documented and complete re solution of the ulcers was seen within 6 weeks of time. CONCLUSION : Targeted delivery of voriconazole by intrastromal injection may be a safe and effective way to treat cases of deep - seated recalcitrant fungal keratitis responding poorly to conventional tr eatment modalities

  12. Design and Evaluation of Voriconazole Loaded Solid Lipid Nanoparticles for Ophthalmic Application

    Science.gov (United States)

    Khare, Anubha; Singh, Inderbir; Pawar, Pravin; Grover, Kanchan

    2016-01-01

    Voriconazole is a second-generation antifungal agent with excellent broad spectrum of antifungal activity commercially available for oral and intravenous administration. Systemic administration of voriconazole is associated with side effects including visual and hepatic abnormalities. This study assessed the feasibility of using solid lipid nanoparticles for ocular delivery of voriconazole adopting stearic acid as lipidic material, tween 80 as a stabilizer, and Carbopol 934 as controlled release agent and for increasing the precorneal residence time in eye. The systems were prepared using two different methods, that is, ultrasonication method and microemulsion technique. The results indicated that the larger particle size of SLNs was found with microemulsion technique (308 ± 3.52 nm to 343 ± 3.51) compared to SLN prepared with ultrasonication method (234 ± 3.52 nm to 288 ± 4.58 nm). The polydispersity index values were less than 0.3 for all formulations and zeta potential of the prepared formulations by these two methods varied from −22.71 ± 0.63 mV to −28.86 ± 0.58 mV. Powder X-ray diffraction and differential scanning calorimetry indicated decrease in crystallinity of drug. The in vitro release study and the SLN formulations prepared with ultrasonication method demonstrated sustained release up to 12 hours. This study demonstrated that SLN prepared by ultrasonication method is more suitable than microemulsion technique without causing any significant effect on corneal hydration level. PMID:27293896

  13. Design and Evaluation of Voriconazole Loaded Solid Lipid Nanoparticles for Ophthalmic Application

    Directory of Open Access Journals (Sweden)

    Anubha Khare

    2016-01-01

    Full Text Available Voriconazole is a second-generation antifungal agent with excellent broad spectrum of antifungal activity commercially available for oral and intravenous administration. Systemic administration of voriconazole is associated with side effects including visual and hepatic abnormalities. This study assessed the feasibility of using solid lipid nanoparticles for ocular delivery of voriconazole adopting stearic acid as lipidic material, tween 80 as a stabilizer, and Carbopol 934 as controlled release agent and for increasing the precorneal residence time in eye. The systems were prepared using two different methods, that is, ultrasonication method and microemulsion technique. The results indicated that the larger particle size of SLNs was found with microemulsion technique (308±3.52 nm to 343±3.51 compared to SLN prepared with ultrasonication method (234±3.52 nm to 288±4.58 nm. The polydispersity index values were less than 0.3 for all formulations and zeta potential of the prepared formulations by these two methods varied from −22.71±0.63 mV to −28.86±0.58 mV. Powder X-ray diffraction and differential scanning calorimetry indicated decrease in crystallinity of drug. The in vitro release study and the SLN formulations prepared with ultrasonication method demonstrated sustained release up to 12 hours. This study demonstrated that SLN prepared by ultrasonication method is more suitable than microemulsion technique without causing any significant effect on corneal hydration level.

  14. 甲基纤维素滴眼液使用和存放过程中的微生物监测分析%Microbial monitoring analysis of methylcellulose eye drops during use and storage

    Institute of Scientific and Technical Information of China (English)

    宫瑞中; 张红; 王丽; 王峻峰; 王婧; 张琳; 冀明

    2015-01-01

    香味菌和木糖葡萄球菌.结论 防腐剂尼泊金乙酯可以降低MC滴眼液使用过程中的微生物污染率;滴眼液的常见使用环境对MC滴眼液的微生物污染情况无明显影响.MC滴眼液污染的菌群均属于大气、土壤等环境菌种,并非眼部常见致病菌.%Background It is imperative for the microbial monitor after opening the bottle of eyedrops in order to ensure the safety during use of ophthalmic solutions with multi-dose packaging.Objective This study was to research the microbiological properties and sterile duration of methylcellulose (MC) eye drops in three common environmental conditions,including room temperature condition of community,refrigeration condition of community and room temperature condition of hospital.Methods MC eye drops were assigned to the community room temperature group,community refrigeration group and hospital room temperature group,and 200 bottles of MC eye drops with or without ethylparaben were collected in each group,including sealed or unsealed drugs at average.The containers of all the eye drops were opened and the opening times were record.The drugs was admistered 1 drop for 3 times per day,with the opening period for 5-10 seconds.Then the drugs were preserved in different environments based on grouping.Microbial isolation and purification were performed by the same lab technician at 8:00 from 1 through 10 days after opening of drugs with automatic microbial analyzer.Results In the unsealed MC eye drops without ethylparaben,the bacterial positive rates were about 30% in the community room temperature group,community refrigeration group and hospital room temperature group,but no microbial colony was seen in the sealed eye drops.Ten days after opening of containers,the bacterial cultured rates were 30%,32% and 36% in the eye drops without ethylparaben in the community room temperature group,community refrigeration group and hospital room temperature group,and those in the eye drops

  15. Ineffectiveness of intrastromal voriconazole for filamentous fungal keratitis

    Directory of Open Access Journals (Sweden)

    Niki M

    2014-06-01

    Full Text Available Masanori Niki, Hiroshi Eguchi, Yuki Hayashi, Tatsuro Miyamoto, Fumika Hotta, Yoshinori MitamuraDepartment of Ophthalmology, Institute of Health Biosciences, The University of Tokushima Graduate School, Tokushima-shi, JapanPurpose: The purpose of this study is to describe the ineffectiveness of intrastromal voriconazole injection for filamentous fungal keratitis by contrasting the effectiveness for yeast keratitis.Methods: We examined seven fungal keratitis patients prospectively. All yeast was identified by molecular phylogenetic analyses of the chromosomal regions coding for the D1/D2 domain of the large-subunit 26S ribosomal RNA gene. All filamentous fungi were identified by the sequencing of internal transcribed spacers of the ribosomal DNA gene regions. Approximately 0.1 mL of voriconazole diluted with saline to 1.0% was injected with a 30-gauge needle inserted obliquely into the three to five clear cornea sites around the abscess. All subjects were administered natamycin ointment and oral itraconazole. When needed, intravenous micafungin, voriconazole, and/or intracameral voriconazole were added. Clinical courses were observed by the slit lamp microscope. Histopathology was examined when the corneas were removed.Results: All cases that were caused by yeast healed quickly after injections. Two cases of keratitis caused by Fusarium, and one case caused by Aspergillus, did not heal completely. In the Fusarium cases, additional antifungal medications (3.0% topical voriconazole and intravenous injection of micafungin were needed. After optical penetrating keratoplasty in one of the cases, fungi were found in the deep stroma of the removed cornea. In the case of Aspergillus keratitis, pathological findings also showed fungi deep in the stroma of the removed cornea and the keratitis recurred after therapeutic penetrating keratoplasty.Conclusion: Intrastromal voriconazole injection is successful in treating yeast keratitis. However this is not the

  16. Case 215: voriconazole-induced periostitis.

    Science.gov (United States)

    Tailor, Tina D; Richardson, Michael L

    2015-03-01

    History A 74-year-old woman presented with multifocal bone pain, including pain in multiple ribs, bilateral shoulders, and bilateral hips. The pain began several months before presentation and was quite severe, ultimately necessitating control with narcotics. At examination, strength in both lower extremities was slightly reduced, sensation and reflexes were intact, and range of motion was full, though painful. There were no notable constitutional symptoms of fever or weight loss. Laboratory work-up was remarkable for elevated alkaline phosphatase level (277 U/L [4.6 mkat/L]). The patient had undergone left lung transplantation 8 years prior for pulmonary fibrosis. A thorough pulmonary work-up for the cause of fibrosis, which included gathering an exposure, occupational, allergy, and previous infectious history, and a rheumatoid work-up were negative. The patient's posttransplantation course was complicated by bronchiolitis obliterans from chronic rejection and by recent pulmonary embolism, for which she was undergoing anticoagulation therapy at the time of presentation. Additionally, the patient experienced repeated pulmonary infections with Aspergillus, leading to multiple hospitalizations and long-term antifungal prophylaxis with voriconazole. A bone scan from an outside hospital was reviewed, and further imaging was performed.

  17. [Evaluation of voriconazole oral dosage in Japan].

    Science.gov (United States)

    Hamada, Yukihiro; Kawasumi, Noriyo; Hirai, Jun; Yamagishi, Yuka; Mikamo, Hiroshige

    2014-10-01

    Voriconazole (VRCZ), a broad-spectrum triazole, is served in two dosage forms-injection and oral. VRCZ is difference dosage of oral and intravenous administration writing a medical package insert in Japan. 6 mg/kg intravenous injection (IV) twice daily for first day as initial loading dose, followed by 3-4 mg/kg IV twice daily between meals is recommended. 300 mg orally twice daily for first day as initial loading dose, followed by 150-200 mg orally twice daily between meals is recommended. Patients weighing over 40 kg, 200 mg orally twice daily between meals is recommended. Patients weighing under 40 kg, 100 mg orally twice daily between meals is recommended, increase to 150 mg twice daily if inadequate response. This study evaluated VRCZ trough concentration and oral dosage in the 23 cases which administered VRCZ to analysis for TDM in Aichi University Hospital. Spearman rank correlation coefficient was calculated to examine relationships among variables. The level of statistical significance was set at p=0.05. All data were analyzed and processed on JMP 8 (SAS Institute Japan). There was a significant positive correlation between VRCZ trough concentration and dose/weight (r=0.47 p<0.05). In this result, VRCZ oral dosage is appropriate to administer dose/weight (mg/kg) twice a day as same as IV.

  18. Técnica da instilação de colírios em pacientes portadores de glaucoma crônico Eye drop instillation technique in chronic glaucoma patients

    Directory of Open Access Journals (Sweden)

    Paulo Gelman Vaidergorn

    2003-12-01

    Full Text Available OBJETIVO: Verificar a técnica da instilação de colírio em pacientes portadores de glaucoma crônico. MÉTODOS: Estudo prospectivo realizado em 193 pacientes glaucomatosos. Para cada participante era entregue um frasco de colírio lubrificante (Dunason®, Laboratório Alcon, São Paulo, Brasil e solicitado que realizasse uma instilação. RESULTADOS: Os participantes utilizaram, em média, 1,64 ± 1,26 gotas de colírio por instilação e 54,5% dos pacientes fizeram contato do bico do colírio com a superfície ocular. Em 3,1% das instilações nenhuma gota de medicamento atingiu o olho, com o paciente não se dando conta do fato. A oclusão do ponto lacrimal ou a manutenção do olho fechado por dois minutos após a instilação não foi realizada em 87,0% dos participantes, e 61,6% piscaram repetidas vezes imediatamente após instilar a droga. CONCLUSÕES: Verificou-se que a maior parte dos participantes deste estudo efetuou a instilação do colírio de modo incorreto. Isto significa desperdiçar grande parte do conteúdo do frasco, aumentar as possibilidades de toxicidade sistêmica, não aproveitar a plenitude do efeito hipotensor das drogas e contaminar a extremidade do frasco de colírio. Portanto, o ensino da técnica adequada da instilação de colírio é absolutamente necessária para todos os pacientes.PURPOSE: To observe eye drop instillation technique in chronic glaucoma patients. METHODS: This is a prospective study enrolling 193 glaucomatous patients. Each received a sample of lubricant eye drop bottle (Dunason®, Alcon Laboratories, São Paulo, Brazil and was instructed to use it once. RESULTS: All patients used a mean amount of 1.64 ± 1.26 drops. In 54.5% of the patients, the eyedropper touched the eye and adnexa. In 3.1% the drops were not placed in the eye, without the patient being aware of this. In 87.0% of them, neither the lacrimal point occlusion nor the closure of the eyes for two minutes after instillation were

  19. Application of visual fine management in the management of cold storage of ophthalmic eye drops%目视精细管理在眼科眼药水冷藏存放管理中的应用

    Institute of Scientific and Technical Information of China (English)

    王峥嵘; 谌晓兰; 谭璇

    2016-01-01

    目的:探讨目视精细管理在眼科眼药水冷藏存放管理中的应用效果。方法:我科2015年8~12月将目视管理中常用的颜色、标识、定位等方法应用于临床眼科眼药水专科护理质量管理中,对实施目视管理前后护士由存放冷藏眼药水引起的不良结果及患者满意度进行比较。结果:目视精细管理前发生药物过期,药物丢失,交叉感染的次数高于目视精细管理后即目视精细管理使不良事件发生率明显降低,差异具有统计学意义(P<0.05)。管理后患者的满意度较管理前提高了(P<0.05),差异具有统计学意义。结论:通过运用对眼药水冰箱存放容器、眼药水标签的目视管理,减少了用药不良事件的发生率,提高了护理服务质量,提高了患者对护士的满意度;通过对冷藏眼药水管理规范、眼药水标签使用规范以及眼药水冷藏存放流程等的目视管理加强了护理人员风险防范意识,提高了病房精细化管理质量。%Objective:To explore the application effect of visual fine management in the management of cold storage of ophthalmic eye drops .Methods:Meth-ods such as common used colors, labels and positioning in our department dated from August 2015 to December 2015 were applied to professional quality management of clinical ophthalmic eye drops .The adverse results caused by cold storage of eye drops before and after the implementation of visual manage-ment and patient satisfaction were compared.Results:The number of drug expiration, drug loss and cross infection before visual fine management was higher than that after the visual fine management .The visual fine management reduced the incidence of adverse events significantly .The difference was of statistical significance (P<0.05).Patient’s satisfaction was improved after the management (P<0.05).the difference was of statistical significance.Conclusion:The visual management of

  20. Safety and tolerability of voriconazole in patients with baseline renal insufficiency and candidemia.

    NARCIS (Netherlands)

    Oude Lashof, A.M.L.; Sobel, J.D.; Ruhnke, M.; Pappas, P.G.; Viscoli, C.; Schlamm, H.T.; Rex, J.H.; Kullberg, B.J.

    2012-01-01

    Acutely ill patients with candidemia frequently suffer from renal insufficiency. Voriconazole's intravenous formulation with sulfobutylether beta-cyclodextrin (SBECD) is restricted in patients with renal insufficiency. We evaluated the use of intravenous voriconazole formulated with SBECD in candide

  1. Multifocal Aggressive Squamous Cell Carcinomas Induced by Prolonged Voriconazole Therapy: A Case Report

    Directory of Open Access Journals (Sweden)

    C. Morice

    2010-01-01

    Full Text Available Voriconazole is a treatment for severe fungal infections. Prolonged voriconazole therapy may induce skin reactions, with 1% of severe photosensitivity accidents. Recently the imputability of voriconazole in skin carcinogenesis has been suggested. This report concerns a 55-year-old man suffering from pulmonary aspergillosis who presented a phototoxic reaction a few months after introduction of voriconazole, followed by multiple squamous cell carcinomas of sun-exposed skin areas. After voriconazole discontinuation, no new carcinoma was observed. The detection of EBV and HPV in skin lesions was negative. Exploration of gene mutations involved in skin carcinogenesis showed two variants of the MICR gene. The occurrence of multiple, recurrent, aggressive squamous cell carcinomas is rare with voriconazole, but its imputability is strongly suggested. A plausible hypothesis is that several factors including voriconazole uptake, immunosuppression, and genetic background could explain the phenotype of fast-developing skin carcinomas. Voriconazole therapy should be accompanied by stringent photoprotection and skin monitoring.

  2. Multifocal aggressive squamous cell carcinomas induced by prolonged voriconazole therapy: a case report.

    Science.gov (United States)

    Morice, C; Acher, A; Soufir, N; Michel, M; Comoz, F; Leroy, D; Verneuil, L

    2010-01-01

    Voriconazole is a treatment for severe fungal infections. Prolonged voriconazole therapy may induce skin reactions, with 1% of severe photosensitivity accidents. Recently the imputability of voriconazole in skin carcinogenesis has been suggested. This report concerns a 55-year-old man suffering from pulmonary aspergillosis who presented a phototoxic reaction a few months after introduction of voriconazole, followed by multiple squamous cell carcinomas of sun-exposed skin areas. After voriconazole discontinuation, no new carcinoma was observed. The detection of EBV and HPV in skin lesions was negative. Exploration of gene mutations involved in skin carcinogenesis showed two variants of the MICR gene. The occurrence of multiple, recurrent, aggressive squamous cell carcinomas is rare with voriconazole, but its imputability is strongly suggested. A plausible hypothesis is that several factors including voriconazole uptake, immunosuppression, and genetic background could explain the phenotype of fast-developing skin carcinomas. Voriconazole therapy should be accompanied by stringent photoprotection and skin monitoring.

  3. Safety and tolerability of voriconazole in patients with baseline renal insufficiency and candidemia.

    NARCIS (Netherlands)

    Oude Lashof, A.M.L.; Sobel, J.D.; Ruhnke, M.; Pappas, P.G.; Viscoli, C.; Schlamm, H.T.; Rex, J.H.; Kullberg, B.J.

    2012-01-01

    Acutely ill patients with candidemia frequently suffer from renal insufficiency. Voriconazole's intravenous formulation with sulfobutylether beta-cyclodextrin (SBECD) is restricted in patients with renal insufficiency. We evaluated the use of intravenous voriconazole formulated with SBECD in

  4. 那他霉素滴眼液治疗角膜外伤后真菌性角膜炎%The treatment of traumatic fungal keratitis with natamycin eye drops

    Institute of Scientific and Technical Information of China (English)

    皮百木; 穆红梅; 张婉婷; 申飞; 黄明可

    2014-01-01

    Objective To observe clinical effects and safeness of 5% domestic Natamycin eye drops for the treatment of traumatic fungal keratitis.Methods From July 2013 to November 2013,thirty-seven eyes of 37cases of fungal keratitis diagnosed by corneal smear examination were treated by local debridement,iodine cauterization,and application of 5% natamycin eye drops.The therapeutic effect was observed.Results Of thirty-seven cases,30 cases were cured,7 cases were improved.Conclusion Combined with local debridement and iodine cauterization,the 5 % domestic Natamycin eye drop is safe and effective for mild to moderate traumatic fungal keratitis.%目的 观察5%那他霉素滴眼液治疗角膜外伤后真菌性角膜炎的临床疗效.方法 经角膜刮片确诊的真菌性角膜炎的37例(37眼)进行病灶刮除并碘酊烧灼联合国产5%那他霉素滴眼液滴眼,观察疗效.结果 37例中30例痊愈,7例好转.结论 病灶刮除并碘酊烧灼联合国产5%那他霉素滴眼液治疗轻中度外伤性真菌性角膜炎有效.

  5. 小牛血去蛋白提取物眼用凝胶及玻璃酸钠滴眼液治疗相关干眼症应用%Deproteinised calf blood extract eye gel and sodium hyaluronate eye drops in meibomian gland related dry eye

    Institute of Scientific and Technical Information of China (English)

    曲洪强; 高子清; 洪晶

    2013-01-01

    Objective To evaluate the clinic efficacy between deproteinised calf blood extract eye gel and sodium hyaluronate eye drops on recovery of meibomian gland related dry eye,to provide reference for drug treatment of meibomian gland related dry eye.Methods A randomized comparative study of deproteinised calf blood extract eye gel versus sodium hyaluronate eye drops both four times per day on a total of 80 patients (40 patients each group) with meibomian gland related dry eye.Both groups received applications of eyelid margins cleansing,eyelids warm compresses and massage,erythromycin ointment every night as side treatment.Symptom scores,Schirmer test values,tear film break-up times (BUT),fluorescein staining scores,meibo-scores were recorded on the last day before treatment and 30±7 day after start of treatment.Results The symptom scores of pre-and post-treatment in patients with deproteinised calf blood extract eye gel were,14.23±4.64,5.95±2.87; BUT scores 3.28±2.67,5.80±3.05; and fluorescein staining scores 3.71±3.84,1.83±1.535.10±2.416 score,which reached a significant statistic difference (t =3.25,P <0.01).The symptom scores of pre-and post-treatment with sodium hyaluronate eye drops were 13.05±2.14,7.83±2.24;and BUT scores 3.63±2.64,4.89±2.35 which had a statistic difference (t =2.97,P <0.05).Meibo-scores pre-and post-treatment in deproteinised calf blood extract eye gel group and sodium hyaluronate eye drops group were 3.95±1.19 score,3.88±l.43score; 3.93±1.25 score,3.98±1.33 score with no statistic difference in groups (t =3.42,P >0.05).Between the two groups,there were significant statistic difference in symptom (t =3.42,P <0.01),the change of BUTs (t =-2.52,P <0.05) and fluorescein staining scores (t =3.268,P <0.01),however the change of meibo-scores had no statistic difference (t =0.537,P>0.05).Conclusions Topical application of deproteinised calf blood extract eye gel and sodium hyaluronate eye drops both have a clearly

  6. In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus

    NARCIS (Netherlands)

    Seyedmousavi, S.; Meletiadis, J.; Melchers, W.J.G.; Rijs, A.J.M.M.; Mouton, J.W.; Verweij, P.E.

    2013-01-01

    Voriconazole is the recommended drug of first choice to treat infections caused by Aspergillus fumigatus. The efficacy of voriconazole might be hampered by the emergence of azole resistance. However, the combination of voriconazole with anidulafungin could improve therapeutic outcomes in azole-resis

  7. Study on treating fungal keratitis of rabbit eyes using collagen shield delivering fluconazole eye drops made by centrifugal method HAN%离心法制备胶原膜载释氟康唑治疗兔眼真菌性角膜炎的研究

    Institute of Scientific and Technical Information of China (English)

    韩晓梅; 王巾; 祝玉玲

    2009-01-01

    目的 研究用离心法制得的角膜胶原膜载释氟康唑(普芬)眼液在兔眼真菌性角膜炎治疗中的应用.方法 从猪巩膜中提取、纯化胶原,采用离心法制备角膜胶原膜,在普芬眼液内浸泡用于治疗兔眼真菌性角膜炎.结果 胶原膜载释普芬眼液治疗组病灶愈合平均时间11 d,局部滴用普芬眼液组病灶愈合平均时间18 d,两组治愈率和有效率分别为78.94%、63.15%和92.10%、78.94%,差异有统计学意义(P<0.05).结论 应用离心法制得的胶原膜载释普芬眼液是治疗真菌性角膜炎给药途径的创新,具有广阔的发展前景.%Objective To evaluate the effect of collagen shield delivering fluconazole eye drops made by centrifugal method on treating fungal keratitis of rabbit eyes.Methods Using centrifugal method to make corneal collagen shield,after soaked with fluconazole eye drops,the collagen shields were used to treat fungal keratitis of rabbit eyes.Results The healing focus time of collagen shield delivering fluconazole eye drops group was average 11 days,the healing focus time of only delivering fluconazole eye drops group was average 18 days.The cure rate and effective rate of 2 groups were 78.94%,63.15% and 92.10%,78.94%,there were significance between 2 groups(P<0.05).Conclusion It was innovation for corneal collagen shield delivering fluconazole eye drops made by centrifugal method to cure fungal keratitis,which had broad development foreground.

  8. Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients.

    Science.gov (United States)

    Wang, T F; Wang, T; Altman, R; Eshaghian, P; Lynch, J P; Ross, D J; Belperio, J A; Weigt, S S; Saggar, R; Gregson, A; Kubak, B; Saggar, R

    2009-12-01

    We report five cases of possible drug-induced periostitis associated with long-term use of voriconazole therapy after lung transplantation (LT). The diagnosis of periostitis was made by the documentation of bone pain, elevation of serum alkaline phosphatase and characteristic findings on radionuclide bone imaging in the absence of any identifiable rheumatologic disease. This periostitis appears similar to hypertrophic osteoarthopathy (HOA) but does not meet all criteria for HOA. In all patients, the symptoms resolved rapidly after discontinuation of voriconazole therapy. Awareness of this potential syndrome, which manifests as bone pain, elevated serum alkaline phosphatase and a bone scan suggestive of periostitis, is necessary in LT recipients on long-term voriconazole.

  9. The Efficacy of Artificial Tear Gel and Diclofenac Sodium Eye Drops on Dry Eye Syndrome%人工泪液凝胶联合双氯芬酸钠滴眼液治疗干眼症的临床疗效

    Institute of Scientific and Technical Information of China (English)

    刘曦

    2016-01-01

    Objective In order to investigate the clinical effcacy of artiifcial tear gel and diclofenac sodium eye drops on dry eye syndrome.Methods From 2013 to 2015 in our hospital, 120 cases of dry eye syndrome were selected, it is divided into two groups depending on treatment method, the control group was treatment with purely artificial tears gel, observation group used combination therapy with artificial tear gel and diclofenac sodium eye drops. The therapeutic effects were compared.Results The total effective rate in observation group was 91.7%, significantly higher than control group (P<0.05).ConclusionArtiifcial tear gel and diclofenac sodium eye drops can effectively relieve dry eye symptoms, improve treatment effect.%目的:探讨并分析人工泪液凝胶与双氯芬酸钠联合治疗干眼症的疗效。方法选取我院眼科于2013~2015年收治的120例干眼症患者,根据治疗方法的不同,将其分为对照组采用单纯人工泪液凝胶治疗,观察组采用人工泪液凝胶与双氯芬酸钠滴眼液的联合用药治疗。比较两组的治疗效果。结果观察组总有效率为91.7%,高于对照组(P<0.05)。结论采用人工泪液凝胶与双氯芬酸钠滴眼液联合治疗干眼症可以有效缓解临床症状,提高治疗效果。

  10. Ação do colírio de fenilefrina 10% no posicionamento palpebral de indivíduos normais Phenylephrine 10% eye drop action in the eyelid position in healthy subjects

    Directory of Open Access Journals (Sweden)

    Tânia Pereira Nunes

    2008-10-01

    Full Text Available OBJETIVOS: Determinar a ação de uma gota do colírio de fenilefrina 10% sobre as pálpebras superior e inferior de indivíduos normais; verificar a ocorrência de alterações no posicionamento das pálpebras superior e inferior do olho contralateral, após instilação desta medicação. MÉTODOS: Estudo prospectivo observacional, do qual participaram 24 indivíduos normais, com idade entre 20 e 39 anos, submetidos à instilação de uma gota do colírio de fenilefrina 10% no fundo de saco conjuntival superior, aleatoriamente em um dos olhos. Todos os indivíduos foram filmados antes e após a instilação do colírio (3, 10, 15, 30, 45 e 60 minutos. As imagens foram submetidas ao processamento digital e editadas para análise das medidas palpebrais. Foi traçada uma linha horizontal do canto medial até o canto externo. Considerou-se a altura da pálpebra superior a distância entre o ponto mais alto da margem palpebral superior e a linha horizontal traçada. A altura palpebral inferior foi avaliada como a distância entre o ponto mais baixo da margem palpebral inferior e a referida linha. RESULTADOS: Em relação à pálpebra superior, a medida antes da instilação da fenilefrina 10% diferiu significativamente dos demais momentos (pPURPOSE: To determine the upper and lower eyelid position with a single drop of 10% phenylephrine in normal individuals and observe positional lid changes in upper and lower lids of the opposite eye. METHODS: Prospective observational study including 24 healthy subjects of both genders (age range: 20-39 yrs submitted to instillation of a single drop of 10% phenylephrine in the upper fornix of one randomly chosen eye. A video camera recorded the images of both eyes before and after eye drop application at 3, 10, 15, 30, 45 and 60 minutes. The images were digitally processed and edited to analyze lid measurements (upper lid height: distance between the highest upper margin lid point and a horizontal line traced

  11. [New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin

    NARCIS (Netherlands)

    Wout, J.W. van 't; Kuijper, E.J.; Verweij, P.E.; Kullberg, B.J.

    2004-01-01

    The azole antifungal voriconazole and the echinocandin caspofungin have recently become available for the treatment of invasive mycoses. Fluconazole remains the drug of choice for candidemia, except for infections with one of the resistent species such as Candida krusei and some strains of Candida g

  12. A case of pseudomembranous colitis after voriconazole therapy.

    Science.gov (United States)

    Kwon, Jae-Cheol; Kang, Min-Kyu; Kim, Si-Hyun; Choi, Su-Mi; Kim, Hee-Je; Min, Woo-Sung; Lee, Dong-Gun

    2011-09-01

    This is a case report on a 35-year-old man with acute myelogenous leukemia who presented fever and intermittent mucoid loose stool to the emergency center. He had been taking voriconazole for invasive pulmonary aspergillosis. The flexible sigmoidoscopy was consistent with the diagnosis of pseudomembranous colitis.

  13. Enhanced skin deposition and delivery of voriconazole using ethosomal preparations.

    Science.gov (United States)

    Faisal, Waleed; Soliman, Ghareb M; Hamdan, Ahmed M

    2016-10-19

    Despite its broad-spectrum antifungal properties, voriconazole has many side effects when administered systemically. The aim of this work was to develop an ethosomal topical delivery system for voriconazole and test its potential to enhance the antifungal properties and skin delivery of the drug. Voriconazole was encapsulated into various ethosomal preparations and the effect of phospholipid and ethanol concentrations on the ethosomes properties were evaluated. The ethosomes were evaluated for drug encapsulation efficiency, particle size and morphology and antifungal efficacy. Drug permeability and deposition were tested in rat abdominal skin. Drug encapsulation efficiency of up to 46% was obtained and it increased with increasing the phospholipid concentration, whereas the opposite effect was observed for the ethanol concentration. The ethosomes had a size of 420-600 nm and negative zeta potential. The particle size of the ethosomes increased by increasing their ethanol content. The ethosomes achieved similar inhibition zones against Aspergillus flavus at a 2-fold lower drug concentration compared with drug solution in dimethyl sulfoxide. The ex vivo drug permeability through rat abdominal skin was ∼6-fold higher for the ethosomes compared with the drug hydroalcoholic solution. Similarly, the amount of drug deposited in the skin was higher for the ethosomes and was dependent on the ethanol concentration of the ethosomes. These results confirm that voriconazole ethosomal preparations are promising topical delivery systems that can enhance the drug antifungal efficacy and improve its skin delivery.

  14. 滴眼药液监码系统的功能分析与研究%Functional Analysis and Research on the System of Monitoring Code of Eye Drops

    Institute of Scientific and Technical Information of China (English)

    王广林

    2015-01-01

    According to the "drug regulatory code production line Fu code system" requirements formulated by the State Food and drug administration, combined with Shapuaisi eye drops of actual production and management requirements, to meet the ba-sic needs of, the function of eye drop physic liquor supervision code system were analysis and research, describes the project background, research significance and system function, and discusses the design and implementation of monitoring system func-tion code.%根据国家食品药品监督管理局制定的对“药品监管码生产线赋码系统”的需求,结合莎普爱思滴眼液的实际生产情况及管理要求,在满足基本需求的基础上,对滴眼药液监码系统功能进行了分析与研究,阐述了项目的背景、研究意义以及系统的功能,并探讨了监码系统功能的设计与实现。

  15. 普拉洛芬眼药水在青光眼手术前后炎症控制的临床评价%Clinical evaluation Pranoprofen glaucoma eye drops before and after surgery inflammation control

    Institute of Scientific and Technical Information of China (English)

    浦利军; 杨小红

    2015-01-01

    ObjectiveOur retrospective study was aimed to analyze the efficacy and clinical value of using eye drops Pran-oprofen before and after glaucoma surgery.Methods Clinical data of patients received treatment at our hospital from January 2014 to December 2014 was retrospectively analyzed. Patients included were divided into four groups according to the treat-ment: patients in group A ofusing eye drops for treatment in the postoperative TobraDex, Patients in group B using of eye drops Pranoprofen and eye drops TobraDex treatment after surgery,patients in group C one day before surgery beginning with eye drops Pranoprofen, after surgery using the combination method,patients in group D three days before the beginning of eye drops with pranoprofen, after using the combination method.Results D group were significantly lower than the other three groups in postoperative scores 1, 3 and 7 days; A group at seven days after surgery composite score was significantly higher than the other three groups; 15, 30 days after the first, scoring four groups had no significant difference. Flare value of four groups of patients after treatment showed a downward trend, and Group D after surgery 3,7,15,30 day flare values were significantly lower than in group A; A flare group after 30 days will have a value significantly higher than group B, group C; there was no big difference in efficacy between the final four groups of patients.Conclusion Glaucoma patients with eye drops Pranoprofen at the beginning, and in the post with the use of eye drops TobraDex wil be associated controled postoperative inflammation .Excelent scheme can be extended to use in clinical practice.%目的:在青光眼手术前后使用普拉洛芬眼药水并对其疗效及临床价值进行研究,探究疗效好的治疗方案。方法:选取我院2014年1月~2014年12月收治的青光眼患者98例(98眼)作为研究的对象,所有患者均接受青光眼小梁切除术治疗。将这98

  16. 重组人表皮生长因子眼液在白内障术后应用%Recombinant Human Epidermal Growth Factor Eye Drops in Cataract Surgery Applications

    Institute of Scientific and Technical Information of China (English)

    王春梅

    2013-01-01

    Objective To observe the Effects of recombinant human epidermallgrowth factor eye drops after cataract surgery incision healing Effect. Methods:40cases of cataract operation,were randomly divided into two groups,the controllgroup of locallroutine medication,the treatment group added epidermallgrowth factor eye drops with recombinant human,incision healing was observed after cataract surgery. Results:in treatment group,the average healing time was 1.5days shorter than the controllgroup in the 2.5day. Conclusion:the epidermallgrowth factor can accelerate the healing of incision,foreign body friction reduce postoperative scar resulting sense.%目的:观察重组人表皮生长因子眼液在白内障术后切口愈合的效果。方法选择白内障手术40例,随机分成两组,对照组局部常规用药,治疗组加用重组人表皮生长因子眼液,观察白内障术后切口愈合情况。结果治疗组愈合时间平均为1.5d短于对照组2.5d。结论表皮生长因子能加快切口愈合,减轻患者术后切口瘢痕导致的异物摩擦感。

  17. Clinical effect of rotein-free calf blood extract eye gel and sodium hyaluronate eye drops in the prevention and treatment of dry eye after laser-assisted in situ keratomileusis%小牛血去蛋白提取物眼用凝胶与玻璃酸钠滴眼液防治LASIK术后干眼疗效分析

    Institute of Scientific and Technical Information of China (English)

    符郁; 岑育健

    2015-01-01

    目的:比较小牛血去蛋白提取物眼用凝胶与玻璃酸钠滴眼液防治准分子激光原位角膜磨镶术(LASIK)后干眼的临床疗效。方法选取2011年6月至2014年6月于我院就诊的拟行LASIK的近视患者160例(320眼),将其随机分为A组与B组各80例(160眼),其中A组术后使用小牛血去蛋白提取物眼用凝胶治疗,B组使用玻璃酸钠滴眼液治疗。用药前与用药后4周进行干眼主观症状评分、泪膜破裂时间(BUT)、泪液分泌试验(SchirmerⅠ)及角膜荧光素染色检查,评价两组治疗效果。结果治疗4周后,A组临床治疗总有效率为91.25%,较B组的73.75%明显提高,两组间比较差异具有统计学意义(P0.05)外,A组症状评分明显低于B组,泪腺破裂时间明显长于B组,角膜荧光素染色评分明显低于B组,经比较差异均具有统计学意义(P0.05), but the subjective dry eye symptom scores of group A was sig-nificantly lower, with the BUT significantly longer and the score of corneal fluorescein staining significantly lower (P<0.05). Conclusion In the prevention and treatment of dry eye after LASIK, the clinical effect of protein-free calf blood extract eye gel is better than sodium hyaluronate eye drops, which is worthy of further clinical application.

  18. Voriconazole-induced periostitis: beyond post-transplant patients.

    Science.gov (United States)

    Reber, Joshua D; McKenzie, Gavin A; Broski, Stephen M

    2016-06-01

    Voriconazole-induced periostitis (VIP) is a rare but increasingly encountered entity since Food and Drug Administration (FDA) approval of the second generation antifungal medication in 2002. Literature reports most commonly include transplant recipients on immunosuppressive therapy simultaneously requiring antifungal therapy. Nontransplant patients receiving long-term voriconazole have an equal risk of developing the disease, but may experience a delay in diagnosis due to a lack of familiarity with the process outside of the post-transplant and/or immunosuppressed population. We present a case of VIP in a nontransplant, immunocompetent patient on suppressive antifungal therapy for prior abdominal aortic stent graft fungal infection. Radiologist review of current medications and recognition of periostitis on multiple imaging modalities may hasten the diagnosis and lead to earlier treatment and resolution of symptoms.

  19. Voriconazole-induced periostitis in two post-transplant patients.

    Science.gov (United States)

    Bucknor, Matthew D; Gross, Andrew J; Link, Thomas M

    2013-08-01

    While drug-related periostitis has been known of for many years, the specific association of diffuse periostitis with voriconazole (most frequently in transplant patients) has only been recently explicitly addressed in the literature. Recognition of the radiologic and clinical manifestations of voriconazole-related periostitis is important for helping to narrow an otherwise broad differential diagnosis. We present two cases that illustrate different radiologic presentations of this painful cause of diffuse periostitis. Case 1 features a 60 year-old woman with a history of orthotopic heart transplant who was hospitalized for "full body pain" with progressively worsening bone tenderness involving the humeri, knees, femurs, hips, and hands. Case 2 describes a 48 year-old man with a history of acute lymphoblastic leukemia status post stem cell transplant who presented with diffuse arthralgias involving bilateral ankles, knees, wrists, and elbows.

  20. Successful salvage treatment of Lecythophora mutabilis keratitis with topical voriconazole

    Directory of Open Access Journals (Sweden)

    Bora Yüksel

    2011-09-01

    Full Text Available Fungal keratitis is an important ophthalmic problem in the developing world. Filamentous fungi are the most frequently reported pathogens in fungal keratitis. This report aimed to present a case with Lecythophora mutabilis keratitis that treatment failure was seen with topical and systemic amphotericin B lipid complex. Then she was treated successfully topical voriconazole. J Microbiol Infect Dis 2011;1 (2: 75-77

  1. Successful treatment of Beauveria bassiana fungal keratitis with topical voriconazole.

    Science.gov (United States)

    Ogawa, Akiko; Matsumoto, Yukihiro; Yaguchi, Takashi; Shimmura, Shigeto; Tsubota, Kazuo

    2016-04-01

    We describe a 66-year-old woman who suffered from fungal keratitis after corneal transplantation. The causative organism was identified as Beauveria bassiana on the basis of morphological characteristics and the sequence of the internal transcribed spacer region of the ribosomal RNA gene. The patient was successfully treated with topical voriconazole (VRCZ) use only. We, hereby, present the first report of a case with B. bassiana fungal keratitis that responded to topical antifungal VRCZ treatment.

  2. Elevation of blood ciclosporin levels by voriconazole leading to leukoencephalopathy

    Directory of Open Access Journals (Sweden)

    Qu Caihong

    2013-01-01

    Full Text Available We report that one 18-year-old female patient with no epilepsia history developed severe epileptiform seizures while she was receiving "ciclosporin A (CsA-mycophenolate-methylprednisolone" antirejection therapy after combining one week′s voriconazole administration following allogeneic hematopoietic stem cell transplantation (allo-HSCT for myelodysplastic syndromes (MDS. Her blood concentration of CsA was 378 ng/ml (elevated ↑64%, contrasted with the level before the addition of voriconazole on the second day of admission, and the MRI of head showed leukoencephalopathy in bilateral occipital and left frontal lobe on the 4 th day of admission. The most likely mechanism is that because of voriconazole′s enzyme inhibition and CsA as the substrate of hepatic enzymes, voriconazole elevated the blood concentration of CsA and enhanced its toxicity. This case highlights the importance of clinical pharmacists joining the medical team and optimizing the patients′ treatment protocols by performing a systematic literature research, accumulating the knowledge of the potential drug interaction and examining prescriptions.

  3. Soft drop

    Energy Technology Data Exchange (ETDEWEB)

    Larkoski, Andrew J. [Center for Theoretical Physics, Massachusetts Institute of Technology,Cambridge, MA 02139 (United States); Marzani, Simone [Institute for Particle Physics Phenomenology, Durham University,South Road, Durham DH1 3LE (United Kingdom); Soyez, Gregory [IPhT, CEA Saclay, CNRS URA 2306,F-91191 Gif-sur-Yvette (France); Thaler, Jesse [Center for Theoretical Physics, Massachusetts Institute of Technology,Cambridge, MA 02139 (United States)

    2014-05-29

    We introduce a new jet substructure technique called “soft drop declustering”, which recursively removes soft wide-angle radiation from a jet. The soft drop algorithm depends on two parameters — a soft threshold z{sub cut} and an angular exponent β — with the β=0 limit corresponding roughly to the (modified) mass drop procedure. To gain an analytic understanding of soft drop and highlight the β dependence, we perform resummed calculations for three observables on soft-dropped jets: the energy correlation functions, the groomed jet radius, and the energy loss due to soft drop. The β=0 limit of the energy loss is particularly interesting, since it is not only “Sudakov safe” but also largely insensitive to the value of the strong coupling constant. While our calculations are strictly accurate only to modified leading-logarithmic order, we also include a discussion of higher-order effects such as multiple emissions and (the absence of) non-global logarithms. We compare our analytic results to parton shower simulations and find good agreement, and we also estimate the impact of non-perturbative effects such as hadronization and the underlying event. Finally, we demonstrate how soft drop can be used for tagging boosted W bosons, and we speculate on the potential advantages of using soft drop for pileup mitigation.

  4. Fusariose em paciente imunocomprometido: sucesso terapêutico com voriconazol Fusariosis in an immunocompromised patient: therapeutic success with voriconazole

    Directory of Open Access Journals (Sweden)

    Thaís Prota Hussein Pincelli

    2008-08-01

    Full Text Available A infecção por Fusarium solani é afecção fúngica potencialmente grave em pacientes imunocomprometidos, sobretudo naqueles portadores de neoplasias hematológicas. A mortalidade é alta,sendo limitadas as opções terapêuticas devido às condições da imunidade do doente e à relativa resistência do fungo aos antifúngicos utilizados de rotina. O voriconazol tem-se mostrado boa alternativa terapêutica em pacientes neutropênicos que apresentam fusariose refratária ou pouco responsiva à anfotericina B. Neste artigo relata-se caso de fusariose em doente imunocomprometido tratado com sucesso com voriconazol.Fusarium infection is known to be potentially severe in immunocompromised patients, especially those with hematologic malignancies. Mortality rates are high and there are few therapeutic options, due to the severe underlying condition of this group of patients and the relative resistance of Fusarium to conventional antifungal therapy. Voriconazole has been shown to be an effective antifungal agent for neutropenic patients with fusariosis that are refractory or unresponsive to amphotericin B. We report the successful treatment of disseminated Fusarium infection in an immunocompromised host.

  5. CoQ10-containing eye drops prevent UVB-induced cornea cell damage and increase cornea wound healing by preserving mitochondrial function.

    Science.gov (United States)

    Mencucci, Rita; Favuzza, Eleonora; Boccalini, Carlotta; Lapucci, Andrea; Felici, Roberta; Resta, Francesco; Chiarugi, Alberto; Cavone, Leonardo

    2014-10-09

    We evaluated the potential protective effects of Coenzyme Q10 (CoQ10) on human corneal cells and rabbit eyes after ultraviolet B (UVB) exposure and a model of wound healing in rabbit eyes after corneal epithelium removal. Human corneal epithelium cells (HCE) were exposed to a source of UVB radiation (312 nM) in the presence of different CoQ10 concentrations or vehicle. The mitochondrial function and cell survival were evaluated by means of 3-(4,5-dimethylthiazole-2-yl)2,5-diphenyl-tetrazolium (MTT) reduction and lactic dehydrogenase (LDH) release. Furthermore, quantitation of oxygen consumption and mitochondrial membrane potential were conducted. In vivo rabbit models were adopted to evaluate the effect of CoQ10 on UVB-induced conjunctival vessel hyperemia and corneal recovery after ethanol induced corneal lesion. In UVB-exposed HCE cells, CoQ10 addition led to an increased survival rate and mitochondrial function. Furthermore, oxygen consumption was maintained at control levels and adenosine triphosphate (ATP) decline was completely prevented in the CoQ10-treated cells. Interestingly, in an in vivo model, CoQ10 was able dose-dependently to reduce UVB-induced vessel hyperemia. Finally, in a model of corneal epithelium removal, 12 hours from surgery, animals treated with CoQ10 showed a reduction of damaged area in respect to vehicle controls, which lasted until 48 hours. We demonstrated that CoQ10 reduces corneal damages after UVB exposure in vivo and in vitro by preserving mitochondrial function. Also, for the first time to our knowledge we showed that the administration of CoQ10 after corneal epithelium removal promotes corneal wound healing. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.

  6. Soft Drop

    CERN Document Server

    Larkoski, Andrew J; Soyez, Gregory; Thaler, Jesse

    2014-01-01

    We introduce a new jet substructure technique called "soft drop declustering", which recursively removes soft wide-angle radiation from a jet. The soft drop algorithm depends on two parameters--a soft threshold $z_\\text{cut}$ and an angular exponent $\\beta$--with the $\\beta = 0$ limit corresponding roughly to the (modified) mass drop procedure. To gain an analytic understanding of soft drop and highlight the $\\beta$ dependence, we perform resummed calculations for three observables on soft-dropped jets: the energy correlation functions, the groomed jet radius, and the energy loss due to soft drop. The $\\beta = 0$ limit of the energy loss is particularly interesting, since it is not only "Sudakov safe" but also largely insensitive to the value of the strong coupling constant. While our calculations are strictly accurate only to modified leading-logarithmic order, we also include a discussion of higher-order effects such as multiple emissions and (the absence of) non-global logarithms. We compare our analytic r...

  7. Neurologic Adverse Events Associated with Voriconazole Therapy: Report of Two Pediatric Cases

    Science.gov (United States)

    Demir, Sevliya Öcal; Atici, Serkan; Akkoç, Gülşen; Yakut, Nurhayat; İkizoğlu, Nilay Baş; Eralp, Ela Erdem; Soysal, Ahmet; Bakir, Mustafa

    2016-01-01

    Although voriconazole, a triazole antifungal, is a safe drug, treatment with this agent is associated with certain adverse events such as hepatic, neurologic, and visual disturbances. The current report presents two cases, one a 9-year-old boy and the other a 17-year-old girl, who experienced neurologic side effects associated with voriconazole therapy. Our aim is to remind readers of the side effects of voriconazole therapy in order to prevent unnecessary investigations especially for psychological and ophthalmologic problems. The first case was a 9-year-old boy with cystic fibrosis and invasive aspergillosis that developed photophobia, altered color sensation, and fearful visual hallucination. The second case was a 17-year-old girl with cystic fibrosis and allergic bronchopulmonary aspergillosis, and she experienced photophobia, fatigue, impaired concentration, and insomnia, when the dose of voriconazole therapy was increased from 12 mg/kg/day to 16 mg/kg/day. The complaints of the two patients disappeared after discontinuation of voriconazole therapy. Our experience in these patients reminded us of the importance of being aware of the neurologic adverse events associated with voriconazole therapy in establishing early diagnosis and initiating prompt treatment. In addition, although serum voriconazole concentration was not measured in the present cases, therapeutic drug monitoring for voriconazole seems to be critically important in preventing neurologic side effects in pediatric patients. PMID:27313918

  8. Voriconazole-Resistant Penicillium oxalicum: An Emerging Pathogen in Immunocompromised Hosts

    OpenAIRE

    Chowdhary, Anuradha; Kathuria, Shallu; Agarwal, Kshitij; Sachdeva, Neelam; Singh, Pradeep K.; Jain, Sandeep; Meis, Jacques F.

    2014-01-01

    Penicillium species are rarely reported agents of infections in immunocompromised patients. We report 3 cases of invasive mycosis caused by voriconazole-resistant Penicillium oxalicum in patients with acute myeloid leukemia, diabetes mellitus, and chronic obstructive pulmonary disease, while on voriconazole therapy. Penicillium oxalicum has not been previously recognized as a cause of invasive mycoses.

  9. Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.

    NARCIS (Netherlands)

    Klont, R.R.; Eggink, C.A.; Rijs, A.J.M.M.; Wesseling, P.; Verweij, P.E.

    2005-01-01

    A case of invasive Fusarium keratitis in a previously healthy male patient was treated successfully with cornea transplantation and systemic and topical voriconazole after treatment failure with topical amphotericin B and systemic itraconazole. Topical voriconazole was well tolerated, and, in conjun

  10. Multifocal nodular periostitis associated with prolonged voriconazole therapy in a lung transplant recipient.

    Science.gov (United States)

    Ayub, Asad; Kenney, Charles V; McKiernan, Fergus E

    2011-03-01

    We report a case of painful, nodular periostitis in a lung transplant recipient on long-term voriconazole therapy. Symptoms, signs, and laboratory abnormalities resolved quickly after drug withdrawal. The presentation more closely resembles periostitis deformans than hypertrophic osteoarthropathy, suggesting that the fluoride moiety of voriconazole may be pathogenic for this condition. Clinicians should be aware of this association.

  11. Plasma Fluoride Level as a Predictor of Voriconazole-Induced Periostitis in Patients With Skeletal Pain

    OpenAIRE

    Moon, Woo J.; Scheller, Erica L.; Suneja, Anupam; Livermore, Jacob A.; Malani, Anurag N.; Moudgal, Varsha; Kerr, Lisa E.; Ferguson, Eric; Vandenberg, David M.

    2014-01-01

    Periostitis has been an infrequently observed side effect of long-term, high-dose voriconazole therapy. We report a retrospective study correlating elevated plasma fluoride concentrations and the presence of periostitis among patients who received long-term voriconazole therapy and developed skeletal pain.

  12. Neurologic Adverse Events Associated with Voriconazole Therapy: Report of Two Pediatric Cases

    Directory of Open Access Journals (Sweden)

    Sevliya Öcal Demir

    2016-01-01

    Full Text Available Although voriconazole, a triazole antifungal, is a safe drug, treatment with this agent is associated with certain adverse events such as hepatic, neurologic, and visual disturbances. The current report presents two cases, one a 9-year-old boy and the other a 17-year-old girl, who experienced neurologic side effects associated with voriconazole therapy. Our aim is to remind readers of the side effects of voriconazole therapy in order to prevent unnecessary investigations especially for psychological and ophthalmologic problems. The first case was a 9-year-old boy with cystic fibrosis and invasive aspergillosis that developed photophobia, altered color sensation, and fearful visual hallucination. The second case was a 17-year-old girl with cystic fibrosis and allergic bronchopulmonary aspergillosis, and she experienced photophobia, fatigue, impaired concentration, and insomnia, when the dose of voriconazole therapy was increased from 12 mg/kg/day to 16 mg/kg/day. The complaints of the two patients disappeared after discontinuation of voriconazole therapy. Our experience in these patients reminded us of the importance of being aware of the neurologic adverse events associated with voriconazole therapy in establishing early diagnosis and initiating prompt treatment. In addition, although serum voriconazole concentration was not measured in the present cases, therapeutic drug monitoring for voriconazole seems to be critically important in preventing neurologic side effects in pediatric patients.

  13. Economic evaluation of voriconazole in the treatment of invasive aspergillosis in the Netherlands.

    NARCIS (Netherlands)

    Jansen, J.P.; Meis, J.F.G.M.; Blijlevens, N.M.A.; Wout, J.W. van 't

    2005-01-01

    OBJECTIVE: To asses the cost-effectiveness of voriconazole in comparison to conventional amphotericin B and itraconazole for the treatment of invasive aspergillosis in the Netherlands. METHODS: The cost-effectiveness of voriconazole in comparison to conventional amphotericin B or itraconazole was ev

  14. Clinical study on high concentrations of sodium hyaluronate eye drops for moderate to severe dry eye%高浓度玻璃酸钠滴眼液治疗中重度干眼的临床研究

    Institute of Scientific and Technical Information of China (English)

    田玉景; 张钦

    2014-01-01

    AIM: To observe the efficacy of high concentrations of sodium hyaluronate ( 3g/L SH ) for moderate to severe dry eye. METHODS: Forty moderate to severe dry eye patients were included in the study according to the diagnosis criteria and randomized into two groups. The patients of the trial group received topical administration of high concentration sodium hyaluronate (3g/L), and those of the control group received sodium hyaluronate ( 1g/L ) plus recombinant human epidermal growth factor. The dry eye symptom scores, ocular surface disease index ( OSDI) scores, tear film break-up time ( BUT) , SchirmerⅠ test and corneal fluorescein staining score were evaluated. All the indexes were compared between the two groups 2wk before and after treatment. RESULTS: There were no significant differences of the indicators between the two groups before treatment. After 2wk treatment, the differences were statistically significant compared to former except for the SchirmerⅠtest. Compared with the control group, the symptom scores and the OSDI scores were lowered. No significant differences were found in the other indicators between these two groups. CONCLUSION: Topical usage of highconcentrations of sodium hyaluronate (3g/L) is beneficial for remitting the ocular symptoms in moderate to severe dry eyes, and also improve the quality of life of patients.%目的:观察高浓度玻璃酸钠滴眼液治疗中重度干眼的临床疗效。  方法:中重度干眼患者40例随机分成试验组和对照组,每组各20例。试验组用玻璃酸钠滴眼液(3g/L)、对照组玻璃酸钠滴眼液(1g/L)联合重组人表皮生长因子滴眼液治疗,治疗前和治疗2 wk后,通过症状评分、眼表疾病指数( OSDI)评分、泪膜破裂时间( BUT )、泪液分泌试验(Schirmer I test,SIt)、角膜荧光素染色评分(FL)等评价两组疗效。  结果:治疗前,两组各项指标差异均无统计学意义。治疗2 wk后,除SIt外,两组的其他指标和治

  15. Determination of benzalkonium chloride in Dextran 70and glycerol eye drops%右旋糖酐70甘油滴眼液中苯扎氯铵含量测定方法研究

    Institute of Scientific and Technical Information of China (English)

    朱样根; 龚楚良

    2012-01-01

    Objective: To determine the content of benzalkonium chloride in Dextran 70 and glycerol eye drops by HPLC. Methods; The chromatographic conditions were as follows; the column was Kromasil C18 (250 mm x 4. 6 mm,5 (um)column;the mobile phase consisted of acetonitrile -0. 03 mol · L-1 sodium dihydrogen phosphate (pH 7. 0 ) ( 43: 57 ) ; the flow rate was 2. 0 mL · min -; the column temperature was 35℃; the detection wavelength was at 214 nm;the injection volume was 20 uX;the separable degree of benzalkonium chloride between C12,C14, C16,should meet rules. Results;The calibration curve of benzalkonium chloride ranged from 1.28-3.00 u,g had good linearity with peak area (r = 0. 9999, n = 7 ) ; The recovery ( n = 6) was 100. 9% ; RSD = 0. 9%. Conclusion: The method is simple, fast, and accurate, with high sensitivity and good repeatability, and can be used for content determination of benzalkonium chloride in Dextran 70 and glycerol eye drops.%目的:建立高效液相色谱法测定右旋糖酐70甘油滴眼液中苯扎氯铵的含量.方法:以氰基硅烷键合硅胶为填充剂;以乙腈-0.03 mol·L-1磷酸二氢钠溶液(用1 mol·L-1氢氧化钠溶液调pH至7.0)(43∶ 57)为流动相;流速:2.0 mL·min -1;柱温:35℃;检测波长214 nm.苯扎氯铵C12、C14、C16之间的分离度应符合规定.结果:苯扎氯铵在1.28~3.00 μg范围内与峰面积线性关系良好(r =0.9999,n=7);平均回收率(n=6)为100.9%,RSD=0.9%.结论:该法操作简便,快速、准确,灵敏度高,重复性好,可用于右旋糖酐70甘油滴眼液中苯扎氯铵含量测定.

  16. Determination of benzalkonium chloride in compound tropicamide eye drops by HPLC%HPLC法测定复方托吡卡胺滴眼液中苯扎氯铵的含量

    Institute of Scientific and Technical Information of China (English)

    何丹; 杨林

    2013-01-01

    Objective :To establish an HPLC method for detecting the content of Benzalkonium Chloride in Compound Tropicamide Eye Drops .Methods :A Alltech Alltima -CN column (250cm × 4 .6mm ,5μm) was used ,and the mobile phase was 0 .1mol・L -1 NaAc solution -acetonitrile (60 :40) ,HAc was used to adjust pH to 5 ,column temperature was 30℃ ,at a flow rate of 2 .0ml・min -1 and detection wavelength of 254 nm .Results :The linear range of Benzalkonium Chloride was 0 .02~0 .5mg・mL -1 ;The correlation coefficient was 0 .9999 .The average recovery of Benzalkonium Chloride was 98 .91% (RSD=0 .44% ,n=9 ) .Conclusion :The method is accurate ,simple ,rapid and suitable for the quality control of Benzalkonium Chloride in Compound Tropicamide eye drops .%目的:建立超高效液相色谱法测定复方托吡卡胺滴眼液中苯扎氯铵的含量测定方法。方法:色谱柱为Alltech Alltima -CN(250cm ×4.6mm ,5μm),流动相为0.1mol・L -1醋酸钠溶液(用冰醋酸调节pH值至5.0)-乙腈(60:40),检测波长254nm ,流速为2.0ml・min -1,柱温30℃,进样体积50μL。结果:苯扎氯铵在0.02至0.5mg・mL -1浓度范围内线性关系良好(r=0.9999);平均回收率为98.91%,RSD=0.44%(n=9)。结论:该方法准确、简便、快速、可靠,能有效控制复方托吡卡胺滴眼液中苯扎氯铵的含量。

  17. Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm.

    Science.gov (United States)

    Pulcrano, Giovanna; Panellis, Dimitrios; De Domenico, Giovanni; Rossano, Fabio; Catania, Maria Rosaria

    2012-06-01

    The ability to form biofilm on different surfaces is typical of most Candida species. Microscopic structure and genetic aspects of fungal biofilms have been the object of many studies because of very high resistance to antimycotic agents because of the scarce permeability of the external matrix and to the alterations in cell metabolism. In our study, 31 isolates of Candida parapsilosis, isolated from bloodstream infections, were tested for their ability to produce biofilm and were found to be good producers. The susceptibility to voriconazole, assayed by colorimetrical XTT assay, revealed a very elevated minimum inhibitory concentrations for sessile cells in comparison with planktonic ones. The addition of ambroxol, a mucolytic agent, increased the susceptibility of biofilm forming cells to voriconazole. Expression of the efflux pump genes CDR and MDR was analyzed in biofilms alone or treated with ambroxol, evidencing a role of ambroxol in the expression of genes involved in azole resistance mechanisms of C. parapsilosis biofilms. In conclusion, our data seem to encourage the use of different substances in combination with classical antimycotics, with the aim of finding a solution to the increasing problem of the resistance of biofilms formed on medical devices by nonalbicans Candida species.

  18. Statins and voriconazole induce programmed cell death in Acanthamoeba castellanii.

    Science.gov (United States)

    Martín-Navarro, Carmen M; López-Arencibia, Atteneri; Sifaoui, Ines; Reyes-Batlle, María; Valladares, Basilio; Martínez-Carretero, Enrique; Piñero, José E; Maciver, Sutherland K; Lorenzo-Morales, Jacob

    2015-05-01

    Members of the genus Acanthamoeba are facultative pathogens of humans, causing a sight-threatening keratitis and a life-threatening encephalitis. In order to treat those infections properly, it is necessary to target the treatment not only to the trophozoite but also to the cyst. Furthermore, it may be advantageous to avoid parasite killing by necrosis, which may induce local inflammation. We must also avoid toxicity of host tissue. Many drugs which target eukaryotes are known to induce programmed cell death (PCD), but this process is poorly characterized in Acanthamoeba. Here, we study the processes of programmed cell death in Acanthamoeba, induced by several drugs, such as statins and voriconazole. We tested atorvastatin, fluvastatin, simvastatin, and voriconazole at the 50% inhibitory concentrations (IC50s) and IC90s that we have previously established. In order to evaluate this phenomenon, we investigated the DNA fragmentation, one of the main characteristics of PCD, with quantitative and qualitative techniques. Also, the changes related to phosphatidylserine exposure on the external cell membrane and cell permeability were studied. Finally, because caspases are key to PCD pathways, caspase activity was evaluated in Acanthamoeba. All the drugs assayed in this study induced PCD in Acanthamoeba. To the best of our knowledge, this is the first study where PCD induced by drugs is described quantitatively and qualitatively in Acanthamoeba.

  19. Dry Eye

    Science.gov (United States)

    ... Eye > Facts About Dry Eye Facts About Dry Eye This information was developed by the National Eye ... the best person to answer specific questions. Dry Eye Defined What is dry eye? Dry eye occurs ...

  20. Eye Allergies

    Science.gov (United States)

    ... Español Eye Health / Eye Health A-Z Eye Allergies Sections What Are Eye Allergies? Eye Allergy Symptoms ... allergy diagnosis Eye allergy treatment What Are Eye Allergies? Written by: David Turbert Reviewed by: Brenda Pagan- ...

  1. Refractory Scedosporium apiospermum Keratitis Successfully Treated with Combination of Amphotericin B and Voriconazole

    Directory of Open Access Journals (Sweden)

    Mohd-Tahir Fadzillah

    2013-01-01

    Full Text Available Aim. To report a case of refractory fungal keratitis caused by Scedosporium apiospermum. Methods. Interventional case report. Results. A 47-year-old Malay housewife presented with left eye cornea ulcer as her first presentation of diabetes mellitus. There was no history of ocular trauma, contact lens used, or cornea foreign body. Scedosporium apiospermum was isolated from the cornea scrapping. Her cornea ulcer initially responded well to topical Amphotericin B within 3 days but subsequently worsened. Repeat cornea scrapping also yields Scedosporium apiospermum. This refractory keratitis was successfully treated with a combination of topical Amphotericin B and Voriconazole over 6 weeks. Conclusion. Scedosporium apiospermum keratitis is an opportunistic infection, which is difficult to treat despite tight control of diabetes mellitus and intensive antifungal treatment. The infection appeared to have very quick onset but needed long duration of treatment to completely heal. Surgical debridement always plays an important role as a therapeutic procedure as well as establishes the diagnosis through repeat scrapping.

  2. Pediatric Clinical Pharmacology of Voriconazole: Role of Pharmacokinetic/Pharmacodynamic Modeling in Pharmacotherapy.

    Science.gov (United States)

    Kadam, Rajendra S; Van Den Anker, Johannes N

    2016-09-01

    Voriconazole is a potent antifungal agent used for the treatment of invasive fungal infections caused by Aspergillus and Candida species in adult and pediatric patients. Voriconazole has a narrow therapeutic index and a large intra- and inter-individual pharmacokinetics (PK) variability. Several factors including non-linear PK, age, body weight, cytochrome P450 2C19 genotype, concomitant drugs, liver function, and food are responsible for the large variability in voriconazole PK. A combination of a narrow therapeutic index with a large PK variability results in treatment failure in many patients at clinically recommended doses. There is an urgent need to establish an optimal dosing regimen for pediatric patients 60 %) treatment failure rates. Therapeutic drug monitoring is commonly used in clinical practice to optimize the voriconazole dosing regimens in pediatric patients, but it is associated with several practical limitations. Implementation of a PK model-guided individualized dose selection will help in reducing the PK variability and will improve therapeutic outcomes. In this review, we have summarized the covariates influencing the PK of voriconazole in adult and pediatric patients, emphasizing that the clearance of voriconazole is significantly different between adult and pediatric patients owing to developmental changes in the major clearance pathways. Moreover, we have provided the limitations of the current dosing regimens and have proposed a new dosing method using a PK model-guided dose individualization of voriconazole in pediatric patients.

  3. Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies

    Directory of Open Access Journals (Sweden)

    Kem P Krueger

    2009-08-01

    Full Text Available Kem P Krueger, A Christie NelsonSchool of Pharmacy, University of Wyoming, Laramie, WY, USAAbstract: Invasive aspergillosis is a life-threatening fungal infection predominately affecting immunocompromised individuals. The incidence of inpatient-treated aspergillosis cases in the US is estimated to be between 3.02 and 3.80 per 10,000 hospitalized patients. The estimated difference in hospital costs of patients with an aspergillosis infection is US$36,867 to US$59,356 higher than those of patients without the infection. Voriconazole is a synthetic, broad spectrum triazole antifungal agent, with FDA-approved indications for the treatment of invasive aspergillosis, esophageal candidiasis, candidemia in nonneutropenic patients, invasive candidiasis, and infections due to Scedosporium apiospermum and Fusarium species in patients refractory to or intolerant of other therapy. Eight cost-effectiveness analyses, one cost-minimization analysis, and one cost analysis were identified from a Medline search. The 10 pharmacoeconomic analyses were conducted in six different countries comparing voriconazole to conventional amphotericin B, liposomal amphotericin B, itraconazole, and caspofungin. All the cost-effectiveness and cost-minimization analyses identified voriconazole as the most cost-effective therapy. The cost analysis demonstrated voriconazole cost-savings. While the acquisition costs of voriconazole are higher than those of conventional amphotericin B, the toxicity profile and rate of treatment success associated with voriconazole result in lower total treatment costs per successfully treated patient.Keywords: voriconazole, antifungal agents, invasive aspergillosis, pharmacoeconomics 

  4. Microemulsions as vehicles for topical administration of voriconazole: formulation and in vitro evaluation.

    Science.gov (United States)

    El-Hadidy, Gladious Naguib; Ibrahim, Howida Kamal; Mohamed, Magdi Ibrahim; El-Milligi, Mohamed Farid

    2012-01-01

    This work was undertaken to investigate microemulsion (ME) as a topical delivery system for the poorly water-soluble voriconazole. Different ME components were selected for the preparation of plain ME systems with suitable rheological properties for topical use. Two permeation enhancers were incorporated, namely sodium deoxycholate or oleic acid. Drug-loaded MEs were evaluated for their physical appearance, pH, rheological properties and in vitro permeation studies using guinea pig skin. MEs based on polyoxyethylene(10)oleyl ether (Brij 97) as the surfactant showed pseudoplastic flow with thixotropic behavior and were loaded with voriconazole. Jojoba oil-based MEs successfully prolonged voriconazole release up to 4 h. No significant changes in physical or rheological properties were recorded on storage for 12 months at ambient conditions. The presence of permeation enhancers favored transdermal rather than dermal delivery. Sodium deoxycholate was more effective than oleic acid for enhancing the voriconazole permeation. Voriconazole-loaded MEs, with and without enhancers, showed significantly better antifungal activity against Candida albicans than voriconazole supersaturated solution. In conclusion, the studied ME formulae could be promising vehicles for topical delivery of voriconazole.

  5. Infecção por Scedosporium apiospermum e tratamento com Voriconazol Scedosporium apiospermum infection and treatment with Voriconazole

    Directory of Open Access Journals (Sweden)

    Renan Rangel Bonamigo

    2007-12-01

    Full Text Available A infecção pelo Scedosporium apiospermum pode tornar-se grave quando afeta pacientes imunodeprimidos, contexto em que diagnóstico e tratamento são geralmente difíceis. Os autores apresentam caso de paciente diabética usuária de ciclosporina, metotrexato e corticoesteróide sistêmico para o tramento de artrite reumatóide e que apresentou úlceras cutâneas pelo S. apiospermum. Após uso de itraconazol, sem sucesso, ocorreu resolução do quadro com o uso de voriconazol, nova alternativa para determinadas infecções fúngicas.Infection by Scedosporium apiospermum may be severe when it affects immunosuppressed patients, circumstances under which diagnosis and treatment are difficult. The authors present the case of a diabetic patient using cyclosporine, methotrexate and systemic steroids to treat rheumatoid arthritis, who presented ulcers caused by S. apiospermum. After unsuccessful treatment with itraconazole, there was good response to voriconazole therapy. This drug represents a new alternative for the treatment of fungal infections.

  6. Voriconazole Enhances the Osteogenic Activity of Human Osteoblasts In Vitro through a Fluoride-Independent Mechanism

    Science.gov (United States)

    Allen, Kahtonna C.; Sanchez, Carlos J.; Niece, Krista L.; Wenke, Joseph C.

    2015-01-01

    Periostitis, which is characterized by bony pain and diffuse periosteal ossification, has been increasingly reported with prolonged clinical use of voriconazole. While resolution of clinical symptoms following discontinuation of therapy suggests a causative role for voriconazole, the biological mechanisms contributing to voriconazole-induced periostitis are unknown. To elucidate potential mechanisms, we exposed human osteoblasts in vitro to voriconazole or fluconazole at 15 or 200 μg/ml (reflecting systemic or local administration, respectively), under nonosteogenic or osteogenic conditions, for 1, 3, or 7 days and evaluated the effects on cell proliferation (reflected by total cellular DNA) and osteogenic differentiation (reflected by alkaline phosphatase activity, calcium accumulation, and expression of genes involved in osteogenic differentiation). Release of free fluoride, vascular endothelial growth factor (VEGF), and platelet-derived growth factor (PDGF) was also measured in cell supernatants of osteoblasts exposed to triazoles, with an ion-selective electrode (for free fluoride) and enzyme-linked immunosorbent assays (ELISAs) (for VEGF and PDGF). Voriconazole but not fluconazole significantly enhanced the proliferation and differentiation of osteoblasts. In contrast to clinical observations, no increases in free fluoride levels were detected following exposure to either voriconazole or fluconazole; however, significant increases in the expression of VEGF and PDGF by osteoblasts were observed following exposure to voriconazole. Our results demonstrate that voriconazole can induce osteoblast proliferation and enhance osteogenic activity in vitro. Importantly, and in contrast to the previously proposed mechanism of fluoride-stimulated osteogenesis, our findings suggest that voriconazole-induced periostitis may also occur through fluoride-independent mechanisms that enhance the expression of cytokines that can augment osteoblastic activity. PMID:26324277

  7. 溴芬酸钠滴眼液治疗干眼症的临床观察%Clinical Efficacy Observation of Bromfenac Sodium Eye Drops in the Treatment of Xerophthalmia

    Institute of Scientific and Technical Information of China (English)

    庞彦英; 韩艳飞; 代淑静; 韩二杰; 杨云东

    2016-01-01

    OBJECTIVE:To observe the clinical efficacy and safety of Bromfenac sodium eyed drops in the treatment of xe-rophthalmia. METHODS:80 patients with xerophthalmia were randomly divided into observation group and control group,with 40 cases in each group. Control group was given 0.1% Sodium hyaluronate,one drop,qd;observation group was given 0.1% Sodi-um hyaluronate eye drops,one drop,bid. Both groups received 14 d of treatment. The subjective symptom and sign,the time of lacrimal film break-up,fluorescent staining score and schemer test were observed in 2 groups before treatment,3,7,14 d after treatment. Clinical efficacy and the occurrence of ADR were observed in 2 groups. RESULTS:There was no statistical significance in subjective symptom and sign,the time of lacrimal film break-up,fluorescent staining score and tear between 2 groups before treatment,3,7 d after treatment(P>0.05). 14 d after treatment,subjective symptom and sign and fluorescent staining score of 2 groups were decreased significantly,and the time of lacrimal film break-up was prolonged and secretion was increased significant-ly;the observation group was significantly better than the control group,with statistical significance (P0.05). CONCLUSIONS:Sodium hyaluronate eye drops is effective for xerophthalmia,and can relieve the symptoms with good safety.%目的:观察溴芬酸钠滴眼液治疗干眼症的临床疗效及安全性。方法:将80例干眼症患者按随机数字表法分为对照组和观察组,各40例。对照组患者给予0.1%浓度的玻璃酸钠滴眼液1滴,qd;观察组患者给予0.1%的溴芬酸钠滴眼液1滴,bid。两组患者均治疗14 d。观察两组患者治疗前及治疗后3、7、14 d自觉症状和体征、泪膜破裂时间及荧光素染色评分,采用泪液分泌试验(schimer)测量泪液分泌量,并比较两组患者临床疗效及不良反应发生情况。结果:治疗前及治疗后3、7 d,两组患者自觉症状和体征、泪

  8. The clinical characteristics of fungal keratitis in eyes after Descemet’s stripping and automated endothelial keratoplasty

    Directory of Open Access Journals (Sweden)

    Araki-Sasaki K

    2014-09-01

    Full Text Available Kaoru Araki-Sasaki,1,2 Atsuko Fukumoto,1 Yasuhiro Osakabe,3 Hideya Kimura,1 Shinichiro Kuroda1 1Nagata Eye Clinic, Nara, Japan; 2Department of Ophthalmology, Japan Community Health Care Organization, Hoshigaoka Medical Center, Osaka, Japan; 3Department of Molecular Pathology, Tokyo Medical University, Tokyo, Japan Abstract: The purpose of this study was to describe the clinical characteristics of fungal keratitis caused by Candida albicans in an eye after Descemet stripping automated endothelial keratoplasty (DSAEK. A 72-year-old male with a history of three trabeculectomies, cataract surgery, and two DSAEK procedures developed a corneal ulcer in his right eye two years after his last DSAEK. Fungal keratitis was most likely related to the immunosuppressive conditions that occurred due to the previous operations, the continuous use of steroid eye drops, and the use of disposable soft contact lenses. A smear and culture from the ulcer detected Candida albicans. Slit-lamp examination showed the characteristic feature was the presence of interface infiltrates located between the host and the graft cornea and in the enlarged area around the ulcer. Two weeks after intense antimycotic treatments with voriconazole, miconazole, and natamycin, perforation of the cornea occurred and further therapeutic penetrating keratoplasty was required. Histological analysis revealed an accumulation of infiltrated cells and fibrotic tissue. The poor prognosis for fungal keratitis that occurs in eyes after undergoing DSAEK may be related to the rapid expansion of inflammatory cells through the interface between the host and the graft. In eyes that develop fungal keratitis after DSAEK, special attention should be paid to the possibility that perforation could occur in these patients. Keywords: DSAEK, Candida albicans, fungal keratitis, keratomycosis, post-operative infection

  9. Multifocal periostitis as a complication of chronic use of voriconazole in a lung transplant recipient.

    Science.gov (United States)

    Tedja, R; El-Sherief, A; Olbrych, T; Gordon, S

    2013-08-01

    Fungal infections are common in solid organ transplantation. An increasing number of transplant recipients receive antifungal therapy for prolonged duration owing to invasive fungal infections. Herein, we describe a diagnosis of periostitis as a complication of chronic use of voriconazole in a lung transplant recipient. The patient was diagnosed with probable pulmonary aspergillosis and was treated with oral voriconazole for a total of 9 months. Evidence of multifocal periostitis was observed in the axial and appendicular skeleton. Early recognition of this phenomenon is important to prevent unnecessary tests and procedures. Prompt discontinuation of voriconazole should result in improvement of symptoms.

  10. A case of periostitis secondary to voriconazole therapy in a heart transplant recipient.

    Science.gov (United States)

    Wise, Steven M; Wilson, Michael A

    2011-03-01

    A 66-year-old man with a history of heart transplant for idiopathic dilated cardiomyopathy presented with progressive bone pain and myalgias. He has been on voriconazole for a pulmonary Aspergillus infection for 9 months. He had an elevated alkaline phosphatase of 280. There is no history of rheumatologic disease. Drug-induced periostitis has recently been reported in patients on long-term voriconazole therapy after lung transplantation for prophylaxis and treatment of Aspergillus infection. This case demonstrates the same phenomenon in a heart transplant patient. This patient's symptoms improved after discontinuation of voriconazole.

  11. Voriconazole-associated soft tissue ossification: an undescribed cause of glenohumeral joint capsulitis.

    Science.gov (United States)

    Raghavan, Meera; Hayes, Alex

    2014-09-01

    Voriconazole-related periostitis has been increasingly described in the literature over the last several years as a recognizable disease entity, especially in lung transplant patients. This relationship should be considered when approaching immunosuppressed patients presenting with diffuse bone pain and imaging findings of periostitis. We present a case of voriconazole-associated periostitis, capsular and enthesial ossification and glenuhumeral capsulitis in a patient with a hematologic malignancy. To the authors' knowledge, soft tissue ossification associated with voriconazole has not been described in the radiology literature.

  12. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.

    Science.gov (United States)

    2004-01-01

    Systemic fungal infections are difficult to treat and often fatal. Established treatment options include conventional amphotericin B or one of its lipid-based or liposomal formulations, or a triazole antifungal such as fluconazole or itraconazole. [symbol: see text]Caspofungin (Cancidas--Merck Sharp & Dohme) and [symbol: see text]voriconazole (Vfend--Pfizer) are two new antifungals for severe infections caused by Candida spp. (invasive candidiasis) and Aspergillus spp. (invasive aspergillosis). Caspofungin is the first licensed echinocandin antifungal, while voriconazole is a triazole. Promotional claims for caspofungin include that it "provides an effective, yet less toxic, alternative to amphotericin B" while voriconazole is claimed to offer "significantly improved survival in invasive aspergillosis compared with amphotericin B". Here we consider the place of caspofungin and voriconazole in managing patients with severe fungal infections.

  13. Periostitis secondary to prolonged voriconazole therapy in a lung transplant recipient.

    Science.gov (United States)

    Lustenberger, David P; Granata, Jaymes D; Scharschmidt, Thomas J

    2011-11-09

    This article reports a case of perostitis deformans in a lung transplantation patient taking the fluoride-containing medication voriconazole, a relatively new and potent anti-fungal. The patient had a normal range of motion in all joints and a normal gait. On radiographs at presentation, multifocal areas of periostitis were visualized involving the left-hand first, second, and third proximal phalanx shafts. Similar periostitis was present on the left-hand third, fourth, and fifth middle phalanx shafts. Plain radiographs of the right hand also demonstrated multifocal periostitis of the third and fourth proximal and middle phalanges. Aggressive periostitis at the level of the right fourth proximal and middle phalanges was also present. Given her long-term treatment with voriconazole and a presentation consistent with periostitis deformans, voriconazole was presumed to be the offending agent and was replaced with itraconazole. The patient's symptoms resolved shortly after withdrawal of voriconazole.Voriconazole-associated periostitis has only recently been reported in the literature. Food and Drug Administration-approved in 2002, voriconazole is efficacious in treating serious, invasive fungal infections that are generally seen in immunocompromised patients. Due to the novel nature of voriconazole and the uncommon indications for its long-term use, the periostitis deformans described in this article may be unfamiliar to the orthopedic surgeon. Consequently, a patient presenting with bone pain and periosteal involvement on plain radiographs may provoke a broad, expensive, and ultimately unnecessary diagnostic evaluation. The clinical case and imaging findings presented here can help to promote understanding of this benign condition and its simple cure: voriconazole discontinuation.

  14. Pharmacoeconomic analysis of voriconazole vs. caspofungin in the empirical antifungal therapy of febrile neutropenia in Australia.

    Science.gov (United States)

    Al-Badriyeh, Daoud; Liew, Danny; Stewart, Kay; Kong, David C M

    2012-05-01

    In two major clinical trials, voriconazole and caspofungin were recommended as alternatives to liposomal amphotericin B for empirical use in febrile neutropenia. This study investigated the health economic impact of using voriconazole vs. caspofungin in patients with febrile neutropenia. A decision analytic model was developed to measure downstream consequences of empirical antifungal therapy. Clinical outcomes measured were success, breakthrough infection, persistent base-line infection, persistent fever, premature discontinuation and death. Treatment transition probabilities and patterns were directly derived from data in two relevant randomised controlled trials. Resource use was estimated using an expert clinical panel. Cost inputs were obtained from latest Australian sources. The analysis adopted the perspective of the Australian hospital system. The use of caspofungin led to a lower expected mean cost per patient than voriconazole (AU$40,558 vs. AU$41,356), with a net cost saving of AU$798 (1.9%) per patient. Results were most sensitive to the duration of therapy and the alternative therapy used post-discontinuation. In uncertainty analysis, the cost associated with caspofungin is less than that with voriconazole in 65.5% of cases. This is the first economic evaluation of voriconazole vs. caspofungin for empirical therapy. Caspofungin appears to have a higher probability of having cost-savings than voriconazole for empirical therapy. The difference between the two medications does not seem to be statistically significant however.

  15. Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole.

    Science.gov (United States)

    Gerber, Bernhard; Guggenberger, Roman; Fasler, David; Nair, Gayathri; Manz, Markus G; Stussi, Georg; Schanz, Urs

    2012-09-20

    We here investigate the occurrence of fluoride intake-associated alterations in patients with hematologic disease on triazol antifungal medication. Clinical, laboratory, and radiology data of overall 43 patients with hematologic malignancies taking voriconazole (n = 20), posaconazole (n = 8), and itraconazole (n = 4), and a hematologic patient control group (n = 11) are described. Bone pain and radiologic evidence of periostitis were exclusively observed in patients receiving long-term voriconazole. Cessation of treatment led to clinical improvement in all cases. In line with clinical evidence, fluoride serum concentration was elevated in patients receiving voriconazole (median, 156.5 μg/L; interquartile range, 96.8 μg/L; normal < 30 μg/L) but not in the other treatment groups (P < .001 for all comparisons vs voriconazole). We conclude that serum fluoride levels were elevated on average 5-fold above normal levels in hematologic patients receiving voriconazole. Clinically relevant skeletal disease was associated with renal insufficiency and above 10-fold elevated fluoride levels, and was reversible on termination of voriconazole treatment.

  16. Determination of Benzalkonium Chloride in Besifloxacin Hydrochloride Eye Drops by HPLC%盐酸贝西沙星滴眼液中苯扎氯铵的HPLC法测定

    Institute of Scientific and Technical Information of China (English)

    陈再新; 朱峰; 王勇军

    2013-01-01

    An HPLC method was established for the determination of benzalkonium chloride in besifloxacin hydrochloride eye drops.A Kromasil C18 column was used,with the mobile phase of 5 mmol/L ammonium acetate (containing 1% triethylamine,adjust pH to 5.2±0.5 with glacial acetic acid)-acetonitrile (29 ∶ 71),at the detection wavelength of 215 nm.The flow rate was 1.0 ml/min.The calibration curve of benzalkonium chloride was linear in the concentration range of 5-15 μg/ml (R2=0.998 3).The average recovery was 99.4 % with RSD of 0.42 %.%建立了高效液相色谱法测定盐酸贝西沙星滴眼液中苯扎氯铵的含量.采用Kromasil C18柱,5 mmol/L乙酸铵溶液(含1%三乙胺,用冰乙酸调至pH 5.2±0.5)-乙腈(29∶71)为流动相,检测波长为215nm,流速1.0 ml/min.苯扎氯铵在5~15 μg/ml浓度范围内线性关系良好(R2=0.998 3),平均回收率为99.4% (RSD=-0.42%).

  17. Determination of Benzalkonium Chloride in Glutathione Eye Drops by HPLC%高效液相色谱法测定谷胱甘肽滴眼液中苯扎氯铵的含量

    Institute of Scientific and Technical Information of China (English)

    欧嘉娜

    2012-01-01

      Objective:To establish a HPLC method For the determination of Benzalkonium Chloride in Glutathione eye drops. Methods:The sample was analyzed on an Agilent Zorbax SB-CN column (4.6mm ×250mm,5μm) with mobile phase consisting of 0.1%phosphoric acid and acetonitrile and tetrahydrofuran (52∶38∶10) and the detection wavelength was 214nm. Results:The Calibration curves of Benzalkonium Chloride was linear in the range of 50~250μg/ml and the linear equation was Y=20674X-79747(r=0.99979). The average recoveries was 100.9% with RSD 0.19%. Conclusion :This method is simple, rapid, accurate and with good repeatability and recovery, it cab be used as a quality control method for this preparation.%  目的:建立测定谷胱甘肽滴眼液中苯扎氯铵含量的方法.方法:采用Agilent Zorbax SB-CN柱(4.6mm×250mm,5μm);流动相:0.1%磷酸水溶液-乙腈-四氢呋喃(52∶38∶10);检测波长:214nm.结果:苯扎氯铵的线性范围为50~250μg/ml,线性回归方程为Y=20674X-79747(r=0.99979).平均回收率分别为100.9%,RSD为0.19%.结论:该方法简便、快速、准确,具有良好的重复性和回收率,可作为该制剂的质量控制标准.

  18. Comparative Study of Recombinant Bovine Basic Fibroblast Growth Factor Ophthalmic Gel and Sodium Hyaluronate Eye Drops for Treating Meibomian Gland Abnormality Related Dry Eye%重组牛碱性成纤维细胞生长因子眼用凝胶和玻璃酸钠滴眼液治疗睑板腺异常相关干眼疗效比较

    Institute of Scientific and Technical Information of China (English)

    王雪飞; 覃冬菊; 李明哲

    2014-01-01

    Objective To investigate the efficacy of Recombinant Bovine Basic Fibroblast growth Factor Ophthalmic gel and Sodium Hyaluronate Eye Drops for the treatment of meibomian gland abnormality related dry eye. Methods 73 patients (73 eyes) with meibo-mian gland abnormaly related dry eye in the department of ophthalmology of our hospital from march 2012 to march 2013 were ran-domly divided into the Recombinant Bovine Basic Fibroblast growth Factor Ophthalmic gel group (observation group) and Sodium Hyaluronate Eye Drops group( control group) . And the clinical symptom score, tear film breakup time ( BUT) , Schirmer test ( Schirmer Ia), corneal fluorescein staining score (FL) and meibomian gland score before treatment and on 15, 30 d after treatment were compared between the two groups. Results The clinical symptom scores, BUT and FL scores after 30 d treatment in the two groups were both better than those before treatment and after 15 d treatment (all P 0. 05) . The effective rate of the observation group was higher than that of the control group and the total effect had statistically significant difference between the two groups( P 0.05)。观察组治疗总有效率明显高于对照组( P <0.05)。结论重组牛碱性成纤维细胞生长因子眼用凝胶和玻璃酸钠滴眼液均可改善患者的临床症状,延长泪膜破裂时间,修复角膜损伤,但前者疗效优于后者。两者对睑板腺功能障碍的改善作用均不佳,需配合其他药物治疗。

  19. Eye redness

    Science.gov (United States)

    Bloodshot eyes; Red eyes; Scleral injection; Conjunctival injection ... There are many causes of a red eye or eyes. Some are medical emergencies. Others are a cause for concern, but not an emergency. Many are nothing to worry about. Eye ...

  20. PHARMACOKINETICS OF ORALLY ADMINISTERED VORICONAZOLE IN AFRICAN PENGUINS (SPHENISCUS DEMERSUS) AFTER SINGLE AND MULTIPLE DOSES.

    Science.gov (United States)

    Hyatt, Michael W; Wiederhold, Nathan P; Hope, William W; Stott, Katharine E

    2017-06-01

    Aspergillosis is a common respiratory fungal disease in African penguins ( Spheniscus demersus ) under managed care, and treatment failures with itraconazole due to drug resistance are increasingly common, leading to recent use of voriconazole. Empirical dosing with voriconazole based on other avian studies has resulted in adverse clinical drug effects in penguins. The objective of this study was to determine oral voriconazole pharmacokinetics (PK) in African penguins (n = 18). Single and once daily multiple oral doses of 5 mg/kg voriconazole were evaluated with a 4-mo washout period between trials. Plasma voriconazole concentrations were determined via high-performance liquid chromatography. Data was modeled using 3-compartamental population methodologies that supported first-order elimination. Observed mean peak concentration (1.89 μg/ml) after single dosing PK analysis was determined within the first hour following voriconazole administration. In the multiple-dose trial average plasma voriconazole concentrations were significantly higher on days 4 and 7 as compared with day 2. The mean estimates for volume of distribution (V/F) and clearance (Cl/F) for the multiple-dose study were 3.34 L and 0.18 L/hr, respectively. Monte Carlo simulations determined the median area under the curve (AUC0-24) at 84 hr was 37.7 μg·h/ml. As this assessment was comparable with the average AUC in humans receiving the recommended human oral dosage 200 mg b.i.d., it suggests that 5 mg/kg p.o. s.i.d. could be a safe and effective regimen in African penguins for treatment of aspergillosis. However, due to potential drug accumulation and subsequent toxicity, therapeutic drug monitoring with dosage adjustments is recommended to individualize dosing.

  1. Evaluation of intravenous voriconazole in patients with compromised renal function

    Directory of Open Access Journals (Sweden)

    Lilly Craig M

    2013-01-01

    Full Text Available Abstract Background Incorporation of the solubilizing excipient, sulfobutylether-β-cyclodextrin (SBECD, in the intravenous (IV formulation of voriconazole has resulted in the recommendation that this formulation be used with caution in patients with creatinine clearances (Clcr  Methods A total of 128 patients aged 11–93 years who had a baseline Clcr cr and Clcr levels while on therapy were compared with baseline values and between groups. Results The groups had similar characteristics apart from the larger proportion of females that received fluconazole. Baseline Scr was higher in those receiving caspofungin, but maximal increases of Scr and decreases in Clcr were greatest for the fluconazole group. Acute kidney injury (AKI, assessed by RIFLE criteria, was more frequent in the fluconazole vs. the caspofungin group (p  Conclusions Treatment of fungal infections in patients with compromised renal function with an SBECD-containing antifungal agent was not associated with AKI in clinical practice. Since the infecting organism was associated with AKI, decision on which antifungal to use should be determined by susceptibilities to the organism and not the incorporation of SBECD in the IV formulation.

  2. Determination of Benzalkonium Chloride in Compound Aspartate, Vitamin B6 and Dipotassium Glycyrrhe-tate Eye Drops%复方门冬维甘滴眼液中苯扎氯铵的测定

    Institute of Scientific and Technical Information of China (English)

    董超琪

    2014-01-01

    目的::建立测定复方门冬维甘滴眼液中苯扎氯铵含量的方法。方法:采用Agilent Zorbax C18色谱柱(150 mm ×4.6 mm,5μm),以乙腈-5 mmol·L-1醋酸铵溶液(含1%三乙胺,用冰醋酸调节pH至5.0±0.5)(65∶35)为流动相,流速为1.0 ml·min-1,检测波长为214 nm。结果:苯扎氯铵在50.00~150.00μg·ml-1范围内与峰面积线性关系良好,r=0.9980;平均回收率为99.1%,RSD为0.6%。结论:该方法简便,迅速,灵敏度高,具有良好的重复性及回收率,可用于复方门冬维甘滴眼液中苯扎氯铵的测定。%Objective:To develop a method to determine benzalkonium chloride in compound aspartate, vitamin B6 and dipotassi-umglycyrrhetateeyedrops.Methods:TheseparationwasperformedonanAgilentZorbaxC18(150mm×4.6mm,5μm)column. The mobile phase consisted of acetonitrile-5 mmol·L-1 ammonium acetate ( in which 1% triethylamine was added, then the pH value was adjusted to 5. 0 ± 0. 5 by acetic acid) 65∶35(v/v). The flow rate was 1. 0 ml·min-1 and the detection wavelength was 214nm. Re-sults:Benzalkonium chloride had a good linearity within the range of 50. 00-150. 00μg·ml-1(r=0. 998 0), and the average recovery was 99. 1%(RSD=0. 6%). Conclusion:The method is simple, rapid and sensitive with good repeatability and recovery. It can be used to determine benzalkoinum chloride in compound aspartate, vitamin B6 and dipotassium glycyrrhetate eye drops.

  3. Iatrogenic cushing syndrome secondary to a probable interaction between voriconazole and budesonide.

    Science.gov (United States)

    Jones, Whitney; Chastain, Cody A; Wright, Patty W

    2014-07-01

    Oral budesonide is commonly used for the management of Crohn's disease given its high affinity for glucocorticoid receptors and low systemic activity due to extensive first-pass metabolism through hepatic cytochrome P450 (CYP) 3A4. Voriconazole, a second-generation triazole antifungal agent, is both a substrate and potent inhibitor of CYP isoenzymes, specifically CYP2C19, CYP2C9, and CYP3A4; thus, the potential for drug-drug interactions with voriconazole is high. To our knowledge, drug-drug interactions between voriconazole and corticosteroids have not been specifically reported in the literature. We describe a 48-year-old woman who was receiving oral budesonide 9 mg/day for the management of Crohn's disease and was diagnosed with fluconazole-resistant Candida albicans esophagitis; oral voriconazole 200 mg every 12 hours for 3 weeks was prescribed for treatment. Because the patient experienced recurrent symptoms of dysphagia, a second 3-week course of voriconazole therapy was taken. Seven weeks after originally being prescribed voriconazole, she came to her primary care clinic with elevated blood pressure, lower extremity edema, and weight gain; she was prescribed a diuretic and evaluated for renal dysfunction. At a follow-up visit 6 weeks later with her specialty clinic, the patient's blood pressure was elevated, and her physical examination was notable for moon facies, posterior cervical fat pad prominence, and lower extremity pitting edema. Iatrogenic Cushing syndrome due to a drug-drug interaction between voriconazole and budesonide was suspected, and voriconazole was discontinued. Budesonide was continued as previously prescribed for her Crohn's disease. On reevaluation 2 months later, the patient's Cushingoid features had markedly regressed. To our knowledge, this is the first published case report of iatrogenic Cushing syndrome due to a probable interaction between voriconazole and oral budesonide. In patients presenting with Cushingoid features who

  4. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.

    NARCIS (Netherlands)

    Kullberg, B.J.; Sobel, J.D.; Ruhnke, M.; Pappas, P.; Viscoli, C.; Rex, J.H.; Cleary, J.D.; Rubinstein, E.; Church, L.W.; Brown, J.M.; Schlamm, H.T.; Oborska, I.T.; Hilton, F.; Hodges, M.R.

    2005-01-01

    BACKGROUND: Voriconazole has proven efficacy against invasive aspergillosis and oesophageal candidiasis. This multicentre, randomised, non-inferiority study compared voriconazole with a regimen of amphotericin B followed by fluconazole for the treatment of candidaemia in non-neutropenic patients. ME

  5. Fusarium Endophthalmitis following Cataract Surgery: Successful Treatment with Intravitreal and Systemic Voriconazole

    Directory of Open Access Journals (Sweden)

    Paulo A. Alves da Costa Pertuiset

    2016-01-01

    Full Text Available Purpose. To report a case of postoperative endophthalmitis caused by Fusarium species successfully treated with intravitreal and systemic voriconazole after treatment failure with amphotericin B. Methods. Clinical case report of a 60-year-old immunocompetent woman who presents with endophthalmitis of unknown origin 4 weeks after uneventful cataract extraction and IOL implantation surgery. IOL explantation, vitrectomy with capsular bag removal, vitreous aspiration for culture, and intravitreal injection of amphotericin B (5 μg/0.1 mL were performed. Diagnosis was established by culturing the vitreous aspirate on a Sabouraud agar medium and staining with lactophenol blue solution. Five days later, there was no clinical response. The decision was made to administer a single dose of intravitreal voriconazole (2.5 μg/0.1 mL and oral voriconazole (200 mg BID for 30 days. Results. Fusarium sp. grew on culture. Treatment with local and systemic voriconazole was started after no improvement with vitrectomy, IOL explantation, and intravitreal amphotericin B. After 1 month of treatment, the infection resolved and best-corrected visual acuity was 20/25. Conclusion. In patients with endophthalmitis caused by Fusarium sp., topical and systemic voriconazole treatment should be considered in cases resistant to intravitreal amphotericin B.

  6. Update on the optimal use of voriconazole for invasive fungal infections

    Directory of Open Access Journals (Sweden)

    Asma Lat George R Thompson III

    2011-02-01

    Full Text Available Asma Lat1 George R Thompson III21Department of Pharmacy, New York-Presbyterian Hospital, Columbia University Medical Center, New York, NY, USA; 2Department of Medical Microbiology and Immunology, Coccidioidomycosis Serology Laboratory, and the Department of Medicine, Division of Infectious Diseases, University of California-Davis, Sacramento, CA, USAAbstract: Voriconazole is an extended-spectrum triazole with excellent bioavailability that has now become the treatment of choice for aspergillosis. It has a unique side effect profile compared with other azoles, as well as a number of clinically important drug–drug interactions. These factors, along with a correlation between increased serum levels and improved outcomes, have prompted an interest in therapeutic drug monitoring of this agent. The pharmacology and clinical outcomes data of voriconazole are presented in this review.Keywords: therapeutic drug monitoring, aspergillosis, candidiasis, voriconazole

  7. Healthy Eyes

    Science.gov (United States)

    ... los Ojos Cómo hablarle a su oculista Healthy Eyes Having a comprehensive dilated eye exam is one ... or contact lenses. What is a comprehensive dilated eye exam? A comprehensive dilated eye exam is a ...

  8. Combination of intracameral and intrastromal voriconazole in the treatment of recalcitrant Acremonium fungal keratitis.

    Science.gov (United States)

    Haddad, Randa S; El-Mollayess, Georges M

    2012-01-01

    We present a report of a 28-year-old female with fungal keratitis due to Acremonium that was unresponsive to full medical therapy over 3 weeks. The patient was treated with superficial keratectomy, intrastromal and intracameral voriconazole injections. There was a marked clinical improvement beginning on day 3 post-therapy that was sustained until the last follow-up at 6 months. This is the first case of fungal keratitis due to Acremonium treated by a combination of intrastromal and intracameral voriconazole. This cost-effective treatment modality proved to be significant in impeding the progression of this potentially blinding disease and improving visual prognosis.

  9. Eye drop vaccination against sheep brucellosis and tests for distinguishing between vaccinated and nature infected sheep%布鲁氏菌弱毒疫苗粘膜免疫及检测方法的研究

    Institute of Scientific and Technical Information of China (English)

    赵兵; 曾凡明; 任明; 何倩倪; 彭传真; 张志新; 赵天博; 陈荣贵; 王海军; 马文勇; 努尔·赛力克; 伊恒博

    2012-01-01

    To differential detection of brucellosis in vaccinated and nature infected sheep, three groups of ewes aged 12 months to 14 months (20 for each group) were divided including two groups vaccinated via eye drop with live attenuated vaccine Brucella S2 (Brucella swine) and A19 (B. abortus) respectively with half dose of vaccination, and one group infected with a pathogenicity strain M16 (B. melitensis) to determine the sensitivity of serum agglutination test (SAT), the cysteine agglutination test (CAT) and the complement fixation test (CFT)) for distinguishing vaccinated and infected sheep. The results showed that specific antibodies against the vaccines were lasted at detectable levels for 6 months post vaccination. But the virulent strain of M16 was 100% detectable after 12 months of infection, the bacterial isolates were existed at high titres in breast cells, breast lymph nodes and iliac lymph. We conclude that the conventional serological and bacteria isolation methods could be used for distinguishing between vaccinated and infected sheep after 6 months of vaccination and infection.%为研究布鲁氏菌弱毒疫苗粘膜免疫及其检测方法,本实验采用粘膜点眼途径对健康母羊接种布鲁氏杆菌猪2号疫苗(S2)、牛19号疫苗(A19)和羊强毒株(M16),筛选布鲁氏杆菌病鉴别检测方法.将12月龄~14月龄母羊60只随机分为3组,以常规疫苗推荐剂量进行半量粘膜点眼接种.采集血液、淋巴、脏器进行布鲁氏菌病血清学检测和细菌学分离以及PCR检测.结果表明:布鲁氏菌弱毒疫苗抗体水平持续6个月,其中血清学的试管凝集试验、半胱氨酸凝集试验与补体结合试验的阳性符合率达到100%.细菌分离期为6个月,乳腺、乳腺淋巴、髂淋巴分离率较高;而强毒株M16的抗体水平和细菌分离持续12个月以上.结果显示以常规血清学和细菌学检测方法在点眼免疫布鲁氏菌S2、A19苗6个月后可以进行野毒感染和疫苗免疫畜的鉴别诊断.

  10. Coalescence of a Drop inside another Drop

    Science.gov (United States)

    Mugundhan, Vivek; Jian, Zhen; Yang, Fan; Li, Erqiang; Thoroddsen, Sigurdur

    2016-11-01

    Coalescence dynamics of a pendent drop sitting inside another drop, has been studied experimentally and in numerical simulations. Using an in-house fabricated composite micro-nozzle, a smaller salt-water drop is introduced inside a larger oil drop which is pendent in a tank containing the same liquid as the inner drop. On touching the surface of outer drop, the inner drop coalesces with the surrounding liquid forming a vortex ring, which grows in time to form a mushroom-like structure. The initial dynamics at the first bridge opening up is quantified using Particle Image Velocimetry (PIV), while matching the refractive index of the two liquids. The phenomenon is also numerically simulated using the open-source code Gerris. The problem is fully governed by two non-dimensional parameters: the Ohnesorge number and the diameter ratios of the two drops. The validated numerical model is used to better understand the dynamics of the phenomenon. In some cases a coalescence cascade is observed with liquid draining intermittently and the inner drop reducing in size.

  11. Divergent electrophysiologic profile of fluconazole and voriconazole in an experimental whole-heart model of proarrhythmia.

    Science.gov (United States)

    Frommeyer, Gerrit; Fischer, Christina; Lange, Philipp S; Leitz, Patrick; Fehr, Michael; Bogossian, Harilaos; Milberg, Peter; Eckardt, Lars

    2016-04-05

    In several case reports a prolongation of the QT-interval and even proarrhythmic effects of fluconazole and voriconazole were reported. The aim of the present study was to investigate if application of fluconazole or voriconazole has the potential to provoke polymorphic ventricular tachycardia in a sensitive model of proarrhythmia. In female rabbits, fluconazole (10, 30 and 50 µM, n=6) and voriconazole (10, 30 and 50 µM, n=6) were infused after obtaining baseline data. Eight endocardial and epicardial monophasic action potentials and a simultaneously recorded 12-lead ECG showed a significant QT prolongation after application of fluconazole as compared with baseline (10 µM:+12 ms, 30 µM:+22 ms, 50 µM:+37 ms; Pfluconazole induced a significant increase (30 µM:+15 ms, 50 µM:+16 ms; Pfluconazole led to the reproducible induction of EADs in 4 of 6 hearts and polymorphic ventricular tachycardia in 3 of 6 hearts (36 episodes). In the present study, voriconazole demonstrated a safe electrophysiologic profile despite significant QT prolongation. In contrast, fluconazole led to a more marked prolongation of myocardial repolarization combined with a more marked increase of dispersion of repolarization. These results imply that application of fluconazole might be torsadogenic and the QT-interval should be closely monitored.

  12. Successful treatment of Batrachochytrium salamandrivorans infections in salamanders requires synergy between voriconazole, polymyxin E and temperature.

    Science.gov (United States)

    Blooi, M; Pasmans, F; Rouffaer, L; Haesebrouck, F; Vercammen, F; Martel, A

    2015-06-30

    Chytridiomycosis caused by the chytrid fungus Batrachochytrium salamandrivorans (Bsal) poses a serious threat to urodelan diversity worldwide. Antimycotic treatment of this disease using protocols developed for the related fungus Batrachochytrium dendrobatidis (Bd), results in therapeutic failure. Here, we reveal that this therapeutic failure is partly due to different minimum inhibitory concentrations (MICs) of antimycotics against Bsal and Bd. In vitro growth inhibition of Bsal occurs after exposure to voriconazole, polymyxin E, itraconazole and terbinafine but not to florfenicol. Synergistic effects between polymyxin E and voriconazole or itraconazole significantly decreased the combined MICs necessary to inhibit Bsal growth. Topical treatment of infected fire salamanders (Salamandra salamandra), with voriconazole or itraconazole alone (12.5 μg/ml and 0.6 μg/ml respectively) or in combination with polymyxin E (2000 IU/ml) at an ambient temperature of 15 °C during 10 days decreased fungal loads but did not clear Bsal infections. However, topical treatment of Bsal infected animals with a combination of polymyxin E (2000 IU/ml) and voriconazole (12.5 μg/ml) at an ambient temperature of 20 °C resulted in clearance of Bsal infections. This treatment protocol was validated in 12 fire salamanders infected with Bsal during a field outbreak and resulted in clearance of infection in all animals.

  13. Validated LC method for the estimation of voriconazole in bulk and formulation

    Directory of Open Access Journals (Sweden)

    Patel C

    2009-01-01

    Full Text Available Reversed phase high performance liquid chromatographic method was developed and validated for the estimation of voriconazole in bulk and formulation using prominence diode array detector. Selected mobile phase was a combination of water:acetonitrile (35:65 % v/v and wavelength selected was 256 nm. Retention time of voriconazole was 3.95 min. Linearity of the method was found to be 0.1 to 2 µg/ml, with the regression coefficient of 0.999. This method was validated according to ICH guidelines. Quantification was done by calculating area of the peak and the detection limit and quantitation limit ware 0.026 µg/ml and 0.1 µg/ml, respectively. There was no significant difference in the intra day and inter day analysis of voriconazole determined for three different concentrations using this method. Present method can be applied for the determination of voriconazole in quality control of formulation without interference of the excipients.

  14. Pharmacodynamics of Voriconazole in Children : Further Steps along the Path to True Individualized Therapy

    NARCIS (Netherlands)

    Huurneman, Luc J.; Neely, Michael; Veringa, Anette; Docobo Perez, Fernando; Ramos-Martin, Virginia; Tissing, Wim J.; Alffenaar, Jan-Willem C.; Hope, William

    2016-01-01

    Voriconazole is the agent of choice for the treatment of invasive aspergillosis in children at least 2 years of age. The galactomannan index is a routinely used diagnostic marker for invasive aspergillosis and can be useful for following the clinical response to antifungal treatment. The aim of this

  15. Economic Evaluation of Voriconazole for the Treatment of Candidemia in Canadian Adults

    Directory of Open Access Journals (Sweden)

    Coleman Rotstein

    2008-01-01

    Full Text Available BACKGROUND: Candidemia is a common cause of nosocomial bloodstream infection. When selecting therapeutic treatments for candidemia, cost-effectiveness is an important consideration. The present study assessed the cost-effectiveness of voriconazole for the treatment of candidemia.

  16. [Hepatosplenic and kidneys candidasis complicating an acute myeloblastic leukemia. A case treated with voriconazole and caspofungin].

    Science.gov (United States)

    Elouennass, M; Doghmi, K; Fagot, T; Soler, C; Mac Nab, C; Foissaud, V; De Revel, T; Hervé, V

    2005-01-01

    We report the observation of hepato-splenic and kidneys candidiasis complicating the chemotherapy of a myeloblastic leukemia (LAM5b). Following the lack of effectiveness of a first line treatement, using amphotericine B liposomale and 5-fluorocytosine, implementation of an association of new molecules, a triazole of second generation (voriconazole) and an echinocandine (caspofungine) has allowed a successful result.

  17. Pharmacokinetic effect of voriconazole on cyclosporine in the treatment of aspergillosis after renal transplantation.

    Science.gov (United States)

    Park, Seok J; Song, Im-Sook; Kang, Sun W; Joo, Hyun; Kim, Tae H; Yoon, Young C; Kim, Euiyong; Choi, Yeong-Lim; Shin, Jae-Gook; Son, Ji H; Kim, Yeong H

    2012-11-01

    Azole antifungal agents are essential drugs in the treatment of fungal infections in renal transplant patients. As azoles, these antifungal agents are inhibitors of CYP3A4 and P-glycoprotein (P-gp); and thus therapeutic drug monitoring is important. We evaluated a patient with cutaneous and pulmonary aspergillosis who was successfully treated with voriconazole and a low cyclosporine trough level (3.2 - 27.9 ng/ml) for 3 months. During that period, the patient showed good allograft function with the co-administration of voriconazole and cyclosporine. We measured the patient's genotype of MDR1, CYP3A4, CYP3A5 and CYP2C19 enzymes in addition to the intracellular concentration of cyclosporine in peripheral blood mononuclear cells (PBMCs). The intracellular concentration of cyclosporine in PBMC is 3.2 times higher with no functionally defected alleles in MDR1, CYP3A4, CYP3A5 or CYP2C19 enzymes when cyclosporine is co-administered with voriconazole ex vivo. Although other confounding factors causing immunological modulation may exist, it is plausible that low serum and high intracellular cyclosporine concentrations, due to the inhibition of P-gp activity by voriconazole, also contribute to an immunosuppressive state.

  18. In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium strains causing keratitis.

    Science.gov (United States)

    Al-Hatmi, Abdullah M S; Meletiadis, Joseph; Curfs-Breuker, Ilse; Bonifaz, Alexandro; Meis, Jacques F; De Hoog, G Sybren

    2016-04-01

    Fusarium species cause a broad spectrum of infections, from superficial to disseminated disease. Because Fusarium species are intrinsically resistant to most antifungal drugs, new approaches are needed. The aim of the present study was to evaluate the in vitro combination of natamycin with currently used antifungal drugs. The in vitro interactions of combinations between natamycin and voriconazole, itraconazole and micafungin applied to 20 clinical Fusarium strains (members of Fusarium falciforme, Fusarium napiforme, Fusarium petroliphilum, Fusarium proliferatum, Fusarium pseudensiforme and Fusarium sacchari) were evaluated using a chequerboard microdilution method. The MICs of all drugs alone and in combination were determined visually after 48 h and interactions were assessed using fractional inhibitory concentration index (FICI) analysis. MICs of voriconazole and natamycin alone were 4 to >16 and 4-8 mg/L, respectively. Values were reduced 3.5-10-fold to 0.02-0.5 mg/L and 0.5-5-fold to 0.13-2 mg/L in combination, for the currently used antifungals and natamycin, respectively, demonstrating additive to synergistic interactions. The combinations natamycin/voriconazole, natamycin/itraconazole and natamycin/micafungin were synergistic (FICI ≤0.5) for 70%, 15% and 5% of the strains, respectively. No antagonism was found. The combination of natamycin with voriconazole was strongly synergistic at clinically achievable serum concentrations. © The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

  19. RP-HPTLC method for determination of Voriconazole in bulk and in cream formulation

    Directory of Open Access Journals (Sweden)

    Manali W. Jain

    2017-02-01

    Full Text Available Voriconazole is used as an antifungal agent. A new rapid, simple, economical and environmental friendly Reversed -Phase High-Performance Thin-Layer Chromatography (RP-HPTLC has been developed and validated for quantitative determination of voriconazole in bulk and in cream formulation. RP-HPTLC separation was performed on aluminium plates precoated with silica gel 60RP-18F-254S as the stationary phase using Acetonitrile: Water (60:40% v/v as mobile phase. Quantification was achieved by densitometric analysis at 257 nm over the concentration range of 200–1200 ng/band. The method was found to give compact and well resolved band for Voriconazole at Retention factor (Rf 0.48 ± 0.02. The linear regression analysis data for calibration graph showed good linear relationship with r2 = 0.999. The method was validated for precision, recovery, robustness, ruggedness and sensitivity as per International conference on Harmonization (ICH guidelines. The Limit of Detection (LOD and Limit of Quantification (LOQ were found to be 19.99 ng and 60.60 ng, respectively. The proposed developed RP-HPTLC method can be applied for identification and quantitative determination of Voriconazole in bulk and in cream formulation.

  20. Voriconazole, a safe alternative for treating infections caused by the Chrysosporium anamorph of Nannizziopsis vriesii in bearded dragons (Pogona vitticeps).

    Science.gov (United States)

    Van Waeyenberghe, L; Baert, K; Pasmans, F; van Rooij, P; Hellebuyck, T; Beernaert, L; de Backer, P; Haesebrouck, F; Martel, A

    2010-09-01

    Dermal and systemic infections caused by the Chrysosporium anamorph of Nannizziopsis vriesii (CANV) are highly prevalent in reptiles and may result in severe disease and high mortality. Due to the high incidence of therapeutic failures, optimizing treatment is required. We first determined in this study the minimal inhibitory concentrations (MIC) of itraconazole, voriconazole, amphotericin B and terbinafine against 32 CANV isolates. For voriconazole, amphotericin B and terbinafine a monomodal MIC distribution was seen, whereas a bimodal MIC distribution was present for itraconazole, indicating acquired resistance in one isolate. Fourteen naturally-infected bearded dragons (Pogona vitticeps), from the same owner, were treated orally with either itraconazole (5 mg/kg q24h) or voriconazole (10 mg/kg q24h). The clinical condition, drug plasma concentrations and the presence of CANV in skin samples were followed. The animals were treated until complete clearance of the fungus. The plasma concentrations of voriconazole and itraconazole exceeded the minimal inhibitory concentrations of the CANV isolates. Elimination of CANV was achieved on average after 27 and 47 days of treatment with itraconazole and voriconazole, respectively. Whereas only 2 out of 7 survived after itraconazole treatment, only a single animal died in the voriconazole treated group. In conclusion, based on a limited number of animals, voriconazole applied at a regimen of 10 mg/kg bodyweight (BW) q24h seems to be a safe and effective antimycotic drug to eliminate CANV infections in bearded dragons.

  1. Voriconazole is a safe and effective anti-fungal prophylactic agent during induction therapy of acute myeloid leukemia

    Directory of Open Access Journals (Sweden)

    Akash Shah

    2016-01-01

    Full Text Available Background: Antifungal prophylaxis (AFP reduces the incidence of invasive fungal infections (IFIs during induction therapy of acute myeloid leukemia (AML. Posaconazole is considered the standard of care. Voriconazole, a generic cheaper alternative is a newer generation azole with broad anti-fungal activity. There is limited data on the use of voriconazole as a prophylactic drug. Materials and Methods: A single-center, prospective study was performed during which patients with AML undergoing induction chemotherapy received voriconazole as AFP (April 2012 to February 2014. Outcomes were compared with historical patients who received fluconazole as AFP (January 2011-March 2012, n = 66. Results: Seventy-five patients with AML (median age: 17 years [range: 1-75]; male:female 1.6:1 received voriconazole as AFP. The incidence of proven/probable/possible (ppp IFI was 6.6% (5/75. Voriconazole and fluconazole cohorts were well-matched with respect to baseline characteristics. Voriconazole (when compared to fluconazole reduced the incidence of pppIFI (5/75, 6.6% vs. 19/66, 29%; P < 0.001, need to start therapeutic (empiric + pppIFI antifungals (26/75, 34% vs. 51/66, 48%; P < 0.001 and delayed the start of therapeutic antifungals in those who needed it (day 16 vs. day 10; P < 0.001. Mortality due to IFI was also reduced with the use of voriconazole (1/75, 1.3% vs. 6/66, 9%; P = 0.0507, but this was not significant. Three patients discontinued voriconazole due to side-effects. Conclusion: Voriconazole is an effective and safe oral agent for IFI prophylaxis during induction therapy of AML. Availability of generic equivalents makes this a more economical alternative to posaconazole.

  2. Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation

    Directory of Open Access Journals (Sweden)

    V. I. Ignatieva

    2015-01-01

    Full Text Available Introduction. Based on clinical studies data voriconazole is recommended as the drug of choice for treatment of invasive aspergillosis (IA – a widespread infectious complications occurring in immunocompromised patients and is characterized by severe clinical course and high mortality.The aim of this study was to assess the cost-effectiveness of voriconazole compared to other preparations recommended in the Russian practice for the treatment of IA in adult patients.Materials and methods. The authors constructed a «decision tree» type of model, which compared the three treatment alternatives for the IA in adult patients, depending on the drug in first-line therapy: 1 voriconazole, 2, caspofungin, or 3 amphotericin B lipid complex (LC. Efficacy was assessed as the probability of patient survival within 14 weeks of starting treatment. We took into account the drugs cost and an increase in the hospitalization duration due to the development of serious adverse events. The model parameters were determined on the basis of the published results of clinical studies, the costs were calculated on the basis of medicines prices in the public procurement and the average bed-day cost in system of obligatory health insurance. Probabilistic sensitivity analysis was performed.Results. It has been shown that the use of voriconazole for treatment of IA is the dominant strategy compared to the use of caspofungin and amphotericin B LC, providing cost reduction while achieving maximum effect. Probabilistic sensitivity analysis (1000 simulations showed stability of the revealed pattern.Conclusion. The use of voriconazole in the treatment of IA allows to save the greatest number of lives at minimal cost compared to other preparations recommended in the Russian practice.

  3. Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation

    Directory of Open Access Journals (Sweden)

    V. I. Ignatieva

    2015-06-01

    Full Text Available Introduction. Based on clinical studies data voriconazole is recommended as the drug of choice for treatment of invasive aspergillosis (IA – a widespread infectious complications occurring in immunocompromised patients and is characterized by severe clinical course and high mortality.The aim of this study was to assess the cost-effectiveness of voriconazole compared to other preparations recommended in the Russian practice for the treatment of IA in adult patients.Materials and methods. The authors constructed a «decision tree» type of model, which compared the three treatment alternatives for the IA in adult patients, depending on the drug in first-line therapy: 1 voriconazole, 2, caspofungin, or 3 amphotericin B lipid complex (LC. Efficacy was assessed as the probability of patient survival within 14 weeks of starting treatment. We took into account the drugs cost and an increase in the hospitalization duration due to the development of serious adverse events. The model parameters were determined on the basis of the published results of clinical studies, the costs were calculated on the basis of medicines prices in the public procurement and the average bed-day cost in system of obligatory health insurance. Probabilistic sensitivity analysis was performed.Results. It has been shown that the use of voriconazole for treatment of IA is the dominant strategy compared to the use of caspofungin and amphotericin B LC, providing cost reduction while achieving maximum effect. Probabilistic sensitivity analysis (1000 simulations showed stability of the revealed pattern.Conclusion. The use of voriconazole in the treatment of IA allows to save the greatest number of lives at minimal cost compared to other preparations recommended in the Russian practice.

  4. Elevated fluoride levels and periostitis in pediatric hematopoietic stem cell transplant recipients receiving long-term voriconazole.

    Science.gov (United States)

    Tarlock, Katherine; Johnson, Darren; Cornell, Cathy; Parnell, Shawn; Meshinchi, Soheil; Baker, K Scott; Englund, Janet A

    2015-05-01

    Azole therapy is widely utilized in hematopoietic stem cell transplant (HCT) recipients for the treatment of aspergillus. Complications of voriconazole treatment related to its elevated fluoride content have been described in adults, including reports of symptomatic skeletal fluorosis. We review fluoride levels, clinical, and laboratory data in five pediatric HCT recipients on long-term voriconazole therapy, all found to have elevated serum fluoride levels. Two patients had toxic fluoride levels, one infant had symptoms of significant pain with movement and radiographs confirmed skeletal fluorosis. Monitoring fluoride levels in children, especially with skeletal symptoms, should be considered in patients on long-term voriconazole.

  5. Eye Injuries

    Science.gov (United States)

    The structure of your face helps protect your eyes from injury. Still, injuries can damage your eye, sometimes severely enough that you could lose your vision. Most eye injuries are preventable. If you play sports or ...

  6. Eye Wear

    Science.gov (United States)

    Eye wear protects or corrects your vision. Examples are Sunglasses Safety goggles Glasses (also called eyeglasses) Contact ... jobs and some sports carry a risk of eye injury. Thousands of children and adults get eye ...

  7. Eye Cancer

    Science.gov (United States)

    Cancer of the eye is uncommon. It can affect the outer parts of the eye, such as the eyelid, which are made up ... adults are melanoma and lymphoma. The most common eye cancer in children is retinoblastoma, which starts in ...

  8. Eye Diseases

    Science.gov (United States)

    ... the back of the eye Macular degeneration - a disease that destroys sharp, central vision Diabetic eye problems ... defense is to have regular checkups, because eye diseases do not always have symptoms. Early detection and ...

  9. The effect of esmolol on children's heart rate who accept squint correction and adrenaline eye drop%艾司洛尔对斜视矫正术眼滴肾上腺素对患儿心率的影响

    Institute of Scientific and Technical Information of China (English)

    王淑珍; 顾恩华

    2012-01-01

    目的 观察艾司洛尔对斜视矫正术眼滴肾上腺素对患儿的心率影响.方法 选择6~10岁斜视矫正术的患儿90例,随机分为3组,各30例.A组(对照组,术眼滴0.9%生理盐水),B组(术眼滴肾上腺素),C组(术眼滴肾上腺素,并静脉注入艾司洛尔拮抗).监测并记录入手术室前的心率,视基础值为T0,麻醉前T1,麻醉后5 min T2,眼滴肾上腺素,或同时静脉给予艾司洛尔后2min为T3,5min为T4,10 min为T5,60 min为T6.结果 3组(T0-T2)心率的变化比较,差异无统计学意义;B、C 两组心率(T3-T5)各时间点与A组比较,差异有统计学意义,但C组(T3-T5)心率上升明显低于B组,差异有统计学意义.结论 斜视矫正术眼滴肾上腺素可使心率瞬间显著上升,静脉助注艾司洛尔可显著抑制其上升,维持患儿围术期心率平稳.%Objective To observe the effect of esmolol on children's heart rate who accept squint correction and adrenaline eye drop.Methods Selected six to ten years old children with squint correction of 90 cases were randomly divided into three groups,each group had 30 cases.Group A was control group and accepted 0.9% physiological saline to sick eye.Group B dropped the adrenaline to sick eye.Group C dropped the adrenaline to sick eye and accepted intravenous injection esmolol antagonist.Monitored and recorded the heart rate before children came into the operating room.The basic value was T0.Before anesthesia was T1,5 minutes after anesthesia was T2,sick eye accepted adrenaline,or at the same time to intravenous injection esmolol then 2 minutes was T3,5 minutes was T4,10 minutes was T5 and 60 minutes was T6.Results The difference of heart rate change (T0-T2) in three groups was not statistically significant.Compared heart rate (T3-T5) of each time point in group B and C with group A,the difference was statistically significant.But heart rate rise (T3-T5) in group C was significantly lower than in group B,the difference was statistically

  10. Scedosporium apiospermum eumycetoma successfully treated with oral voriconazole: report of a case and review of the Brazilian reports on scedosporiosis.

    Science.gov (United States)

    Oliveira, Flávio de Mattos; Unis, Gisela; Hochhegger, Bruno; Severo, Luiz Carlos

    2013-01-01

    We describe a case of white-grain eumycetoma caused by Scedosporium apiospermum in an immunocompetent host that was successfully treated with oral voriconazole, and we review the Brazilian reports on scedosporiosis.

  11. Evaluation of sulfobutylether-β-cyclodextrin (SBECD) accumulation and voriconazole pharmacokinetics in critically ill patients undergoing continuous renal replacement therapy.

    Science.gov (United States)

    Kiser, Tyree H; Fish, Douglas N; Aquilante, Christina L; Rower, Joseph E; Wempe, Michael F; MacLaren, Robert; Teitelbaum, Isaac

    2015-02-03

    Intravenous (IV) voriconazole is not recommended in patients with creatinine clearance 50 ml/min to avoid potentially toxic accumulation of sulfobutylether-β-cyclodextrin (SBECD). The purpose of this study was to evaluate the pharmacokinetics of SBECD, voriconazole, and voriconazole N-oxide in critically ill patients undergoing continuous renal replacement therapy (CRRT) and to determine if CRRT removes SBECD sufficiently to allow for the use of IV voriconazole without significant risk of SBECD accumulation. This prospective, open-label pharmacokinetic study enrolled patients >18 years old receiving IV voriconazole for a known or suspected invasive fungal infection while undergoing CRRT. Serial blood and effluent samples were collected on days 1, 3, 5, 7, and every 3 to 5 days thereafter. SBECD, voriconazole, and voriconazole N-oxide plasma and effluent concentrations were measured by liquid chromatography-tandem mass spectrometry. Pharmacokinetic, pharmacodynamic, and pharmacogenetic analyses were conducted. Ten patients (mean ± standard deviation (SD)) 53 ± 11 years old, 50% male, 81 ± 14 kg, with Acute Physiologic and Chronic Health Evaluation II (APACHE II) scores of 31.5 ± 3.8 were evaluated. All patients underwent continuous venovenous hemofiltration (CVVH) with a median predilution replacement fluid rate of 36 (interquartile range (IQR) 32 to 37) ml/kg/hr and total ultrafiltration rate of 38 (IQR 34 to 39) ml/kg/hr. Mean ± SD voriconazole and SBECD dosages administered were 8.1 ± 2.1 mg/kg/day and 129 ± 33 mg/kg/day, respectively. Voriconazole plasma trough concentrations were >1 mg/L in all patients with CVVH accounting for only 15% of the total body clearance. CVVH accounted for 86% of the total body clearance of SBECD with the majority of the dose being recovered in the effluent. Minimal increases in dose normalized SBECD area under the concentration-time curve from 0 to 12 hours (AUC0-12) (4,484 ± 4,368 to 4,553

  12. Genetic variation in plant CYP51s confers resistance against voriconazole, a novel inhibitor of brassinosteroid-dependent sterol biosynthesis.

    Directory of Open Access Journals (Sweden)

    Wilfried Rozhon

    Full Text Available Brassinosteroids (BRs are plant steroid hormones with structural similarity to mammalian sex steroids and ecdysteroids from insects. The BRs are synthesized from sterols and are essential regulators of cell division, cell elongation and cell differentiation. In this work we show that voriconazole, an antifungal therapeutic drug used in human and veterinary medicine, severely impairs plant growth by inhibiting sterol-14α-demethylation and thereby interfering with BR production. The plant growth regulatory properties of voriconazole and related triazoles were identified in a screen for compounds with the ability to alter BR homeostasis. Voriconazole suppressed growth of the model plant Arabidopsis thaliana and of a wide range of both monocotyledonous and dicotyledonous plants. We uncover that voriconazole toxicity in plants is a result of a deficiency in BRs that stems from an inhibition of the cytochrome P450 CYP51, which catalyzes a step of BR-dependent sterol biosynthesis. Interestingly, we found that the woodland strawberry Fragaria vesca, a member of the Rosaceae, is naturally voriconazole resistant and that this resistance is conferred by the specific CYP51 variant of F. vesca. The potential of voriconazole as a novel tool for plant research is discussed.

  13. Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity.

    Science.gov (United States)

    Bouatou, Yassine; Samer, Caroline Flora; Ing Lorenzini, Kuntheavy Roseline; Daali, Youssef; Daou, Samira; Fathi, Marc; Rebsamen, Michela; Desmeules, Jules; Calmy, Alexandra; Escher, Monica

    2014-01-01

    Voriconazole is metabolized by cytochrome P450 (CYP) 2C19 and CYP 3A4. Drug-drug interactions and genetic polymorphisms modulate their activities. A 35-year old African female patient with resistant HIV and a cerebral mass of unknown origin was treated with voriconazole for a suspicion of disseminated Aspergillosis infection. Voriconazole trough concentrations (C0) were within target range while the patient was under esomeprazole, a CYP2C19 inhibitor. Phenotyping showed decreased CYP2C19 activity, whereas genotyping showed a variant allele associated with increased enzyme activity. The patient was switched to ranitidine because of the introduction of atazanavir. CYP3A4 inhibition by atazanavir combined with uninhibited CYP2C19 activity resulted in subtherapeutic voriconazole C0. The reintroduction of esomeprazole allowed restoring voriconazole C0 back to target range. The integration of drug-drug interactions and pharmacogenetics data is crucial to interpret drug concentrations correctly, thus preventing suboptimal exposure to voriconazole.

  14. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia

    DEFF Research Database (Denmark)

    Jørgensen, Karsten Juhl; Gøtzsche, Peter C; Dalbøge, Christina S

    2014-01-01

    BACKGROUND: Opportunistic fungal infections are a major cause of morbidity and mortality in neutropenic cancer patients and antifungal therapy is used both empirically and therapeutically in these patients. OBJECTIVES: To compare the benefits and harms of voriconazole with those of amphotericin B...... and fluconazole when used for prevention or treatment of invasive fungal infections in cancer patients with neutropenia. SEARCH METHODS: Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library (2014, Issue 1 2014), MEDLINE (to January 2014). Letters, abstracts and unpublished trials were...... and adverse effects leading to discontinuation of therapy were extracted independently by two review authors. MAIN RESULTS: Three trials were included. One trial compared voriconazole to liposomal amphotericin B as empirical treatment of fever of unknown origin (suspected fungal infection) in neutropenic...

  15. Voriconazole-induced periostitis causing arthralgias mimicking a flare of granulomatosis with polyangiitis.

    Science.gov (United States)

    Gladue, Heather S; Fox, David A

    2013-12-01

    We describe a case of voriconazole-induced periostitis that occurred in a 68-year-old woman with granulomatosis with polyangiitis. Our patient presented with months of severe hip pain limiting her daily activities, which was initially felt to be a flare of her granulomatosis with polyangiitis. However, upon further review, she had an elevated alkaline phosphatase and periostitis on her hip radiograph; voriconazole was held, and within 2 days she had marked improvement in her pain. Although this clinical syndrome is well documented in transplant patients, it is a rare complication in patients with autoimmune disorders. However, it is important because it may cause severe arthralgias that can mimic a flare of rheumatic diseases.

  16. Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis.

    Science.gov (United States)

    Heinz, Werner J; Egerer, Gerlinde; Lellek, Heinrich; Boehme, Angelika; Greiner, Jochen

    2013-05-01

    Invasive aspergillosis is an important cause of morbidity and mortality in haematological patients. Current guidelines recommend voriconazole as first-line therapy. A change in class of antifungal agent is generally recommended for salvage therapy. The focus of this analysis was to assess if posaconazole is suitable for salvage therapy following voriconazole treatment. This was a retrospective investigation on patients with sequential antifungal therapy of posaconazole after voriconazole identified at four German hospitals. Response rates at 30 and 60 days following start of posaconazole application and toxicity of azoles by comparing liver enzymes and cholestasis parameters were evaluated. Data were analysed by descriptive statistics. Overall, the success rate was 72.2% [15 of 36 patients showed complete response (41.7%), 11 patients partial response (30.6%) at any time point], eight patients failed treatment and two were not evaluable. Mean laboratory values increased during voriconazole and decreased during posaconazole treatment: aspartate aminotransferase (increase: 31.9 U l(-1) vs. decrease: 19.6 U l(-1) ), alanine aminotransferase (32.4 U l(-1) vs. 19.8 U l(-1) ), gamma-glutamyl transferase (124.2 U l(-1) vs. 152.3 U l(-1) ) and alkaline phosphatase (71.5 U l(-1) vs. 40.3 U l(-1) ) respectively. No patient discontinued posaconazole therapy due to an adverse event. In this analysis posaconazole was a safe and effective antifungal salvage therapy in patients with prior administration of another triazole.

  17. Successful treatment of an invasive fungal infection caused by Talaromyces sp. with voriconazole

    Directory of Open Access Journals (Sweden)

    Uluhan Sili

    2015-06-01

    Full Text Available Invasive fungal infections (IFI are on the rise due to increasing numbers of immunosuppressed and critically ill patients. A malignant-looking pulmonary nodule in an immunosuppressed patient may indeed be caused by a fungal organism. We report a patient, who was eventually diagnosed with an IFI caused by an agent of hyalohyphomycosis, Talaromyces sp. determined via molecular methods and succesfully treated with voriconazole.

  18. Voriconazole-Induced Periostitis Mimicking Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation.

    Science.gov (United States)

    Sweiss, Karen; Oh, Annie; Rondelli, Damiano; Patel, Pritesh

    2016-01-01

    Voriconazole is an established first-line agent for treatment of invasive fungal infections in patients undergoing allogeneic stem cell transplantation (ASCT). It is associated with the uncommon complication of periostitis. We report this complication in a 58-year-old female undergoing HSCT. She was treated with corticosteroids with minimal improvement. The symptoms related to periostitis can mimic chronic graft-versus-host disease in patients undergoing HSCT and clinicians should differentiate this from other diagnoses and promptly discontinue therapy.

  19. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].

    Science.gov (United States)

    Blanco, M T; Cañadas, J; García-Martos, P; Marín, P; García-Tapia, A; Rodríguez, J

    2009-09-01

    This study has been conducted to asses the in vitro activity of the novel triazole antifungal agent posaconazole against 123 clinically important isolates of yeasts. Susceptibility was tested using the Sensititre YeastOne microdilution commercial method. Minimum inhibitory concentrations (MICs) were determined at the recommended endpoints and time intervals. The activity of posaconazole against Candida glabrata was compared with those of fluconazole, itraconazole, ketoconazole and voriconazole. The most susceptible species to posaconazole were C. albicans, C. parapsilosis, C. tropicalis and C. dubliniensis. Candida glabrata was the least susceptible. The percentage of strains with MIC for posaconazole >or= 1 mg/L was 9%, all of them were C. glabrata. The species with MIC for itraconazole >or= 0.5 mg/L were 36% (41 C. glabrata, 1 C. krusei, 1 C. guilliermondii, 1 C. ciferrii). Candida glabrata strains resistant to fluconazole, ketoconazole and voriconazole were 8%, 4% and 4%, respectively. Posaconazole exhibited good activity to the majority of Candida species. However, it was similar to itraconazole and less active than ketoconazole and voriconazole against C. glabrata.

  20. Treatment of pediatric refractory coccidioidomycosis with combination voriconazole and caspofungin: a retrospective case series.

    Science.gov (United States)

    Levy, Emily R; McCarty, James M; Shane, Andi L; Weintrub, Peggy S

    2013-06-01

    Coccidioidomycosis is a spectrum of diseases caused by the dimorphic fungi Coccidioides. Current regimens for severe or disseminated disease include fluconazole, itraconazole, or amphotericin; newer triazoles (ie, voriconazole, posaconazole) have been demonstrated to be useful in refractory disease. Previous reported experience with combination triazole and caspofungin therapy has been very limited; however, the utility of this combination for treatment of other invasive fungal diseases suggests potential benefit in refractory coccidioidomycosis. We conducted a retrospective review of 9 pediatric patients treated with combination voriconazole and caspofungin (V/C) salvage therapy for refractory coccidioidomycosis at two children's hospitals between January 2000 and June 2012. Nine children with refractory coccidioidomycosis were treated with V/C salvage therapy after failing conventional therapy consisting of a triazole, amphotericin B, or a combination of both. Eight of the 9 patients are currently in remission; 1 patient with central nervous system involvement continues to progress. We report our positive clinical experience treating medically refractory coccidioidomycosis in the pediatric population with concurrent voriconazole and caspofungin therapy. Additional in vitro and in vivo evaluations are warranted to support the role of V/C salvage therapy for refractory coccidioidomycosis.

  1. Uso de voriconazol en el período neonatal. Reporte de dos casos = Voriconazole use during the neonatal period. Report of two cases

    Directory of Open Access Journals (Sweden)

    Carvajal Kalil, Luis Fernando

    2011-06-01

    Full Text Available Las infecciones micóticas son cada vez más frecuentes en las unidades de cuidado intensivo y aumentan la tasas de morbilidad y mortalidad. En años recientes se han desarrollado nuevos antimicóticos, entre ellos el voriconazol que es, en el momento actual, el tratamiento de elección para los casos de aspergilosis en pacientes adultos y niños mayores de dos años y se considera una opción terapeútica en otras infecciones micóticas. A pesar de esto, la experiencia de su uso en neonatos es escasa y aún se desconocen el perfil de seguridad y las variaciones en cuanto a farmacodinámica y farmacocinética en este grupo etario. Se presentan los casos de dos neonatos de sexo masculino con infecciones micóticas (Aspergillus y Rhodotorula que fueron tratados con voriconazol con buena tolerancia y respuesta clínica adecuada

  2. Paying attention to the impact of anti-inflammatory eye drops on corneal biomechanical parameters%角膜屈光手术医师应注意抗炎类滴眼液对术后角膜生物力学的影响

    Institute of Scientific and Technical Information of China (English)

    白继

    2012-01-01

    Corneal refractive surgery continues to develop accompanied by a rapid advance in scientific knowledge and technology.Improvement in visual quality after corneal refractive surgery is an issue of increasing concerns.Furthermore,corneal biomechanical alteration after corneal refractive surgery is a new problem.Corneal biomechanical parameters vary upon not only the quality of refractive surgery,but also the human physiological cycles and application of some postoperative drugs.These effects are sometimes very important factors for 'unstable'outcomes.At present,much attention has been focused on the change of corneal biomechanics after operation,but the event of postoperative application of anti-inflammatory eye drops leading to ocular hypertension,refractive regression,even visual quality decline is still not well understood.Herein,the therapeutic effects and adverse responses of topical anti-inflammatory eye drops,especially the change in characteristics of corneal biomechanics after corneal refractive surgery,as well as the application of topical anti-inflammatory eye drops were discussed.It is essential that corneal refractive surgeons should fully understand the potential impact of anti-inflammatory eye drops on corneal biomechanics after corneal refractive surgery.%伴随科学技术的进步,角膜屈光手术疗效得到了不断的提高,人们在改善患者视觉质量的同时,也关注到角膜屈光手术后角膜生物力学改变带来的影响.角膜生物力学相关参数不但受角膜屈光手术的直接影响,同时也受到人体生理周期以及术后一些药物的影响,而这些影响是导致部分手术疗效不“稳定”的重要因素.手术对角膜生物力学的影响已受到了较多的关注,但对于术后部分抗炎类滴眼液的应用可能引发眼压升高、屈光回退、甚至视觉质量下降等了解尚不够.本文对抗炎类滴眼液在角膜屈光手术后局部应用的作用及其不良反应进行阐述,

  3. 羟糖甘滴眼液对视网膜脱离玻璃体切割术后泪膜功能的影响%Effect of Tears Naturale Forte Eye Drops on the Function of Tear Film in Patients after Vitrectomy for Retinal Detachment

    Institute of Scientific and Technical Information of China (English)

    刘卫华; 杨新怀; 黄勤; 聂鑫; 覃旭方; 全婵娟; 袁建枚

    2015-01-01

    目的:探讨羟糖甘滴眼液对视网膜脱离玻璃体切割术后泪膜功能的影响。方法选择2010年7月—2012年7月接受玻璃体切割术治疗的视网膜脱离80例,根据治疗方案分为观察组和对照组,每组40例。对照组术后给予妥布霉素地塞米松滴眼液+眼膏,观察组在对照组基础上给予羟糖甘滴眼液。观察两组术前、术后3、7、30 d干眼症评分、泪膜破裂时间(BUT)、基础泪液分泌试验(Slt)、角膜荧光素染色评分(CFS)。结果两组术后3、7、30 d BUT观察组高于对照组(P<0.05),且术后30 d观察组恢复正常水平,术后7 d观察组干眼症评分低于对照组(P<0.05)。结论羟糖甘滴眼液可以缓解玻璃体切割术后患者干眼症状,对早期恢复泪膜稳定性有积极意义。%Objective To discuss the effect of Tears Naturale Forte Eye Drops on the function of tear film in pa-tients after vitrectomy for retinal detachment. Methods Eighty patients undergoing treatment after vitrectomy for ratinal detachment during July 2010 and July 2012 were divided into observation group (n=40) and control group (n=40) ac-cording to the treatment protocols. The control group was treated with Tobramycin and Dexamethasone Eye Drops+Ocu-lentum , while the observation group was treated with Tears Naturale Forte Eye Drops based on the treatment of observation group. The scores of xeroma, breakup time of tear film ( BUT) , Schirmerl test ( Slt) , corneal fluorescein staining ( CFS) before the operation and on the post-operative 3rd d, 7th d and 30th d in two groups were compared. Results The BUT scores in observation group on the post-operative 3rdd, 7thd and 3rd d were significantly higher than those in control group (P<0. 05), and the BUT score in observation group on the post-operative 30 d returned to normal, and xeroma score on the post-operative 7thd in observation group was significantly lower than that in control group (P<0. 05). Conclusion

  4. 带状疱疹性角膜炎采用阿昔洛韦联合玻璃酸钠及氟米龙眼液治疗的临床体会%The Clinical Experience of Acyclovir Combined With Sodium Hyaluronate and Fluorometholone Eye Drops in Treatment of Herpes Zoster Keratitis

    Institute of Scientific and Technical Information of China (English)

    赵艳辉

    2015-01-01

    目的:对带状疱疹性角膜炎采用阿昔洛韦联合玻璃酸钠及氟米龙眼液治疗的临床效果进行研究分析。方法选取我院收治的带状疱疹性角膜炎患者进行临床研究。结果治疗组总有效率90.00%、畏光消失时间(8.02±3.11)min,荧光素染色阴性时间(12.13±3.02)min,同对照组患者的70.00%(、11.05±2.61)min和(15.47±2.38)min相比,P<0.05。结论阿昔洛韦联合玻璃酸钠及氟米龙眼液治疗带状疱疹性角膜炎疾病效果显著。%ObjectiveAnalysis the clinical effect of herpes zoster keratitis with acyclovir combined with sodium hyaluronate and fluorometholone eye drops in the treatment of Herpes zoster keratitis.Methods Selected patients with herpes zoster keratitis in our hospital.Results The total effective rate of treatment group reached to 90%, photophobia disappeared time (8.02 ± 3.11) min, lfuorescein staining negative time (12.13 ± 3.02) min with 70% of control patients, (11.05 ± 2.61) min and (15.47 ± 2.38) min,P<0.05.Conclusion Acyclovir combined with sodium hyaluronate and lfuorometholone eye drops in treatment of herpes zoster keratitis disease has clinically signiifcant.

  5. Efeito do colírio de 5-fluorouracil sobre o epitélio corneano íntegro de coelhos Effects of 5-fluorouracil eye drops on intact rabbit corneal epithelium

    Directory of Open Access Journals (Sweden)

    Lucieni Cristina Barbarini Ferraz

    2003-08-01

    Full Text Available OBJETIVO: Observar os efeitos da aplicação tópica de 5-fluorouracil (5-FU sobre o epitélio corneano íntegro. MÉTODOS: Foram utilizados 10 coelhos albinos (14 olhos, divididos em: grupo controle (GC, 4 olhos nos quais não se administraram drogas, grupo 1 (G1, 5 olhos que receberam 5-fluorouracil na concentração 1,25% e grupo 2 (G2, 5 olhos que receberam 5-fluorouracil na concentração de 2,5%. A droga foi instilada 4 vezes por dia, durante 7 dias, quando os animais foram sacrificados, os olhos removidos, separando-se a córnea que foi preparada de modo convencional para estudo em microscópico eletrônico de varredura. RESULTADOS: GC: observaram-se células de formato hexagonal, claras, escuras e intermediárias, compondo o epitélio corneano de coelhos. Presença de numerosas microplicas, principalmente nas células claras. Cada célula possui cerca de 1 a 3 criptas. Nos animais do G1, observou-se maior número de células escuras, regiões com diminuição no número de criptas; alterações da superfície celular, protusão na região do núcleo e descamação de células epiteliais. Os do G2 tiveram aumento de microprojeções na superfície celular, modificações nas junções intercelulares até separação de células adjacentes; diminuição do número e variabilidade no tamanho das criptas. As alterações mais freqüentes ocorreram nas células da periferia da córnea. CONCLUSÃO: O 5-fluorouracil teve efeitos deletérios no epitélio íntegro corneano de coelhos. As alterações observadas foram mais importantes nos animais que receberam a droga mais concentrada (G2 e mais freqüentes na periferia da córnea.PURPOSE: To assess the influence of the antiproliferative agent (5-FU on the intact rabbit corneal epithelium. METHODS: 10 rabbits (14 eyes,were divided into: control group (CG, 4 eyes without drug administration; G1, 5 eyes underwent treatment with topical 12.5 mg/ml 5-fluorouracil and G2, 5 eyes received 5-fluorouracil

  6. Pharmacokinetics of a single dose of voriconazole administered orally with and without food to red-tailed hawks (Buteo jamaicensus).

    Science.gov (United States)

    Parsley, Ruth A; Tell, Lisa A; Gehring, Ronette

    2017-04-01

    OBJECTIVE To determine the pharmacokinetics of voriconazole administered PO with or without food to red-tailed hawks (Buteo jamaicensus) and whether any observed variability could be explained by measured covariates to inform dose adjustments. ANIMALS 7 adult red-tailed hawks. PROCEDURES In a crossover study design, hawks were randomly assigned to first receive voriconazole (15 mg/kg, PO) injected into a dead mouse (n = 3; fed birds) or without food (4; unfed birds). Sixteen days later, treatments were reversed. Blood samples were collected at various points to measure plasma voriconazole concentrations by ultraperformance liquid chromatography. Pharmacokinetic data were analyzed by noncompartmental methods and fit to a compartmental model through nonlinear mixed-effects regression, with feeding status and body weight investigated as covariates. RESULTS Voriconazole was well absorbed, with quantifiable plasma concentrations up to 24 hours after administration. Mean plasma half-life was approximately 2 hours in fed and unfed birds. Administration of the voriconazole in food delayed absorption, resulting in a significant delay in time to maximum plasma concentration. The final compartmental model included a categorical covariate to account for this lag in absorption as well as body weight as a covariate of total body clearance (relative to unknown bioavailability). CONCLUSIONS AND CLINICAL RELEVANCE A single dose of voriconazole (15 mg/kg) administered PO to red-tailed hawks resulted in mean plasma voriconazole concentrations greater than the targeted value (1 μg/mL). Additional studies with larger sample sizes and multidose regimens are required before the model developed here can be applied in clinical settings.

  7. Efficacy and safety of benzalkonium chloride (BAK)-free eye drops in treatment of glaucoma and ocular hypertension: a Meta-analysis%不含苯扎氯铵的抗青光眼滴眼液疗效及安全性的Meta分析

    Institute of Scientific and Technical Information of China (English)

    麻南; 胡莲娜; 高付林

    2011-01-01

    Objective To evaluate the efficacy and safety of BAK-free eye drops in treatment of glaucoma and ocular hypertension. Design Meta-analysis. Participants Published literature in Medline(1966-2011), Embase(1966-2010), Cochrane library(2010) and CBM (1979-2010) which compared antiglaucoma drugs containing BAK with BAK-free. Methods According to evaluation guidelines of Cochrane collaboration, clinical controlled trials of antiglaucoma drugs in treatment of glaucoma and ocular hypertension were searched using Medline, Embase, the Cochrane Library and CBM. Methodology qualities of literatures were performed by experienced researchers according to the Jadad Score. RevMan 4.2 offered by Cochrane was used for Meta-analysis. Main Outcome Measures Intraocular pressure and drug adverse events. Results Only 6 literatures (2313 eyes) were included for Meta-analysis . The result of analysis showed that BAK-free eye drops could control the intraoptic pressure as well as eye drops containing BAK (P=0.38). However, adverse event rates (such as conjunctival hyperemia, allergic conjunctivitis and dry eye) in BAK-free group were much lower than BAK containing group (P=0.02, 0.004, 0.01, respectively). Conclusion Meta-analysis shows that BAK-free eye drops have equal efficacy and much better safety when compared with BAK containing eye drops in treatment of glaucoma and ocular hypertension. More high quality perspective studies are still required for further analysis. (Ophthalmol CHN, 2011, 20: 283-286)%目的 通过荟萃分析评价不含苯扎氯铵(BAK)的滴眼液治疗青光眼和高眼压症的有效性及安全性.设计荟萃分析.研究对象Medline(1966-2011年)、Embase(1966-2010年)、Cochrane图书馆(2010年)及中国生物医学文献数据库CBM(1979-2010年)有关含与不含BAK的滴眼液治疗青光眼和高眼压症的临床对照研究文献资料.方法 采用Cochrane系统评价的方法检索文献,按照纳入和排除标准限定研究对象,通过Jadad评

  8. Clinical outcomes of sleeveless phacotip assisted levitation of dropped nucleus.

    Science.gov (United States)

    Agarwal, Amar; Narang, Priya; A Kumar, Dhivya; Agarwal, Ashvin

    2014-10-01

    To demonstrate the feasibility of a sleeveless phacotip-assisted approach to levitate dropped nucleus. This single-centre, retrospective, interventional, non-comparative case series reviewed the medical records of 34 eyes of 34 patients. Corrected and uncorrected distance visual acuity (CDVA, UDVA), early and late postoperative complications and ultrasound biomicroscopic (UBM) evaluation of the sclerotomy site was analysed. At 18 months follow-up, the mean postoperative UDVA and CDVA in Snellen's decimal equivalent was 0.42 ± 0.16 and 0.91 ± 0.2, respectively. There was a significant improvement in the UDVA (p=0.001) and CDVA (p=0.002). Nucleus drop occurred following intraoperative posterior capsular rupture in 25 eyes (73.5%), zonular weakness in 5 eyes (14.8%) and post-trauma in 4 eyes (11.7%). In the early postoperative period, corneal oedema was seen in 2 eyes, pigment dispersion in 3 eyes and vitritis in 2 eyes. There was loss of CDVA in 1 (2.9%) eye due to persistent cystoid macular oedema. UBM did not reveal any vitreous incarceration into the sclerotomy site. Dropped nucleus was successfully levitated into anterior chamber with this technique, resulting in a significant visual outcome with a favourable complication rate. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

  9. Drag on Sessile Drops

    Science.gov (United States)

    Milne, Andrew J. B.; Fleck, Brian; Nobes, David; Sen, Debjyoti; Amirfazli, Alidad; University of Alberta Mechanical Engineering Collaboration

    2013-11-01

    We present the first ever direct measurements of the coefficient of drag on sessile drops at Reynolds numbers from the creeping flow regime up to the point of incipient motion, made using a newly developed floating element differential drag sensor. Surfaces of different wettabilities (PMMA, Teflon, and a superhydrophobic surface (SHS)), wet by water, hexadecane, and various silicone oils, are used to study the effects of drop shape, and fluid properties on drag. The relation between drag coefficient and Reynolds number (scaled by drop height) varies slightly with liquid-solid system and drop volume with results suggesting the drop experiences increased drag compared to similar shaped solid bodies due to drop oscillation influencing the otherwise laminar flow. Drops adopting more spherical shapes are seen to experience the greatest force at any given airspeed. This indicates that the relative exposed areas of drops is an important consideration in terms of force, with implications for the shedding of drops in applications such as airfoil icing and fuel cell flooding. The measurement technique used in this work can be adapted to measure drag force on other deformable, lightly adhered objects such as dust, sand, snow, vesicles, foams, and biofilms. The authours acknowledge NSERC, Alberta Innovates Technology Futures, and the Killam Trusts.

  10. Bubble and drop interfaces

    CERN Document Server

    Miller

    2011-01-01

    The book aims at describing the most important experimental methods for characterizing liquid interfaces, such as drop profile analysis, bubble pressure and drop volume tensiometry, capillary pressure technique, and oscillating drops and bubbles. Besides the details of experimental set ups, also the underlying theoretical basis is presented in detail. In addition, a number of applications based on drops and bubbles is discussed, such as rising bubbles and the very complex process of flotation. Also wetting, characterized by the dynamics of advancing contact angles is discussed critically. Spec

  11. Eye Anatomy

    Science.gov (United States)

    ... News About Us Donate In This Section Eye Anatomy en Español email Send this article to a ... You at Risk For Glaucoma? Childhood Glaucoma Eye Anatomy Five Common Glaucoma Tests Glaucoma Facts and Stats ...

  12. Eye trauma

    African Journals Online (AJOL)

    2011-02-02

    Feb 2, 2011 ... will invariably lead to lid swelling, making the examination far more difficult. ... protect the eye with a pad or shield, give tetanus prophylaxis and refer. ... A study on penetrating eye injuries in South African children found.

  13. A clinical study of the efficacy of topical corticosteroids on dry eye

    OpenAIRE

    Yang, Chong-qing; Sun, Wen; Gu, Yang-Shun

    2006-01-01

    Objective: To evaluate the effect of topical corticosteroid for treatment of moderate or severe dry eye. Methods: Sixty eyes of 30 patients with moderate or severe dry eye, who were not sensitive to artificial tears, were treated with 0.1% fluorometholone eye drops. Subjective symptom and objective tests were used to evaluate the efficacy of treatment before and after application of 0.1% fluorometholone eye drops for 1 week and 1 month. Side effects were also evaluated. Results: After 1 week ...

  14. Turbulence, bubbles and drops

    NARCIS (Netherlands)

    Veen, van der Roeland Cornelis Adriaan

    2016-01-01

    In this thesis, several questions related to drop impact and Taylor-Couette turbulence are answered. The deformation of a drop just before impact can cause a bubble to be entrapped. For many applications, such as inkjet printing, it is crucial to control the size of this entrapped bubble. To study t

  15. Youth Crime Drop. Report.

    Science.gov (United States)

    Butts, Jeffrey A.

    This report examines the recent drop in violent crime in the United States, discussing how much of the decrease seen between 1995-99 is attributable to juveniles (under age 18 years) and older youth (18-24 years). Analysis of current FBI arrest data indicates that not only did America's violent crime drop continue through 1999, but falling youth…

  16. Recurrent Acremonium infection in a kidney transplant patient treated with voriconazole: a case report Infecção recidivante por Acremonium em paciente transplantado renal tratado com voriconazol: relato de caso

    Directory of Open Access Journals (Sweden)

    Felipe Francisco Tuon

    2010-08-01

    Full Text Available Acremonium infection is rare and associated with immunosuppression. A case of recurrent cutaneous Acremonium infection after short term voriconazole use is described. Surgical resection was the definitive therapy. Oral voriconazole was used in the treatment of Acremonium infection, but recurrence was associated with short therapy. Prolonged antifungal therapy and surgical resection are discussed for the treatment of localized lesions.Infecção por Acremonium é rara e pode estar associada com imunossupressão. Descrevemos um caso de infecção recorrente de pele por Acremonium após tratamento breve com voriconazol. Ressecção cirúrgica foi o tratamento definitivo. Terapia prolongada com antifúngicos e ressecção cirúrgica são discutidas para o tratamento de doenças fúngicas localizadas.

  17. Generation of reactive oxygen species in the anterior eye segment. Synergistic codrugs of N-acetylcarnosine lubricant eye drops and mitochondria-targeted antioxidant act as a powerful therapeutic platform for the treatment of cataracts and primary open-angle glaucoma

    Directory of Open Access Journals (Sweden)

    Mark A. Babizhayev

    2016-12-01

    Mitochondrial targeting of compounds with universal types of antioxidant activity represents a promising approach for treating a number of ROS-related ocular diseases of the aging eye and can be implicated in the management of cataracts and primary open-angle glaucoma.

  18. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies.

    Science.gov (United States)

    Raad, Issam I; Zakhem, Aline El; Helou, Gilbert El; Jiang, Ying; Kontoyiannis, Dimitrios P; Hachem, Ray

    2015-03-01

    Invasive aspergillosis (IA) is a life-threatening infection in severely immunocompromised haematological malignancy patients. In this study, the efficacy and safety of caspofungin, voriconazole or the combination as primary and salvage therapy in patients with IA were compared. The study included 181 patients with haematological malignancies and IA who received primary or salvage therapy with caspofungin, voriconazole or the combination. In total, 138 patients who received treatment for ≥7 days were analysed; 86 underwent primary antifungal therapy (15 with caspofungin, 38 with voriconazole and 33 with both). Among the salvage therapy patients, 17 received caspofungin, 24 received voriconazole and 35 received both. In the primary therapy group, no difference in therapy response was found, but caspofungin was associated with higher IA mortality rates. A multivariate competing risk analysis of primary antifungal therapy revealed that voriconazole was independently associated with lower IA-associated mortality rates than caspofungin (hazard ratio=0.2, 95% confidence interval 0.06-0.96; P=0.04). In the salvage therapy group, the three treatment groups had similar responses and IA-associated mortality rates. The combination of voriconazole and caspofungin did not result in better outcomes compared with voriconazole alone, as primary or salvage therapy, in haematological malignancy patients. However, voriconazole was associated with a lower Aspergillus-associated mortality rate compared with caspofungin monotherapy.

  19. Drop Tower Physics

    Science.gov (United States)

    Dittrich, William A. Toby

    2014-10-01

    The drop towers of yesteryear were used to make lead shot for muskets, as described in The Physics Teacher1 in April 2012. However, modern drop towers are essentially elevators designed so that the cable can "break" on demand, creating an environment with microgravity for a short period of time, currently up to nine seconds at the drop tower in Bremen, Germany. Using these drop towers, one can briefly investigate various physical systems operating in this near zero-g environment. The resulting "Drop Tower Physics" is a new and exciting way to challenge students with a physical example that requires solid knowledge of many basic physics principles, and it forces them to practice the scientific method. The question is, "How would a simple toy, like a pendulum, behave when it is suddenly exposed to a zero-g environment?" The student must then postulate a particular behavior, test the hypothesis against physical principles, and if the hypothesis conforms to these chosen physical laws, the student can formulate a final conclusion. At that point having access to a drop tower is very convenient, in that the student can then experimentally test his or her conclusion. The purpose of this discussion is to explain the response of these physical systems ("toys") when the transition is made to a zero-g environment and to provide video demonstrations of this behavior to support in-class discussions of Drop Tower Physics.

  20. 高效液相色谱法测定重组人干扰素α1b滴眼液中苯扎氯铵的含量%Determination of benzalkonium chloride content in recombinant human interferon a1b eye drops by high performance liquid chromatography

    Institute of Scientific and Technical Information of China (English)

    牛晓霞; 曹艳; 吴美英

    2013-01-01

    Objective To determine the benzalkonium chloride content in recombinant human interferon α1b (rhIFNα1b) eye drops by high performance liquid chromatography (HPLC).Methods The benzalkonium chloride content in rhIFNα1b eye drops was determined by HPLC.A Waters Symmetry C18 column was used with the mobile phase of V(A):V(B) =65:35 [A:acetonitrile; B:5 mmol/L ammonium acetate containing 1% triethylamine,adjusted with acetic acid to pH(5.0 ± 0.2)] at a flow rate of 1.0 ml/min.The detection wavelength,sample load and column temperature were 262 nm,20 μl and room temperature,respectively.The method was verified,and used for determination of benzalkonium chloride contents in three batches of rhIFNα1b eye drops.Results The method showed good specificity and suitability in determination of benzalkonium chloride content,of which the minimum detection limit and minimum quantitation limit were 0.53 and 1.48 μg/ml respectively.The standard curve showed good linearity within a benzlkonium chloride concentration range of 10 ~ 50 μg/ml (R2 =0.9991).The RSD of peak areas of six samples loaded were 1.78%.The mean recovery rate of samples at theoretical benzalkonium chloride concentrations of 22,24 and 26 μg/ml was 97.90%,with a RSD of 0.96%.The relative benzalkonium chloride contents in three batches of rIFNα1b eye drops were 19.27,19.89 and 19.76 μg/ml,which were 96.34%,94.46% and 98.80% of stated amounts,respectively.Conclusion The developed HPLC method was simple,sensitive and accurate,which might be used for determinatioin of benzalkonium chloride content in recombinant human interferon α1b eye drops.%目的 采用高效液相色谱法(high performance liquid chromatography,HPLC)测定重组人干扰素α1b(recombinant human interferon α1b,rhIFNα1b)滴眼液中苯扎氯铵(benzalkonium chloride)的含量.方法 采用HPLC法测定rhIFNα1b滴眼液中苯扎氯铵含量,色谱条件:流动相:乙腈:5 mmol/L醋酸铵[含1%三乙胺

  1. In vitro antifungal activity of fluconazole and voriconazole against non-Candida yeasts and yeast-like fungi clinical isolates.

    Science.gov (United States)

    Mandras, Narcisa; Roana, Janira; Scalas, Daniela; Fucale, Giacomo; Allizond, Valeria; Banche, Giuliana; Barbui, Anna; Li Vigni, Nicolò; Newell, Vance A; Cuffini, Anna Maria; Tullio, Vivian

    2015-10-01

    The risk of opportunistic infections caused by non-Candida yeasts and yeast-like fungi is increasingly common, mainly in immunocompromised patients. Appropriate first-line therapy has not been defined and standardized, mainly due to the low number of cases reported. To improve empirical treatment guidelines, we describe the susceptibility profile to fluconazole and voriconazole of 176 non-Candida yeasts and yeast-like fungi collected from hospitals in Piedmont, North West Italy from January 2009 to December 2013. The results showed that most isolates are susceptible to voriconazole (94%), but less susceptible to fluconazole (78%), suggesting that voriconazole could be used as first-line therapy in infections caused by these fungi.

  2. The slow relaxation dynamics in active pharmaceutical ingredients studied by DSC and TSDC: Voriconazole, miconazole and itraconazole.

    Science.gov (United States)

    Ramos, Joaquim J Moura; Diogo, Hermínio P

    2016-03-30

    The slow molecular mobility of three active pharmaceutical drugs (voriconazole, miconazole and itraconazole) has been studied by differential scanning calorimetry (DSC) and thermally stimulated depolarization currents (TSDC). This study yielded the main kinetic features of the secondary relaxations and of the main (glass transition) relaxation, in particular their distribution of relaxation times. The dynamic fragility of the three glass formers was determined from DSC data (using two different procedures) and from TSDC data. According to our results voriconazole behaves as a relatively strong liquid, while miconazole is moderately fragile and itraconazole is a very fragile liquid. There are no studies in this area published in the literature relating to voriconazole. Also not available in the literature is a slow mobility study by dielectric relaxation spectroscopy in the amorphous miconazole. Apart from that, the results obtained are in reasonable agreement with published works using different experimental techniques. Copyright © 2016 Elsevier B.V. All rights reserved.

  3. The Drop Tower Bremen -An Overview

    Science.gov (United States)

    von Kampen, Peter; Könemann, Thorben; Rath, Hans J.

    The Center of Applied Space Technology and Microgravity (ZARM) was founded in 1985 as an institute of the University of Bremen, which focuses on research on gravitational and space-related phenomena. In 1988, the construction of ZARM`s drop tower began. Since its inau-guration in September 1990, the eye-catching Drop Tower Bremen with a height of 146m and its characteristic glass roof has become twice a landmark on the campus of the University of Bremen and the emblem of the technology park Bremen. As such an outstanding symbol of space science in Bremen the drop tower provides an european unique facility for experiments under conditions of high-quality weightlessness with residual gravitational accelerations in the microgravity regime. The period of maximum 4.74s of each freely falling experiment at the Drop Tower Bremen is only limited by the height of the drop tower vacuum tube, which was fully manufactured of steal and enclosed by an outer concrete shell. Thus, the pure free fall height of each microgravity drop experiment is approximately 110m. By using the later in-stalled catapult system established in 2004 ZARM`s short-term microgravity laboratory is able to nearly double the time of free fall. This world-wide inimitable capsule catapult system meets scientists` demand of extending the period of weightlessness. During the catapult operation the experiment capsule performs a vertical parabolic flight within the drop tower vacuum tube. In this way the time of microgravity can be extended to slightly over 9s. Either in the drop or in the catapult operation routine the repetition rates of microgravity experiments at ZARM`s drop tower facility are the same, generally up to 3 times per day. In comparison to orbital platforms the ground-based laboratory Drop Tower Bremen represents an economic alternative with a permanent access to weightlessness on earth. Moreover, the exceptional high quality of weightlessness in order of 1e-6 g (in the frequency range below 100

  4. Voriconazole-induced periostitis post transplant: an illustrative review of thoracic computed tomography imaging manifestations.

    Science.gov (United States)

    Rheinboldt, M; Delproposto, Z; Agarwal, R

    2015-12-01

    Voriconazole, first commercially approved in 2002 as a second-generation antifungal agent, is commonly used in the immunocompromised setting as both a therapeutic and prophylactic agent. Since 2009, scattered case reports and small case series have detailed a secondary drug-related hyperfluorosis-induced painful periostitis that can occur in the treated patient population. We present a pictorial review of the thoracic imaging manifestations utilizing 3 illustrative cases in the setting of both solid organ and bone marrow transplantation. Knowledge of the relatively characteristic radiographic appearance and distribution, when coupled with the appropriate clinical context and associated laboratory findings, is important in narrowing an otherwise relatively broad differential diagnosis.

  5. Voriconazole-Induced Periostitis Mimicking Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation

    Directory of Open Access Journals (Sweden)

    Karen Sweiss

    2016-01-01

    Full Text Available Voriconazole is an established first-line agent for treatment of invasive fungal infections in patients undergoing allogeneic stem cell transplantation (ASCT. It is associated with the uncommon complication of periostitis. We report this complication in a 58-year-old female undergoing HSCT. She was treated with corticosteroids with minimal improvement. The symptoms related to periostitis can mimic chronic graft-versus-host disease in patients undergoing HSCT and clinicians should differentiate this from other diagnoses and promptly discontinue therapy.

  6. Successful Treatment of Fungal Osteomyelitis with Voriconazole in a Patient with CGD

    Directory of Open Access Journals (Sweden)

    Mahsa Oaji

    2010-12-01

    Full Text Available Background:Chronic granulomatous disease (CGD is an immunodeficiency affecting phagocytic leukocytes. Defective respiratory burst mechanism renders the affected patients to be susceptible to catalase positive microorganisms. With the great successes in antibacterial prophylaxis and therapy, fungal infections are a persistent problem. Invasive aspergillosis is the most important cause of mortality in CGD. Case Presentation: We describe a nine year-old boy with CGD who presented with aspergillus induced skull osteomyelitis. He was successfully treated with voriconazole after initial failure of amphotericin B therapy. Conclusion: Currently, newer triazoles are recommended as initial therapy for invasive aspergillosis in immunodeficiency states such as CGD.

  7. Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?

    Science.gov (United States)

    Pagano, L; Valentini, C G; Fianchi, L; Caira, M

    2011-02-01

    The proportion of patients with cancers who develop invasive fungal infections has increased dramatically over the past few decades. Most of these infections are diagnosed in patients with hematological malignancies, mainly in patients with acute myeloid leukemia and those undergoing allogeneic hematopoietic stem cell transplantation. For years deoxycolate amphotericin B has been considered the drug of choice for the treatment of invasive aspergillosis, but it has been outclassed by its lipid formulations and new triazoles (i.e. voriconazole), that produced better response rates; nonetheless recovery from neutropenia remains the most important factor influencing outcome.

  8. Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole.

    Science.gov (United States)

    Erwin, Gary E; Fitzgerald, John E

    2007-12-01

    Allergic bronchopulmonary aspergillosis and allergic fungal sinusitis are closely related disorders that rarely present in the same individual. The mainstay of treatment for allergic bronchopulmonary aspergillosis is systemic corticosteroids. Itraconazole is used as adjunctive therapy in refractory cases. Allergic fungal sinusitis requires initial sinus surgery followed by systemic steroids. Antifungal therapy has not proven to be beneficial in allergic fungal sinusitis. We report a case of concomitant allergic bronchopulmonary aspergillosis and allergic fungal sinusitis that was refractory to standard therapy but had dramatic clinical response following treatment with voriconazole.

  9. Use of combination therapy to successfully treat breakthrough Trichosporon asahii infection in an acute leukemia patient receiving voriconazole

    Directory of Open Access Journals (Sweden)

    Jia Chen

    2014-10-01

    Full Text Available Trichosporon species is an important life-threatening opportunistic systemic pathogen, especially in leukemia patients. Voriconazole is proved to be a promising agent in past decade. However, recently we observed a case of breakthrough Trichosporon asahii infection while receiving voriconazole, which calls for an alternative treatment strategy. A combination therapy of liposomal amphotericin B (AmB plus caspofungin – in which liposomal AmB dose was reduced due to renal toxicity – was administered to successfully treat this patient.

  10. Modest efficacy of voriconazole against murine infections by Sporothrix schenckii and lack of efficacy against Sporothrix brasiliensis.

    Science.gov (United States)

    Fernández-Silva, Fabiola; Capilla, Javier; Mayayo, Emilio; Guarro, Josep

    2014-02-01

    The efficacy of voriconazole (VRC) was evaluated against two strains of each of the two most common species causing sporotrichosis, Sporothrix schenckii sensu stricto and Sporothrix brasiliensis, using a murine model of disseminated infection. Voriconazole was administered at doses of 20 or 40 mg kg(-1) per day by gavage. The drug showed some efficacy, especially at 40 mg kg(-1) per day, in prolonging the survival and reducing fungal load in spleen and liver in mice infected with S. schenckii, whereas in animals infected with S. brasiliensis the drug did not work.

  11. Voriconazole Disposition After Single and Multiple, Oral Doses in Healthy, Adult Red-tailed Hawks ( Buteo jamaicensis ).

    Science.gov (United States)

    Gentry, Jordan; Montgerard, Christy; Crandall, Elizabeth; Cruz-Espindola, Crisanta; Boothe, Dawn; Bellah, Jamie

    2014-09-01

    Voriconazole is effective for treatment of aspergillosis, a common disease in captive red-tailed hawks ( Buteo jamaicensis ). To determine the disposition and safety of voriconazole after single and multiple, oral doses, 12 adult red-tailed hawks were studied in 2 phases. In phase 1, each bird received a single dose of voriconazole solution (10 mg/kg) by gavage. Blood samples were collected at 0, 0.5, 1, 3, 6, 9, 12, 16, 24, and 36 hours after treatment. In phase 2, each of 8 birds received voriconazole oral solution at 10 mg/kg PO q12h for 14 days. Plasma samples were collected on days 0, 5, and 10 and after the final dose and were processed as in phase 1. Plasma samples were submitted for analysis of voriconazole levels by high-performance liquid chromatography and ultraviolet spectrophotometry and for measurement of selected plasma biochemical parameters. After single dosing, voriconazole concentrations reached a (mean ± SD) peak (Cmax) of 4.7 ± 1.3 μg/mL at 2.0 ± 1.2 hours. The disappearance half-life (t1/2) was 2.8 ± 0.7 hours, and the mean residence time (MRT) was 4.6 ± 0.9 hours. After the last dose at 14 days, the mean Cmax of voriconazole was 4.5 ± 2.7 μg/mL at 2.4 ± 1.1 hours. The t1/2 was 2.1 ± 0.8 hours, and the MRT was 3.5 ± 1.1 hours. Although concentrations of several plasma biochemical parameters were significantly different at study end compared with prestudy concentrations, only plasma creatine kinase activity was outside the reference range. No adverse reactions were observed in any of the birds. After both single and multiple dosing at 10 mg/kg, voriconazole concentrations exceeded the minimum inhibitory concentration to inhibit 90% (MIC90) of Aspergillus species (1 μg/mL) by at least fourfold and remained above the MIC90 for 8.8 ± 1.1 hours after single dosing versus 6.5 ± 1.5 hours after multiple dosing (P = .003). This difference suggests that more frequent dosing (eg, up to q8h) may be necessary to maintain target

  12. Rain Drop Charge Sensor

    Science.gov (United States)

    S, Sreekanth T.

    begin{center} Large Large Rain Drop Charge Sensor Sreekanth T S*, Suby Symon*, G. Mohan Kumar (1) , S. Murali Das (2) *Atmospheric Sciences Division, Centre for Earth Science Studies, Thiruvananthapuram 695011 (1) D-330, Swathi Nagar, West Fort, Thiruvananthapuram 695023 (2) Kavyam, Manacaud, Thiruvananthapuram 695009 begin{center} ABSTRACT To study the inter-relations with precipitation electricity and precipitation microphysical parameters a rain drop charge sensor was designed and developed at CESS Electronics & Instrumentation Laboratory. Simultaneous measurement of electric charge and fall speed of rain drops could be done using this charge sensor. A cylindrical metal tube (sensor tube) of 30 cm length is placed inside another thick metal cover opened at top and bottom for electromagnetic shielding. Mouth of the sensor tube is exposed and bottom part is covered with metal net in the shielding cover. The instrument is designed in such a way that rain drops can pass only through unhindered inside the sensor tube. When electrically charged rain drops pass through the sensor tube, it is charged to the same magnitude of drop charge but with opposite polarity. The sensor tube is electrically connected the inverted input of a current to voltage converter operational amplifier using op-amp AD549. Since the sensor is electrically connected to the virtual ground of the op-amp, the charge flows to the ground and the generated current is converted to amplified voltage. This output voltage is recorded using a high frequency (1kHz) voltage recorder. From the recorded pulse, charge magnitude, polarity and fall speed of rain drop are calculated. From the fall speed drop diameter also can be calculated. The prototype is now under test running at CESS campus. As the magnitude of charge in rain drops is an indication of accumulated charge in clouds in lightning, this instrument has potential application in the field of risk and disaster management. By knowing the charge

  13. Diabetes eye exams

    Science.gov (United States)

    Diabetic retinopathy - eye exams; Diabetes - eye exams; Glaucoma - diabetic eye exam; Macular edema - diabetic eye exam ... if the doctor who takes care of your diabetes checks your eyes, you need an eye exam ...

  14. What Is Dry Eye?

    Medline Plus

    Full Text Available ... Causes of Dry Eye Dry Eye Treatment What Is Dry Eye? Written By: Kierstan Boyd Reviewed By: ... your eyes do not produce enough tears, it is called dry eye. Dry eye is also when ...

  15. Facts About Pink Eye

    Science.gov (United States)

    ... Information > Pink Eye (Conjunctivitis) > Facts About Pink Eye Facts About Pink Eye Pink eye is one of ... for preventing eye infections. Last Reviewed: November 2015 Fact Sheet Blurb The National Eye Institute (NEI) is ...

  16. Cost effectiveness of caspofungin vs. voriconazole for empiric therapy in Turkey.

    Science.gov (United States)

    Turner, S J; Senol, E; Kara, A; Al-Badriyeh, D; Dinleyici, E C; Kong, D C M

    2014-08-01

    Invasive fungal infections from febrile neutropenia are associated with significant cost and mortality. The mainstay of treatment has been liposomal amphotericin B, however, echinocandins and azoles have shown promise as alternative treatments. Data on clinical efficacy exist, however, data incorporating pharmacoeconomic considerations are required in Turkey. The aim of this study was to investigate the cost effectiveness of caspofungin vs. voriconazole in empiric treatment of febrile neutropenia in Turkey. A decision analytic model was utilised, built upon two randomised-controlled trials and supplemented with expert panel input from clinicians in Turkey. A five-point composite outcome measure was utilised and sensitivity analyses were performed to demonstrate the robustness of the model. The base case scenario resulted in caspofungin being preferred by TL2,533, TL29,256 and TL2,536 per patient treated, successfully treated patient and patient survival, respectively (approx. USD1414, 16 328 and 1415); sensitivity analyses did not change the outcome. Monte Carlo simulation highlighted a 78.8% chance of favouring caspofungin. The result was moderately sensitive to treatment duration and acquisition cost of the antifungal agents compared. This is the first pharmacoeconomic study comparing caspofungin to voriconazole within Turkey, resulting in an advantage towards caspofungin. The study will aid in formulary decision-making based on the clinical and economic consequences of each agent in the Turkish health care setting.

  17. Successful voriconazole treatment of invasive pulmonary aspergillosis in a patient with acute biphenotypic leukemia

    Directory of Open Access Journals (Sweden)

    Hirano,Teiichi

    2009-08-01

    Full Text Available A 23-year old woman with acute biphenotypic leukemia (ABL complained of chest pain with cough, high fever and hemoptysis during induction chemotherapy, although she had been treated with anti-biotics and micafungin. We made a clinical diagnosis of invasive pulmonary aspergillosis (IPA based on a consolidation in the right upper lung field on a chest radiograph as well as a high level of serum beta-D-glucan (with no evidence of tuberculosis and candidiasis. We changed her treatment from micafungin to voriconazole. Later, we discovered an air-crescent sign by CT scan that supported the diagnosis of IPA. Following voriconazole treatment, clinical symptoms ceased and abnormal chest shadows improved gradually and concurrently with a recovery of neutrophils. IPA must be considered in immunocompromised patients with pulmonary infiltrates who do not respond to broad-spectrum antibiotics. Serological tests and CT findings can aid in early diagnosis of IPA, which, along with treatment for IPA, will improve clinical outcomes.

  18. Your Eyes

    Science.gov (United States)

    ... eyes to see millions of colors. Helping You See It All Rods and cones process the light to give you the total picture. You're ... get cloudy, causing a cataract . A cataract prevents light from reaching the retina and makes it difficult to see. The eyes you have will be yours forever — ...

  19. Eyes - bulging

    Science.gov (United States)

    ... emotional support is important. When to Contact a Medical Professional Call your health care provider if: You have bulging eyes and the cause has not yet been diagnosed. Bulging eyes are accompanied by other symptoms. ... The provider will ask about your medical history and do a physical exam. Some questions ...

  20. Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole

    NARCIS (Netherlands)

    Espinel-Ingroff, A.; Pfaller, M.A.; Bustamante, B.; Canton, E.; Fothergill, A.; Fuller, J.; Gonzalez, G.M.; Lass-Florl, C.; Lockhart, S.R.; Martin-Mazuelos, E.; Meis, J.F.G.M.; Melhem, M.S.; Ostrosky-Zeichner, L.; Pelaez, T.; Szeszs, M.W.; St-Germain, G.; Bonfietti, L.X.; Guarro, J.; Turnidge, J.

    2014-01-01

    Although epidemiological cutoff values (ECVs) have been established for Candida spp. and the triazoles, they are based on MIC data from a single laboratory. We have established ECVs for eight Candida species and fluconazole, posaconazole, and voriconazole based on wild-type (WT) MIC distributions fo

  1. Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species

    NARCIS (Netherlands)

    Al-Hatmi, A.M.; Normand, A.C.; Ranque, S.; Piarroux, R.; Hoog, G.S. de; Meletiadis, J.; Meis, J.F.G.M.

    2017-01-01

    We compared EUCAST and CLSI methods versus Etest for antifungal susceptibility testing of 20 clinically relevant Fusarium species against amphotericin B, posaconazole, and voriconazole. The median Etest amphotericin B and posaconazole MICs were 1 dilution higher than the median EUCAST and the CLSI M

  2. Lambda-dropping

    DEFF Research Database (Denmark)

    Danvy, Olivier; Schultz, Ulrik Pagh

    1997-01-01

    ;rbæk's case study presented at PEPM '95, most polyvariant specializers for procedural programs operate on recursive equations. To this end, in a pre-processing phase, they lambda-lift source programs into recursive equations, As a result, residual programs are also expressed as recursive equations, often......Lambda-lifting a functional program transforms it into a set of recursive equations. We present the symmetric transformation: lambda-dropping. Lambda-dropping a set of recursive equations restores block structure and lexical scope.For lack of scope, recursive equations must carry around all...... with dozens of parameters, which most compilers do not handle efficiently. Lambda-dropping in a post-processing phase restores their block structure and lexical scope thereby significantly reducing both the compile time and the run time of residual programs....

  3. Effect of voriconazole and other azole antifungal agents on CYP3A activity and metabolism of tacrolimus in human liver microsomes.

    Science.gov (United States)

    Zhang, Shimin; Pillai, Venkateswaran C; Mada, Sripal Reddy; Strom, Steve; Venkataramanan, Raman

    2012-05-01

    Azole antifungal agents are known to inhibit cytochrome P450 3A (CYP3A) enzymes. Limited information is available regarding the effect of voriconazole on CYP3A activity. We examined the effect of voriconazole on CYP3A activity in human liver microsomes as measured by the formation of 6β-hydroxytestosterone from testosterone. We also evaluated the interaction between voriconazole and tacrolimus, an immunosuppressive drug, using human liver microsomes. The effect of voriconazole on CYP3A activity and tacrolimus metabolism was compared to that of other azole antifungal agents. CYP3A4 activity and the metabolism of tacrolimus were measured in the absence and in the presence of various concentrations of voriconazole (0-1.43 mM), fluconazole (0-1.63 mM), itraconazole (0-14 µM) and ketoconazole (0-0.19 µM). At a concentration of 21.2 ± 15.4 µM and 29.8 ± 12.3 µM, voriconazole inhibited the formation of 6β-hydroxytestosterone from testosterone and the metabolism of tacrolimus by 50%, respectively. The rank order of inhibition of 6β-hydroxytestosterone formation from testosterone and the metabolism of tacrolimus, is ketoconazole > itraconazole > voriconazole > fluconazole. Our observations suggest that voriconazole at clinically relevant concentrations will inhibit the hepatic metabolism of tacrolimus and increase the concentration of tacrolimus more than two-fold. Close monitoring of the blood concentrations and adjustment in the dose of tacrolimus are warranted when transplant patients receiving tacrolimus are treated with voriconazole.

  4. Impact of granular drops

    KAUST Repository

    Marston, J. O.

    2013-07-15

    We investigate the spreading and splashing of granular drops during impact with a solid target. The granular drops are formed from roughly spherical balls of sand mixed with water, which is used as a binder to hold the ball together during free-fall. We measure the instantaneous spread diameter for different impact speeds and find that the normalized spread diameter d/D grows as (tV/D)1/2. The speeds of the grains ejected during the “splash” are measured and they rarely exceed twice that of the impact speed.

  5. 高效液相色谱法测定离子敏感型左氧氟沙星原位胶化滴眼液在兔房水中的含量%HPLC determination of ion-sensitive levofloxacin situ gel eye drops in rabbit aqueous humor

    Institute of Scientific and Technical Information of China (English)

    杨远荣; 任贻军; 倪梦君

    2012-01-01

    Objective To establish an HPLC method to determine 0. 3% ion-sensitive levofloxacin situ gel eye drops in rabbit aqueous humor. Methods Eye drop (50 μL) was administered in rabbit eyes. The concentration of levofloxacin in rabbit aqueous humor was determined by HPLC. The internal standard was gatifloxacin extracted with dichlormeth-ane. The mobile phase was 0. 2% triethylamine (pH being adjusted to 3. 0 with phosphoric acid) -acetonitrile (86: 14), the detection wavelength was 293 nm, and the column temperature was 30℃. Results The calibration curve was linear over 0. 05 - 5. 0 μg·mL-1 (A = 2. 478C+0. 033 93, r=0. 999 6), the relative recoveries of levofloxacin at high, medium, and low concentration (2.0, 0.5, and 0. 1 μg·mL-1) were (103. 81 + 0. 06)%, (109.66 + 0.02)%, and (96. 90+0. 09)%. The intra-day and inter-day RSDs were less than 10%. Conclusion The method is accurate and reliable, which can be used for the determination of levofloxacin in rabbit aqueous humor.%目的 建立高效液相色谱法测定0.3%离子敏感型左氧氟沙星原位胶化滴眼液在兔房水内含量的方法.方法 在实验组家兔眼中滴入该滴眼液50μL,用高效液相色谱法测定该滴眼液在兔眼房水中的浓度,以加替沙星为内标,用二氯甲烷萃取;以0.2%三乙胺溶液(用磷酸调节pH至3.0)-乙腈(86:14)为流动相;紫外检测波长293 nm,柱温30℃.结果 在0.05~5 μg,mL-1左氧氟沙星与峰面积线性关系良好;高、中、低(2.0、0.5、0.1 μg,mL-1)3种浓度的相对回收率分别为(103.81±0.06)%、(109.66±0.02)%、(96.90±0.09)%.日内、日间精密度RSD均<10%.结论 该方法准确、可靠,可用于测定兔眼房水中左氧氟沙星含量.

  6. Management of invasive aspergillosis in patients with COPD: rational use of voriconazole

    Directory of Open Access Journals (Sweden)

    Florence Ader

    2009-07-01

    voriconazole is recommended as a first-line treatment of IPA. This review assesses the use of voriconazole in COPD patients. Keywords: chronic obstructive pulmonary disease, corticosteroid, Aspergillus, invasive pulmonary aspergillosis, voriconazole

  7. Coalescence of sessile drops

    CERN Document Server

    Nikolayev, Vadim; Pomeau, Yves; Andrieu, Claire

    2016-01-01

    We present an experimental and theoretical description of the kinetics of coalescence of two water drops on a plane solid surface. The case of partial wetting is considered. The drops are in an atmosphere of nitrogen saturated with water where they grow by condensation and eventually touch each other and coalesce. A new convex composite drop is rapidly formed that then exponentially and slowly relaxes to an equilibrium hemispherical cap. The characteristic relaxation time is proportional to the drop radius R * at final equilibrium. This relaxation time appears to be nearly 10 7 times larger than the bulk capillary relaxation time t b = R * $\\eta$/$\\sigma$, where $\\sigma$ is the gas--liquid surface tension and $\\eta$ is the liquid shear viscosity. In order to explain this extremely large relaxation time, we consider a model that involves an Arrhenius kinetic factor resulting from a liquid--vapour phase change in the vicinity of the contact line. The model results in a large relaxation time of order t b exp(L/R...

  8. Sessile drops in microgravity

    CERN Document Server

    Sparavigna, Amelia Carolina

    2013-01-01

    Interfaces with a liquid are governing several phenomena. For instance, these interfaces are giving the shape of sessile droplets and rule the spread of liquids on surfaces. Here we analyze the shape of sessile axisymmetric drops and how it is depending on the gravity, obtaining results in agreement with experimental observations under conditions of microgravity.

  9. Drop-out probabilities of IrisPlex SNP alleles

    DEFF Research Database (Denmark)

    Andersen, Jeppe Dyrberg; Tvedebrink, Torben; Mogensen, Helle Smidt;

    2013-01-01

    In certain crime cases, information about a perpetrator's phenotype, including eye colour, may be a valuable tool if no DNA profile of any suspect or individual in the DNA database matches the DNA profile found at the crime scene. Often, the available DNA material is sparse and allelic drop-out o...

  10. Glaucoma and dry eye disease: the role of preservatives in glaucoma medications

    Directory of Open Access Journals (Sweden)

    Ratna Sitompul

    2011-11-01

    Full Text Available Glaucoma is a common cause of irreversible blindness with increasing prevalence. Some of glaucoma patients will also experience dry eye. Dry eye is the most frequent side effect related to benzalkonium chloride (BAC-containing eye drop  used for glaucoma patients. In addition, glaucoma and dry eyes have shared risk factors that are old age and female. Dry eye among glaucoma patients need to be treated promptly as it produces discomfort, reduces patients’ compliance and   decreases success rate of glaucoma therapy. Dry eye symptoms can be treated by applying preservative-free eye drop, giving combination of preservative containing and preservative-free eye drop to reduce BAC exposure, prescribing artificial tear and conducting surgery to minimize or eliminate the need of topical medication. (Med J Indones 2011; 20:302-5Keywords: benzalkonium chloride, dry eye, glaucoma

  11. What Is Dry Eye?

    Medline Plus

    Full Text Available ... Español Eye Health / Eye Health A-Z Dry Eye Sections What Is Dry Eye? Dry Eye Symptoms ... Dry Eye Dry Eye Treatment What Is Dry Eye? Written By: Kierstan Boyd Reviewed By: Brenda Pagan- ...

  12. What Is Dry Eye?

    Medline Plus

    Full Text Available ... Español Eye Health / Eye Health A-Z Dry Eye Sections What Is Dry Eye? Dry Eye Symptoms ... Dry Eye Dry Eye Treatment What Is Dry Eye? Leer en Español: ¿Qué Es el Ojo Seco? ...

  13. Eumycetoma of the hand caused by Leptosphaeria tompkinsii and refractory to medical therapy with voriconazole.

    Science.gov (United States)

    Cartwright, Katharine E; Clark, Tristan W; Hussain, Abid M; Wiselka, Martin; Borman, Andrew; Johnson, Elizabeth M

    2011-10-01

    We report on the first case of eumycetoma caused by the organism Leptosphaeria tompkinsii to be diagnosed and possibly acquired within the United Kingdom. Conventional culture of fungal grains and surgical tissue specimens was negative and the diagnosis was achieved using panfungal polymerase chain reaction and sequencing technology. Despite limited surgical resection and prolonged antifungal therapy with voriconazole, the patient developed progressive disease with mycetoma bone involvement. This case highlights the usefulness of molecular diagnostic techniques in eumycetoma where organisms may fail to grow with conventional culture or be difficult to identify morphologically. It also reminds us that eumycetoma is a difficult infection to treat and despite optimism regarding the efficacy of the newer triazole antifungals in this condition, treatment failures may still occur.

  14. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin

    Institute of Scientific and Technical Information of China (English)

    SHI Jun-yan; WANG He; GUO Li-na; XU Ying-chun; SHI Yi; L(U) Huo-xiang; LIU Yong; ZHAO Wang-sheng; CHEN Dong-mei; XI Li-yan; ZHOU Xin

    2010-01-01

    Background During recent years, the incidence of serious infections caused by opportunistic fungi has increased dramatically due to alterations of the immune status of patients with hematological diseases, malignant tumors,transplantations and so forth. Unfortunately, the wide use of triazole antifungal agents to treat these infections has lead to the emergence of Aspergillus spp. resistant to triazoles. The present study was to assess the in vitro activities of five antifungal agents (voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin) against different kinds of Aspergillus spp. that are commonly encountered in the clinical setting.Methods The agar-based Etest MIC method was employed. One hundred and seven strains of Aspergillus spp. (5 species) were collected and prepared according to Etest Technique Manuel. Etest MICs were determined with RPMI agar containing 2% glucose and were read after incubation for 48 hours at 35℃. MIC50, MIC90 and MIC range were acquired by Whonet 5.4 software.Results The MIC90 of caspofungin against A. fumigatus, A. flavus and A. nidulans was 0.094 μg/ml whereas the MIC90 against A. niger was 0.19 μg/ml. For these four species, the MlC90 of caspofungin was the lowest among the five antifungal agents. For A. terrus, the MIC90 of posaconazole was the lowest. For A. fumigatus and A. flavus, the MlC90in order of increasing was caspofungin, posaconazole, voriconazole, itraconazole, and amphotericin B. The MIC of amphotericin B against A. terrus was higher than 32 μg/ml in all 7 strains tested.Conclusions The in vitro antifungal susceptibility test shows the new drug caspofungin, which is a kind of echinocandins, has good activity against the five species of Aspergillus spp. and all the triazoles tested have better in vitro activity than traditional amphotericin B.

  15. What Is Dry Eye?

    Medline Plus

    Full Text Available ... Eye Symptoms Causes of Dry Eye Dry Eye Treatment What Is Dry Eye? Written By: Kierstan Boyd ... your vision. Privacy Policy Related New Dry Eye Treatment is a Tear-Jerker Jul 21, 2017 Three ...

  16. Diabetic Eye Disease

    Science.gov (United States)

    ... Other Dental Problems Diabetes & Sexual & Urologic Problems Diabetic Eye Disease What is diabetic eye disease? Diabetic eye disease is a group of ... loss can occur. How does diabetes affect my eyes? Diabetes affects your eyes when your blood glucose, ...

  17. Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.

    NARCIS (Netherlands)

    Espinel-Ingroff, A.; Barchiesi, F.; Cuenca-Estrella, M.; Fothergill, A.; Pfaller, M.A.; Rinaldi, M.; Rodriguez-Tudela, J.L.; Verweij, P.E.

    2005-01-01

    A multicenter (six-center) study evaluated the performance (interlaboratory reproducibility, compatibility with reference methods, and categorical agreement) of 24-h visual and 48-h spectrophotometric MICs. MICs of fluconazole, itraconazole, voriconazole, and posaconazole were compared to reference

  18. Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.

    NARCIS (Netherlands)

    Espinel-Ingroff, A.; Barchiesi, F.; Cuenca-Estrella, M.; Fothergill, A.; Pfaller, M.A.; Rinaldi, M.; Rodriguez-Tudela, J.L.; Verweij, P.E.

    2005-01-01

    A multicenter (six-center) study evaluated the performance (interlaboratory reproducibility, compatibility with reference methods, and categorical agreement) of 24-h visual and 48-h spectrophotometric MICs. MICs of fluconazole, itraconazole, voriconazole, and posaconazole were compared to reference

  19. The new Drop Tower catapult system

    Science.gov (United States)

    von Kampen, Peter; Kaczmarczik, Ulrich; Rath, Hans J.

    2006-07-01

    The Center of Applied Space Technology and Microgravity (ZARM) was founded in 1985 as an institute of the University Bremen, which focuses on research on gravitational and space-related phenomena. In 1988, the construction of the "Drop Tower" began. Since then, the eye-catching tower with a height of 146 m and its characteristic glass roof has become the emblem of the technology centre in Bremen. The Drop Tower Bremen provides a facility for experiments under conditions of weightlessness. Items are considered weightless, when they are in "free fall", i.e. moving without propulsion within the gravity field of the earth. The height of the tower limits the simple "free fall" experiment period to max. 4.74 s. With the inauguration of the catapult system in December 2004, the ZARM is entering a new dimension. This world novelty will meet scientists' demands of extending the experiment period up to 9.5 s. Since turning the first sod on May 3rd, 1988, the later installation of the catapult system has been taken into account by building the necessary chamber under the tower. The catapult system is located in a chamber 10 m below the base of the tower. This chamber is almost completely occupied by 12 huge pressure tanks. These tanks are placed around the elongation of the vacuum chamber of the drop tube. In its centre there is the pneumatic piston that accelerates the drop capsule by the pressure difference between the vacuum inside the drop tube and the pressure inside the tanks. The acceleration level is adjusted by means of a servo hydraulic breaking system controlling the piston velocity. After only a quarter of a second the drop capsule achieves its lift-off speed of 175 km/h. With this exact speed, the capsule will rise up to the top of the tower and afterwards fall down again into the deceleration unit which has been moved under the drop tube in the meantime. The scientific advantages of the doubled experiment time are obvious: during almost 10 s of high

  20. Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain

    Directory of Open Access Journals (Sweden)

    Grau S

    2016-12-01

    Full Text Available Santiago Grau,1 Jose Ramon Azanza,2 Isabel Ruiz,3 Carlos Vallejo,4 Josep Mensa,5 Johan Maertens,6 Werner J Heinz,7 Jon Andoni Barrueta,8 Carmen Peral,9 Francisco Jesús Mesa,8 Miguel Barrado,10 Claudie Charbonneau,11 Darío Rubio-Rodríguez,12 Carlos Rubio-Terrés12 1Pharmacy Department, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, 2Clinical Pharmacology Department, Clínica Universidad de Navarra, Pamplona, 3Infectious Diseases Department, Hospital Universitari Vall d’Hebron, Barcelona, 4Hematology Department, Hospital Universitario Donostia, San Sebastián, 5Infectious Diseases Department, Hospital Clínic de Barcelona, Barcelona, Spain; 6Hematology Department, University Hospital Gasthuisberg, Leuven, Belgium; 7Hematology/Oncology Department, Medizinische Klinik und Poliklinik II, Universitätsklinikum, Würzburg, Germany; 8Medical Department, 9Economics and Outcomes Research Department, Pfizer S.L.U, Alcobendas, 10Clinical Trials Department, Trial Form Support, Madrid, Spain; 11Pharmacoeconomics Department, Pfizer International Operations, Paris, France; 12Pharmacoeconomics Department, Health Value, Madrid, Spain Objective: According to a recent randomized, double-blind clinical trial comparing the combination of voriconazole and anidulafungin (VOR+ANI with VOR monotherapy for invasive aspergillosis (IA in patients with hematologic disease or with hematopoietic stem cell transplant, mortality was lower after 6 weeks with VOR+ANI than with VOR monotherapy in a post hoc analysis of patients with galactomannan-based IA. The objective of this study was to compare the cost-effectiveness of VOR+ANI with VOR, from the perspective of hospitals in the Spanish National Health System.Methods: An economic model with deterministic and probabilistic analyses was used to determine costs per life-year gained (LYG for VOR+ANI versus VOR in patients with galactomannan-based IA. Mortality, adverse event rates, and life expectancy were

  1. ACUTE EFFECT OF FLUCONAZOLE, ITRACONAZOLE AND VORICONAZOLE ON BLOOD GLUCOSE IN NORMOGLYCEAMIC & DIABETIC RATS: AN EXPERIMENTAL STUDY

    Directory of Open Access Journals (Sweden)

    Jadhav Amol, Nayak BB, Vakade Kiran P, Sanghishetti Vijay Prasad, Vijay Kumar AN, Vrushali Nibrad, Raul AR

    2015-01-01

    Full Text Available Anti-fungal and antimicrobials are frequently co-prescribed either to manage or treat either the secondary complications or other diseases. Among antifungal drugs Fluconazole, Itraconazole & Voriconazole are most commonly used. The present study was undertaken to further confirm the effect of Voriconazole as well as other antifungal drugs on blood Glucose level. Aim & Objectives: 1. To Study the effect of Fluconazole, Itraconazole & Voriaconazole in Normoglycemic & Diabetic Rats on Blood Glucose. 2. To compare the effects between all drugs. Material & Methodology: Grouping: Animals divided into 8 groups in each group 6 animals. Group 1- 4: Normoglycemic rats, Group 5-8 Diabetic rats (alloxan induced Group 1,5: received vehicle (Normal saline Group 2,6: received Fluconazole (18mg/kg BW, Group 3,7 received Itraconazole (18mg/kg BW Group 4,8 received Voriconazole (18mg/kg BW. The glucose levels were estimated by Glucometer method (Accu-check active at the interval of 0, ½ hr, 1hrs, 2hrs & 4hrs after drug administration. Results: Effect on blood glucose in Normoglycemic Rats: Voriconazole had a significant hypoglycaemic effect which appeared after 1 hr (‘p’ value= 0.0102 of administration & persisted up to 2 hrs (‘p’ value=0.0001. However effect of Voriconzole was found to be declined after 2 hrs. There was no significant change in blood glucose in normoglycemic rats with Fluconazole & Itraconazole. Effect on blood glucose in Diabetic Rats: (Table 2: Voriconazole had a significant hypoglycaemic effect which appeared after 1 hr (‘p’ value=0.013 of administration & persisted up to 2 hrs (‘p’ value=0.001 in acute studies. However effect of Voriconzole was found to be declined after 2 hrs. There was no significant change in blood glucose in diabetic rats with Fluconazole & Itraconazole treated. Conclusion: Itraconazole, Fluconazole can be safely used in diabetic with fungal infections. Voriconazole should be avoided in diabetics to

  2. Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops

    OpenAIRE

    Eiichi Uchio

    2008-01-01

    Eiichi UchioDepartment of Ophthalmology, Fukuoka University School of Medicine, Fukuoka, JapanAbstract: Olopatadine hydrochloride exerts a wide range of pharmacological actions such as histamine H1 receptor antagonist action, chemical mediator suppressive action, and eosinophil infiltration suppressive action. Olopatadine hydrochloride 0.1% ophthalmic solution (Patanol®) was introduced to the market in Japan in October 2006. In a conjunctival allergen challenge (CAC) test, olopatadine...

  3. Coalescence of Liquid Drops

    CERN Document Server

    Eggers, J; Stone, H A; Eggers, Jens; Lister, John R.; Stone, Howard A.

    1999-01-01

    When two drops of radius $R$ touch, surface tension drives an initially singular motion which joins them into a bigger drop with smaller surface area. This motion is always viscously dominated at early times. We focus on the early-time behavior of the radius $\\rmn$ of the small bridge between the two drops. The flow is driven by a highly curved meniscus of length $2\\pi \\rmn$ and width $\\Delta\\ll\\rmn$ around the bridge, from which we conclude that the leading-order problem is asymptotically equivalent to its two-dimensional counterpart. An exact two-dimensional solution for the case of inviscid surroundings [Hopper, J. Fluid Mech. ${\\bf 213}$, 349 (1990)] shows that R)]$; and thus the same is true in three dimensions. The case of coalescence with an external viscous fluid is also studied in detail both analytically and numerically. A significantly different structure is found in which the outer fluid forms a toroidal bubble of radius $\\Delta \\propto \\rmn^{3/2}$ at the meniscus and $\\rmn \\sim (t\\gamma/4\\pi\\eta)...

  4. Validación de un método cromatográfico para la cuantificación de latanoprost 50 µg/mL en el colirio de producción nacional Validation of a chromatographic method for quantitation of 50 µg/mL Latanoprost in a Cuban eye drops

    Directory of Open Access Journals (Sweden)

    Caridad Margarita García Peña

    2012-12-01

    Full Text Available Introducción: el latanoprost está indicado para el tratamiento de la presión intraocular elevada en pacientes con hipertensión ocular o glaucoma de ángulo abierto. Objetivo: desarrollar y validar un método analítico por cromatografía líquida de alta resolución, aplicable al control de la calidad del latanoprost 50 µg/mL, colirio. Métodos: para cuantificar el principio activo en el producto terminado, la separación se realizó a través de una columna cromatográfica Altima C-18 (10 µm (250 × 4 mm, con detección ultravioleta a 205 nm, empleando una fase móvil compuesta por acetonitrilo-buffer fosfato pH 4,5 (650:350 y la cuantificación de este frente a una muestra de referencia con el método del estándar externo. Resultados: los resultados de los parámetros evaluados en la validación del método se encontraron dentro de los límites establecidos. Conclusiones: el método analítico desarrollado y validado por cromatografía líquida de alta resolución para el control de la calidad del colirio de latanoprost 50 µg/mL, resultó específico, lineal, exacto y preciso en el rango de concentraciones estudiadas, por lo que puede emplearse de manera confiable y segura.Introduction: Latanoprost is indicated to treat high intraocular pressure in patients suffering from ocular hypertension or from open angle glaucoma. Objective: to develop and to validate a high performance liquid chromatography-based analytical method for quality control of 50 µg/mL Latanoprost eye drops. Methods: to quantify the active principle of the final product, the separation was performed through Altima C-18 chromatographic column (10 µm (250 × 4 mm, with ultraviolet detection at 205 nm, and a mobile phase made up of acetonitryle-phosphate buffer of pH= 4.5 (650:350. The quantification of the principle against a reference sample was carried out with the external standard method. Results: the results of the evaluated parameters in the validation of the

  5. Simultaneous Determination of Three Active Ingredients in Compound Allantoin VitaminB6-E and Aminoethylsulfonic Acid Eye Drops by HPLC-DAD%HPLC-DAD同时测定复方尿维氨滴眼液中3种活性成分的含量

    Institute of Scientific and Technical Information of China (English)

    金鹏飞; 吴学军; 邹定; 马捷; 姜文清; 郭郁

    2009-01-01

    OBJECTIVE To establish a high performance liquid chromatography-diode array detection (HPLC-DAD) method for the simultaneous determination of chondroitin sulfate sodium, allantoin and vitamin B_6 in Compound Allantoin VitaminB_6-E and Aminoethylsulfonic Acid Eye Drops. METHODS An Alltima C_(18) column (4.6 mm×250 mm, 5 μm particle size) was used for the separation at room temperature, with 25 mmol-L~(-1) ammonium dihydrogen phosphate (containing 0.01% heptanesulfonic acid sodium salt)-acetonitrile (95:5) as the mobile phase at the flow rate of 0.5 mL·min~(-1). The detection wavelengthes for chondroitin sulfate sodium, allantoin and vitamin B_6 were 195, 215 and 291 ran, respectively. RESULTS The method showed good linearity for chondroitin sulfate sodium, allantoin and vitamin B_6, with all correlation coefficients (r) greater than 0.999 6. The specificity study showed satisfactory resolutions between chondroitin sulfate sodium, allantoin, vitamin B_6 other ingredients and forced degradation products. The precisions and stability were satisfactory with all relative standard deviations (RSD) of peak areas lower than 2.0%, and the spiked recovery of three ingredients ranged from 99.01% to 101.92%. CONCLUSION This method is an accurate, fast and simple method for the simultaneous determination of chondroitin sulfate sodium, allantoin and vitamin B6 in Compound Allantoin VitaminB_6-E and Aminoethylsulfonic Acid Eye Drops.%目的 应用高效液相色谱-二极管阵列检测器(HPLC-DAD),建立复方尿维氨滴眼液中硫酸软骨素钠,尿囊素和维生素B6含量的同时测定方法.方法 采用Alltima C_(18)色谱柱(4.6 mm×250 mm,5μm),以25 mmol·L~(-1)磷酸二氢铵(含0.01%辛烷磺酸钠)-乙睛(95:5)为流动相,流速0.5 mL·min~(-1),室温测定,硫酸软骨素钠,尿囊素和维生素B6的检测波长分别为195,215和291mm.结果 硫酸软骨素钠,尿囊素和维生素B6的线性关系良好,线性相关系数(r)都大于0.999 6;专属性强,3

  6. Simultaneous Determination of Vitamin C and Vitamin B1 in Liming Eye Drops by RP-HPLC%RP-HPLC法同时测定利明滴眼液中维生素C和维生素B1的含量

    Institute of Scientific and Technical Information of China (English)

    何笑荣; 姜文清; 霍秀颖; 崔嘉芯; 邹定

    2012-01-01

    OBJECTIVE: To establish the method for the simultaneous determination of vitamin C and vitamin B1 in Liming eye drops. METHODS:RP-HPLC method was adopted. The separation was carried out on Alltim Cu column with mobile phase consisted of methanol-30 mmol·L‐1 ammonium dihydrogen phosphate solution (5:95, adjusted pH to 3.2) at the flow rate of 0.6 mL· min‐1. The detection wavelength was set at 246 nm and column temperature was 25 ℃. RESULTS:The linear ranges of vitamin C and vitamin B, were 7.5~360 μg·mL‐1 (r=0.999 6, n=5), 11.92-198.64 μg·mL‐1(r=0.999 8, n=5),respectively. The detection limits were 7.5 ng and 11.9 ng,respectively. The RSDs of intra-day and inter-day and reproducibility did not exceed 2.0%,respectively. The average recoveries were 102.85% and 101.43% (n=3). CONCLUSION: The method is simple, sensitive, accurate and could be applied to the quality control of Liming eye drops.%目的:建立同时测定利明滴眼液中维生素C和维生素B1含量的方法.方法:采用反相高效液相色谱法.色谱柱为AlltimC18,流动相为甲醇-30 mmol· L-1磷酸二氢铵溶液(5∶95,pH 3.2),流速为0.6mL·min-1,检测波长为246nm,柱温为25℃.结果:维生素C和维生素B1的检测浓度线性范围分别为7.5~360、11.92~198.64 μg·mL-1(r=0.9996、0.999 8,n=5);最低检测限分别为7.5、11.9 ng;日内、日间RSD和重复性试验RSD均小于2.0%;平均回收率分别为102.85%、101.43%(n=3).结论:该方法简单、灵敏、准确,能有效控制该制剂的质量.

  7. Schizophyllum commune: a new organism in eye infection.

    Science.gov (United States)

    Saha, Suman; Sengupta, Jayangshu; Banerjee, Debdulal; Khetan, Archana; Mandal, Santi Mohan

    2013-04-01

    We report a case of mycotic keratitis caused by a rare fungus Schizophyllum commune. Clinical examination, slit-lamp examination, and microbiological evaluation of the corneal ulcer were done, and its treatment outcome was studied. The fungal etiology was established by conventional microbiological techniques, polymerase chain reaction and speciation by DNA sequencing. Corneal scraping showed the presence of fungal filaments. The fungus was identified as S. commune based on DNA sequence analysis of the internal transcribed spacer region. The organism was susceptible to amphotericin B and voriconazole and demonstrated resistance to anidulafungin, itraconazole, and fluconazole. Therapeutic keratoplasty was performed but there was recurrence of the infection in the graft, which was controlled with topical voriconazole and intracameral amphotericin B. At the end of 3 months, the affected eye had developed phthisis bulbi. The best of our knowledge, this is the first reported case of keratitis caused by the rare fungus S. commune. Management of these cases is difficult, and surgical procedures may be needed.

  8. Hydrodynamics of evaporating sessile drops

    CERN Document Server

    Barash, L Yu

    2010-01-01

    Several dynamical stages of the Marangoni convection of an evaporating sessile drop are obtained. We jointly take into account the hydrodynamics of an evaporating sessile drop, effects of the thermal conduction in the drop and the diffusion of vapor in air. The stages are characterized by different number of vortices in the drop and the spatial location of vortices. During the early stage the array of vortices arises near a surface of the drop and induces a non-monotonic spatial distribution of the temperature over the drop surface. The number of near-surface vortices in the drop is controlled by the Marangoni cell size, which is calculated similar to that given by Pearson for flat fluid layers. The number of vortices quickly decreases with time, resulting in three bulk vortices in the intermediate stage. The vortex structure finally evolves into the single convection vortex in the drop, existing during about 1/2 of the evaporation time.

  9. Leidenfrost Drop on a Step

    Science.gov (United States)

    Lagubeau, Guillaume; Le Merrer, Marie; Clanet, Christophe; Quere, David

    2008-11-01

    When deposited on a hot plate, a water droplet evaporates quickly. However, a vapor film appears under the drop above a critical temperature, called Leidenfrost temperature, which insulates the drop from its substrate. Linke & al (2006) reported a spontaneous movement of such a drop, when deposited on a ratchet. We study here the case of a flat substrate decorated with a single micrometric step. The drop is deposited on the lower part of the plate and pushed towards the step at small constant velocity. If the kinetic energy of the drop is sufficient, it can climb up the step. In that case, depending on the substrate temperature, the drop can either be decelerated or accelerated by the step. We try to understand the dynamics of these drops, especially the regime where they accelerate. Taking advantage of this phenomenon, we could then build a multiple-step setup, making it possible for a Leidenfrost drop to climb stairs.

  10. Validation of 24-Hour Posaconazole and Voriconazole MIC Readings versus the CLSI 48-Hour Broth Microdilution Reference Method: Application of Epidemiological Cutoff Values to Results from a Global Candida Antifungal Surveillance Program▿

    Science.gov (United States)

    Pfaller, M. A.; Boyken, L. B.; Hollis, R. J.; Kroeger, J.; Messer, S. A.; Tendolkar, S.; Diekema, D. J.

    2011-01-01

    We performed 24- and 48-h MIC determinations of posaconazole and voriconazole against more than 16,000 clinical isolates of Candida species. By using the 24- and 48-h epidemiological cutoff values (ECVs), the categorical agreement between the 24-h and reference 48-h broth microdilution results ranged from 97.1% (C. parapsilosis and voriconazole) to 99.8% (C. krusei and voriconazole), with 0.0 to 2.9% very major discrepancies (VMD). The essential agreement (within 2 log2 dilutions) between the 24- and 48-h results was 99.6% for both posaconazole and voriconazole. The MIC results obtained for both posaconazole and voriconazole after only 24 h of incubation may be used to determine the susceptibilities of Candida spp. to these important antifungal agents. The applications of ECVs to this large collection of Candida isolates suggests the potential to develop 24-h species-specific clinical breakpoints for both posaconazole and voriconazole. PMID:21289155

  11. A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles

    Directory of Open Access Journals (Sweden)

    Chung H

    2015-05-01

    Full Text Available Hyewon Chung,1,* Howard Lee,1,2,* HyeKyung Han,1 Hyungmi An,1 Kyoung Soo Lim,1,3 YongJin Lee,4 Joo-Youn Cho,1 Seo Hyun Yoon,1 In-Jin Jang,1 Kyung-Sang Yu1 1Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Republic of Korea; 2Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea; 3Department of Clinical Pharmacology and Therapeutics, CHA University School of Medicine and CHA Bundang Medical Center, Seongnam, Republic of Korea; 4Medical and Regulatory Affairs Team, Samyang Biopharmaceuticals Corporation, Seoul, Republic of Korea *These authors contributed equally to this work Purpose: SYP-1018 is a lyophilized polymeric nanoparticle formulation of voriconazole that is under development for intravenous dosing. This study compared the pharmacokinetic and tolerability profiles of SYP-1018 with those of Vfend®, the marketed formulation of voriconazole. The effect of CYP2C19 polymorphism on the voriconazole pharmacokinetics was also evaluated.  Methods: An open-label, two-treatment, two-period, two-sequence crossover study was conducted in 52 healthy male volunteers, who randomly received a single intravenous infusion of either of the two voriconazole formulations at 200 mg. Blood samples were collected up to 24 hours after drug administration for pharmacokinetic analysis. The plasma concentrations of voriconazole were determined using liquid chromatography with tandem mass spectrometry, and the pharmacokinetic parameters were estimated using a noncompartmental method. CYP2C19 genotype was identified in 51 subjects.  Results: The geometric mean ratio (90% confidence interval of SYP-1018 to Vfend® was 0.99 (0.93–1.04 for the maximum plasma concentrations (Cmax and 0.97 (0.92–1.01 for the area under the concentration–time curve (AUC from dosing to the last

  12. Comparative Evaluation of Etest, EUCAST, and CLSI Methods for Amphotericin B, Voriconazole, and Posaconazole against Clinically Relevant Fusarium Species.

    Science.gov (United States)

    Al-Hatmi, Abdullah M S; Normand, Anne-Cécile; Ranque, Stephane; Piarroux, Renaud; de Hoog, G Sybren; Meletiadis, Joseph; Meis, Jacques F

    2017-01-01

    We compared EUCAST and CLSI methods versus Etest for antifungal susceptibility testing of 20 clinically relevant Fusarium species against amphotericin B, posaconazole, and voriconazole. The median Etest amphotericin B and posaconazole MICs were 1 dilution higher than the median EUCAST and the CLSI MICs. The essential agreement (within ±1/±2 dilutions) was 60/90%, 80/95%, and 70/85% between the Etest and EUCAST methods and 80/95%, 75/95%, and 45/100% between the Etest and CLSI methods for amphotericin B, voriconazole, and posaconazole, respectively. The categorical agreement was >85%. Etest can be used for antifungal susceptibility testing of Fusarium species. Copyright © 2016 American Society for Microbiology.

  13. A clinical study of the efficacy of topical corticosteroids on dry eye

    Institute of Scientific and Technical Information of China (English)

    YANG Chong-qing; SUN Wen; GU Yang-shun

    2006-01-01

    Objective: To evaluate the effect of topical corticosteroid for treatment of moderate or severe dry eye. Methods: Sixty eyes of 30 patients with moderate or severe dry eye, who were not sensitive to artificial tears, were treated with 0.1% fluorometholone eye drops. Subjective symptom and objective tests were used to evaluate the efficacy of treatment before and after application of 0.1% fluorometholone eye drops for 1 week and 1 month. Side effects were also evaluated. Results: After 1 week of treatment, subjective symptoms were improved in all dry eye patients; objective tests were improved in all dry eye patients 1month after treatment, and the difference was significant. Conclusion: Topical corticosteroid drops can rapidly and effectively relieve the symptoms and signs of moderate or severe dry eye.

  14. Combination Therapy of Advanced Invasive Pulmonary Aspergillosis in Transiently Neutropenic Rats Using Human Pharmacokinetic Equivalent Doses of Voriconazole and Anidulafungin▿

    OpenAIRE

    van de Sande, Wendy W. J.; Mathot, Ron A.A.; ten Kate, Marian T.; van Vianen, Wim; Tavakol, Mehri; Rijnders, Bart J. A.; Bakker-Woudenberg, Irma A. J. M.

    2009-01-01

    At present, voriconazole (VOR) is the drug of first choice for treating invasive pulmonary aspergillosis (IPA). However, particularly in advanced stages of disease and in the severely immunocompromised host, the mortality remains substantial. The combination of VOR with an echinocandin may improve the therapeutic outcome. We investigate here whether combining VOR and anidulafungin (ANI) in advanced IPA in transiently neutropenic rats results in a higher therapeutic efficacy. Since VOR is meta...

  15. Development of a liquid chromatography tandem mass spectrometry method for the simultaneous measurement of voriconazole, posaconazole and itraconazole.

    Science.gov (United States)

    Wadsworth, John M; Milan, Anna M; Anson, James; Davison, Andrew S

    2017-01-01

    Background Azole-based antifungals are the first-line therapy for some of the most common mycoses and are now also being used prophylactically to protect immunocompromised patients. However, due to variability in both their metabolism and bioavailability, therapeutic drug monitoring is essential to avoid toxicity but still gain maximum efficacy. Methods Following protein precipitation of serum with acetonitrile, 20  µL of extract was injected onto a 2.1 × 50 mm Waters Atlantis dC18 3  µm column. Detection was via a Waters Quattro Premier XE tandem mass spectrometer operating in ESI-positive mode. Multiple reaction monitoring (MRM) detected two product ions for each compound and one for each isotopically labelled internal standard. Ion suppression, linearity, stability, matrix effects, recovery, imprecision, lower limits of measuring interval and detection were all assessed. Results Optimal chromatographic separation was achieved using gradient elution over 8 minutes. Voriconazole, posaconazole and itraconazole eluted at 1.71, 2.73 and 3.41 min, respectively. The lower limits of measuring interval for all three compounds was 0.1 mg/L. The assay was linear to 10 mg/L for voriconazole (R(2 )= 0.995) and 5 mg/L for posaconazole (R(2 )= 0.990) and itraconazole (R(2 )= 0.991). The assay was both highly accurate and precise with % bias of voriconazole, posaconazole and itraconazole, respectively, when compared with previous NEQAS samples. The intra-assay precision (CV%) was 1.6%, 2.5% and 1.9% for voriconazole, posaconazole and itraconazole, respectively, across the linear range. Conclusion A simple and robust method has been validated for azole antifungal therapeutic drug monitoring. This new assay will result in a greatly improved sample turnaround time and will therefore vastly increase the clinical utility of azole antifungal drug monitoring.

  16. Superheated drop neutron spectrometer

    CERN Document Server

    Das, M; Roy, B; Roy, S C; Das, Mala

    2000-01-01

    Superheated drops are known to detect neutrons through the nucleation caused by the recoil nuclei produced by the interactions of neutrons with the atoms constituting the superheated liquid molecule. A novel method of finding the neutron energy from the temperature dependence response of SDD has been developed. From the equivalence between the dependence of threshold energy for nucleation on temperature of SDD and the dependence of dE/dx of the recoil ions with the energy of the neutron, a new method of finding the neutron energy spectrum of a polychromatic as well as monochromatic neutron source has been developed.

  17. Your Eyes

    Science.gov (United States)

    ... people you know — like your grandparents — probably wear glasses. To the Brain! Think of the optic nerve as the great messenger in the back of your eye. The rods and cones of the retina change the colors and shapes you see into millions of nerve ...

  18. Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin combination therapies.

    Science.gov (United States)

    Abidi, Maheen Z; Sohail, Muhammad R; Cummins, Nathan; Wilhelm, Mark; Wengenack, Nancy; Brumble, Lisa; Shah, Harshal; Jane Hata, Donna; McCullough, Ann; Wendel, Amy; Vikram, Holenarasipur R; Kusne, Shimon; Litzow, Mark; Letendre, Louis; Lahr, Brian D; Poeschla, Eric; Walker, Randall C

    2014-11-01

    As invasive mucormycosis (IM) numbers rise, clinicians suspect prior voriconazole worsens IM incidence and severity, and believe combination anti-fungal therapy improves IM survival. To compare the cumulative incidence (CI), severity and mortality of IM in eras immediately before and after the commercial availability of voriconazole all IM cases from 1995 to 2011 were analysed across four risk-groups (hematologic/oncologic malignancy (H/O), stem cell transplantation (SCT), solid organ transplantation (SOT) and other), and two eras, E1 (1995-2003) and E2, (2004-2011). Of 101 IM cases, (79 proven, 22 probable): 30 were in E1 (3.3/year) and 71 in E2 (8.9/year). Between eras, the proportion with H/O or SCT rose from 47% to 73%, while 'other' dropped from 33% to 11% (P = 0.036). Between eras, the CI of IM did not significantly increase in SCT (P = 0.27) or SOT (P = 0.30), and patterns of anatomic location (P = 0.122) and surgical debridement (P = 0.200) were similar. Significantly more patients received amphotericin-echinocandin combination therapy in E2 (31% vs. 5%, P = 0.01); however, 90-day survival did not improve (54% vs. 59%, P = 0.67). Since 2003, the rise of IM reflects increasing numbers at risk, not prior use of voriconazole. Frequent combination of anti-fungal therapy has not improved survival.

  19. Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain

    Science.gov (United States)

    Grau, Santiago; Azanza, Jose Ramon; Ruiz, Isabel; Vallejo, Carlos; Mensa, Josep; Maertens, Johan; Heinz, Werner J; Barrueta, Jon Andoni; Peral, Carmen; Mesa, Francisco Jesús; Barrado, Miguel; Charbonneau, Claudie; Rubio-Rodríguez, Darío; Rubio-Terrés, Carlos

    2017-01-01

    Objective According to a recent randomized, double-blind clinical trial comparing the combination of voriconazole and anidulafungin (VOR+ANI) with VOR monotherapy for invasive aspergillosis (IA) in patients with hematologic disease or with hematopoietic stem cell transplant, mortality was lower after 6 weeks with VOR+ANI than with VOR monotherapy in a post hoc analysis of patients with galactomannan-based IA. The objective of this study was to compare the cost-effectiveness of VOR+ANI with VOR, from the perspective of hospitals in the Spanish National Health System. Methods An economic model with deterministic and probabilistic analyses was used to determine costs per life-year gained (LYG) for VOR+ANI versus VOR in patients with galactomannan-based IA. Mortality, adverse event rates, and life expectancy were obtained from clinical trial data. The costs (in 2015 euros [€]) of the drugs and the adverse event-related costs were obtained from Spanish sources. A Tornado plot and a Monte Carlo simulation (1,000 iterations) were used to assess uncertainty of all model variables. Results According to the deterministic analysis, for each patient treated with VOR+ANI compared with VOR monotherapy, there would be a total of 0.348 LYG (2.529 vs 2.181 years, respectively) at an incremental cost of €5,493 (€17,902 vs €12,409, respectively). Consequently, the additional cost per LYG with VOR+ANI compared with VOR would be €15,785. Deterministic sensitivity analyses confirmed the robustness of these findings. In the probabilistic analysis, the cost per LYG with VOR+ANI was €15,774 (95% confidence interval: €15,763–16,692). The probability of VOR+ANI being cost-effective compared with VOR was estimated at 82.5% and 91.9%, based on local cost-effectiveness thresholds of €30,000 and €45,000, respectively. Conclusion According to the present economic study, combination therapy with VOR+ANI is cost-effective as primary therapy of IA in galactomannan

  20. Why Do Eyes Water?

    Science.gov (United States)

    ... Lifesaver Kids Talk About: Coaches Why Do Eyes Water? KidsHealth > For Kids > Why Do Eyes Water? Print ... out of your nose. continue Why Do Eyes Water? Eyes water for lots of different reasons besides ...

  1. Eye muscle repair - discharge

    Science.gov (United States)

    ... Lazy eye repair - discharge; Strabismus repair - discharge; Extraocular muscle surgery - discharge ... You or your child had eye muscle repair surgery to correct eye muscle ... term for crossed eyes is strabismus. Children most often ...

  2. Why Do Eyes Water?

    Science.gov (United States)

    ... Happens in the Operating Room? Why Do Eyes Water? KidsHealth > For Kids > Why Do Eyes Water? A ... out of your nose. continue Why Do Eyes Water? Eyes water for lots of different reasons besides ...

  3. About the Eye

    Medline Plus

    Full Text Available ... eye behind the iris that helps to focus light on the retina. It allows the eye to ... of the eye. It regulates the amount of light entering the eye through the pupil. Pupil (PYOO- ...

  4. Recommended Sports Eye Protectors

    Science.gov (United States)

    ... Financial Assistance Information Vision Screening and Eye Exams Zika Virus and Vision Eye Problems Eye Problems Amblyopia ( ... Eye Health Report Reports and External Resources The Cost of Vision Problems The Future of Vision Vision ...

  5. Eye Safety at Home

    Science.gov (United States)

    ... Financial Assistance Information Vision Screening and Eye Exams Zika Virus and Vision Eye Problems Eye Problems Amblyopia ( ... Eye Health Report Reports and External Resources The Cost of Vision Problems The Future of Vision Vision ...

  6. Eye Safety at Work

    Science.gov (United States)

    ... Financial Assistance Information Vision Screening and Eye Exams Zika Virus and Vision Eye Problems Eye Problems Amblyopia ( ... Eye Health Report Reports and External Resources The Cost of Vision Problems The Future of Vision Vision ...

  7. Eye Movement Disorders

    Science.gov (United States)

    ... work properly. There are many kinds of eye movement disorders. Two common ones are Strabismus - a disorder in ... the eyes, sometimes called "dancing eyes" Some eye movement disorders are present at birth. Others develop over time ...

  8. About the Eye

    Medline Plus

    Full Text Available ... eye behind the iris that helps to focus light on the retina. It allows the eye to ... of the eye. It regulates the amount of light entering the eye through the pupil. Pupil (PYOO- ...

  9. Conjunctivitis (Pink Eye)

    Science.gov (United States)

    ... that can be embedded on web pages. Conjunctivitis (Pink Eye) One-Page Overview Pink, itchy eyes? Conjunctivitis – ... protect yourself from getting and spreading pink eye . Pink Eye: What To Do Discusses causes and treatment, ...

  10. Eye Disease Simulations

    Science.gov (United States)

    ... USAJobs Home > Eye Health Information > Eye Disease Simulations Eye Disease Simulations Age-Related Macular Degeneration Cataract Diabetic ... information page Back to top Diabetic Retinopathy Diabetic Eye Disease information page Back to top Glaucoma Glaucoma ...

  11. Eye Involvement in TSC

    Science.gov (United States)

    ... Privacy Policy Sitemap Learn Engage Donate About TSC Eyes Campbell (1905) first described the eye involvement in ... some form of eye involvement. Nonretinal and Retinal Eye Findings Facial angiofibromas may involve the eyelids of ...

  12. Eye Complications in IBD

    Science.gov (United States)

    ... Home > Resources > Eye Complications in IBD Go Back Eye Complications in IBD Email Print + Share Approximately 10% ... doctor’s attention sooner rather than later. TYPES OF EYE DISORDERS UVEITIS One of the most common eye ...

  13. Pharmacokinetic/pharmacodynamic analysis of voriconazole against Candida spp. and Aspergillus spp. in children, adolescents and adults by Monte Carlo simulation.

    Science.gov (United States)

    Xu, Gaoqi; Zhu, Liqin; Ge, Tingyue; Liao, Shasha; Li, Na; Qi, Fang

    2016-06-01

    The objective of this study was to investigate the cumulative fraction of response of various voriconazole dosing regimens against six Candida and six Aspergillus spp. in immunocompromised children, immunocompromised adolescents, and adults. Using pharmacokinetic parameters and pharmacodynamic data, 5000-subject Monte Carlo simulations (MCSs) were conducted to evaluate the ability of simulated dosing strategies in terms of fAUC/MIC targets of voriconazole. According to the results of the MCSs, current voriconazole dosage regimens were all effective for children, adolescents and adults against Candida albicans, Candida parapsilosis and Candida orthopsilosis. For adults, dosing regimens of 4 mg/kg intravenous every 12 h (q12h) and 300 mg orally q12h were sufficient to treat fungal infections by six Candida spp. (C. albicans, C. parapsilosis, Candida tropicalis, Candida glabrata, Candida krusei and C. orthopsilosis) and five Aspergillus spp. (Aspergillus fumigatus, Aspergillus flavus, Aspergillus terreus, Aspergillus niger and Aspergillus nidulans). However, high doses should be recommended for children and adolescents in order to achieve better clinical efficacy against A. fumigatus and A. nidulans. The current voriconazole dosage regimens were all ineffective against A. niger for children and adolescents. All voriconazole dosage regimens were not optimal against Aspergillus versicolor. This is the first study to evaluate clinical therapy of various voriconazole dosing regimens against Candida and Aspergillus spp. infections in children, adolescents and adults using MCS. The pharmacokinetic/pharmacodynamic-based dosing strategy provided a theoretical rationale for identifying optimal voriconazole dosage regimens in children, adolescents and adults in order to maximise clinical response and minimise the probability of exposure-related toxicity.

  14. Eye Contricks

    Directory of Open Access Journals (Sweden)

    Nicholas J Wade

    2011-06-01

    Full Text Available Pictorial images are icons as well as eye-cons: they provide distillations of objects or ideas into simpler shapes. They create the impression of representing that which cannot be presented. Even at the level of the photograph, the links between icon and object are tenuous. The dimensions of depth and motion are missing from icons, and these alone introduce all manner of potential ambiguities. The history of art can be considered as exploring the missing link between icon and object. Eye-cons can also be illusions—tricks of vision so that what is seen does not necessarily correspond to what is physically presented. Pictorial images can be spatialised or stylised; spatialised images generally share some of the projective characteristics of the object represented. Written words are also icons, but they do not resemble the objects they represent—they are stylised or conventional. Icons as stylised words and spatialised images were set in delightful opposition by René Magritte in a series of pipe paintings, and this theme is here alluded to. Most of visual science is now concerned with icons—two-dimensional displays on computer monitors. Is vision now the science of eye-cons?

  15. Recurrent Scedosporium apiospermum mycetoma successfully treated by surgical excision and voriconazole

    Directory of Open Access Journals (Sweden)

    Chi-Hsuan Chiang

    2014-03-01

    Full Text Available Scedosporium apiospermum is an emerging opportunistic fungus that can cause localized infection in healthy hosts or severe disseminated disease in immunocompromised hosts. Most cases are reported in Western Europe, Australia, and North America. We report a 52-year-old immunocompetent Taiwanese woman who presented with a 6-year history of recurrent asymptomatic papulonodular lesions on her right foot after minor trauma. Deep fungal infection caused by Scedosporium sp. was diagnosed after a skin biopsy with fungal culture of the skin specimen. She underwent two surgical excisions, each followed by a 4-month course of oral itraconazole and intralesional injections of amphotericin B as well, but similar lesions recurred at the same location 1 year later. She had another surgical excision and the pathological findings showed mycetoma. The fungus was identified as S. apiospermum by PCR assay of fungal culture specimen using the internal transcriber spacers (ITS1, similarity 99.4%; ITS2, similarity 100% and the D1–D2 (similarity 99.0% regions of the ribosomal operon. After 4 months of oral voriconazole (400 mg/day, no recurrence was noted in the subsequent 2 years.

  16. [Cryptococcal meningitis successfully treated with liposomal amphotericin B and voriconazole in an elderly patient].

    Science.gov (United States)

    Ogaki, Kotaro; Noda, Kazuyuki; Fukae, Jiro; Furuya, Tsuyoshi; Hirayama, Takashi; Fujishima, Kenji; Hattori, Nobutaka; Okuma, Yasuyuki

    2010-12-01

    Abstract An 81-year-old woman who had microscopic polyangiitis that was being treated with corticosteroids for 2 months was admitted to our department because of fever and clouding of consciousness. Neurological examination showed disturbance of consciousness and nuchal stiffness. Analysis of cerebrospinal fluid (CSF) revealed pleocytosis, low glucose level, and elevated protein levels. On the basis of the presence of Cryptococcus neoformans in CSF, the patient was diagnosed with cryptococcal meningitis. On the basis of established practice guidelines, liposomal amphotericin B (L-AMB) was administered to avoid the possible nephrotoxicity of amphotericin B. After the treatment was started, the patient's condition gradually improved. The results of CSF analysis also showed a gradual recovery. Because the cryptococcal antigen in CSF did not disappear completely, voriconazole (VRCZ) was administered orally; subsequently, the CSF cryptococcal antigen titer gradually decreased. During the course of the treatment with L-AMB and VRCZ, there were no severe side effects that required a change in treatment. To the best of our knowledge, in Japan, the combination of L-AMB and VRCZ has rarely been reported to be effective for the treatment of cryptococcal meningitis. The recovery of our patient indicates that the administration of L-AMB and VRCZ to elderly patients with cryptococcal meningitis and renal insufficiency is safe and leads to a successful outcome.

  17. Voriconazole Composited Polyvinyl Alcohol/Hydroxypropyl-β-Cyclodextrin Nanofibers for Ophthalmic Delivery

    Science.gov (United States)

    Sun, Xiaoyi; Cai, Zhengyuan; Yu, Lingyan; Lv, Yuanyuan

    2016-01-01

    Voriconazole (VRC) incorporated in composited polyvinyl alcohol (PVA)/hydroxypropyl-β-cyclodextrin (HPβCD) blended nanofibers were produced via electrospinning for efficient ophthalmic delivery. The VRC loading capacity increased with increasing HPβCD content. The optimal solution for electrospinning consisted of 8% (w/v) PVA, 4% (w/v) HPβCD and 0.5% (w/v) VRC. The nanofibers exhibited bead-free average fiber diameters of 307±31 nm and VRC was released in vitro in a sustained manner. The VRC nanofibers were characterized by infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), differential scanning calorimetry (DSC) and scanning electron microscopy (SEM). The proton nuclear magnetic resonance (1H-NMR) was used to analyze the molar ratio of HPβCD/VRC in the nanofibers. Compared with a VRC solution, the nanofibers significantly prolonged the half life, and increased the bioavailability of VRC in rabbit tears. No obvious signs of irritation were observed after application in the conjunctival sac. VRC nanofibers are promising for ophthalmic drug delivery and further pharmacodynamics studies are needed. PMID:27974859

  18. Tuning mechanical properties of pharmaceutical crystals with multicomponent crystals: voriconazole as a case study.

    Science.gov (United States)

    Sanphui, Palash; Mishra, Manish Kumar; Ramamurty, Upadrasta; Desiraju, Gautam R

    2015-03-02

    Crystals of voriconazole, an antifungal drug, are soft in nature, and this is disadvantageous during compaction studies where pressure is applied on the solid. Crystal engineering is used to make cocrystals and salts with modified mechanical properties (e.g., hardness). Cocrystals with biologically safe coformers such as fumaric acid, 4-hydroxybenzoic acid, and 4-aminobenzoic acid and salts with hydrochloric acid and oxalic acid are prepared through solvent assisted grinding. The presence (salt) or absence (cocrystal) of proton transfer in these multicomponent crystals is unambiguously confirmed with single crystal X-ray diffraction. All the cocrystals have 1:1 stoichiometry, whereas salts exhibit variable stoichiometries such as HCl salt (1:2) and oxalate salts (1:1.5 and 1:1). The nanoindentation technique was applied on single crystals of the salts and cocrystals. The salts exhibit better hardness than the drug and cocrystals in the order salts ≫ drug > cocrystals. The molecular origin of this mechanical modulation is explained on the basis of slip planes in the crystal structure and relative orientations of the molecules with respect to the nanoindentation direction. The hydrochloride salt is the hardest solid in this family. This may be useful for tableting of the drug during formulation and in drug development.

  19. Force-length recording of eye muscles during local-anesthesia surgery in 32 strabismus patients

    NARCIS (Netherlands)

    H.J. Simonsz (Huib)

    1994-01-01

    textabstractAbstract. Force-length recordings were made from isolated human eye muscles during strabismus surgery in local, eye-drop anesthesia in 32 adult patients. From each muscle three recordings were made: (1) while the patient looked with the other eye into the field of action of the recorded

  20. Investigations of levitated helium drops

    Science.gov (United States)

    Whitaker, Dwight Lawrence

    1999-11-01

    We report on the development of two systems capable of levitating drops of liquid helium. Helium drops of ˜20 mum have been levitated with the radiation pressure from two counter-propagating Nd:YAG laser beams. Drops are produced with a submerged piezoelectric transducer, and could be held for up to three minutes in our optical trap. Calculations show that Brillouin and Raman scattering of the laser light in the liquid helium produces a negligible rate of evaporation of the drop. Evaporation caused by the enhanced vapor pressure of the curved drop surfaces appears to be a significant effect limiting the drop lifetimes. Helium drops as large as 2 cm in diameter have been suspended in the earth's gravitational field with a magnetic field. A commercial superconducting solenoid provides the necessary field, field-gradient product required to levitate the drops. Drops are cooled to 0.5 K with a helium-3 refrigerator, and can be held in the trap indefinitely. We have found that when two or more drops are levitated in the same magnetic trap, the drops often remain in a state of apparent contact without coalescing. This effect is a result of the evaporation of liquid from between the two drops, and is found to occur only for normal fluid drops. We can induce shape oscillations in charged, levitated drops with an applied ac electric field. We have measured the resonance frequencies and damping rates for the l = 2 mode of oscillation as function of temperature. We have also developed a theory to describe the small amplitude shape oscillations of a He II drop surrounded by its saturated vapor. In our theory, we have considered two sets of boundary conditions---one where the drop does not evaporate and another in which the liquid and vapor are in thermodynamic equilibrium. We have found that both solutions give a frequency that agrees well with experiment, but that the data for the damping rate agree better with the solution without evaporation.

  1. Eye Contricks

    Directory of Open Access Journals (Sweden)

    N Wade

    2011-04-01

    Full Text Available Icons are eye-cons: they provide a distillation of a complex object or idea into a simple pictorial shape. They create the impression of representing that which cannot be presented. Even at the level of the photograph, the links between icon and object are tenuous. The dimension of distance or depth is missing from the icon, and this alone introduces all manner of potential ambiguities. The history of art can be considered as an exploration of the missing link between icon and object. Eye-cons are more honest—they are tricks of vision so that what is seen does not necessarily correspond to what is presented. They are visual allusions rather than visual illusions, although they can display illusory effects. At its broadest, icon can be equated with image. The concept of image has thrived on its vagueness, and so attempts have been made to refine it. An icon corresponds to an optical image: it shares some of the projective characteristics of the object represented. Written words are also icons but they do not resemble the objects they represent—they are stylised or conventional rather than spatialised and projective. Words and images were set in delightful opposition by René Magritte (1898-1967 in a series of pipe paintings, and he also played on the theme of the arbitrariness of the verbal labels assigned to objects. What is surprising is that Magritte did not apply his painterly skills to transforming the word shapes he used. A similar reluctance to transform the typefaces pervades visual poetry. My interests are in the visual rather than the poetic dimension, and I will present a range of my own eye contricks which play with letter and word shapes in a variety of ways.

  2. Safety and outcome of treatment with voriconazole in a large cohort of immunocompromised children and adolescents

    Directory of Open Access Journals (Sweden)

    Pieper, Stephanie

    2015-02-01

    Full Text Available Objectives: Post-marketing data on safety and outcome of voriconazole (VCZ treatment in pediatric patients is limited. We performed a retrospective, single center analysis of safety, tolerance and antifungal efficacy in a large cohort of children and adolescents requiring VCZ therapy.Patients and methods: The cohort included 107 patients (0.2–18 years of age with hematological disorders (85; 42 post allo-HSCT, primary immunodeficiencies (9, AIDS (4, metabolic diseases (5 and solid tumors (4 who received 252 courses of VCZ for possible (12 and probable/proven (25 invasive fungal diseases (IFDs, as primary (127 or secondary (79 prophylaxis or as empiric therapy (9. VCZ was given IV (10 and (37/or (205 PO at recommended dosages until intolerance or maximum efficacy. IFDs and outcomes were assessed by EORTC/MSG consensus criteria.Results: VCZ was administered at a median maintenance dosage of 5.9 mg/kg twice daily (range, 2.2–22.0 for a median of 65 days (range 1–1,002. While on treatment, increases in hepatic transaminases, serum bilirubin and alkaline phosphatase, skin eruptions and neurological adverse events (AEs were observed in 53.5, 23.6, 10.9, 5.6 and 4.8% of courses, respectively. At end of treatment (EOT, mean alkaline phosphatase, aspartate aminotransferase and serum bilirubin values were slightly elevated relative to baseline (p<0.01. AEs prompting discontinuation of VCZ occurred in 18 courses (7.1%. Treatment success was observed in 16/37 patients with proven/probable/possible IFDs, and in 187/215 courses of empiric therapy and prophylaxis. Overall survival was 97.6% at EOT and 92.1% at 3 month post EOT, respectively.Conclusions: VCZ displayed acceptable clinical safety and tolerance and was effective in the management of IFDs in severely immunocompromised children and adolescents.

  3. In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei.

    Science.gov (United States)

    Ricardo, Elisabete; Miranda, Isabel M; Faria-Ramos, Isabel; Silva, Raquel M; Rodrigues, Acácio Gonçalves; Pina-Vaz, Cidália

    2014-08-01

    Candida krusei is an important agent of opportunistic infections that often displays resistance to several antifungals. We describe here the in vivo acquisition of resistance to voriconazole (VRC) by C. krusei isolates recovered from a leukemia patient during a long period of VRC therapy. In order to mimic the in vivo development of VRC resistance, a susceptible C. krusei isolate was exposed daily to 1 μg/ml of VRC in vitro. Interestingly, after 5 days of exposure to VRC, a MIC of 4 μg/ml was achieved; this value remained constant after 25 additional days of treatment with VRC and also after 30 consecutive days of incubation in VRC-free medium. Our objective was to determine the associated molecular resistance mechanisms, such as expression of efflux pump genes and ERG11 gene mutations, among the resistant strains. Synergistic effects between the efflux blocker tacrolimus (FK506) and VRC were found in all of the resistant strains. Moreover, ABC1 gene expression increased over time in both the in vivo- and in vitro-induced resistant strains, in contrast to the ABC2 and ERG11 genes, whose expression was invariably lower and constant. ERG11 gene sequencing showed two different types of mutations, i.e., heterozygosity at T1389T/C, corresponding to synonymous mutations, in C. krusei strains and a missense mutation at position T418C, resulting in a change from Tyr to His, among resistant C. krusei clinical isolates. This study highlights the relevance of ATP-dependent efflux pump (namely, Abc1p) activity in VRC resistance and describes new mutations in the ERG11 gene among resistant C. krusei clinical isolates.

  4. Gas Pressure-Drop Experiment

    Science.gov (United States)

    Luyben, William L.; Tuzla, Kemal

    2010-01-01

    Most chemical engineering undergraduate laboratories have fluid mechanics experiments in which pressure drops through pipes are measured over a range of Reynolds numbers. The standard fluid is liquid water, which is essentially incompressible. Since density is constant, pressure drop does not depend on the pressure in the pipe. In addition, flow…

  5. Pressure drop in contraction flow

    DEFF Research Database (Denmark)

    Rasmussen, Henrik Koblitz

    This note is a supplement to Dynamic of Polymeric Liquids (DPL) page 178. DPL gives an equation for the pressure drop in a tapered (and circular) contraction, valid only at low angles. Here the general definition of contraction flow (the Bagley correction) and a more general method to find...... the pressure drop in a contraction are given....

  6. Phaeoacremonium parasiticum phaeohyphomycosis in a patient with systemic lupus erythematosus treated successfully with surgical debridement and voriconazole: A case report and review of the literature

    Directory of Open Access Journals (Sweden)

    Rima I. El-Herte

    2014-01-01

    Full Text Available A 26-year old woman presented for evaluation of extensive edema, erythema, sinus tract formation and purulent drainage from the left lower extremity after trauma from a wooden object approximately three months prior. Skin biopsies and blood cultures revealed Phaeoacremonium parasiticum consistent with a diagnosis of phaeohyphomycosis. Despite hospitalization and initial treatment with several antifungals, including voriconazole, her infection progressed. Surgical debridement with split thickness skin grafting was performed. Subsequent clinical improvement allowed a transition from intravenous to oral voriconazole and discharge home. Seven months post presentation she remained on oral voriconazole with significant improvement and no clinical evidence of recurrence. This case illustrates an approach to management where aggressive debridement with split-thickness skin grafting and a prolonged course of intravenous and oral antifungals resulted in a good long-term outcome for the patient.

  7. Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis.

    Science.gov (United States)

    Zhao, Ying Jiao; Khoo, Ai Leng; Tan, Gloria; Teng, Monica; Tee, Caroline; Tan, Ban Hock; Ong, Benjamin; Lim, Boon Peng; Chai, Louis Yi Ann

    2015-11-02

    Invasive fungal infections (IFIs) are associated with high mortality rates and large economic burdens. Triazole prophylaxis is used for at-risk patients with hematological malignancies or stem cell transplants. We evaluated both the efficacy and the cost-effectiveness of triazole prophylaxis. A network meta-analysis (NMA) of randomized controlled trials (RCTs) evaluating fluconazole, itraconazole capsule and solution, posaconazole, and voriconazole was conducted. The outcomes of interest included the incidences of IFIs and deaths. This was coupled with a cost-effectiveness analysis from patient perspective over a lifetime horizon. Probabilities of transitions between health states were derived from the NMA. Resource use and costs were obtained from the Singapore health care institution. Data on 5,505 participants in 21 RCTs were included. Other than itraconazole capsule, all triazole antifungals were effective in reducing IFIs. Posaconazole was better than fluconazole (odds ratio [OR], 0.35 [95% confidence interval [CI], 0.16 to 0.73]) and itraconazole capsule (OR, 0.25 [95% CI, 0.06 to 0.97]), but not voriconazole (OR, 1.31 [95% CI, 0.43 to 4.01]), in preventing IFIs. Posaconazole significantly reduced all-cause deaths, compared to placebo, fluconazole, and itraconazole solution (OR, 0.49 to 0.54 [95% CI, 0.28 to 0.88]). The incremental cost-effectiveness ratio for itraconazole solution was lower than that for posaconazole (Singapore dollars [SGD] 12,546 versus SGD 26,817 per IFI avoided and SGD 5,844 versus SGD 12,423 per LY saved) for transplant patients. For leukemia patients, itraconazole solution was the dominant strategy. Voriconazole was dominated by posaconazole. All triazole antifungals except itraconazole capsule were effective in preventing IFIs. Posaconazole was more efficacious in reducing IFIs and all-cause deaths than were fluconazole and itraconazole. Both itraconazole solution and posaconazole were cost-effective in the Singapore health care

  8. In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species.

    Science.gov (United States)

    Valentín, A; Cantón, E; Pemán, J; Fernandez-Rivero, M E; Tormo-Mas, M A; Martínez, J P

    2016-12-01

    To evaluate the in vitro activity of anidulafungin combined with amphotericin B or voriconazole against Candida spp. biofilms. Four Candida albicans, four Candida tropicalis, four Candida glabrata, two Candida parapsilosis and two Candida orthopsilosis blood isolates were tested by the microdilution chequerboard method combined with the XTT metabolic assay. Biofilm MIC was defined as the lowest concentration producing 50% metabolic inhibition with respect to control (BMIC50). Concentrations in the combinations ranged from 1/8 × BMIC50 to 4 × BMIC50 found for each antifungal tested alone. Anidulafungin plus amphotericin B acted synergistically against C. albicans and C. glabrata biofilms [fractional inhibitory concentration index (FICI): 0.082-0.387], but showed no interaction against C. tropicalis, C. parapsilosis and C. orthopsilosis (FICI: 0.516-2.099). The combination of these antifungals failed to completely remove biofilms of C. albicans and C. glabrata, decreasing the metabolic activity of the biofilms up to 80% and 95%, respectively, which did not occur when each antifungal was used alone. Anidulafungin plus voriconazole showed no interaction against all isolates. Using a less stringent criterion previously proposed to define synergism (FICI  1.25), antagonistic interactions were found against some isolates. Anidulafungin with amphotericin B results in a synergistic effect against C. albicans and C. glabrata biofilms at serum concentrations of the drugs, but showed no interaction against C. tropicalis and C. parapsilosis complex. Anidulafungin plus voriconazole showed no interaction against the five Candida species assayed. Biofilms of C. tropicalis were found to be the most resistant towards the combinations assayed. The results presented may be of potential interest in the clinical setting. © The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For

  9. Correlation between In Vitro Susceptibility of Scedosporium apiospermum to Voriconazole and In Vivo Outcome of Scedosporiosis in Guinea Pigs

    OpenAIRE

    Capilla, Javier; Guarro, Josep

    2004-01-01

    We have evaluated the efficacy of voriconazole (VRC) in a systemic infection by Scedosporium apiospermum in immunodepressed guinea pigs. Animals were infected with two strains; one required a VRC MIC of 0.5 to 1 μg/ml, common for this fungus, and the other required a high MIC (8 μg/ml), unusual in this species. VRC prolonged survival and reduced fungal load in kidney and brain tissues of the animals infected with the first strain but was unable to prolong survival or to reduce fungal load in ...

  10. Antifungal susceptibility testing of Exophiala spp.: a head-to-head comparison of amphotericin B, itraconazole, posaconazole and voriconazole.

    Science.gov (United States)

    Fothergill, Annette W; Rinaldi, Michael G; Sutton, Deanna A

    2009-02-01

    Frequently, diseases caused by black yeasts are chronic in nature with a high morbidity. In addition, these infections are often fatal and relapse is common, even after prolonged treatment. Although the CLSI Document M38-A outlines methods for antifungal susceptibility testing of moulds, Exophiala spp. are not directly discussed. In an effort to determine the antifungal susceptibility patterns of Exophiala spp. we tested 160 clinical isolates against amphotericin B, itraconazole, posaconazole, and voriconazole in a head-to-head comparison. Posaconazole and itraconazole were the most active in vitro with MICs falling well below the achievable serum levels typically observed with standard dosing regimens.

  11. What Is Dry Eye?

    Medline Plus

    Full Text Available ... Tips & Prevention News Ask an Ophthalmologist Patient Stories Español Eye Health / Eye Health A-Z Dry Eye ... Eye Treatment What Is Dry Eye? Leer en Español: ¿Qué Es el Ojo Seco? Written By: Kierstan ...

  12. About the Eye

    Medline Plus

    Full Text Available ... Ask a Scientist Video Series Glossary The Visual System Your Eyes’ Natural Defenses Eye Health and Safety First Aid Tips Healthy Vision Tips Protective Eyewear Sports and Your Eyes Fun Stuff Cool Eye Tricks Links to More Information Optical Illusions Printables About the Eye Your eyes ...

  13. About the Eye

    Medline Plus

    Full Text Available ... Ask a Scientist Video Series Glossary The Visual System Your Eyes’ Natural Defenses Eye Health and Safety First Aid Tips Healthy Vision Tips Protective Eyewear Sports and Your Eyes Fun Stuff Cool Eye Tricks Links to More Information Optical Illusions Printables About the Eye Your eyes ...

  14. Liquid drops on soft solids

    Science.gov (United States)

    Lubbers, Luuk A.; Weijs, Joost H.; Das, Siddhartha; Botto, Lorenzo; Andreotti, Bruno; Snoeijer, Jacco H.

    2014-03-01

    A sessile drop can elastically deform a substrate by the action of capillary forces. The typical size of the deformation is given by the ratio of surface tension and the elastic modulus, γ / E , which can reach up to 10-100 microns for soft elastomers. In this talk we theoretically show that the contact angles of drops on such a surface exhibit two transitions when increasing γ / E : (i) the microsocopic geometry of the contact line first develops a Neumann-like cusp when γ / E is of the order of few nanometers, (ii) the macroscopic angle of the drop is altered only when γ / E reaches the size of the drop. Using the same framework we then show that two neighboring drops exhibit an effective interaction, mediated by the deformation of the elastic medium. This is in analogy to the well-known Cheerios effect, where small particles at a liquid interface attract each other due to the meniscus deformations. Here we reveal the nature of drop-drop interactions on a soft substrate by combining numerical and analytical calculations.

  15. EyeGENE

    Data.gov (United States)

    U.S. Department of Health & Human Services — The eyeGENE® Biorepository and corresponding Database contain family history and clinical eye exam data from subjects enrolled in eyeGENE® Program coupled to...

  16. Eye Injuries in Sports

    Science.gov (United States)

    ... in Sports Which sports cause the most eye injuries?Sports cause more than 40,000 eye injuries each ... and racquet sports.When it comes to eye injuries, sports can be classified as low risk, high risk ...

  17. What Is Dry Eye?

    Medline Plus

    Full Text Available ... Member Services Advocacy Foundation About Subspecialties & More Eye Health Home Annual Meeting Clinical Education Practice Management Member ... Center Redmond Ethics Center Global Ophthalmology Guide Eye Health Find an Ophthalmologist Academy Store Eye Health A- ...

  18. What Is Dry Eye?

    Medline Plus

    Full Text Available ... Member Services Advocacy Foundation About Subspecialties & More Eye Health Home Annual Meeting Clinical Education Practice Management Member ... Center Redmond Ethics Center Global Ophthalmology Guide Eye Health Find an Ophthalmologist Academy Store Eye Health A- ...

  19. Eye muscle repair - slideshow

    Science.gov (United States)

    ... page: //medlineplus.gov/ency/presentations/100062.htm Eye muscle repair - series—Normal anatomy To use the sharing ... the eyeball to the eye socket. The external muscles of the eye are found behind the conjunctiva. ...

  20. Pink Eye (Conjunctivitis)

    Science.gov (United States)

    ... you have allergic conjunctivitis. Preventing the spread of pink eye Practice good hygiene to control the spread ... can return to school or child care. Preventing pink eye in newborns Newborns' eyes are susceptible to ...

  1. About the Eye

    Medline Plus

    Full Text Available ... Glossary The Visual System Your Eyes’ Natural Defenses Eye Health and Safety First Aid Tips Healthy Vision ... to More Information Optical Illusions Printables About the Eye Your eyes are made up of many different ...

  2. About the Eye

    Science.gov (United States)

    ... Glossary The Visual System Your Eyes’ Natural Defenses Eye Health and Safety First Aid Tips Healthy Vision ... to More Information Optical Illusions Printables About the Eye Your eyes are made up of many different ...

  3. Eye Injuries (For Parents)

    Science.gov (United States)

    ... Habits for TV, Video Games, and the Internet Eye Injuries KidsHealth > For Parents > Eye Injuries Print A ... sand, dirt, and other foreign bodies on the eye surface) Wash your hands thoroughly before touching the ...

  4. Excited Sessile Drops Perform Harmonically

    CERN Document Server

    Chang, Chun-Ti; Steen, Paul H

    2013-01-01

    In our fluid dynamics video, we demonstrate our method of visualizing and identifying various mode shapes of mechanically oscillated sessile drops. By placing metal mesh under an oscillating drop and projecting light from below, the drop's shape is visualized by the visually deformed mesh pattern seen in the top view. The observed modes are subsequently identified by their number of layers and sectors. An alternative identification associates them with spherical harmonics, as demonstrated in the tutorial. Clips of various observed modes are presented, followed by a 10-second quiz of mode identification.

  5. Safety evaluation of rabbit corneas with subconjunctival injection of voriconazole%结膜下注射伏立康唑对兔眼角膜的安全性评价

    Institute of Scientific and Technical Information of China (English)

    闫瑾; 贾淑杰; 刘美欣; 韩泉洪; 张毅

    2015-01-01

    Objective To evaluate the safety of rabbit corneas with subconjunctival injection of voriconazole, and explore a safe range of antibiotic dose. Methods According to body weights, total 25 healthy rabbits were randomly divided into control group, and voriconazole (50, 100, 200, and 400μg) groups. The eyes of control group received subconjunctival injection of 0.1 mL balanced salt solution (BBS), and those treatment groups received 0.1 mL injection containing Voriconazole for injection 50, 100, 200, and 400μg, respectively. Every rabbit received five injections, once daily. Before the administration and 1, 7, and 14 d after the last injection, basic situations of the eyes were observed with slit lamp biomicroscopy and direct ophthalmscopy. Ultrastructures of the corneas were detected in vivo observation 1, 7, and 14 d after the last injection, respectively, and endothelial cell counts and corneal thicknesses were performed at the same time using confocal microscopy. Fourteen days after the last injection, pathological observations were carried out for corneal morphology. Results Subconjunctival injection of voriconazole in the rabbits at doses of 50 and 100μg, there was no abnormality in corneal cells, but at doses of 200 and 400μg, the rabbits showed edema cornea, exfoliation of corneal epithelium and abnormities in ultrastructures. However, there was no significant difference in endothelial cell counts and corneal thickness with those of control group at any time points. Conclusion It is safe for corneas of rabbit subconjunctival injection of voriconazole at the dose ≤100μg.%目的:评估结膜下注射伏立康唑对兔眼角膜的安全性,寻找兔眼结膜下注射伏立康唑的安全剂量。方法健康成年新西兰白兔25只,按体质量随机分为对照组、伏立康唑(50、100、200、400μg)组。对照组结膜下注射0.1 mL生理盐水,伏立康唑组均结膜下注射0.1 mL伏立康唑注射液,分别含50、100、200、400

  6. Pulmonary Delivery of Voriconazole Loaded Nanoparticles Providing a Prolonged Drug Level in Lungs: A Promise for Treating Fungal Infection.

    Science.gov (United States)

    Das, Pranab Jyoti; Paul, Paramita; Mukherjee, Biswajit; Mazumder, Bhaskar; Mondal, Laboni; Baishya, Rinku; Debnath, Mita Chatterjee; Dey, Kumar Saurav

    2015-08-03

    Current therapies are insufficient to prevent recurrent fungal infection especially in the lower part of the lung. A careful and systematic understanding of the properties of nanoparticles plays a significant role in the design, development, optimization, and in vivo performances of the nanoparticles. In the present study, PLGA nanoparticles containing the antifungal drug voriconazole was prepared and two best formulations were selected for further characterization and in vivo studies. The nanoparticles and the free drug were radiolabeled with technetium-99m with 90% labeling efficiency, and the radiolabeled particles were administered to investigate the effect on their blood clearance, biodistribution, and in vivo gamma imaging. In vivo deposition of the drug in the lobes of the lung was studied by LC-MS/MS study. The particles were found to be spherical and had an average hydrodynamic diameter of 300 nm with a smooth surface. The radiolabeled particles and the free drug were found to accumulate in various major organs. Drug accumulation was more pronounced in the lung in the case of administration of the nanoparticles than that of the free drug. The free drug was found to be excreted more rapidly than the nanoparticle containing drug following the inhalation route as assessed by gamma scintigraphy study. Thus, the study reveals that pulmonary administration of nanoparticles containing voriconazole could be a better therapeutic choice even as compared to the iv route of administration of the free drug and/or the drug loaded nanoparticles.

  7. Laser photocoagulation - eye

    Science.gov (United States)

    Laser coagulation; Laser eye surgery; Photocoagulation; Laser photocoagulation - diabetic eye disease; Laser photocoagulation - diabetic retinopathy; Focal photocoagulation; Scatter (or pan retinal) photocoagulation; Proliferative ...

  8. Drop spreading with random viscosity

    CERN Document Server

    Xu, Feng

    2016-01-01

    We examine theoretically the spreading of a viscous liquid drop over a thin film of uniform thickness, assuming the liquid's viscosity is regulated by the concentration of a solute that is carried passively by the spreading flow. The solute is assumed to be initially heterogeneous, having a spatial distribution with prescribed statistical features. To examine how this variability influences the drop's motion, we investigate spreading in a planar geometry using lubrication theory, combining numerical simulations with asymptotic analysis. We assume diffusion is sufficient to suppress solute concentration gradients across but not along the film. The solute field beneath the bulk of the drop is stretched by the spreading flow, such that the initial solute concentration immediately behind the drop's effective contact lines has a long-lived influence on the spreading rate. Over long periods, solute swept up from the precursor film accumulates in a short region behind the contact line, allowing patches of elevated v...

  9. 45-FOOT HIGH DROP TOWER

    Data.gov (United States)

    Federal Laboratory Consortium — The Drop Tower is used to simulate and measure the impact shocks that are exerted on parachute loads when they hit the ground. It is also used for HSL static lift to...

  10. The influence of protein free calf blood extract eye gel on dry eye after pterygium surgery

    Directory of Open Access Journals (Sweden)

    Cai-Ni Ji

    2013-07-01

    Full Text Available AIM: To investigate the influence of protein free calf blood extract eye gel on dry eye after pterygium surgery. METHODS: Thirty six patients(40 eyeswith primary nasal pterygium were enrolled in this study, which were divided into study group and control group randomly, with 20 eyes in each group. All patients received pterygium excision and limbal stem cell autograft surgery and tobramicin dexamethasone eye drops after surgery. Patients of the study group received protein free calf blood extract eye gel while those of the control group received 0.1% sodium hyaluronate eye drops furthermore. Ocular surface disease index(OSDIquestionnaire, tear film break-up time(BUTand Schirmer's Ⅰ test Ⅰ(SⅠtwere carried before and 3 months after surgery to evaluate the dry eye degree of the patients. RESULTS: There was no statistical difference between the age, gender and size of the pterygium of the study and control groups preoperatively. There was no statistical difference between the OSDI(2.33±1.02 vs 2.32±0.93, BUT(8.80±2.48 vs 8.35±2.28seconds and SⅠt(4.30±2.30 vs 4.40±2.44of the two groups preoperatively. There was statistical difference between the OSDI(1.45±0.47 vs 1.81±0.60, BUT(11.20±2.07 vs 9.50±2.40seconds and SⅠt(8.35±3.13 vs 6.35±2.18of the two groups 3 months postoperatively, which was also different from that of the preoperative data correspondingly. CONCLUSION: Protein free calf blood extract eye gel could reduce the dry eye after pterygium surgery.

  11. Comparative study measuring the dilatory effect of a mydriatic device (Mydriasert®) versus topical drops

    Science.gov (United States)

    Saenz-de-Viteri, Manuel; Fernández-Robredo, Patricia; de Nova, Elisa; Bonet-Farriol, Elvira; Sabater, Alfonso L.; Zarranz-Ventura, Javier; Caire, Josemaria; Sádaba, Luis M.; Salinas-Alamán, Angel; García-Layana, Alfredo

    2013-01-01

    AIM To compare the mydriatic efficacy of an ophthalmic insert (Mydriasert, MY) versus phenylephrine and tropicamide (PT) eye drops. METHODS Two controlled, prospective, randomized, single-blind studies were performed. In the first study, a total of 80 eyes from 40 outpatient-clinic patients were analyzed. PT drops were applied to the right eye, and a MY device was inserted in the left eye for 30min. Time until maximal pupil dilation for each eye was then assessed. In the second study, 80 eyes from 80 patients undergoing cataract surgery were analyzed. Pupil dilation was achieved using either PT drops three-times for one hour prior to surgery (40 patients), or a MY device was inserted one hour prior to surgery (40 patients). RESULTS In the first study, MY achieved superior mydriasis compared to PT eye drops at 90min (9.04±1.33mm vs 8.78±1.37mm, P=0.012). However MY took longer than PT drops to achieve maximal dilation, and mydriasis was inferior in eyes with MY compared to PT drops at 30min (7.21±1.73mm vs 8.22±1.43mm, P<0.001), the two groups only becoming similar by 60min (8.85±1.44mm vs 8.71±1.27mm, P=0.236). In the second study, both MY and PT achieved similar levels of mydriasis at the beginning of surgery (8.75±0.76mm with MY vs 8.77±0.63mm with PT), and also at the end of surgery (7.96±1.06mm with MY vs 8.32±0.72mm with PT), with no significant difference between groups (P=0.08). MY was well tolerated and cardiovascular effects were not influenced by dilation method. CONLUSION MY could be a safe and efficacious alternative for mydriasis. The mydriatic effect of MY is as good as conventional PT eye drops after 60min, and is superior after 90min. MY also maintains good pupil dilation during cataract surgery. PMID:24392328

  12. Effect of Tetracaine on Intraocular Pressure in Normal and Hypertensive Rabbit Eyes

    Directory of Open Access Journals (Sweden)

    Ali Asghar Sarchahi

    2012-01-01

    Full Text Available Purpose: To evaluate the effect of tetracaine on intraocular pressure (IOP in normal and hypertensive rabbit eyes. Methods: The study was conducted on 12 healthy rabbits as controls and 6 healthy rabbits in which an experimental model of ocular hypertension (OHT was induced by administration of 70 mL/kg of tap water through an orogastric tube. One drop of tetracaine was instilled in the left eye while a drop of normal saline (placebo was applied to the right eye of the control group. IOP was measured before and 0, 5, 10, 15, 20, 25, 30, 35 and 40 minutes after drop administration in this group. The OHT group also received one drop of tetracaine and normal saline in the left eyes and right eyes respectively, immediately after water loading; the instillation of drops was repeated after 55 minutes. IOP was measured before and 0, 5, 10, 15, 20, 25, 30, 35, 40, 55, 70, 85, 100 and 115 minutes after water loading in this group. Results: Tetracaine treated eyes in both groups (ocular hypertensive and normal controls demonstrated significant IOP reduction at time zero (immediately after drop instillation which was sustained up to 20 minutes, as compared to placebo treated eyes (P<0.05. In ocular hypertensive rabbits, repeat instillation of tetracaine significantly reduced IOP at 55 minutes up to 30 minutes thereafter. Conclusion: Topical tetracaine can reduce IOP; this fact should be considered in experiments evaluating IOP reducing agents.

  13. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.

    NARCIS (Netherlands)

    Espinel-Ingroff, A.; Barchiesi, F.; Cuenca-Estrella, M.; Pfaller, M.A.; Rinaldi, M.; Rodriguez-Tudela, J.L.; Verweij, P.E.

    2005-01-01

    The aim of this study was to compare MICs of fluconazole, itraconazole, posaconazole, and voriconazole obtained by the European Committee on Antibiotic Susceptibility Testing (EUCAST) and CLSI (formerly NCCLS) methods in each of six centers for 15 Candida albicans (5 fluconazole-resistant and 4 susc

  14. Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study

    NARCIS (Netherlands)

    Minea, B; Nastasa, V; Moraru, R F; Kolecka, A; Flonta, M M; Marincu, I; Man, A; Toma, F; Lupse, M; Doroftei, B; Marangoci, N; Pinteala, M; Boekhout, T; Mares, M

    2015-01-01

    This is the first multi-centre study regarding yeast infections in Romania. The aim was to determine the aetiological spectrum and susceptibility pattern to fluconazole, voriconazole and the novel compound MXP-4509. The 551 isolates were identified using routine laboratory methods, matrix-assisted l

  15. Pharmacodynamics of voriconazole against wild-type and azole-resistant aspergillus flavus isolates in a nonneutropenic murine model of disseminated aspergillosis

    NARCIS (Netherlands)

    S.M. Rudramurthy; S. Seyedmousavi (Seyedmojtaba); Dhaliwal, M. (Manpreet); A. Chakrabarti; J.F. Meis (Jacques F.); J.W. Mouton (Johan)

    2016-01-01

    textabstractInvasive aspergillosis (IA) due to Aspergillus flavus is associated with high mortality. Although voriconazole (VRC) is widely recommended as the first-line treatment for IA, emergence of azole resistance in Aspergillus spp. is translating to treatment failure. We evaluated the efficacy

  16. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.

    NARCIS (Netherlands)

    Espinel-Ingroff, A.; Aller, A.I.; Canton, E.; Castanon-Olivares, L.R.; Chowdhary, A.; Cordoba, S.; Cuenca-Estrella, M.; Fothergill, A.; Fuller, J.; Govender, N.; Hagen, F.; Illnait-Zaragozi, M.T.; Johnson, E.; Kidd, S.; Lass-Florl, C.; Lockhart, S.R.; Martins, M.A.; Meis, J.F.G.M.; Melhem, M.S.; Ostrosky-Zeichner, L.; Pelaez, T.; Pfaller, M.A.; Schell, W.A.; St-Germain, G.; Trilles, L.; Turnidge, J.

    2012-01-01

    Epidemiological cutoff values (ECVs) for the Cryptococcus neoformans-Cryptococcus gattii species complex versus fluconazole, itraconazole, posaconazole, and voriconazole are not available. We established ECVs for these species and agents based on wild-type (WT) MIC distributions. A total of 2,985 to

  17. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.

    NARCIS (Netherlands)

    Espinel-Ingroff, A.; Barchiesi, F.; Cuenca-Estrella, M.; Pfaller, M.A.; Rinaldi, M.; Rodriguez-Tudela, J.L.; Verweij, P.E.

    2005-01-01

    The aim of this study was to compare MICs of fluconazole, itraconazole, posaconazole, and voriconazole obtained by the European Committee on Antibiotic Susceptibility Testing (EUCAST) and CLSI (formerly NCCLS) methods in each of six centers for 15 Candida albicans (5 fluconazole-resistant and 4 susc

  18. Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model

    NARCIS (Netherlands)

    Siopi, M.; Mavridou, E.; Mouton, J.W.; Verweij, P.E.; Zerva, L.; Meletiadis, J.

    2014-01-01

    BACKGROUND: Although voriconazole reached the bedside 10 years ago and became the standard care in the treatment of invasive aspergillosis, reliable clinical breakpoints are still in high demand. Moreover, this has increased due to the recent emergence of azole resistance. METHODS: Four clinical wil

  19. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.

    NARCIS (Netherlands)

    Espinel-Ingroff, A.; Aller, A.I.; Canton, E.; Castanon-Olivares, L.R.; Chowdhary, A.; Cordoba, S.; Cuenca-Estrella, M.; Fothergill, A.; Fuller, J.; Govender, N.; Hagen, F.; Illnait-Zaragozi, M.T.; Johnson, E.; Kidd, S.; Lass-Florl, C.; Lockhart, S.R.; Martins, M.A.; Meis, J.F.G.M.; Melhem, M.S.; Ostrosky-Zeichner, L.; Pelaez, T.; Pfaller, M.A.; Schell, W.A.; St-Germain, G.; Trilles, L.; Turnidge, J.

    2012-01-01

    Epidemiological cutoff values (ECVs) for the Cryptococcus neoformans-Cryptococcus gattii species complex versus fluconazole, itraconazole, posaconazole, and voriconazole are not available. We established ECVs for these species and agents based on wild-type (WT) MIC distributions. A total of 2,985 to

  20. Trichosporon faecale invasive infection in a patient with severe aplastic anemia: Efficacy of voriconazole and liposomal amphotericin B before neutrophil recovery

    Directory of Open Access Journals (Sweden)

    Baptiste Pérard

    2015-09-01

    Full Text Available We report a case of a 51-year old man with a severe aplastic anemia who developed an invasive trichosporonosis to Trichosporon faecale with fungemia and skin lesions during severe neutropenia. The treatment was successful before neutrophil recovery with a combination of voriconazole and liposomal amphotericin B.

  1. Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model

    NARCIS (Netherlands)

    Siopi, M.; Mavridou, E.; Mouton, J.W.; Verweij, P.E.; Zerva, L.; Meletiadis, J.

    2014-01-01

    BACKGROUND: Although voriconazole reached the bedside 10 years ago and became the standard care in the treatment of invasive aspergillosis, reliable clinical breakpoints are still in high demand. Moreover, this has increased due to the recent emergence of azole resistance. METHODS: Four clinical wil

  2. Multicenter Comparison of the VITEK 2 Antifungal Susceptibility Test with the CLSI Broth Microdilution Reference Method for Testing Amphotericin B, Flucytosine, and Voriconazole against Candida spp.▿

    Science.gov (United States)

    Pfaller, M. A.; Diekema, D. J.; Procop, G. W.; Rinaldi, M. G.

    2007-01-01

    A fully automated commercial antifungal susceptibility test system (VITEK 2; bioMérieux, Inc., Hazelwood, MO) was compared in three different laboratories with the Clinical and Laboratory Standards Institute (formerly the NCCLS) reference broth microdilution method (BMD) by testing 2 quality control strains, 10 reproducibility strains, and 426 isolates of Candida spp. against amphotericin B, flucytosine, and voriconazole. Reference BMD MIC endpoints were established after 24 and 48 h of incubation. VITEK 2 system MIC endpoints were determined spectrophotometrically after 9.1 to 27.1 h of incubation (mean, 12 to 14 h). Excellent essential agreement (within 2 dilutions) between the VITEK 2 system and the 24- and 48-h BMD MICs was observed for all three antifungal agents: amphotericin B, 99.1% and 97%, respectively; flucytosine, 99.1% and 98.8%, respectively; and voriconazole, 96.7% and 96%, respectively. Both intra- and interlaboratory agreements were >98% for all three drugs. The overall categorical agreements between the VITEK 2 system and BMD for flucytosine and voriconazole were 98.1 to 98.6% at the 24-h BMD time point and 96.9 to 97.4% at the 48-h BMD time point. The VITEK 2 system reliably detected flucytosine and voriconazole resistance among Candida spp. and demonstrated excellent quantitative and qualitative agreement with the reference BMD method. PMID:17913927

  3. Eating for Your Eyes

    Science.gov (United States)

    Stastny, Sherri Nordstrom; Garden-Robinson, Julie

    2011-01-01

    An educational program targeting older adults was developed to increase knowledge regarding nutrition and eye health. With age, the chance for eye disease increases, so prevention is critical. The Eating for Your Eyes program has promoted behavior changes regarding eye health among the participants. This program is easily replicated and use is…

  4. Eye Injuries (For Parents)

    Science.gov (United States)

    ... the eye nausea or vomiting after an eye injury Think Prevention! Kids who play sports should wear protective goggles or unbreakable glasses as needed. Keep chemicals and other potentially dangerous objects out of the reach of children. Reviewed by: Steven Dowshen, ... (Conjunctivitis) Eyes Corneal Abrasions Styes Activity: Eyes ...

  5. In vitro fluconazole and voriconazole susceptibilities of Candida bloodstream isolates in Korea: use of the CLSI and EUCAST epidemiological cutoff values.

    Science.gov (United States)

    Jang, Min Joong; Shin, Jong Hee; Lee, Wee Gyo; Kim, Mi-Na; Lee, Kyungwon; Lee, Hye Soo; Lee, Mi-Kyung; Chang, Chulhun L; Jang, Hee-Chang; Song, Eun Song; Kim, Soo Hyun; Shin, Myung-Geun; Suh, Soon-Pal; Ryang, Dong-Wook

    2013-05-01

    At present, the clinical breakpoints (CBPs) of both fluconazole and voriconazole are available only for 3 common Candida species in the Clinical and Laboratory Standards Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing (EUCAST) methods. Epidemiological cutoff values (ECVs) were recently applied to both methods to detect the emergence of acquired resistance (i.e., non-wild-type isolates) among 5 common Candida species. We performed a nationwide study to determine the fluconazole and voriconazole susceptibility of Candida bloodstream isolates (BSIs) using both the CLSI and EUCAST methods. A total of 423 BSIs of 5 Candida species were collected from 8 hospitals. The azole susceptibilities were assessed on the basis of the species-specific CBPs and ECVs. Of the 341 BSIs of 3 common Candida species (i.e., C. albicans, C. tropicalis, and C. parapsilosis), 0.3% and 0.9%, 0.0% and 1.5% of isolates were categorized as fluconazole and voriconazole resistant according to the CLSI and EUCAST CBPs, respectively. Of 423 total BSIs, 1.4% and 2.6% had fluconazole minimum inhibitory concentrations (MICs) exceeding the ECVs according to the CLSI and EUCAST, respectively; 1.0% and 2.1% had voriconazole MICs exceeding the ECVs according to the CLSI and EUCAST, respectively. Categorical agreement between the methods using ECVs was 98.3% for fluconazole and 98.3% for voriconazole. The EUCAST and CLSI methods using ECVs provide highly concordant results. Moreover, non-wild-type isolates with possibly acquired azole resistance were rare among the BSIs of 5 common Candida species in Korea.

  6. Drop Spreading with Random Viscosity

    Science.gov (United States)

    Xu, Feng; Jensen, Oliver

    2016-11-01

    Airway mucus acts as a barrier to protect the lung. However as a biological material, its physical properties are known imperfectly and can be spatially heterogeneous. In this study we assess the impact of these uncertainties on the rate of spreading of a drop (representing an inhaled aerosol) over a mucus film. We model the film as Newtonian, having a viscosity that depends linearly on the concentration of a passive solute (a crude proxy for mucin proteins). Given an initial random solute (and hence viscosity) distribution, described as a Gaussian random field with a given correlation structure, we seek to quantify the uncertainties in outcomes as the drop spreads. Using lubrication theory, we describe the spreading of the drop in terms of a system of coupled nonlinear PDEs governing the evolution of film height and the vertically-averaged solute concentration. We perform Monte Carlo simulations to predict the variability in the drop centre location and width (1D) or area (2D). We show how simulation results are well described (at much lower computational cost) by a low-order model using a weak disorder expansion. Our results show for example how variability in the drop location is a non-monotonic function of the solute correlation length increases. Engineering and Physical Sciences Research Council.

  7. Broadly Applicable Nanowafer Drug Delivery System for Treating Eye Injuries

    Science.gov (United States)

    2016-09-01

    255. Pixels within the threshold region were then counted using the Measure subroutine for all planes in the image stack to record the crystal volume...collected at hourly time intervals. Tear samples from Cys-NW treated eyes contained measurable levels of Cys for up to 2 h and was not detectable in the third...resulting in extremely low bioavailability. For this reason, topical Cys eye drops must be administered several times in a day to achieve a measurable

  8. Drop stability in wind: theory

    Science.gov (United States)

    Lee, Sungyon

    2015-11-01

    Water drops may remain pinned on a solid substrate against external forcing due to contact angle hysteresis. Schmucker and White investigated this phenomenon experimentally in a high Reynolds number regime, by measuring the critical wind velocity at which partially wetting water drops depin inside a wind tunnel. Due to the unsteady turbulent boundary layer, droplets are observed to undergo vortex-shedding induced oscillations. By contrast, the overall elongation of the drop prior to depinning occurs on a much slower timescale with self-similar droplet shapes at the onset. Based on these observations, a simple, quasi-static model of depinning droplet is developed by implementing the phenomenological description of the boundary layer. The resultant model successfully captures the critical onset of droplet motion and is the first of on-going studies that connect the classical boundary layer theory with droplet dynamics.

  9. Dry eye syndrome among computer users

    Science.gov (United States)

    Gajta, Aurora; Turkoanje, Daniela; Malaescu, Iosif; Marin, Catalin-Nicolae; Koos, Marie-Jeanne; Jelicic, Biljana; Milutinovic, Vuk

    2015-12-01

    Dry eye syndrome is characterized by eye irritation due to changes of the tear film. Symptoms include itching, foreign body sensations, mucous discharge and transitory vision blurring. Less occurring symptoms include photophobia and eye tiredness. Aim of the work was to determine the quality of the tear film and ocular dryness potential risk in persons who spend more than 8 hours using computers and possible correlations between severity of symptoms (dry eyes symptoms anamnesis) and clinical signs assessed by: Schirmer test I, TBUT (Tears break-up time), TFT (Tear ferning test). The results show that subjects using computer have significantly shorter TBUT (less than 5 s for 56 % of subjects and less than 10 s for 37 % of subjects), TFT type II/III in 50 % of subjects and type III 31% of subjects was found when compared to computer non users (TFT type I and II was present in 85,71% of subjects). Visual display terminal use, more than 8 hours daily, has been identified as a significant risk factor for dry eye. It's been advised to all persons who spend substantial time using computers to use artificial tears drops in order to minimize the symptoms of dry eyes syndrome and prevents serious complications.

  10. Interfacial Instabilities in Evaporating Drops

    Science.gov (United States)

    Moffat, Ross; Sefiane, Khellil; Matar, Omar

    2007-11-01

    We study the effect of substrate thermal properties on the evaporation of sessile drops of various liquids. An infra-red imaging technique was used to record the interfacial temperature. This technique illustrates the non-uniformity in interfacial temperature distribution that characterises the evaporation process. Our results also demonstrate that the evaporation of methanol droplets is accompanied by the formation of wave-trains in the interfacial temperature field; similar patterns, however, were not observed in the case of water droplets. More complex patterns are observed for FC-72 refrigerant drops. The effect of substrate thermal conductivity on the structure of the complex pattern formation is also elucidated.

  11. Two Different Approaches for Oral Administration of Voriconazole Loaded Formulations: Electrospun Fibers versus β-Cyclodextrin Complexes

    Directory of Open Access Journals (Sweden)

    Panoraia I. Siafaka

    2016-02-01

    Full Text Available In this work, a comparison between two different preparation methods for the improvement of dissolution rate of an antifungal agent is presented. Poly(ε-caprolactone (PCL electrospun fibers and β-cyclodextrin (β-CD complexes, which were produced via an electrospinning process and an inclusion complexation method, respectively, were addressed for the treatment of fungal infections. Voriconazole (VRCZ drug was selected as a model drug. PCL nanofibers were characterized on the basis of morphology while phase solubility studies for β-CDs complexes were performed. Various concentrations (5, 10, 15 and 20 wt % of VRCZ were loaded to PCL fibers and β-CD inclusions to study the in vitro release profile as well as in vitro antifungal activity. The results clearly indicated that all formulations showed an improved VRCZ solubility and can inhibit fungi proliferation.

  12. Two Different Approaches for Oral Administration of Voriconazole Loaded Formulations: Electrospun Fibers versus β-Cyclodextrin Complexes.

    Science.gov (United States)

    Siafaka, Panoraia I; Üstündağ Okur, Neslihan; Mone, Mariza; Giannakopoulou, Spyridoula; Er, Sevda; Pavlidou, Eleni; Karavas, Evangelos; Bikiaris, Dimitrios N

    2016-02-25

    In this work, a comparison between two different preparation methods for the improvement of dissolution rate of an antifungal agent is presented. Poly(ε-caprolactone) (PCL) electrospun fibers and β-cyclodextrin (β-CD) complexes, which were produced via an electrospinning process and an inclusion complexation method, respectively, were addressed for the treatment of fungal infections. Voriconazole (VRCZ) drug was selected as a model drug. PCL nanofibers were characterized on the basis of morphology while phase solubility studies for β-CDs complexes were performed. Various concentrations (5, 10, 15 and 20 wt %) of VRCZ were loaded to PCL fibers and β-CD inclusions to study the in vitro release profile as well as in vitro antifungal activity. The results clearly indicated that all formulations showed an improved VRCZ solubility and can inhibit fungi proliferation.

  13. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates

    Directory of Open Access Journals (Sweden)

    Débora Alves Nunes Mario

    2012-05-01

    Full Text Available The extensive use of azole antifungal agents has promoted the resistance of Candida spp to these drugs. Candida glabrata is a problematic yeast because it presents a high degree of primary or secondary resistance to fluconazole. In Brazil, C. glabrata has been less studied than other species. In this paper, we compared the activity of three major classes of antifungal agents (azoles, echinocandins and polyenes against fluconazole-susceptible (FS and fluconazole-resistant (FR C. glabrata strains. Cross-resistance between fluconazole and voriconazole was remarkable. Among the antifungal agents, the echinocandins were the most effective against FS and FR C. glabrata and micafungin showed the lowest minimal inhibitory concentrations.

  14. In vitro resistance of clinical Fusarium species to amphotericin B and voriconazole using the EUCAST antifungal susceptibility method.

    Science.gov (United States)

    Taj-Aldeen, Saad J; Salah, Husam; Al-Hatmi, Abdullah M S; Hamed, Manal; Theelen, Bart; van Diepeningen, Anne D; Boekhout, Teun; Lass-Flörl, Cornelia

    2016-08-01

    Susceptibility testing using the EUCAST-AFST method against 39 clinical Fusarium strains consecutively collected from local and invasive infections during the last 10years assessed the in vitro activities of amphotericin B (AmB) and triazole antifungal agents. In addition, the susceptibility pattern of 12 reference strains from the CBS-KNAW Fungal Biodiversity Centre (CBS) was evaluated. In particular Fusarium petroliphilum and F. solani sensu lato were involved in disseminated infections and known for treatment failure. AmB displayed the lowest MICs followed by voriconazole VRC, posaconazole (POC). Itraconazole (ITC) showed high MIC values, displaying in vitro resistance. Clinical isolates were significantly (P Fusarium and that susceptibility testing is important and may improve the prognosis of these infections. Copyright © 2016 Elsevier Inc. All rights reserved.

  15. Fluid flow in drying drops

    NARCIS (Netherlands)

    Gelderblom, H.

    2013-01-01

    When a suspension drop evaporates, it leaves behind a drying stain. Examples of these drying stains encountered in daily life are coffee or tea stains on a table top, mineral rings on glassware that comes out of the dishwasher, or the salt deposits on the streets in winter. Drying stains are also pr

  16. New identities for sessile drops

    CERN Document Server

    Hajirahimi, Maryam; Fatollahi, Amir H

    2014-01-01

    A new set of mathematical identities is presented for axi-symmetric sessile drops on flat and curved substrates. The geometrical parameters, including the apex curvature and height, and the contact radius, are related by the identities. The validity of the identities are checked by various numerical solutions both for flat and curved substrates.

  17. Egg Drop: An Invention Workshop

    Science.gov (United States)

    McCormack, Alan J.

    1973-01-01

    Describes an activity designed to stimulate elementary and junior high students to become actively engaged in thinking creatively rather than only analytically, convergently, or repetitively. The activity requires students to devise means of dropping an egg from a height without it breaking. (JR)

  18. Evaporating Drops of Alkane Mixtures

    OpenAIRE

    Guéna, Geoffroy; Poulard, Christophe; Cazabat, Anne-Marie

    2005-01-01

    22 pages 9 figures; Alkane mixtures are model systems where the influence of surface tension gradients during the spreading and the evaporation of wetting drops can be easily studied. The surface tension gradients are mainly induced by concentration gradients, mass diffusion being a stabilising process. Depending on the relative concentration of the mixture, a rich pattern of behaviours is obtained.

  19. ``Quantum'' interference with bouncing drops

    Science.gov (United States)

    Bohr, Tomas; Andersen, Anders; Madsen, Jacob; Reichelt, Christian; Lautrup, Benny; Ellegaard, Clive; Levinsen, Mogens

    2013-11-01

    In a series of recent papers (most recently) Yves Couder and collaborators have explored the dynamics of walking drops on the surface of a vibrated bath of silicon oil and have demonstrated a close analogy to quantum phenomena. The bouncing drop together with the surface wave that it excites seems to be very similar to the pilot wave envisaged by de Broglie for quantum particles. In particular, have studied a double slit experiment with walking drops, where an interference pattern identical to the quantum version is found even though it is possible to follow the orbits of the drops and unambigously determine which slit it goes through, something which in quantum mechanics would be ruled out by the Heisenberg uncertainly relations. We have repeated the experiment and present a somewhat more complicated picture. Theoretically, we study a Schrödinger equation with a source term originating from a localised ``particle'' being simultaneously guided by the wave. We present simple solutions to such a field theory and discuss the fundamental difficulties met by such a theory in order to comply with quantum mechanics.

  20. Drops, contact lines, and electrowetting

    NARCIS (Netherlands)

    Mannetje, 't D.J.C.M.

    2013-01-01

    In this work, we study the behaviour of drops and contact lines under the influence of electric fields, and how these can answer fundamental and industrial questions. Our focus is on studying the varying balance of the electric field, hysteresis forces and inertia as the speed of a contact line chan

  1. Evaporating Drops of Alkane Mixtures

    CERN Document Server

    Gu'ena, G; Poulard, C; Cazabat, Anne-Marie; Gu\\'{e}na, Geoffroy; Poulard, Christophe

    2005-01-01

    Alkane mixtures are model systems where the influence of surface tension gradients during the spreading and the evaporation of wetting drops can be easily studied. The surface tension gradients are mainly induced by concentration gradients, mass diffusion being a stabilising process. Depending on the relative concentration of the mixture, a rich pattern of behaviours is obtained.

  2. Drops spreading on flexible fibers

    Science.gov (United States)

    Somszor, Katarzyna; Boulogne, François; Sauret, Alban; Dressaire, Emilie; Stone, Howard

    2015-11-01

    Fibrous media are encountered in many engineered systems such as textile, paper and insulating materials. In most of these materials, fibers are randomly oriented and form a complex network in which drops of wetting liquid tend to accumulate at the nodes of the network. Here we investigate the role of the fiber flexibility on the spreading of a small volume of liquid on a pair of crossed flexible fibers. A drop of silicone oil is dispensed at the point of contact of the fibers and we characterize the liquid morphologies as we vary the volume of liquid, the angle between the fibers, and the length and bending modulus of the fibers. Drop morphologies previously reported for rigid fibers, i.e. a drop, a column and a mixed morphology, are also observed on flexible fibers with modified domains of existence. Moreover, at small inclination angles of the fibers, a new behavior is observed: the fibers bend and collapse. Depending on the volume, the liquid can adopt a column or a mixed morphology on the collapsed fibers. We rationalize our observations with a model based on energetic considerations. Our study suggests that the fiber flexibility adds a rich variety of behaviors that can be crucial for industrial applications.

  3. Pressure drop in contraction flow

    DEFF Research Database (Denmark)

    Rasmussen, Henrik Koblitz

    This note is a supplement to Dynamic of Polymeric Liquids (DPL) page 178. DPL gives an equation for the pressure drop in a tapered (and circular) contraction, valid only at low angles. Here the general definition of contraction flow (the Bagley correction) and a more general method to find...

  4. Perceptions of eye health in schools in Pakistan

    Directory of Open Access Journals (Sweden)

    Qureshi Mohammad

    2006-03-01

    Full Text Available Abstract Background Research exploring children's and their teachers' perceptions of eye health is lacking. This paper reports for the first time on perceptions of primary schoolchildren and their teachers of healthy and diseased eyes, things that keep eyes healthy and damage them, and what actions to be taken in case of an eye injury. Methods Using draw and write technique, 160 boys and girls (9–12 years old attending four primary schools in Abbottabad district, northern Pakistan, were invited to draw pictures in response to a set of semi-structured questions and then label them. Sixteen teachers who were currently teaching the selected students were interviewed one-on-one. Results Analysis of text accompanying 800 drawings and of the interview scripts revealed that most children and teachers perceived healthy eyes to be those which could see well, and diseased eyes to be those which have redness, watering, dirty discharge, pain, and itching; or those which have "weak eyesight" and blindness. Among things that students and teachers thought damage the eyes included sun, television, and sharp pointed objects, particularly pencils. Teachers noted that children with eye problems "have difficulty seeing the blackboard well", "screw up their eyes", and "hold their books too close". Conclusion We conclude that schoolchildren and their teachers had a good knowledge of eye health, but many of them had serious misconceptions e.g., use of kohl, medicines and eye drops keeps eyes healthy. Kohl is an important source of lead and can reduce children's intelligence even at low blood levels. Health education in schools must take into account children's existing knowledge of and misconceptions about various aspects of eye health. Such steps if taken could improve the relevance of eye health education to schoolchildren.

  5. Pars Plana Vitrectomy and Intravitreal Phacoemulsification for Dropped Nuclei

    Directory of Open Access Journals (Sweden)

    Khalil Ghasemi Falavarjani

    2012-01-01

    Full Text Available Purpose: To report the outcomes of pars plana vitrectomy (PPV and intravitreal phacoemulsification in patients with dropped nuclei/nuclear fragments following complicated cataract surgery. Methods: In this retrospective case series, charts of patients who had undergone PPV and intravitreal phacoemulsification for removal of dislocated nuclei/lens fragments were reviewed. After standard PPV, a conventional phacoemulsification probe with an amputated sleeve was used for grasping and emulsifying the nucleus/nuclear fragments in mid/anterior vitreous cavity. Pre- and postoperative visual acuity, and intra- and postoperative complications were recorded. Results: A total of 22 patients with mean age of 71.1΁8.2 years were studied. Mean interval between complicated cataract surgery and PPV was 26.6΁36.5 (range: 0-120 days. Patients were followed for a mean of 105.5΁57.5 days. Preoperatively, best corrected visual acuity was 2.4΁0.6 logMAR which was improved to 1.4΁0.6 logMAR at final follow-up (P<0.001. Intraoperative complications included iatrogenic peripheral retinal breaks in three eyes. Postoperative complications consisted of epiretinal membrane formation in one eye, hypotony in one eye, and medically-controlled glaucoma in 2 eyes. Conclusion: In this series, PPV and intravitreal phacoemulsification using a conventional phacoemulsification probe in patients with dropped nuclei/nuclear fragments following complicated cataract surgery resulted in visual improvement without any complications directly attributable to the probe.

  6. What Is Dry Eye?

    Medline Plus

    Full Text Available ... information about eye health and preserving your vision. Privacy Policy Related New Dry Eye Treatment is a ... the Academy Financial Relationships with Industry Medical Disclaimer Privacy Policy Terms of Service For Advertisers For Media ...

  7. What Is Dry Eye?

    Medline Plus

    Full Text Available ... is also when your eyes do not make the right type of tears. How do tears work? ... you blink, a film of tears spreads over the eye. This keeps the eye’s surface smooth and ...

  8. What Is Dry Eye?

    Medline Plus

    Full Text Available ... tissue covering the white of your eye and inside your eyelids. Normally, our eyes constantly make tears ... Multimedia Public & Patients: Contact Us About the Academy Jobs at the Academy Financial Relationships with Industry Medical ...

  9. What Is Dry Eye?

    Medline Plus

    Full Text Available ... Pediatric Ophthalmology Education Center Oculofacial Plastic Surgery Center Laser Surgery Education Center Redmond Ethics Center Global Ophthalmology Guide Eye ... What Is Dry Eye? Leer en Español: ¿Qué ...

  10. TUBERCULOSIS AND THE EYE

    African Journals Online (AJOL)

    Key words: Mycobacteria; Tuberculosis; Eye ... of tuberculous eye disease or ocular tuberculosis has also been raised. Ocular ... patients with ocular complaints, compiled in an area ..... tuberculomas are usually solitary and may measure up.

  11. About the Eye

    Medline Plus

    Full Text Available ... you see. Check out the diagrams below to learn about each part of your eye and what ... the optic nerve to the brain. Watch now! Learn how the different parts of your eye work ...

  12. About the Eye

    Medline Plus

    Full Text Available ... The Visual System Your Eyes’ Natural Defenses Eye Health and Safety First Aid ... Your eyes are made up of many different parts that work together to help you see. Check out the ...

  13. What Is Dry Eye?

    Medline Plus

    Full Text Available ... about eye health and preserving your vision. Privacy Policy Related New Dry Eye Treatment is a Tear- ... Academy Financial Relationships with Industry Medical Disclaimer Privacy Policy Terms of Service For Advertisers For Media Ophthalmology ...

  14. Preventing eye injuries

    Directory of Open Access Journals (Sweden)

    Daksha Patel

    2016-01-01

    Full Text Available The main challenge in developing a strategy to prevent eye injuries is that there are so many different causes and situations that can lead to eye injuries, each requiring a different approach.

  15. Common Eye Disorders

    Science.gov (United States)

    ... www.cdc.gov/emailupdates/">What's this? Submit Button Common Eye Disorders Recommend on Facebook Tweet Share Compartir ... macular degeneration, cataract, diabetic retinopathy, and glaucoma. Other common eye disorders include amblyopia and strabismus. For a ...

  16. Prevention and treatment of transient dry eye following excimer laser surgery

    Directory of Open Access Journals (Sweden)

    V. V. Pogorelovа

    2015-01-01

    Full Text Available To compare dry eye symptoms after LASIK with mechanical keratome-created flaps and femtosecond laser keratome-created flaps as well as to analyze the efficacy of Systane® Ultra Monodose used to prevent and to treat transient dry eye after excimer laser surgery. Methods: 98 patients (194 eyes with myopia and compound myopic astigmatism who underwent excimer laser surgery were included in the study. In group 1 patients with pre-op dry eye, femtosecond laser-assisted LASIK was performed, Systane® Ultra Monodose was prescribed postoperatively. In group 2 patients with pre-op dry eye, LASIK was performed using mechanical microkeratome, Systane® Ultra Monodose was prescribed postoperatively. In group 3 patients without pre-op dry eye, LASIK was performed using mechanical microkeratome, standard anti-inflammatory therapy without any lubricant eye drops was prescribed. Patients were followed up for 60 days. Results: It was demonstrated that excimer laser surgery provokes transient dry eye in all patients, therefore, artificial tears are required for 2 months and more after the surgery. Post-operative lubricant eye drops use improves tear film stability, tear production, tear osmolarity, and objective signs of dry eye. Femtosecond laser decreases clinical and functional symptoms of transient dry eye as compared with mechanical microkeratome and provides more rapid visual recovery. Conclusion: Systane® Ultra Monodose has both high efficiency and good tolerability. It can be recommended for the prevention and treatment of dry eye following excimer laser surgery.

  17. Prevention and treatment of transient dry eye following excimer laser surgery

    Directory of Open Access Journals (Sweden)

    V. V. Pogorelovа

    2014-01-01

    Full Text Available To compare dry eye symptoms after LASIK with mechanical keratome-created flaps and femtosecond laser keratome-created flaps as well as to analyze the efficacy of Systane® Ultra Monodose used to prevent and to treat transient dry eye after excimer laser surgery. Methods: 98 patients (194 eyes with myopia and compound myopic astigmatism who underwent excimer laser surgery were included in the study. In group 1 patients with pre-op dry eye, femtosecond laser-assisted LASIK was performed, Systane® Ultra Monodose was prescribed postoperatively. In group 2 patients with pre-op dry eye, LASIK was performed using mechanical microkeratome, Systane® Ultra Monodose was prescribed postoperatively. In group 3 patients without pre-op dry eye, LASIK was performed using mechanical microkeratome, standard anti-inflammatory therapy without any lubricant eye drops was prescribed. Patients were followed up for 60 days. Results: It was demonstrated that excimer laser surgery provokes transient dry eye in all patients, therefore, artificial tears are required for 2 months and more after the surgery. Post-operative lubricant eye drops use improves tear film stability, tear production, tear osmolarity, and objective signs of dry eye. Femtosecond laser decreases clinical and functional symptoms of transient dry eye as compared with mechanical microkeratome and provides more rapid visual recovery. Conclusion: Systane® Ultra Monodose has both high efficiency and good tolerability. It can be recommended for the prevention and treatment of dry eye following excimer laser surgery.

  18. The all seeing eye?

    NARCIS (Netherlands)

    Koenderink, Jan J.

    2014-01-01

    The All Seeing Eye? Did you know that you are probably a believer in the All Seeing Eye? The odds are that I’m right—why? Well, the bulk of mainstream vision literature blindly relies on the All Seeing Eye. It is written all over papers, albeit between the lines. Understandably so, for scientists re

  19. About the Eye

    Medline Plus

    Full Text Available ... other programs with respect to blinding eye diseases, visual disorders, mechanisms of visual function, preservation of sight, and the special health ... Eye Ask a Scientist Video Series Glossary The Visual System Your Eyes’ Natural Defenses Eye Health and ...

  20. What Is Dry Eye?

    Medline Plus

    Full Text Available ... Tips & Prevention News Ask an Ophthalmologist Patient Stories Español Eye Health / Eye Health A-Z Dry Eye ... when I sleep? Feb 10, 2016 Leer en Español: ¿Qué Es el Ojo Seco? Find an Ophthalmologist ...

  1. About the Eye

    Medline Plus

    Full Text Available ... other programs with respect to blinding eye diseases, visual disorders, mechanisms of visual function, preservation of sight, and the special health ... Eye Ask a Scientist Video Series Glossary The Visual System Your Eyes’ Natural Defenses Eye Health and ...

  2. The all seeing eye?

    NARCIS (Netherlands)

    Koenderink, Jan J.|info:eu-repo/dai/nl/070864543

    2014-01-01

    The All Seeing Eye? Did you know that you are probably a believer in the All Seeing Eye? The odds are that I’m right—why? Well, the bulk of mainstream vision literature blindly relies on the All Seeing Eye. It is written all over papers, albeit between the lines. Understandably so, for scientists

  3. Non-coalescence of oppositely charged drops

    CERN Document Server

    Ristenpart, W D; Belmonte, A; Dollar, F; Stone, H A

    2009-01-01

    Oppositely charged drops have long been assumed to experience an attractive force that favors their coalescence. In this fluid dynamics video we demonstrate the existence of a critical field strength above which oppositely charged drops do not coalesce. We observe that appropriately positioned and oppositely charged drops migrate towards one another in an applied electric field; but whereas the drops coalesce as expected at low field strengths, they are repelled from one another after contact at higher field strengths. Qualitatively, the drops appear to `bounce' off one another. We directly image the transient formation of a meniscus bridge between the bouncing drops.

  4. How to freeze drop oscillations with powders

    Science.gov (United States)

    Marston, Jeremy; Zhu, Ying; Vakarelski, Ivan; Thoroddsen, Sigurdur

    2012-11-01

    We present experiments that show when a water drop impacts onto a bed of fine, hydrophobic powder, the final form of the drop can be very different from the spherical form with which it impacts. For all drop impact speeds, the drop rebounds due to the hydrophobic nature of the powder. However, we observe that above a critical impact speed, the drop undergoes a permanent deformation to a highly non-spherical shape with a complete coverage of powder, thus creating a deformed liquid marble. This powder coating acts to freeze the drop oscillations during rebound.

  5. Medicare Benefits and Your Eyes

    Science.gov (United States)

    ... Subscribe to eNews Close Donate Medicare Benefits & Your Eyes Eye Health is Important! As you age, your risk ... that you need. Ask about eye exams! Routine Eye Exams Medicare does not generally cover the costs ...

  6. Prevent Eye Injuries from Fireworks

    Science.gov (United States)

    ... Financial Assistance Information Vision Screening and Eye Exams Zika Virus and Vision Eye Problems Eye Problems Amblyopia ( ... Eye Health Report Reports and External Resources The Cost of Vision Problems The Future of Vision Vision ...

  7. Dancing drops over vibrating substrates

    Science.gov (United States)

    Borcia, Rodica; Borcia, Ion Dan; Helbig, Markus; Meier, Martin; Egbers, Christoph; Bestehorn, Michael

    2017-04-01

    We study the motion of a liquid drop on a solid plate simultaneously submitted to horizontal and vertical harmonic vibrations. The investigation is done via a phase field model earlier developed for describing static and dynamic contact angles. The density field is nearly constant in every bulk region (ρ = 1 in the liquid phase, ρ ≈ 0 in the vapor phase) and varies continuously from one phase to the other with a rapid but smooth variation across the interfaces. Complicated explicit boundary conditions along the interface are avoided and captured implicitly by gradient terms of ρ in the hydrodynamic basic equations. The contact angle θ is controlled through the density at the solid substrate ρ S , a free parameter varying between 0 and 1 [R. Borcia, I.D. Borcia, M. Bestehorn, Phys. Rev. E 78, 066307 (2008)]. We emphasize the swaying and the spreading modes, earlier theoretically identified by Benilov and Billingham via a shallow-water model for drops climbing uphill along an inclined plane oscillating vertically [E.S. Benilov, J. Billingham, J. Fluid Mech. 674, 93 (2011)]. The numerical phase field simulations will be completed by experiments. Some ways to prevent the release of the dancing drops along a hydrophobic surface into the gas atmosphere are also discussed in this paper.

  8. Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.

    Science.gov (United States)

    Minea, B; Nastasa, V; Moraru, R F; Kolecka, A; Flonta, M M; Marincu, I; Man, A; Toma, F; Lupse, M; Doroftei, B; Marangoci, N; Pinteala, M; Boekhout, T; Mares, M

    2015-02-01

    This is the first multi-centre study regarding yeast infections in Romania. The aim was to determine the aetiological spectrum and susceptibility pattern to fluconazole, voriconazole and the novel compound MXP-4509. The 551 isolates were identified using routine laboratory methods, matrix-assisted laser desorption ionisation time-of-flight mass spectrometry (MALDI-TOF MS) and DNA sequence analysis. Susceptibility testing was performed using the European Committee for Antimicrobial Susceptibility Testing (EUCAST) method and breakpoints. The yeasts originated from superficial infections (SUP, 51.5 %), bloodstream infections (BSI, 31.6 %) and deep-seated infections (DEEP, 16.9 %), from patients of all ages. Nine genera and 30 species were identified. The 20 Candida species accounted for 94.6 % of all isolates. C. albicans was the overall leading pathogen (50.5 %). Lodderomyces elongisporus is reported for the first time as a fungaemia cause in Europe. C. glabrata and Saccharomyces cerevisiae, as well as the non-Candida spp. and non-albicans Candida spp. groups, showed decreased fluconazole susceptibility (fluconazole resistance was 10.2 %. C. krusei accounted for 27 of the 56 fluconazole-resistant isolates. The overall voriconazole resistance was 2.5 % and was due mainly to C. glabrata and C. tropicalis isolates. Fluconazole resistance rates for the three categories of infection were similar to the overall value; voriconazole resistance rates differed: 4 % for BSI, 3.2 % for DEEP and 1.4 % for SUP. The antifungal activity of MXP-4509 was superior to voriconazole against C. glabrata and many fluconazole-resistant isolates. There was a large percentage of non-albicans Candida isolates. A large part of the high fluconazole resistance was not acquired but intrinsic, resulting from the high percentage of C. krusei.

  9. EYE GAZE TRACKING

    DEFF Research Database (Denmark)

    2017-01-01

    This invention relates to a method of performing eye gaze tracking of at least one eye of a user, by determining the position of the center of the eye, said method comprising the steps of: detecting the position of at least three reflections on said eye, transforming said positions to spanning...... a normalized coordinate system spanning a frame of reference, wherein said transformation is performed based on a bilinear transformation or a non linear transformation e.g. a möbius transformation or a homographic transformation, detecting the position of said center of the eye relative to the position...... of said reflections and transforming this position to said normalized coordinate system, tracking the eye gaze by tracking the movement of said eye in said normalized coordinate system. Thereby calibration of a camera, such as knowledge of the exact position and zoom level of the camera, is avoided...

  10. Star-shaped Oscillations of Leidenfrost Drops

    CERN Document Server

    Ma, Xiaolei; Burton, Justin C

    2016-01-01

    We experimentally investigate the self-organized, star-shaped oscillations of Leidenfrost drops. The drops levitate on a cushion of evaporated vapor over a heated, curved surface. We observe modes with $n = 2-13$ lobes around the drop periphery. We find that both the wavelength and frequency of the oscillations depend only on the capillary length of the liquid, and are independent of the drop radius and substrate temperature. However, the number of observed modes depend sensitively on the liquid viscosity. The dominant frequency of pressure variations under the drop is approximately twice that the drop oscillation frequency, consistent with a parametric forcing mechanism. Our results suggest that the star-shaped oscillations are hydrodynamic in origin, and are driven by capillary waves beneath the drop. The exact mechanism by which the vapor flow initiates the capillary waves is likely related to static "brim waves" in levitated, viscous drops.

  11. Critical point wetting drop tower experiment

    Science.gov (United States)

    Kaukler, W. F.; Tcherneshoff, L. M.; Straits, S. R.

    1984-01-01

    Preliminary results for the Critical Point Wetting CPW Drop Tower Experiment are produced with immiscible systems. Much of the observed phenomena conformed to the anticipated behavior. More drops will be needed to test the CPW theory with these immiscible systems.

  12. Multilaboratory Study of Epidemiological Cutoff Values for Detection of Resistance in Eight Candida Species to Fluconazole, Posaconazole, and Voriconazole

    Science.gov (United States)

    Pfaller, M. A.; Bustamante, B.; Canton, E.; Fothergill, A.; Fuller, J.; Gonzalez, G. M.; Lass-Flörl, C.; Lockhart, S. R.; Martin-Mazuelos, E.; Meis, J. F.; Melhem, M. S. C.; Ostrosky-Zeichner, L.; Pelaez, T.; Szeszs, M. W.; St-Germain, G.; Bonfietti, L. X.; Guarro, J.; Turnidge, J.

    2014-01-01

    Although epidemiological cutoff values (ECVs) have been established for Candida spp. and the triazoles, they are based on MIC data from a single laboratory. We have established ECVs for eight Candida species and fluconazole, posaconazole, and voriconazole based on wild-type (WT) MIC distributions for isolates of C. albicans (n = 11,241 isolates), C. glabrata (7,538), C. parapsilosis (6,023), C. tropicalis (3,748), C. krusei (1,073), C. lusitaniae (574), C. guilliermondii (373), and C. dubliniensis (162). The 24-h CLSI broth microdilution MICs were collated from multiple laboratories (in Canada, Brazil, Europe, Mexico, Peru, and the United States). The ECVs for distributions originating from ≥6 laboratories, which included ≥95% of the modeled WT population, for fluconazole, posaconazole, and voriconazole were, respectively, 0.5, 0.06 and 0.03 μg/ml for C. albicans, 0.5, 0.25, and 0.03 μg/ml for C. dubliniensis, 8, 1, and 0.25 μg/ml for C. glabrata, 8, 0.5, and 0.12 μg/ml for C. guilliermondii, 32, 0.5, and 0.25 μg/ml for C. krusei, 1, 0.06, and 0.06 μg/ml for C. lusitaniae, 1, 0.25, and 0.03 μg/ml for C. parapsilosis, and 1, 0.12, and 0.06 μg/ml for C. tropicalis. The low number of MICs (<100) for other less prevalent species (C. famata, C. kefyr, C. orthopsilosis, C. rugosa) precluded ECV definition, but their MIC distributions are documented. Evaluation of our ECVs for some species/agent combinations using published individual MICs for 136 isolates (harboring mutations in or upregulation of ERG11, MDR1, CDR1, or CDR2) and 64 WT isolates indicated that our ECVs may be useful in distinguishing WT from non-WT isolates. PMID:24419346

  13. Electrohydrodynamics of a particle-covered drop

    Science.gov (United States)

    Ouriemi, Malika; Vlahovska, Petia

    2014-11-01

    We study the dynamics of a drop nearly-completely covered with a particle monolayer in a uniform DC electric field. The weakly conducting fluid system consists of a silicon oil drop suspended in castor oil. A broad range of particle sizes, conductivities, and shapes is explored. In weak electric fields, the presence of particles increases drop deformation compared to a particle-free drop and suppresses the electrohydrodynamic flow. Very good agreement is observed between the measured drop deformation and the small deformation theory derived for surfactant-laden drops (Nganguia et al., 2013). In stronger electric fields, where drops are expected to undergo Quincke rotation (Salipante and Vlahovska, 2010), the presence of the particles greatly decreases the threshold for rotation and the stationary tilted drop configuration observed for clean drop is replaced by a spinning drop with either a wobbling inclination or a very low inclination. These behaviors resemble the predicted response of rigid ellipsoids in uniform electric fields. At even stronger electric fields, the particles can form dynamic wings or the drop implodes. The similar behavior of particle-covered and surfactant-laden drops provides new insights into understanding stability of Pickering emulsions. Supported by NSF-CBET 1437545.

  14. Evaluation of In Vitro Cytochrome P450 Inhibition and In Vitro Fate of Structurally Diverse N-Oxide Metabolites: Case Studies with Clozapine, Levofloxacin, Roflumilast, Voriconazole and Zopiclone.

    Science.gov (United States)

    Giri, Poonam; Naidu, Sneha; Patel, Nirmal; Patel, Harilal; Srinivas, Nuggehally R

    2017-08-01

    The role of metabolite(s) to elicit potential clinical drug-drug interaction (DDI) via cytochrome P450 enzymes (CYP) is gaining momentum. In this context, the role of N-oxides for in vitro CYP inhibition has not been evaluated. The objectives of this study were: (a) to examine in vitro CYP inhibition of N-oxides of clozapine, levofloxacin, roflumilast, voriconazole and zopiclone in a tiered approach and (b) evaluate in vitro fate of aforementioned N-oxides examined in recombinant CYPs, human microsomes and hepatocytes. CYP enzymes evaluated in the work included: CYP1A2, 2B6, 2C9, 2C19, 2D6 and 3A4 using standard procedures for incubation with appropriate probe substrates. The initial cutoff for CYP inhibition was ≥50% using 2 and 10 µM concentrations of various N-oxide metabolites (Tier 1). IC50 values were constructed for the CYP pathway(s) that showed ≥50% inhibition (Tier 2). In addition, co-incubation of N-oxides with parent was performed to evaluate potentiation of CYP inhibition (Tier 3). N-oxides of clozapine (CYP2B6/2C19) and voriconazole (CYP2C9/3A4) showed CYP inhibition ≥50%. Clozapine-N-oxide inhibited CYP2B6 and CYP2C19 pathways with IC50 of 8.3 and 8.7 µM, respectively. Voriconazole-N-oxide inhibited CYP2B6 and CYP2C19 pathways with IC50 of 10.5 and 11.2 µM, respectively. Co-incubation of clozapine-N-oxide with clozapine potentiated CYP2B6/2C19 pathways; however, incubation of voriconazole-N-oxide with voriconazole did not appear to potentiate the CYP pathways because parent caused an inhibition of almost 80%. None of the N-oxides appeared to further undergo biotransformation as judged by the in vitro metabolic fate experiments (stage 2). Clinical DDI potential of specific CYP enzymes needs to be considered arising due to circulatory concentrations of certain N-oxides depending on the dose size and/or frequency of dosing of the respective parent drugs.

  15. Results from the PharmaSat Nanosatellite Mission: Dose Dependence of Growth and Metabolic Parameters for S. cerevisiae Grown in Microgravity and Challenged by Voriconazole

    Science.gov (United States)

    Ricco, Antonio; Parra, Macarena; Niesel, David; Ly, Diana; Kudlicki, Andrzej; McGinnis, Michael; Hines, John

    We report cellular growth and metabolic activity results for Saccharomyces cerevisiae grown aboard PharmaSat, a 5.0-kg autonomous, self-contained biological nanosatellite launched as a secondary payload in May of 2009 and presently in Earth orbit at 450 km. The response of S. cerevisiae to three dose levels bracketing the minimum inhibitory concentration (MIC) of the antifungal voriconazole was monitored in microgravity using 3-color absorbance to measure metabolic activity and turbidity (cell number), which were characterized chiefly by two param-eters: (1) the doubling time and (2) the time delay before the onset of rapid growth. Growth was conducted in forty-eight 100-L microwells containing the yeast—one fluidically separate bank of 12 wells for each voriconazole concentration, plus a control bank. Yeast were main-tained in stasis until the satellite had been deployed, the orbit stabilized, the communications links established, and the growth temperature of 27 ° C stabilized. To re-initiate yeast growth, RPMI growth medium was added. The S. cerevisiae were grown for approximately 12 hr, at which time they were challenged with varying concentrations (0, 0.25xMIC, MIC, 4xMIC) of voriconazole; the optical density and the color change of the redox-based viability indicator alamar blue were recorded as growth proceeded for an additional 84 hr. Results telemetered to the ground reveal a 33 percent longer lag time in microgravity and 60 percent longer dou-bling time than identical ground control experiments. Lag and doubling times are essentially unaffected by voriconazole at 0.125 g/mL in either environment; they lengthen similarly at 0.5 g/mL, voriconazole's MIC. At four times MIC, ground controls show no significant growth nor metabolic activity as tracked by alamar blue; in space, while there was also no measurable cellu-lar growth, remarkably, metabolic activity was clearly present (n = 12 wells). Explanations for the differences in metabolic activity and

  16. Long-term outcomes of ahmed glaucoma valve implantation in refractory glaucoma at Farabi Eye Hospital, Tehran, Iran

    Directory of Open Access Journals (Sweden)

    Reza Zarei

    2016-01-01

    Conclusion: AGV implantation with adjunctive topical anti-glaucoma drops controlled IOP in approximately 70% of eyes with refractory glaucoma with a median of 40.5 months of follow-up. However, complication rates were higher.

  17. An alternative approach to determine oral bioavailability of drugs that follow Michaelis-Menten elimination: a case study with voriconazole.

    Science.gov (United States)

    Verlindo de Araujo, Bibiana; Farias da Silva, Cristófer; Costa, Teresa Dalla

    2010-01-01

    the determination of oral bioavailability of drugs which follow nonlinear pharmacokinetics is difficult and few methods are available. In this work, an alternative approach to determine oral bioavailability of voriconazole (VRC), used as a model drug, is presented. VRC pharmacokinetics was investigated in Wistar rats after p.o. (40 mg/kg) and i.v. administration (2.5, 5 and 10 mg/kg). VRC elimination showed saturation in all doses investigated, except the lower i.v. dose in which case a 3-compartment model with linear elimination adequately fitted the data. Data for the 2 higher i.v. doses were best described by a 3-compartment model with Michaelis-Menten elimination. A 1-compartment disposition with a saturable metabolic elimination model described the oral profile. VRC absolute oral bioavailability was determined by simultaneous fitting of the i.v. and oral profiles. the Michaelis constant and the maximum velocity estimated after 5 and 10 mg/kg i.v. dosing were 0.54 +/- 0.25 microg/ml and 2.53 +/- 0.54 microg/h, and 0.62 +/- 0.12 microg/ml and 2.74 +/- 0.84 microg/h, respectively. VRC oral bioavailability was determined to be 82.8%. the approach presented is an alternative for determining the bioavailability of drugs with similar nonlinear behavior. 2010 S. Karger AG, Basel.

  18. Teamwork for eye care

    Directory of Open Access Journals (Sweden)

    M Babar Qureshi

    2014-04-01

    Full Text Available Human resource development (HRD – the development of the people who deliver health care – has been identified as one of the key pillars of eye health delivery. HRD is one of the essential building blocks of the World Health Organization (WHO Global Action Plan: ‘Towards universal eye health’. The importance of HRD is also recognised beyond eye care, as can be seen in the WHO Health Systems approach.

  19. Personal Identification by Eyes

    OpenAIRE

    Marinović, Dunja; Čoklo, Miran; Njirić, Sanja; Mužić, Vedrana

    2011-01-01

    Identification of persons through the eyes is in the field of biometrical science. Many security systems are based on biometric methods of personal identification, to determine whether a person is presenting itself truly. The human eye contains an extremely large number of individual characteristics that make it particularly suitable for the process of identifying a person. Today, the eye is considered to be one of the most reliable body parts for human identification. Systems usi...

  20. Infrared Eye: Prototype 2

    Science.gov (United States)

    2016-06-07

    within the wide field and slaved to the operator’s line of sight by means of an eye- tracking system. The images from both cameras are fused and shown...simultaneously on a high resolution CRT display unit, interfaced with the eye- tracking unit in order to optimize the human-machine interface. The IR Eye...system was flight tested using the Advanced system Research Aircraft (Bell 412 helicopter) from the Flight Research Laboratory of the National Research

  1. Drop shaping by laser-pulse impact

    CERN Document Server

    Klein, Alexander L; Visser, Claas Willem; Lhuissier, Henri; Sun, Chao; Snoeijer, Jacco H; Villermaux, Emmanuel; Lohse, Detlef; Gelderblom, Hanneke

    2015-01-01

    We study the hydrodynamic response of a falling drop hit by a laser pulse. Combining high-speed with stroboscopic imaging we report that a millimeter-sized dyed water drop hit by a milli-Joule nanosecond laser-pulse deforms and propels forward at several meters per second, until it eventually fragments. We show that the drop motion results from the recoil momentum imparted at the drop surface by water vaporization. We measure the propulsion speed and the time-deformation law of the drop, complemented by boundary integral simulations. We explain the drop propulsion and shaping in terms of the laser pulse energy and drop surface tension. These findings are crucial for the generation of extreme ultraviolet (EUV) light in lithography machines.

  2. Unstable Leidenfrost Drops on Roughened Surfaces

    CERN Document Server

    Boreyko, Jonathan B

    2010-01-01

    Drops placed on a surface with a temperature above the Leidenfrost point float atop an evaporative vapor layer. In this fluid dynamics video, it is shown that for roughened surfaces the Leidenfrost point depends on the drop size, which runs contrary to previous claims of size independence. The thickness of the vapor layer is known to increase with drop radius, suggesting that the surface roughness will not be able to penetrate the vapor layer for drops above a critical size. This size dependence was experimentally verified: at a given roughness and temperature, drops beneath a critical size exhibited transition boiling while drops above the critical size were in the Leidenfrost regime. These Leidenfrost drops were unstable; upon evaporation down to the critical size the vapor film suddenly collapsed.

  3. What Is Dry Eye?

    Medline Plus

    Full Text Available ... Academy Publications EyeNet Ophthalmology Ophthalmology Retina Information for: International Ophthalmologists Media Medical Students Patients and Public Technicians and Nurses Senior Ophthalmologists ...

  4. What Is Dry Eye?

    Medline Plus

    Full Text Available ... Ophthalmology Education Center Oculofacial Plastic Surgery Center Laser Surgery Education Center Redmond Ethics ... Services Advocacy Foundation About Subspecialties & More Eye ...

  5. Leidenfrost drops on a heated liquid pool

    Science.gov (United States)

    Maquet, L.; Sobac, B.; Darbois-Texier, B.; Duchesne, A.; Brandenbourger, M.; Rednikov, A.; Colinet, P.; Dorbolo, S.

    2016-09-01

    We show that a volatile liquid drop placed at the surface of a nonvolatile liquid pool warmer than the boiling point of the drop can be held in a Leidenfrost state even for vanishingly small superheats. Such an observation points to the importance of the substrate roughness, negligible in the case considered here, in determining the threshold Leidenfrost temperature. A theoretical model based on the one proposed by Sobac et al. [Phys. Rev. E 90, 053011 (2014), 10.1103/PhysRevE.90.053011] is developed in order to rationalize the experimental data. The shapes of the drop and of the liquid substrate are analyzed. The model notably provides scalings for the vapor film thickness profile. For small drops, these scalings appear to be identical to the case of a Leidenfrost drop on a solid substrate. For large drops, in contrast, they are different, and no evidence of chimney formation has been observed either experimentally or theoretically in the range of drop sizes considered in this study. Concerning the evaporation dynamics, the radius is shown to decrease linearly with time whatever the drop size, which differs from the case of a Leidenfrost drop on a solid substrate. For high superheats, the characteristic lifetime of the drops versus the superheat follows a scaling law that is derived from the model, but, at low superheats, it deviates from this scaling by rather saturating.

  6. Eye proprioception may provide real time eye position information.

    Science.gov (United States)

    Wang, Jing; Pan, Yujun

    2013-03-01

    Because of the frequency of eye movements, online knowledge of eye position is crucial for the accurate spatial perception and behavioral navigation. Both the internal monitoring signal (corollary discharge) of eye movements and the eye proprioception signal are thought to contribute to the localization of the eye position in the orbit. However, the functional role of these two eye position signals in spatial cognition has been disputed for more than a century. The predominant view proposes that the online analysis of eye position is exclusively provided by the corollary discharge signal, while the eye proprioception signal only plays a role in the long-term calibration of the oculomotor system. However, increasing evidence from recent behavioral and physiological studies suggests that the eye proprioception signal may play a role in the online monitoring of eye position. The purpose of this review is to discuss the feasibility and possible function of the eye proprioceptive signal for online monitoring of eye position.

  7. What Is Dry Eye?

    Medline Plus

    Full Text Available ... Registry Medicare Physician Payment Meetings and Deadlines Ophthalmology Job Center Our Sites EyeWiki International Society of Refractive ... Registry Medicare Physician Payment Meetings and Deadlines Ophthalmology Job Center Our Sites EyeWiki International Society of Refractive ...

  8. What Is Dry Eye?

    Medline Plus

    Full Text Available ... Deadlines Ophthalmology Job Center Our Sites EyeWiki International Society of Refractive Surgery Museum of Vision Subspecialties Cataract/ ... Deadlines Ophthalmology Job Center Our Sites EyeWiki International Society of Refractive Surgery Museum of Vision Subspecialties Cataract/ ...

  9. About the Eye

    Medline Plus

    Full Text Available ... NIH), the National Eye Institute’s mission is to “conduct and support research, training, health information dissemination, and other programs with respect to blinding eye diseases, visual disorders, mechanisms of visual function, preservation of sight, and the ...

  10. What Is Dry Eye?

    Medline Plus

    Full Text Available ... Emergency Relief EyeCare America Help IRIS Registry Medicare Physician Payment Meetings and Deadlines Ophthalmology Job Center Our ... Emergency Relief EyeCare America Help IRIS Registry Medicare Physician Payment Meetings and Deadlines Ophthalmology Job Center Our ...

  11. About the Eye

    Medline Plus

    Full Text Available ... Optical Illusions Printables About the Eye Your eyes are made up of many different parts that work ... Media Information in Spanish (Información en español) Website, ... Office of Science Communications, Public Liaison, and Education. Technical questions about ...

  12. Eye-Tracking

    Directory of Open Access Journals (Sweden)

    Gabriela GROSSECK

    2006-01-01

    Full Text Available Eye-tracking: one of the newest and most efficient methods of improving on-line marketing communication is called eye-tracking. Marketers have borrowed this technique, usually used in psychological and medical research, in order to study web users with the help of a video camera incorporated in the monitor.

  13. Perception of eye positions

    NARCIS (Netherlands)

    Lorteije, J.A.M.; Wezel, R.J.A. van; Lankheet, M.J.M.

    2002-01-01

    In a two-alternative forced-choice psychophysical test human subjects were tested for their ability to perceive their own viewing direction. A small red flash was presented at different horizontal positions left or right from the subjects' eye position on the screen. Eye positions were recorded with

  14. Understanding pink eye

    Science.gov (United States)

    Pink eye (PE) is a physiological tuber disorder that can result in serious processing complications and storage losses. The earliest external symptoms consist of an ephemeral pinkish discoloration around tuber eyes, predominately at the bud end of the tuber. These pinkish areas can then develop into...

  15. Photorefraction of the Eye

    Science.gov (United States)

    Colicchia, Giuseppe; Wiesner, Hartmut; Zollman, Dean

    2015-01-01

    Photorefraction is a method to easily estimate the refractive state of the eye. The principle of photorefraction involves projecting light into the eye during flash photography and then examining the paths of light that emerge from the pupil after scattering on the back portion of the interior of the eyeball (fundus). We will explain the optical…

  16. Eye tracking social preferences

    NARCIS (Netherlands)

    Jiang, Ting; Potters, Jan; Funaki, Yukihiko

    We hypothesize that if people are motivated by a particular social preference, then choosing in accordance with this preference will lead to an identifiable pattern of eye movements. We track eye movements while subjects make choices in simple three-person distribution experiments. We characterize

  17. BullsEye

    DEFF Research Database (Denmark)

    Klokmose, Clemens Nylandsted; Kristensen, Janus Bager; Bagge, Rolf

    2014-01-01

    implemented primarily in shaders on the GPU. The techniques are realized in the BullsEye computer vision software. We demonstrate experimentally that BullsEye provides sub-pixel accuracy down to a tenth of a pixel, which is a significant improvement compared to the commonly used reacTIVision software....

  18. Footprint Geometry and Sessile Drop Resonance

    Science.gov (United States)

    Chang, Chun-Ti; Daniel, Susan; Steen, Paul H.

    2016-11-01

    How does a sessile drop resonate if its footprint is square (square drop)? In this talk, we discuss the two distinct families of observed modes in our experiments. One family (spherical modes) is identified with the natural modes of capillary spherical caps, and the other (grid modes) with Faraday waves on a square bath (square Faraday waves). A square drop exhibits grid or spherical modes depending on its volume, and the two families of modes arise depending on how wavenumber selection of footprint geometry and capillarity compete. For square drops, a dominant effect of footprint constraint leads to grid modes which are constrained response; otherwise the drops exhibit spherical modes, the characteristic of sessile drops on flat plates. Chun-Ti Chang takes his new position at National Taiwan University on Aug. 15th, 2016. Until then, Chun-Ti Chang is affiliated with Technical University Dortmund, Germany.

  19. Sepsis from dropped clips at laparoscopic cholecystectomy

    Energy Technology Data Exchange (ETDEWEB)

    Hussain, Sarwat E-mail: sarwathussain@hotmail.com

    2001-12-01

    We report seven patients in whom five dropped surgical clips and two gallstones were visualized in the peritoneal cavity, on radiological studies. In two, subphrenic abscesses and empyemas developed as a result of dropped clips into the peritoneal cavity during or following laparoscopic cholecystectomy. In one of these two, a clip was removed surgically from the site of an abscess. In two other patients dropped gallstones, and in three, dropped clips led to no complications. These were seen incidentally on studies done for other indications. Abdominal abscess secondary to dropped gallstones is a well-recognized complication of laparoscopic cholecystectomy (LC). We conclude that even though dropped surgical clips usually do not cause problems, they should be considered as a risk additional to other well-known causes of post-LC abdominal sepsis.

  20. A Different Cone: Bursting Drops in Solids

    Science.gov (United States)

    Zhao, Xuanhe

    2013-03-01

    Drops in fluids tend to be spheres--a shape that minimizes surface energy. In thunderstorm clouds, drops can become unstable and emit thin jets when charged beyond certain limits. The instability of electrified drops in gases and liquids has been widely studied and used in applications including ink-jet printing, electrospinning nano-fibers, microfluidics and electrospray ionization. Here we report a different scenario: drops in solids become unstable and burst under sufficiently high electric fields. We find the instability of drops in solids morphologically resembles that in liquids, but the critical electric field for the instability follows a different scaling due to elasticity of solids. Our observations and theoretical models not only advance the fundamental understanding of electrified drops but also suggest a new failure mechanism of high-energy-density dielectric polymers, which have diverse applications ranging from capacitors for power grids and electric vehicles to muscle-like transducers for soft robots and energy harvesting.

  1. Wild-Type MIC Distributions and Epidemiological Cutoff Values for Posaconazole and Voriconazole and Candida spp. as Determined by 24-Hour CLSI Broth Microdilution▿

    Science.gov (United States)

    Pfaller, M. A.; Boyken, L.; Hollis, R. J.; Kroeger, J.; Messer, S. A.; Tendolkar, S.; Diekema, D. J.

    2011-01-01

    We tested 16,191 strains of Candida against posaconazole and voriconazole, using the CLSI M27-A3 broth microdilution (BMD) method (24-h incubation), in order to define wild-type (WT) populations and epidemiological cutoff values (ECVs). From 2001 to 2009, 8,619 isolates of Candida albicans, 2,415 isolates of C. glabrata, 2,278 isolates of C. parapsilosis, 1,895 isolates of C. tropicalis, 508 isolates of C. krusei, 205 isolates of C. lusitaniae, 177 isolates of C. guilliermondii, and 93 isolates of C. kefyr were obtained from over 100 centers worldwide. The modal MICs (μg/ml) for posaconazole and voriconazole, respectively, were as follows: for C. albicans, 0.016 and 0.007; for C. glabrata, 0.5 and 0.06; for C. parapsilosis, 0.06 and 0.007; for C. tropicalis, 0.03 and 0.015; for C. krusei, 0.25 and 0.12; for C. lusitaniae, 0.03 and 0.007; for C. guilliermondii, 0.12 and 0.03; and for C. kefyr, 0.06 and 0.007. The ECVs (μg/ml [% of isolates that had MICs equal to or less than the ECV]) for posaconazole and voriconazole, respectively, were as follows: 0.06 (98.5) and 0.03 (98.9) for C. albicans, 2 (96.2) and 0.5 (90.4%) for C. glabrata, 0.25 (99.3) and 0.12 (97.9) for C. parapsilosis, 0.12 (97.6) and 0.06 (97.2) for C. tropicalis, 0.5 (99.8) and 0.5 (99.4) for C. krusei, 0.12 (95.6) and 0.03 (96.6) for C. lusitaniae, 0.5 (98.9) and 0.25 (98.3) for C. guilliermondii, and 0.25 (100.0) and 0.015 (100.0) for C. kefyr. In the absence of clinical breakpoints (CBPs) for posaconazole, these WT distributions and ECVs will be useful in surveillance for emergence of reduced susceptibility to posaconazole among Candida spp. Whereas a CBP for susceptibility of ≤1 μg/ml has been established for voriconazole and all species of Candida, it is notable that ECVs for this agent range from 10- to >100-fold lower than the CBP, depending on the species of Candida. The CBP is inadequate in detecting the emergence of voriconazole resistance among most Candida species encountered

  2. Mass Remaining During Evaporation of Sessile Drop

    Science.gov (United States)

    2008-09-01

    to> \\fyj Greek Symbols P Contact angle of sessile drop . n Droplet shape factor = h/d 6 Non-dimensional time = t/i V Air kinematic viscosity...factor n, = h / d (where h = maximum height of the drop ), which can also be directly related to the contact angle (P) of the drop , that is r| = (l-cos(P...three drop size (initial mass or volume) conditions with all other conditions the same. These runs have a constant contact angle , (3 = 16.5° ± 1.5

  3. Rapid Drop Dynamics During Superhydrophobic Condensation

    Science.gov (United States)

    Zhang, Xiaodong; Boreyko, Jonathan; Chen, Chuan-Hua

    2008-11-01

    Rapid drop motion is observed on superhydrophobic surfaces during condensation; condensate drops with diameter of order 10 μm can move at above 100G and 0.1 m/s. When water vapor condenses on a horizontal superhydrophobic surface, condensate drops move in a seemingly random direction. The observed motion is attributed to the energy released through coalescence of neighboring condensate drops. A scaling analysis captured the initial acceleration and terminal velocity. Our work is a step forward in understanding the dynamics of superhydrophobic condensation occurring in both natural water-repellant plants and engineered dropwise condensers.

  4. Numerical simulations of vibrating sessile drop

    Science.gov (United States)

    Kahouadji, Lyes; Chergui, Jalel; Juric, Damir; Shin, Seungwon; Craster, Richard; Matar, Omar

    2016-11-01

    A vibrated drop constitutes a very rich physical system, blending both interfacial and volume phenomena. A remarkable experimental study was performed by M. Costalonga highlighting sessile drop motion subject to horizontal, vertical and oblique vibration. Several intriguing phenomena are observed such as drop walking and rapid droplet ejection. We perform three-dimensional direct numerical simulations of vibrating sessile drops where the phenomena described above are computed using the massively parallel multiphase code BLUE. EPSRC UK Programme Grant MEMPHIS (EP/K003976/1).

  5. Impact force of a falling drop

    Science.gov (United States)

    Soto, Dan; Clanet, Cristophe; Quere, David; Xavier Boutillon Collaboration

    2012-11-01

    Controlling droplet deposition is crucial in many industrial processes such as spraying pesticides on crops, inkjet printing or spray coating. Therefore, the dynamics of drop impacts have been extensively studied for more than one century. However, few literature describe the impacting force of a drop on a solid flat surface, although it might be a way to measure the size distribution of a collection of falling drops. We investigated experimentally how the instantaneous force at impact depends on impact velocity and drop radius. We also propose a new model to understand our observations. Physique et Mecanique des Milieux Heterogenes, CNRS, ESPCI, Paris France & Ladhyx, CNRS, Ecole Polytechnique, Palaiseau, France.

  6. Drops moving along and across a filament

    Science.gov (United States)

    Sahu, Rakesh P.; Sinha-Ray, Suman; Yarin, Alexander; Pourdeyhimi, Behnam

    2013-11-01

    The present work is devoted to the experimental study of oil drop motion both along and across a filament due to the air jet blowing. In case of drop moving along the filament, phenomena such as drop stick-slip motion, shape oscillations, shedding of a tail along the filament, the tail capillary instability and drop recoil motion were observed which were rationalized in the framework of simplified models. Experiments with cross-flow of the surrounding gas relative to the filament with an oil drop on it were conducted, with air velocity in the range of 7.23 to 22.7 m s-1. The Weber number varied from 2 to 40 and the Ohnesorge number varied from 0.07 to 0.8. The lower and upper critical Weber numbers were introduced to distinguish between the beginning of the drop blowing off the filament and the onset of the bag-stamen breakup. The range of the Weber number between these two critical values is filled with three types of vibrational breakup: V1 (a balloon-like drop being blown off), V2 (a drop on a single stamen being blown off), and V3 (a drop on a double stamen being blown off). The Weber number/Ohnesorge number plane was delineated into domains of different breakup regimes. The work is supported by the Nonwovens Cooperative Research Center (NCRC).

  7. Drop deformation by laser-pulse impact

    CERN Document Server

    Gelderblom, Hanneke; Klein, Alexander L; Bouwhuis, Wilco; Lohse, Detlef; Villermaux, Emmanuel; Snoeijer, Jacco H

    2015-01-01

    A free-falling absorbing liquid drop hit by a nanosecond laser-pulse experiences a strong recoil-pressure kick. As a consequence, the drop propels forward and deforms into a thin sheet which eventually fragments. We study how the drop deformation depends on the pulse shape and drop properties. We first derive the velocity field inside the drop on the timescale of the pressure pulse, when the drop is still spherical. This yields the kinetic-energy partition inside the drop, which precisely measures the deformation rate with respect to the propulsion rate, before surface tension comes into play. On the timescale where surface tension is important the drop has evolved into a thin sheet. Its expansion dynamics is described with a slender-slope model, which uses the impulsive energy-partition as an initial condition. Completed with boundary integral simulations, this two-stage model explains the entire drop dynamics and its dependance on the pulse shape: for a given propulsion, a tightly focused pulse results in a...

  8. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.

    Science.gov (United States)

    Espinel-Ingroff, A; Barchiesi, F; Cuenca-Estrella, M; Pfaller, M A; Rinaldi, M; Rodriguez-Tudela, J L; Verweij, P E

    2005-08-01

    The aim of this study was to compare MICs of fluconazole, itraconazole, posaconazole, and voriconazole obtained by the European Committee on Antibiotic Susceptibility Testing (EUCAST) and CLSI (formerly NCCLS) methods in each of six centers for 15 Candida albicans (5 fluconazole-resistant and 4 susceptible-dose-dependent [S-DD] isolates), 10 C. dubliniensis, 7 C. glabrata (2 fluconazole-resistant isolates), 5 C. guilliermondii (2 fluconazole-resistant isolates), 10 C. krusei, 9 C. lusitaniae, 10 C. parapsilosis, and 5 C. tropicalis (1 fluconazole-resistant isolate) isolates. CLSI MICs were obtained visually at 24 and 48 h and spectrophotometric EUCAST MICs at 24 h. The agreement (within a 3-dilution range) between the methods was species, drug, and incubation time dependent and due to lower EUCAST than CLSI MICs: overall, 94 to 95% with fluconazole and voriconazole and 90 to 91% with posaconazole and itraconazole when EUCAST MICs were compared against 24-h CLSI results. The agreement was lower (85 to 94%) against 48-h CLSI endpoints. The overall interlaboratory reproducibility by each method was > or =92%. When the comparison was based on CLSI breakpoint categorization, the agreement was 68 to 76% for three of the four species that included fluconazole-resistant and S-DD isolates; 9% very major discrepancies ( or =64 microg/ml) were observed among fluconazole-resistant isolates and 50% with voriconazole ( or =4 microg/ml). Similar results were observed with itraconazole for seven of the eight species evaluated (28 to 77% categorical agreement). Posaconazole EUCAST MICs were also substantially lower than CLSI MIC modes (0.008 to 1 microg/ml versus 1 to > or =8 microg/ml) for some of these isolates. Therefore, the CLSI breakpoints should not be used to interpret EUCAST MIC data.

  9. International and Multicenter Comparison of EUCAST and CLSI M27-A2 Broth Microdilution Methods for Testing Susceptibilities of Candida spp. to Fluconazole, Itraconazole, Posaconazole, and Voriconazole

    Science.gov (United States)

    Espinel-Ingroff, A.; Barchiesi, F.; Cuenca-Estrella, M.; Pfaller, M. A.; Rinaldi, M.; Rodriguez-Tudela, J. L.; Verweij, P. E.

    2005-01-01

    The aim of this study was to compare MICs of fluconazole, itraconazole, posaconazole, and voriconazole obtained by the European Committee on Antibiotic Susceptibility Testing (EUCAST) and CLSI (formerly NCCLS) methods in each of six centers for 15 Candida albicans (5 fluconazole-resistant and 4 susceptible-dose-dependent [S-DD] isolates), 10 C. dubliniensis, 7 C. glabrata (2 fluconazole-resistant isolates), 5 C. guilliermondii (2 fluconazole-resistant isolates), 10 C. krusei, 9 C. lusitaniae, 10 C. parapsilosis, and 5 C. tropicalis (1 fluconazole-resistant isolate) isolates. CLSI MICs were obtained visually at 24 and 48 h and spectrophotometric EUCAST MICs at 24 h. The agreement (within a 3-dilution range) between the methods was species, drug, and incubation time dependent and due to lower EUCAST than CLSI MICs: overall, 94 to 95% with fluconazole and voriconazole and 90 to 91% with posaconazole and itraconazole when EUCAST MICs were compared against 24-h CLSI results. The agreement was lower (85 to 94%) against 48-h CLSI endpoints. The overall interlaboratory reproducibility by each method was ≥92%. When the comparison was based on CLSI breakpoint categorization, the agreement was 68 to 76% for three of the four species that included fluconazole-resistant and S-DD isolates; 9% very major discrepancies (≤8 μg/ml versus ≥64 μg/ml) were observed among fluconazole-resistant isolates and 50% with voriconazole (≤1 μg/ml versus ≥4 μg/ml). Similar results were observed with itraconazole for seven of the eight species evaluated (28 to 77% categorical agreement). Posaconazole EUCAST MICs were also substantially lower than CLSI MIC modes (0.008 to 1 μg/ml versus 1 to ≥8 μg/ml) for some of these isolates. Therefore, the CLSI breakpoints should not be used to interpret EUCAST MIC data. PMID:16081926

  10. A Modified Christensen's Urea and CLSI Broth Microdilution Method for Testing Susceptibilities of Six Malassezia Species to Voriconazole, Itraconazole, and Ketoconazole

    Science.gov (United States)

    Rincón, S.; Cepero de García, M. C.; Espinel-Ingroff, A.

    2006-01-01

    Two supplemented broths (Christensen's urea with 0.1% Tween 80 and 0.5% Tween 40 and RPMI 1640 with 1% glycerol, 1% peptone, 1.8% glucose, and 0.05% Tween 80) were evaluated to determine voriconazole, itraconazole, and ketoconazole MICs for 200 Malassezia sp. isolates. Malassezia globosa and M. restricta were the least susceptible species (MICs at which 90% of the isolates tested were inhibited, 1 to ≥8 μg/ml versus 0.25 to 1 μg/ml). PMID:16954293

  11. Correlation for Sessile Drop Evaporation

    Science.gov (United States)

    Kelly-Zion, Peter; Pursell, Christopher; Wassom, Gregory; Mandelkorn, Brenton; Nkinthorn, Chris

    2016-11-01

    To better understand how the evaporation of sessile drops and small puddles is controlled by the vapor phase transport mechanisms of mass diffusion and buoyancy-induced convection, the evaporation rates of eight liquids evaporating under a broad range of ambient conditions were correlated with physical and geometrical properties. Examination of the correlation provides valuable insight into how the roles of diffusive and convective transport change with physical and geometrical parameters. The correlation predicts measured evaporation rates to within a root-mean-square error of 7.3%. The correlation is composed of two terms, a term which provides the rate of evaporation under diffusion-only conditions, and a term which provides the influence of convection. This second term suggests the manner in which the processes of diffusion and convection are coupled. Both processes are dependent on the distribution of the vapor, through the molar concentration gradient for diffusion and through the mass density gradient for convection. The term representing the influence of convection is approximately inversely proportional to the square root of diffusivity, indicating the tendency of diffusive transport to reduce convection by making the vapor distribution more uniform. Financial support was provided by the ACS Petroleum Research Fund.

  12. Selenium-binding lactoferrin is taken into corneal epithelial cells by a receptor and prevents corneal damage in dry eye model animals.

    Science.gov (United States)

    Higuchi, Akihiro; Inoue, Hiroyoshi; Kaneko, Yoshio; Oonishi, Erina; Tsubota, Kazuo

    2016-11-11

    The ocular surface is strongly affected by oxidative stress, which causes many ocular diseases including dry eye. Previously, we showed that selenium compounds, e.g., selenoprotein P and Se-lactoferrin, were candidates for treatment of dry eye. This paper shows the efficacy of Se-lactoferrin for the treatment of dry eye compared with Diquas as a control drug using two dry eye models and incorporation of lactoferrin into corneal epithelial cells via lactoferrin receptors. We show the efficacy of Se-lactoferrin eye drops in the tobacco smoke exposure rat dry eye model and short-term rabbit dry eye model, although Diquas eye drops were only effective in the short-term rabbit dry eye model. These results indicate that Se-lactoferrin was useful in the oxidative stress-causing dry eye model. Se-lactoferrin was taken into corneal epithelium cells via lactoferrin receptors. We identified LRP1 as the lactoferrin receptor in the corneal epithelium involved in lactoferrin uptake. Se-lactoferrin eye drops did not irritate the ocular surface of rabbits. Se-lactoferrin was an excellent candidate for treatment of dry eye, reducing oxidative stress by a novel mechanism.

  13. Personal identification by eyes.

    Science.gov (United States)

    Marinović, Dunja; Njirić, Sanja; Coklo, Miran; Muzić, Vedrana

    2011-09-01

    Identification of persons through the eyes is in the field of biometrical science. Many security systems are based on biometric methods of personal identification, to determine whether a person is presenting itself truly. The human eye contains an extremely large number of individual characteristics that make it particularly suitable for the process of identifying a person. Today, the eye is considered to be one of the most reliable body parts for human identification. Systems using iris recognition are among the most secure biometric systems.

  14. Extended release of hyaluronic acid from hydrogel contact lenses for dry eye syndrome.

    Science.gov (United States)

    Maulvi, Furqan A; Soni, Tejal G; Shah, Dinesh O

    2015-01-01

    Current dry eye treatment includes delivering comfort enhancing agents to the eye via eye drops, but low residence time of eye drops leads to low bioavailability. Frequent administration leads to incompliance in patients, so there is a great need for medical device such as contact lenses to treat dry eye. Studies in the past have demonstrated the efficacy of hyaluronic acid (HA) in the treatment of dry eyes using eye drops. In this paper, we present two methods to load HA in hydrogel contact lenses, soaking method and direct entrapment. The contact lenses were characterized by studying their optical and physical properties to determine their suitability as extended wear contact lenses. HA-laden hydrogel contact lenses prepared by soaking method showed release up to 48 h with acceptable physical and optical properties. Hydrogel contact lenses prepared by direct entrapment method showed significant sustained release in comparison to soaking method. HA entrapped in hydrogels resulted in reduction in % transmittance, sodium ion permeability and surface contact angle, while increase in % swelling. The impact on each of these properties was proportional to HA loading. The batch with 200-μg HA loading showed all acceptable values (parameters) for contact lens use. Results of cytotoxicity study indicated the safety of hydrogel contact lenses. In vivo pharmacokinetics studies in rabbit tear fluid showed dramatic increase in HA mean residence time and area under the curve with lenses in comparison to eye drop treatment. The study demonstrates the promising potential of delivering HA through contact lenses for the treatment of dry eye syndrome.

  15. Magnetic eye tracking in mice.

    Science.gov (United States)

    Payne, Hannah L; Raymond, Jennifer L

    2017-09-05

    Eye movements provide insights about a wide range of brain functions, from sensorimotor integration to cognition; hence, the measurement of eye movements is an important tool in neuroscience research. We describe a method, based on magnetic sensing, for measuring eye movements in head-fixed and freely moving mice. A small magnet was surgically implanted on the eye, and changes in the magnet angle as the eye rotated were detected by a magnetic field sensor. Systematic testing demonstrated high resolution measurements of eye position of eye tracking offers several advantages over the well-established eye coil and video-oculography methods. Most notably, it provides the first method for reliable, high-resolution measurement of eye movements in freely moving mice, revealing increased eye movements and altered binocular coordination compared to head-fixed mice. Overall, magnetic eye tracking provides a lightweight, inexpensive, easily implemented, and high-resolution method suitable for a wide range of applications.

  16. Total Site Heat Integration Considering Pressure Drops

    Directory of Open Access Journals (Sweden)

    Kew Hong Chew

    2015-02-01

    Full Text Available Pressure drop is an important consideration in Total Site Heat Integration (TSHI. This is due to the typically large distances between the different plants and the flow across plant elevations and equipment, including heat exchangers. Failure to consider pressure drop during utility targeting and heat exchanger network (HEN synthesis may, at best, lead to optimistic energy targets, and at worst, an inoperable system if the pumps or compressors cannot overcome the actual pressure drop. Most studies have addressed the pressure drop factor in terms of pumping cost, forbidden matches or allowable pressure drop constraints in the optimisation of HEN. This study looks at the implication of pressure drop in the context of a Total Site. The graphical Pinch-based TSHI methodology is extended to consider the pressure drop factor during the minimum energy requirement (MER targeting stage. The improved methodology provides a more realistic estimation of the MER targets and valuable insights for the implementation of the TSHI design. In the case study, when pressure drop in the steam distribution networks is considered, the heating and cooling duties increase by 14.5% and 4.5%.

  17. Aging, Terminal Decline, and Terminal Drop

    Science.gov (United States)

    Palmore, Erdman; Cleveland, William

    1976-01-01

    Data from a 20-year longitudinal study of persons over 60 were analyzed by step-wise multiple regression to test for declines in function with age, for terminal decline (linear relationship to time before death), and for terminal drop (curvilinear relationship to time before death). There were no substantial terminal drop effects. (Author)

  18. Self-Excited Drop Oscillations in Electrowetting

    NARCIS (Netherlands)

    Baret, Jean-Christophe; Decre, Michel M.J.; Mugele, Frieder

    2007-01-01

    We studied millimeter-sized aqueous sessile drops in an ambient oil environment in a classical electrowetting configuration with a wire-shaped electrode placed at a variable height above the substrate. Within a certain range of height and above a certain threshold voltage, the drop oscillates period

  19. Static shapes of levitated viscous drops

    Science.gov (United States)

    Duchemin, L.; Lister, J. R.; Lange, U.

    2005-06-01

    We consider the levitation of a drop of molten glass above a spherical porous mould, through which air is injected with constant velocity. The glass is assumed to be sufficiently viscous compared to air that motion in the drop is negligible. Thus static equilibrium shapes are determined by the coupling between the lubricating pressure in the supporting air cushion and the Young-Laplace equation. The upper surface of the drop is under constant atmospheric pressure; the static shape of the lower surface of the drop is computed using lubrication theory for the thin air film. Matching of the sessile curvature of the upper surface to the curvature of the mould gives rise to a series of capillary "brim" waves near the edge of the drop which scale with powers of a modified capillary number. Several branches of static solutions are found, such that there are multiple solutions for some drop volumes, but no physically reasonable solutions for other drop volumes. Comparison with experiments and full Navier-Stokes calculations suggests that the stability of the process can be predicted from the solution branches for the static shapes, and related to the persistence of brim waves to the centre of the drop. This suggestion remains to be confirmed by a formal stability analysis.

  20. University Drop-Out: An Italian Experience

    Science.gov (United States)

    Belloc, Filippo; Maruotti, Antonello; Petrella, Lea

    2010-01-01

    University students' drop-out is a crucial issue for the universities' efficiency evaluation and funding. In this paper, we analyze the drop-out rate of the Economics and Business faculty of Sapienza University of Rome. We use administrative data on 9,725 undergraduates students enrolled in three-years bachelor programs from 2001 to 2007 and…